https://www.chemdiv.com monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ monthly 0.5 https://www.chemdiv.com/catalog/sets/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/ monthly 0.5 https://www.chemdiv.com/catalog/ monthly 0.5 https://www.chemdiv.com/catalog/complete-list-of-compounds-libraries/ monthly 0.5 https://www.chemdiv.com/catalog/screening-compounds/ monthly 0.5 https://www.chemdiv.com/catalog/building-blocks/ monthly 0.5 https://www.chemdiv.com/catalog/how-to-search-and-order/ monthly 0.5 https://www.chemdiv.com/catalog/screening-libraries/ monthly 0.5 https://www.chemdiv.com/company/ monthly 0.5 https://www.chemdiv.com/company/careers/ monthly 0.5 https://www.chemdiv.com/company/chemistry-game/ monthly 0.5 https://www.chemdiv.com/company/delivery-options/ monthly 0.5 https://www.chemdiv.com/company/publications/ monthly 0.5 https://www.chemdiv.com/company/contacts/ monthly 0.5 https://www.chemdiv.com/terms/ monthly 0.5 https://www.chemdiv.com/terms/privacy-policy/ monthly 0.5 https://www.chemdiv.com/terms/delivery-policy/ monthly 0.5 https://www.chemdiv.com/terms/payment-policy/ monthly 0.5 https://www.chemdiv.com/terms/terms-of-service/ monthly 0.5 https://www.chemdiv.com/terms/legal-terms/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/in-silico-cadd-drug-discovery-services/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/medicinal-chemistry/protac/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/adme-dmpk/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/custom-chemistry/novel-scaffolds-and-discovery-libraries/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/custom-chemistry/dna-encoded-libraries-cdi-capabilities/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/custom-chemistry/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/custom-chemistry/scale-up-synthesis/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/custom-chemistry/macrocycle-compounds/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/assay-development/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/disease-based-models/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/toxicology-safety/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/chemistry-manufacturing-controls/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/nucleases/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/viruses/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Nuclear_receptors/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Deacetylases/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Ion-channels/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Kinases/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Phosphatases/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Proteases/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/GPCR/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Growth-factor-receptors/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/DNA-Damage-Repair-Management/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/cytotoxicity/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Cytokines/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/Inflammation/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/Discovery-chemistry/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/hts/protein-protein-interactions/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/discovery-biology/Infrastructure-for-prioritization-and-acceleration/ monthly 0.5 https://www.chemdiv.com/drug-discovery-services/Hit-Follow-up-Support/ monthly 0.5 https://www.chemdiv.com/catalog/sets/cns-reference-compounds-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/human-phosphatases-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/human-receptors-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/human-transcription-factors-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/human-proteases-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/ion-channels-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/cns-targets-activity-set/ monthly 0.5 https://www.chemdiv.com/catalog/sets/selective-target-activity-profiling-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/therapeutical-diversity-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/chemogenomic-annotated-library-for-phenotypic-screening/ monthly 0.5 https://www.chemdiv.com/catalog/sets/target-identification-phenotypic-screening-library-tips/ monthly 0.5 https://www.chemdiv.com/catalog/sets/launched-clinically-evaluated-drugs-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/annotated-space-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/opportunistic-pathogens-of-immunocompromised-hosts-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/sets/phosphatases/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/representative-diversity-libraries-out-of-1-6m-stock/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/smarttm-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/soluble-diversity-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/targeted-diversity-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/mce-18-trends-in-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/3d-biodiversity-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/3d-diversity-natural-product-like-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/bemis-murcko-clustering-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/3d-pharmacophore-based-diversity-library/ monthly 0.5 https://www.chemdiv.com/catalog/diversity-libraries/fast-follow-up-sar-diverse-screening-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/protein-protein-interaction-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/shape-helix-mimetics-ppi-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ppi-helix-turn-3d-mimetics-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ppi-tripeptide-mimetics-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/peptidomimetic-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/nonpeptide-peptidomimetics-ppi-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cyclic-ugi-ppi-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/alpha-helix-mimetics-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/peptidomimetics-of-beta-turn-motifs-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/macrocycles-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/3d-mimetics-ppi-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/recognition-elements-ppi-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/bcl2-ppi-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/inhibitors-of-beta-catenin-signaling/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mdm2-p53-interaction-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/sh2-ptb-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/nucleoside-mimetics-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/purine-based-nucleoside-mimetics-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cns-mpo-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cns-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gaba-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/purinergic-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/neurotransmitter-transporter-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ligand-gated-ion-channels-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/voltage-gated-ion-channel-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-target-platform-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/protein-kinases-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/akt-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/allosteric-kinases-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/aurora-a-b-kinases-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/kras-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/proline-kinase-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/type-ii-kinase-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/c-met-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/pi3k-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antiviral-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/anti-hiv1-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antiviral-hbv/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/coronavirus-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/androgen-receptor-antagonists-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/anticancer-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antimitotic-tubulin-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/developmental-pathway-hh-wnt-set/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mef2-hdac-class-ii-modulators-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cysteine-proteases-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/serine-proteases-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/prmt-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/immunological-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/pd-1-l1-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/tlr-8-ligands-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/anti-inflammatory-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cardiovascular-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/lipid-metabolism-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/anti-aging-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/regenerative-medicine-focused-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/rar-nuclear-receptors-ligands-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mce-18-trends/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/epitranscriptome-focused-small-molecule-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/rna-isosteric-trinucleotide-mimetics-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/steroid-like-compounds/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/covalent-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/chemokines-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/angiogenesis-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/brd4-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/integrin-receptors-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/indoleamine-2-3-dioxygenase-1-focused-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/neuropeptide-s-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/nucleic-acid-ligands/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/rptp-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/adenosine-receptors-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/glucocorticoid-receptors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/macl-gpib-alpha-interaction-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/sting-agonist-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/proprietary-proteome-targeted-libraries/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antifungal-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antiparasite-library/ monthly 0.5 https://www.chemdiv.com/catalog/infectious_antimicrobials/anti-infective-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antibacterial-compounds-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/new-agro-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/beyond-the-flatland-library-sp3-enriched/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/spiro-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/arginine-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/indole-derivatives/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/natural-product-based-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/3d-fragment-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/fragments-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/dark-chemical-matter-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/frequent-hitters-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ion-channels-focused-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cns-bbb-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/histone-deacetylases-hdac-targeted-library-selection/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ptpn-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/dgk-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/epigenetics-focused-set/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/hsp90-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ppi-inhibitors-tripeptide-mimetics/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/eccentric-ppi-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cns-targets/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/sh2-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/autophagy-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/chelators-targeting-matrix-metalloproteinases-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/arginase-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mcl1-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/bromodomain-modulators-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/plpro-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ace2-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/3clpro/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/natural-compounds-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cysteine-targeted-covalent-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/rna-protein-interaction-inhibitors-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/notum-wnt-signaling-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/carbonic-anhydrase-ii-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/crystallographic-and-19f-nmr-fragment-libraries/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/covalent-fragments-smart-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ocular-diseases-small-molecules-library/ monthly 0.5 https://www.chemdiv.com/catalog/proteases/factor-xia-compounds-library-/ monthly 0.5 https://www.chemdiv.com/catalog/chemical_classes/triazoles/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cpla2-inhibitors/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ror-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/privileged-fragments-annotated-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/analogues-of-approved-drugs-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-family-a/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-family-b/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-family-c/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-frizzled-family/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-taste-family/ monthly 0.5 https://www.chemdiv.com/catalog/epigenetic/epigenetics/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/isomerases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/kinases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/Ligand-gated/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ligases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/lyases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/oxidoreductases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/phosphodiesterases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/proteases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/sigma-opioid-receptors/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/thrombopoietin-receptors/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/toll-like-and-il-1-receptors/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/voltage-gated/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/transferases/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/Protease-Library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mirna-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/covalent-serine-binder-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antibacterial-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/apoptosis-focused-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/beta2-adrenoligands/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/htert-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/calcium-channels-focused-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/lysine-specific-histone-demethylases-kdm-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/stem-cell-modulators-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/dnmt-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/cxcr4-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/g9a-targeted-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ha2-focused-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mmp-inhibitors/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/sugar-and-sugar-like-compound-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/covalent-lysine-binder-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/kinome-scan-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ttg2-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/aryl-hydrocarbon-receptor-ahr-modulators-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/imid-small-molecule-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/celmods-library/ monthly 0.5 https://www.chemdiv.com/catalog/therapeutic-areas/tim-3-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/usp7-target-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/usp-30-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/molglueslike-compounds-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/rna-binding-chemical-space-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/usp21-target-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/glp1r-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/darkkinome/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/novel-drug-targets-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/mitochondria-specific-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/good-adme-properties-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/antiobesity-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/immunology-inflammation/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/transmembrane-protein-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/library-of-hydrophobic-tag-based-targeted-protein-degraders-hyt-tpds/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/natural-inhibitors/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/skin-pathophysiology-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/human-kinases-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/gpcr-reference-compounds-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ferroptosis-library/ monthly 0.5 https://www.chemdiv.com/catalog/focused-and-targeted-libraries/ai-curated-neurodegenerative-library/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/ monthly 0.5 https://www.chemdiv.com/company/media/news/ monthly 0.5 https://www.chemdiv.com/company/media/video/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/ monthly 0.5 https://www.chemdiv.com/company/media/chemdiv-in-publications/ monthly 0.5 https://www.chemdiv.com/company/media/posters/ monthly 0.5 https://www.chemdiv.com/company/media//2016/inspectors-find-big-issues-api-repackager-france/ monthly 0.5 https://www.chemdiv.com/company/media//2016/fda-delay-raises-slim-hope-muscular-dystrophy-drug/ monthly 0.5 https://www.chemdiv.com/company/media//2016/fda-approves-ocaliva/ monthly 0.5 https://www.chemdiv.com/company/media//2016/biomarin-climbs-rumors-may-sanofis-medivation-backup/ monthly 0.5 https://www.chemdiv.com/company/media//2016/novo-nordisk-profit-surges-19-cuts-revenue-view/ monthly 0.5 https://www.chemdiv.com/company/media//2016/sanofi-gets-43-million-u-s-funding-spur-zika-vaccine-development/ monthly 0.5 https://www.chemdiv.com/company/media//2016/medical-news-first-cases-candida-auris-infection-emerge-us/ monthly 0.5 https://www.chemdiv.com/company/media//2016/neuroderm-announces-completion-patient-enrollment-treatment-phase-ii-trial-nd0612h-advanced-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media//2017/chemdivs-executive-director-delivers-two-lectures-drug-discovery-china/ monthly 0.5 https://www.chemdiv.com/company/media//2017/report-amazon-seeks-acquire-large-teva-logistics-center/ monthly 0.5 https://www.chemdiv.com/company/media//2018/celgenes-rd-report-card-somewhat-disappointing-say-analysts/ monthly 0.5 https://www.chemdiv.com/company/media//2019/owkin-nvidia-team-up-to-deliver-ai-to-hospitals/ monthly 0.5 https://www.chemdiv.com/company/media//2019/sanofi-ends-research-in-diabetes-narrows-units-to-spur-profit/ monthly 0.5 https://www.chemdiv.com/company/media//2020/who-reports-record-daily-increase-in-global-coronavirus-cases-up-over-230000/ monthly 0.5 https://www.chemdiv.com/company/media//2021/u-s-judge-rejects-bayers-2-billion-deal-to-resolve-future-roundup-lawsuits/ monthly 0.5 https://www.chemdiv.com/company/media//2021/astrazenecas-antibody-cocktail-fails-to-prevent-covid-19-in-latest-trial/ monthly 0.5 https://www.chemdiv.com/company/media//2021/aldeyra-therapeutics-receives-orphan-drug-designation-from-the-u-s-food-and-drug-administration-for-adx-2191-to-treat-retinitis-pigmentosa/ monthly 0.5 https://www.chemdiv.com/company/media//2021/oxycontin-maker-purdue-dissolved-family-to-pay-4-5-billion-in-bankruptcy-settlement/ monthly 0.5 https://www.chemdiv.com/company/media//2014/molecule-of-the-month-may/ monthly 0.5 https://www.chemdiv.com/company/media//2014/featured-scaffold-month-podophyllotoxin/ monthly 0.5 https://www.chemdiv.com/company/media//2017/acs-national-meeting-exposition/ monthly 0.5 https://www.chemdiv.com/company/media//2017/drug-discovery-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2017/mastering-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2017/bio-2017-international-convention/ monthly 0.5 https://www.chemdiv.com/company/media//2017/acs-national-meeting-exposition-2/ monthly 0.5 https://www.chemdiv.com/company/media//2017/pharma-chemoutsourcing-2017/ monthly 0.5 https://www.chemdiv.com/company/media//2017/biopharm-america/ monthly 0.5 https://www.chemdiv.com/company/media//2017/cns-diseases-world-summit/ monthly 0.5 https://www.chemdiv.com/company/media//2017/modern-drug-discovery-development-summit/ monthly 0.5 https://www.chemdiv.com/company/media//2017/annual-drug-discovery-usa-congress/ monthly 0.5 https://www.chemdiv.com/company/media//2017/medicinal-chemistry-cadd/ monthly 0.5 https://www.chemdiv.com/company/media//2018/efmc-asmc17-efmc-international-symposium-advances-synthetic-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2018/efmc-ismc18-efmc-international-symposium-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2018/meet-chemdiv-7th-international-conference-multicomponent-reactions-related-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2019/meet-chemdiv-better-leads-better-drugs-innovation-screening-libraries/ monthly 0.5 https://www.chemdiv.com/company/media//2017/15-18-june-2015-bio-international-convention/ monthly 0.5 https://www.chemdiv.com/company/media//2017/26-28-june-2015-15th-international-symposium-viral-hepatitis-liver-disease-isvhld/ monthly 0.5 https://www.chemdiv.com/company/media//2017/21-22-july-2015-compound-libraries-usa/ monthly 0.5 https://www.chemdiv.com/company/media//2017/16-20-august-2015-250th-acs-national-meeting-exposition/ monthly 0.5 https://www.chemdiv.com/company/media//2017/21-25-september-2015-13th-annual-discovery-target/ monthly 0.5 https://www.chemdiv.com/company/media//2017/4-8-october-2015-international-meeting-molecular-biology-hepatitis-b-viruses/ monthly 0.5 https://www.chemdiv.com/company/media//2016/j-p-morgan-34th-annual-healthcare-conference/ monthly 0.5 https://www.chemdiv.com/company/media//2016/3rd-annual-drug-discovery-us-congress/ monthly 0.5 https://www.chemdiv.com/company/media//2016/drug-discovery-beyond-rule-five/ monthly 0.5 https://www.chemdiv.com/company/media//2016/iqpc-compound-sample-management/ monthly 0.5 https://www.chemdiv.com/company/media//2016/efmc-ismc-2016-xxiv-efmc-international-symposium-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2016/scis-innovation-design-supply-acquisition-compound-screening-libraries/ monthly 0.5 https://www.chemdiv.com/company/media//2016/14th-annual-congress-international-drug-discovery-science-technology-south-korea-2016-iddst-south-korea-2016/ monthly 0.5 https://www.chemdiv.com/company/media//2017/11th-annual-drug-discovery-chemistry-conference/ monthly 0.5 https://www.chemdiv.com/company/media//2017/6-9-june-2016-bio-international-convention/ monthly 0.5 https://www.chemdiv.com/company/media//2017/october-25-tue-27thu-2016-chemdiv-inc-will-participate-chem-bio-informatics-societycbi/ monthly 0.5 https://www.chemdiv.com/company/media//2017/november-7-mon-8tue-2016-42th-symposium-progress-organic-reactions-syntheses/ monthly 0.5 https://www.chemdiv.com/company/media//2017/conference-exhibition-society-laboratory-automation-screening-slas-2017/ monthly 0.5 https://www.chemdiv.com/company/media//2017/molecular-medicine-tri-conference-2016/ monthly 0.5 https://www.chemdiv.com/company/media//2017/new-perspectives-neurodegenerative-diseases-4/ monthly 0.5 https://www.chemdiv.com/company/media//2017/november-31-mon-december-2-fri-2016-34th-medicinal-chemistry-symposium-international-congress/ monthly 0.5 https://www.chemdiv.com/company/media//2017/deciphering-protein-protein-interactions-ppis-next-big-research-challenge/ monthly 0.5 https://www.chemdiv.com/company/media//2014/new-chemistry-for-k-ras/ monthly 0.5 https://www.chemdiv.com/company/media//2014/pi3-kinase-picking-right-letters-alphabet-soup/ monthly 0.5 https://www.chemdiv.com/company/media//2014/natural-product-libraries/ monthly 0.5 https://www.chemdiv.com/company/media//2014/top-10-scientific-drug-discovery-breakthroughs-deadly-diseases/ monthly 0.5 https://www.chemdiv.com/company/media//2020/67115-2/ monthly 0.5 https://www.chemdiv.com/company/media//2020/67130-2/ monthly 0.5 https://www.chemdiv.com/company/media//2020/bio-active-collections/ monthly 0.5 https://www.chemdiv.com/company/media//2020/novel-anti-cancer-screening-libraries/ monthly 0.5 https://www.chemdiv.com/company/media//2020/chemdiv-inc-opens-the-unique-chemistry-e-commerce-store/ monthly 0.5 https://www.chemdiv.com/company/media//2020/blog-ptpn-targeted-library/ monthly 0.5 https://www.chemdiv.com/company/media//2020/67193-2/ monthly 0.5 https://www.chemdiv.com/company/media//2020/bioactive-compounds-from-chemdiv/ monthly 0.5 https://www.chemdiv.com/company/media//2020/chemical-diversity/ monthly 0.5 https://www.chemdiv.com/company/media//2020/67205-2/ monthly 0.5 https://www.chemdiv.com/company/media//2020/building-blocks/ monthly 0.5 https://www.chemdiv.com/company/media//2020/67215-2/ monthly 0.5 https://www.chemdiv.com/company/media//2020/modern-trends-in-small-molecules-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media//2020/are-you-a-chemical-buyer/ monthly 0.5 https://www.chemdiv.com/company/media//2020/covalent-inhibitors-libraries-and-rna-protein-interaction-inhibitors-libraries-from-chemdiv/ monthly 0.5 https://www.chemdiv.com/company/media//2020/chemdiv-opens-you-gate-to-global-market/ monthly 0.5 https://www.chemdiv.com/company/media//2020/unique-set-of-pre-designed-discovery-libraries-1-600-000-drug-like-and-lead-like-chemistry-space-visit-store-chemdiv-com/ monthly 0.5 https://www.chemdiv.com/company/media//2020/breaking-world-pharma-news/ monthly 0.5 https://www.chemdiv.com/company/media//2020/vladimir-berishvili/ monthly 0.5 https://www.chemdiv.com/company/media//2020/blog-3d-pharmacophore-based-diversity-library/ monthly 0.5 https://www.chemdiv.com/company/media//2020/blog-activity-data-against-5-bacteria-and-2-fungi-in-our-brand-new-library-n/ monthly 0.5 https://www.chemdiv.com/company/media//2020/artificial-intelligence-for-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media//2020/black-friday/ monthly 0.5 https://www.chemdiv.com/company/media//2020/annotated-space/ monthly 0.5 https://www.chemdiv.com/company/media//2020/cadd-services-blog/ monthly 0.5 https://www.chemdiv.com/company/media//2020/merry-christmas-hsppy-holidays-from-chemdiv-company/ monthly 0.5 https://www.chemdiv.com/company/media//2020/67722-2/ monthly 0.5 https://www.chemdiv.com/company/media//2020/we-care-about-your-opinion/ monthly 0.5 https://www.chemdiv.com/company/media//2021/january-is-glaucoma-awareness-month/ monthly 0.5 https://www.chemdiv.com/company/media//2021/unique-business-models-2/ monthly 0.5 https://www.chemdiv.com/company/media//2021/chemdiv-in-publications-and-patents/ monthly 0.5 https://www.chemdiv.com/company/media//2021/chemdivs-library-in-significant-research/ monthly 0.5 https://www.chemdiv.com/company/media//2021/blog-notum-wnt-signaling-library22/ monthly 0.5 https://www.chemdiv.com/company/media//2021/chemdiv-goes-mobile/ monthly 0.5 https://www.chemdiv.com/company/media//2021/february-is-heart-health-awareness-month/ monthly 0.5 https://www.chemdiv.com/company/media//2021/68377-2/ monthly 0.5 https://www.chemdiv.com/company/media//2021/carbonic-anhydrase-ii-library-blog/ monthly 0.5 https://www.chemdiv.com/company/media//2021/68554-2/ monthly 0.5 https://www.chemdiv.com/company/media//2021/march-is-colorectal-cancer-and-kidney-disease-awareness-month/ monthly 0.5 https://www.chemdiv.com/company/media//2021/proteolysis-targeting-chimeras-protac/ monthly 0.5 https://www.chemdiv.com/company/media//2021/akt-library/ monthly 0.5 https://www.chemdiv.com/company/media//2021/fluorine-and-bromine-fragments/ monthly 0.5 https://www.chemdiv.com/company/media//2021/april-is-sarcoidosis-awareness-month/ monthly 0.5 https://www.chemdiv.com/company/media//2021/admet-dmpk/ monthly 0.5 https://www.chemdiv.com/company/media//2021/blog-custom-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2021/your-opinion-matters/ monthly 0.5 https://www.chemdiv.com/company/media//2021/may-is-hepatitis-awareness-month/ monthly 0.5 https://www.chemdiv.com/company/media//2021/dna-encoded-libraries-cdi-capabilities/ monthly 0.5 https://www.chemdiv.com/company/media//2021/chemdiv-is-your-partner-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media//2021/discovery-biology/ monthly 0.5 https://www.chemdiv.com/company/media//2021/visit-chemdivs-virtual-booth-at-the-european-chemical-biology-symposium-2021/ monthly 0.5 https://www.chemdiv.com/company/media//2021/chemdiv-launches-a-new-100000-diverse-compounds-pre-plated-set/ monthly 0.5 https://www.chemdiv.com/company/media//2021/beyond-the-flatland-library-sp3-enriched-87000-compounds-including-4500-three-dimensional-fragments/ monthly 0.5 https://www.chemdiv.com/company/media//2021/new-kras-targeted-library/ monthly 0.5 https://www.chemdiv.com/company/media//2021/science-nature-reviews-june-2021-1/ monthly 0.5 https://www.chemdiv.com/company/media//2021/what-are-dna-nanomachines-and-how-can-they-be-helpful-for-us/ monthly 0.5 https://www.chemdiv.com/company/media//2021/science-nature-reviews-june-2021-2/ monthly 0.5 https://www.chemdiv.com/company/media//2021/we-are-hiring/ monthly 0.5 https://www.chemdiv.com/company/media//2021/key-facts-about-chemdivs-chemical-building-blocks/ monthly 0.5 https://www.chemdiv.com/company/media//2021/science-nature-reviews-july-2021-1/ monthly 0.5 https://www.chemdiv.com/company/media//2021/science-nature-reviews-july-2021-2/ monthly 0.5 https://www.chemdiv.com/company/media//2021/immunotherapy-from-treating-diabetes-to-preventing-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media//2021/meet-chemdiv-at-the-xxvi-efmc-international-symposium-on-medicinal-chemistry-efmc-ismc-2021/ monthly 0.5 https://www.chemdiv.com/company/media//2021/science-nature-reviews-august-2021-1/ monthly 0.5 https://www.chemdiv.com/company/media//2021/blog-ocular-diseases-small-molecules-library/ monthly 0.5 https://www.chemdiv.com/company/media//2021/science-nature-reviews-august-2021-2/ monthly 0.5 https://www.chemdiv.com/company/media//2021/our-covalent-compound-library-is-now-available-in-a-ready-to-dock-format-for-biosolveit-finest-software-for-drug-discoverys-drug-design-dashboard-seesar/ monthly 0.5 https://www.chemdiv.com/company/media//2021/blog-chemdiv-is-now-a-discovery-partner-with-gwynant-therapeutics-and-celyn-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media//2014/6-johannes-kirchmair-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/7-bruce-roth-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/9-andy-bell-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/11-dale-lester-boger-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/13-deepak-dalvie-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/26-kim-vilbour-andersen-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/29-michael-a-foley-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/30-edward-curtis-taylor-jr-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/33-joel-r-huff-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/34-william-j-greenlee-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media//2014/58-robert-g-bergman-ph-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/scientists-discover-common-diabetes-drug-prevent-hemorrhage-fatal-blood-loss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/tesaro-fda-oks-varubi-nausea-vomiting-associated-cancer-chemotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/allergan-announces-fda-approval-updated-label-teflaro-ceftaroline-fosamil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/deadly-fake-viagra-online-pharmacies-suspected-selling-counterfeit-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bayer-healthcare-launches-phase-iii-trials-finerenone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/ge-healthcare-signs-supply-agreement-sartorius-stedim-biotech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/us-fda-accepts-priority-review-janssens-bla-daratumumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/test-shows-old-body-really/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/many-parkinsons-may-memory-problems/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-grants-genentechs-alectinib-priority-review-alk-positive-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-cholesterol-lowering-drugs-discussed-ub-cardiologist-researcher/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-durlaza/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/implant-traps-spreading-cancer-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/acelrxs-arx-04-meets-primary-secondary-endpoints-phase-3-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/lasker-prizes-recognize-ebola-response-dna-damage-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/abbvie-fda-okays-humira-treat-moderate-severe-hidradenitis-suppurativa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/la-jolla-pharmaceutical-company-receives-positive-opinion-european-orphan-committee-ljpc-401/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-grants-fast-track-status-medicinovas-mn-001-treat-idiopathic-pulmonary-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/roche-unlikely-pursue-midsize-acquisition-soon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/raptor-stops-developing-rp103-drug-fails-treat-nonalcoholic-steatohepatitis-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/glenmark-pharmaceuticalss-bi-specific-antibody-gbr-1302-enter-phase-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/mylan-opens-27-14-billion-hostile-bid-perrigo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/takeda-joins-wipo-research-accelerate-rd-new-drugs-neglected-tropical-diseases-malaria-tb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/victoza-tops-sanofis-lyxumia-trial-adding-novos-glp-1-arsenal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/obama-nominates-robert-califf-fda-commissioner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bristol-myers-squibbs-opdivo-nivolumab-receives-breakthrough-therapy-designation-u-s-food-drug-administration-advanced-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-warnings-target-drug-companies-new-zealand-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nurix-celgene-partner-develop-new-therapies-oncology-immunology-immuno-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/amgen-bets-1-7b-xencors-antibody-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/invokana-diabetes-drug-faces-canadian-class-action-lawsuit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/ventrix-initiates-clinical-trial-ventrigel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-asks-pfizer-zoloft-label-update-highlighting-birth-defect-risks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/allergan-gedeon-richter-plc-receive-fda-approval-vraylar-cariprazine-treatment-manic-mixed-episodes-bipolar-disorder-schizophrenia-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/purdue-university-based-pharmaceutical-startup-participate-american-chemical-society/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/amgen-agrees-buy-dutch-firm-dezima-pharma-1-55bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/intas-pharma-expects-u-s-approval-neulasta-biosimilar-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/old-drug-offers-new-hope-treat-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/old-drug-performs-new-tricks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/globaldata-says-world-hiv-therapeutics-market-reach-15-3-bn-2023/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/perrigo-rejects-mylans-unsolicited-exchange-offer-inadequate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/inovio-secures-24m-option-grant-darpa-advance-ebola-program-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pharmaxis-releases-successful-results-phase-1-clinical-trial-boehringer-ingelheim-partnered-drug-pxs-4728a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/stanford-team-re-engineers-virus-deliver-therapies-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/regen-biopharma-inc-initiates-small-molecule-hit-validation-study-cancer-stem-cell-target-gene/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/lupin-raises-diabetes-drug-price-200/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bmj-points-wide-variations-quality-data-new-fda-indications/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/u-s-cancer-drug-prices-3x-higher-europe-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/sun-pharma-recalls-216000-bottles-label-leaches-chemical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/novo-nordisk-build-78m-plant-iran/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/abbvie-reports-positive-results-abt-494-phase-2-clinical-trials-patients-rheumatoid-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/rhythm-metabolic-awarded-fda-grant-advance-ongoing-setmelanotide-clinical-trial-prader-willi-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/viruses-actually-living-entities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/tiny-nano-wrench-can-twist-molecules-custom-shapes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/blood-thinner-plus-antidepressant-cause-brain-cancer-cells-eat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/abbvies-viekirax-ombitasvirparitaprevirritonavir-tablets-receives-approval-japan-treatment-genotype-1-chronic-hepatitis-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/genovate-biotechnology-taiwan-building-55m-insulin-plant-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/contract-manufacturing-india-grows-20-percent-says-idma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/destroying-certain-imported-drugs-new-rule-protect-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/amgen-receives-chmp-positive-opinions-two-new-blood-cancer-treatment-options/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/ec-grants-orphan-drug-designation-zafgens-beloranib-treat-craniopharyngioma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/teva-wins-approval-copaxone-prevent-relapse-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/mercks-weekly-dpp-4-inhibitor-marizev-treat-type-2-diabetes-gets-japanese-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/abbott-increase-india-investment-rd-spend/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/aspirin-may-double-survival-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-test-can-spot-almost-virus-infecting-youor-dog/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-accepts-sanofis-nda-lixisenatide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-drug-works-better-current-treatments-advanced-kidney-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/experimental-drug-shows-promise-mice-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/height-may-linked-increased-cancer-risk-study-contends/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/dompe-omega-pharma-sign-otc-product-range-marketing-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/teva-buys-mexican-pharmaceutical-co-rimsa-2-3b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/3-scientists-share-nobel-prize-medicine-work-parasitic-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-use-existing-drug-help-retrieve-memory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/baxalta-momenta-announce-initiation-pivotal-clinical-trial-m923-biosimilar-version-humira-adalimumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-alkermes-schizophrenia-treatment-aristada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/dopamine-transmission-mediated-d1-receptors-essential-controlling-movements-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/ignorance-bliss-pharmaceutical-industry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/roche-ceo-big-data-needs-big-pharma-vice-versa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-gene-ups-alzheimers-risk-found/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nobel-prize-chemistry-lindahl-modrich-sancar-win-dna-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-keytruda-treatment-patients-metastatic-non-small-cell-lung-cancer-whose-tumors-express-pd-l1-disease-progression-platinum-containing-chemotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/sanofi-puts-allegra-plant-u-s-back-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/crown-bioscience-expands-services-europe-meet-oncology-diabetes-research-demand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/sanofis-genzyme-reports-treatment-effects-maintained-five-years-majority-patients-relapsing-remitting-ms-received-genzymes-lemtrada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/drugs-soon-come-money-back-guarantee/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/prepare-conduct-flu-trials-hospitals-now-urge-experts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-accepts-supplemental-new-drug-application-snda-dalvance-dalbavancin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/aerpio-therapeutics-present-time-2-phase-2a-study-akb-9778-diabetic-macular-edema-data-2015-american-academy-ophthalmology-annual-meeting-retina-subspecialty-day/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/can-gsks-volume-strategy-offset-generic-attack-blockbuster-avodart/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bms-opdivo-gets-jump-keytruda-another-early-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/merck-promotes-oschmann-ceo-replace-kley/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/big-pharma-companies-need-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/lilly-pulls-plug-blockbuster-latest-pipeline-peril/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/atyr-pharma-initiates-phase-1b2-clinical-trial-patients-limb-girdle-muscular-dystrophy-2b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/former-merck-analyst-gets-three-years-insider-trading/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/danish-malaria-vaccine-discovery-provides-potential-cancer-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/jj-says-plenty-firepower-ma-buyback-buyback/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/valeant-us-federal-investigation-drug-pricing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/zafgen-issues-statement-patient-died-beloranib-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/savolitinib-completes-enrolment-phase-ii-clinical-trial-papillary-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/baricitinib-demonstrates-superiority-adalimumab-improving-signs-symptoms-rheumatoid-arthritis-pivotal-phase-3-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/obama-nominates-robert-califf-fda-commissioner-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/ahf-calls-president-obama-withdraw-dr-robert-califf-nominee-head-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-discovery-fructose-lead-treatments-cancer-obesity-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/leo-pharmas-enstilar-gets-fda-approval-topical-treatment-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/ec-approves-basileas-isavuconazole-treat-invasive-aspergillosis-mucormycosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/u-s-oncology-group-rates-blood-cancer-regimens-including-cost/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-praxbind-idarucizumab-specific-reversal-agent-pradaxa-dabigatran-etexilate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/yabao-pharmaceuticals-enters-second-innovative-collaboration-eli-lilly-company-develop-diabetes-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nimbus-therapeutics-announces-global-license-agreement-genentech-business-wire-nimbus-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/23andmes-triumph-long-road-ahead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/apac-multiple-myeloma-treatment-market-value-will-reach-2-8b-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/2016-year-immunotherapy-predictions-buzz-worthy-field/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/2015-fda-approved-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/relypsa-wins-patiromer-ok-gets-hammered-black-box-restrictions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-enstilar-foam/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-onivyde-irinotecan-liposome-injection-advanced-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/early-parkinsons-diagnosis-may-possible-using-skin-odour/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/competitor-undercuts-hedge-fund-bro-selling-aids-drug-1-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/genentech-advances-second-nav1-7-inhibitor-pain-clinical-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-drug-approved-soft-tissue-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/roche-delivers-strong-sales-growth-first-nine-months-2015/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/amgens-imlygic-cancer-drug-recommended-approval-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/oral-vitamin-key-lowering-risk-skin-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/smoking-will-kill-one-billion-people-century/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bristol-myers-squibb-reports-third-quarter-financial-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-role-insulin-studies-tie-hormone-brains-pleasure-center/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/israeli-scientists-help-create-first-3d-map-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/exostar-receives-additional-10-million-investment-merck-global-health-innovation-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/drug-device-combination-opens-potential-new-path-treat-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/tel-aviv-district-court-rules-favor-mylan-listing-tel-aviv-stock-exchange/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/astellas-inititaties-phase-3-registration-trial-gilteritinib-asp2215-relapsed-refractory-acute-myeloid-leukemia-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pfizer-allergan-begin-merger-talks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/astrazenecas-genetic-cancer-drug-lynparza-also-works-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/novo-nordisk-bucks-diabetes-market-pressures-9-sales-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/gilead-tees-another-hep-c-combo-fda-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/celgenes-vidaza-azacitidine-injection-approved-european-commission-new-treatment-elderly-patients-acute-myeloid-leukaemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-expanded-use-melanoma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/two-thirds-people-50-herpes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/partnership-conduct-analytical-stability-studies-small-molecule-new-chemical-entities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bayer-regenerons-eylea-gets-additional-eu-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/shionogi-drug-can-kill-viruses-1-day/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-finding-helps-explain-many-alcohol-drinkers-also-smokers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/study-suggests-unprecedented-3-week-hepatitis-c-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/51413/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/chemical-found-illegal-ayahuasca-plant-may-able-completely-reverse-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/shire-paying-5-9b-dyax-defensive-rare-disease-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bristol-myers-buy-cardioxyl-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nephrogenex-announces-successful-results-toxicity-study-intravenous-pyridorin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/casi-pharmaceuticals-announces-first-patient-dosed-phase-2-trial-enmd-2076-fibrolamellar-carcinoma-flc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/glaxosmithkline-bags-fda-ok-asthma-drug-eyes-respiratory-turnaround/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-vaccine-candidate-shows-great-promise-fighting-respiratory-syncytial-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/gileads-new-four-one-hiv-pill-genvoya-wins-us-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/taiwanj-pharmaceuticals-gains-fda-approval-entering-phase-2-clinical-study-autoimmune-hepatitis-orphan-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/australian-scientists-identify-way-target-neuroblastoma-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-compound-can-reverse-cataract/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/indias-dr-reddys-hit-fda-warning-shares-fall-15-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/google-american-heart-association-announce-joint-research-effort/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bill-ackman-hints-possible-valeant-pharmaceuticals-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/parkinsons-drug-repurposed-save-sight-millions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/astrazeneca-lupus-drug-impresses-mid-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/novel-stem-cell-line-avoids-risk-introducing-transplanted-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/boehringer-ingelheim-announces-completed-enrollment-phase-iii-clinical-trial-biosimilar-candidate-adalimumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/roche-cutting-1200-jobs-major-shift-producing-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/gilead-regeneron-stocks-weather-drug-pricing-furor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-gives-breakthrough-designation-tevas-tardive-dyskinesia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/roche-gets-fda-approval-new-advanced-melanoma-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/swissmedic-approves-xadago-treat-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-new-pill-treat-certain-patients-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-therapeutic-approach-treats-alzheimers-disease-photoactive-chemicals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/drug-limit-spread-deadly-brain-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce-acquisition-vistapharm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-darzalex-patients-previously-treated-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/alzheimers-drug-surprises-researchers-reverses-aging-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/senators-grilled-obamas-nominee-fda-chief-heres-responded/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/u-s-doctor-group-calls-ban-drug-advertising-consumers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-adapt-pharmas-naloxone-nasal-spray/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/lab-grown-vocal-cords-soon-replace-damaged-ones/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/vertex-receives-eu-approval-orkambi-lumacaftorivacaftor-first-medicine-treat-underlying-cause-cystic-fibrosis-people-ages-12-older-two-copies-f508del-mut/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/anti-alcohol-drug-disulfiram-may-flush-hivs-hiding-spots-lead-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/takedas-breakthrough-velcade-heir-wins-early-fda-approval-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/summit-therapeutics-announces-novel-antibiotic-ridinilazole-smt19969-achieves-statistical-superiority-vancomycin-codify-phase-2-clinical-trial-c-difficile-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/alexar-therapeutics-inc-initiates-phase-iia-clinical-trial-alx-101-topical-gel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-portrazza-necitumumab-specific-type-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pfizer-deal-donald-trump-hillary-clinton-finally-agree-something/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/hiv-new-chronic-illness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-patent-paves-way-breast-cancer-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/scientists-create-serotonin-releasing-neurons-human-skin-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-treatment-potential-heart-attack-sufferers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/amgen-amgn-announces-ec-approval-blincyto/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fluad-food-drug-administration-approves-new-boosted-flu-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/samsung-biologics-investing-736-mln-manufacturing-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/merck-kgaa-said-weigh-selling-allergy-therapy-unit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/dr-reddys-lab-shares-hit-import-ban-warning-sink-10/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pfizer-reports-top-line-results-phase-3-study-lyrica-pregabalin-capsules-cv-adults-post-traumatic-peripheral-neuropathic-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/anti-ageing-drug-let-live-120/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/aspirin-targets-key-protein-neurodegenerative-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/redhill-biopharma-completes-dosing-phase-iia-study-rhb-104-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/bristol-myers-squibb-abbvie-receive-fda-approval-empliciti-elotuzumab-treatment-patients-multiple-myeloma-received-one-three-prior-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/janssen-seeks-approval-stelara-us-europe-treat-crohns-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/roche-gains-rights-upsher-smith-inflammatory-disease-compound/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/sosei-subsidiary-heptares-enters-strategic-drug-discovery-collaboration-pfizer-inc-focused-gpcr-targets-across-multiple-therapeutic-areas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/medicines-patent-pool-liverpool-university-develop-new-hiv-nanomedicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/antidepressant-drug-protect-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/coffee-compounds-help-prevent-type-2-diabetes-identified/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pluristem-fukushima-medical-university-evaluate-plx-r18-cells-radiation-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/price-cancer-drugs-varies-388-european-countries-australia-new-zealand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nanobombs-might-deliver-agents-alter-gene-activity-cancer-stem-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/stretchable-wearable-sensor-made-chewing-gum/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/personalizing-cancer-treatment-help-virtual-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/molecule-clears-alzheimers-plaques-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/teva-pharmaceuticals-eagle-pharmaceuticals-announce-fda-approval-bendeka-bendamustine-hydrochloride-injection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/lilly-merck-expand-immuno-oncology-collaboration-adding-abemaciclib-keytruda-combination-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-grants-genentechs-alecensa-alectinib-accelerated-approval-people-specific-type-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pesticide-found-milk-decades-ago-linked-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/wellstat-announces-fda-approval-vistogard-uridine-triacetate-first-antidote-treat-overdoses-early-onset-severe-toxicities-due-5-fluorouracil-5-fu-capecitabine-chemother/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/astrazeneca-talks-dutch-cancer-drugs-firm-acerta-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/drug-approvals-top-2014-high-rd-returns-still-struggle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/mylan-wants-payback-plants-bought-strides-cited-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pharmaceutical-research-firm-ppd-explores-sale-ipo-reuters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/novo-nordisk-files-regulatory-approval-faster-acting-insulin-aspart-us-treatment-type-1-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/scientists-identify-molecular-key-helps-maintain-identity-prevents-conversion-adult-cells-ips-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-bridion-sugammadex-reverse-effects-neuromuscular-blocking-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nurofen-maker-reckitt-benckiser-defends-australia-packaging/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/fda-approves-basaglar-insulin-glargine-injection-long-acting-insulin-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/martin-shkreli-arrested-fbi-hedge-fund-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/china-watchdog-strengthen-drug-trial-inspections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/array-biopharma-reports-top-line-results-binimetinib-phase-3-trial-patients-nras-mutant-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/gsk-receives-positive-top-line-results-sirukumab-phase-iii-programme-supporting-regulatory-filings-rheumatoid-arthritis-2016/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/certain-antidepressants-linked-bipolar-mania/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/amgen-european-commission-approved-use-imlygic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/nine-10-cancers-caused-lifestyle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/good-news-feast-lovers-obesity-promoting-genes-discovered/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/oral-revlimid-plus-dexamethasone-granted-approval-treatment-patients-newly-diagnosed-multiple-myeloma-japan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/scancell-forms-us-investigator-team-lead-phase-ii-checkpoint-inhibitor-combination-study-scib1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pharmaceutical-industry-pay-550-million-2016-part-pprs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/melbourne-researchers-make-pre-eclampsia-pill-breakthrough/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/martin-shkreli-exit-turing-plans-job-cuts-ceo-search/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/hillary-clinton-reveals-plan-battle-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/express-scripts-releases-better-expected-2016-forecast/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/overseas-ma-deals-5-year-high-pharma-healthcar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/zurampic-lesinurad-approved-us-fda-patients-gout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/new-drug-may-slow-alzheimers-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/common-anesthetic-helpful-treating-depression-induced-diet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/indian-pharmaceutical-industry-likely-touch-usd-55-bln-2020-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/pollution-may-cause-antibiotic-resistance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/european-medicines-agency-accepts-fanaptum-iloperidone-marketing-authorization-application-treatment-schizophrenia-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/eagle-pharmaceuticals-announces-fda-approval-docetaxel-injection-non-alcohol-formula/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2015/lupin-gets-fda-nod-generic-femhrt-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gilead-announces-u-s-fda-priority-review-designation-sofosbuvirvelpatasvir-treatment-genotypes-chronic-hepatitis-c-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/takeda-nsgene-partner-perform-research-cell-encapsulation-therapies-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-announces-worldwide-collaboration-momenta-jointly-develop-commercialize-six-biosimilar-products/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-regeneron-line-fda-approval-arthritis-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/good-bacteria-may-help-prevent-pneumonia-says-new-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-acquires-iomet-pharma-expands-immuno-oncology-development-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/immune-pharmaceuticals-announces-2016-immuno-oncology-plan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-incyte-announce-new-lung-cancer-clinical-trial-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-drug-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/common-painkiller-may-also-powerful-cancer-killer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/brca1-deficiency-increases-sensitivity-ovarian-cancer-cells-auranofin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-acquires-uk-drug-discovery-firm-iomet-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/xbrane-signs-deal-helvetic-biopharma-lead-ranibizumab-biosimilar-xlucane/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/botched-french-drug-trial-leaves-1-brain-dead-5-hospital/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/anti-cancer-drug-uses-50-times-less-chemo-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/message-bottle-scientists-flag-smell-test-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/samsung-bioepis-enters-european-market-benepali-first-enbrel-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-halts-production-poland-plant-inspectors-uncover-problems/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/wockhardts-new-sterile-injectable-plant-issued-form-483-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-slams-another-chinese-drugmaker-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-priority-review-status-eisais-snda-anticancer-drug-lenvatinib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lilly-incyte-announce-submission-new-drug-application-fda-oral-daily-baricitinib-treatment-moderate-severe-rheumatoid-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pd-l1-inhibition-well-tolerated-active-metastatic-rcc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-roches-cancer-drug-snags-another-breakthrough-tag/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nih-announces-240-million-project-map-human-genomes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/glaxosmithkline-scientists-accused-stealing-drug-rd-secrets-china-scheme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergans-trial-drug-ibs-d-shows-positive-results-late-stage-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/beards-good-health-yes-huge-variety-bacteria-found-facial-hair-help-develop-new-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scientists-use-protein-blocker-stop-spread-leukaemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fight-superbugs-drug-makers-call-incentives-develop-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biotech-can-fite-step-closer-securing-us-patent-viagra-drug-diabetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/breast-milk-protein-used-fight-antibiotic-resistance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/latin-america-registers-cases-zika-paho-intensifies-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-expands-opdivos-melanoma-approval-include-braf-mutant-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bachem-brings-peptide-small-molecule-generic-apis-dcat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/decoded-key-defence-protein-leads-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-retrieves-amphetamines-impurity-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/indias-mankind-pharma-says-will-build-plant-new-jersey/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-accepts-amgens-biosimilar-biologics-license-application-abp-501/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/edited-stem-cells-offer-hope-precision-therapy-blindness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/researchers-tease-apart-pathway-certain-cancer-cells-use-replicate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/epilepsy-drug-may-help-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/recipharm-wrapping-105m-deal-indian-sterile-injectables-maker-nitin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/memorandum-white-house-cancer-moonshot-task-force/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gadget-spotting-fake-viagra-counterfeit-pills/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-goes-toe-toe-gileads-hep-c-goliath-flags-discount-blockbuster-ok/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-study-leads-scientists-closer-understanding-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-drug-causes-cancer-melt-away-patients-advanced-leukaemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-halaven-eribulin-liposarcoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/seven-1-billion-plus-drugs-seen-reaching-market-2016/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eagle-pharmaceuticals-announces-commercial-availability-docetaxel-injection-non-alcohol-formula/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/coffee-may-protect-liver-cirrhosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-wins-european-approval-lung-cancer-drug-tagrisso/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayers-prostate-cancer-drug-recommended-nice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bowing-pressure-fda-reform-painkiller-approval-process/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/blood-pressure-pills-may-improve-autism-patients-social-skills/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/boehringer-ingelheim-launches-spiriva-respimat-us-market-maintenance-treatment-asthma-adults-adolescents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cognitive-behavioral-therapy-cbt-may-change-brain-volume/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nih-researchers-identify-striking-genomic-signature-shared-five-types-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/51899/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astellas-names-james-robinson-president-americas-operations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biocryst-downgraded-jpmorgan-analysts-await-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-announces-leadership-team-upon-close-allergan-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-puts-full-clinical-hold-cti-biopharmas-blood-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/medicare-may-experiment-caps-cancer-drug-reimbursements/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-buy-swedish-drugmaker-meda-7-2-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/promius-pharma-receives-fda-approval-sernivo-betamethasone-dipropionate-spray-0-05/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nanoparticle-reduces-targeted-cancer-drugs-toxicity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-shares-plunge-sales-copaxone-disappoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/glaxo-fined-37-6m-illegal-behaviour-seroxat-deals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-orphan-status-amarantus-eltoprazine-treat-pd-lid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sun-pharma-calls-merck-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biocons-rosuvastatin-calcium-tablets-get-eu-approval-treat-hyperlipidemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-fda-refuses-approve-mercks-zetia-vytorin-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/51946/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-fda-approves-two-supplemental-indications-harvoni-chronic-hepatitis-c-patients-advanced-liver-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/seeks-56-million-plan-combat-zika-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/flexions-pain-drug-succeeds-study-shares-soar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-class-drug-raises-hope-blood-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/durvalumab-granted-breakthrough-therapy-designation-us-fda-treatment-patients-pd-l1-positive-urothelial-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/world-bank-provides-150-million-combat-zika-virus-latin-america-caribbean/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-offers-eu-concessions-allergan-generics-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/zurampic-lesinurad-approved-european-union-patients-gout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cdc-brazil-start-big-study-test-zika-link-birth-defects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-researchers-develop-mini-brains-study-neurological-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cipla-eu-completes-550m-acquisition-us-firms-invagen-exelan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lannett-receives-fda-approval-temozolomide-capsules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-ceo-heather-bresch-elected-chair-generic-pharmaceutical-association/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/obi-pharma-reports-topline-results-obi-822821-randomized-controlled-phase-23-clinical-trial-patients-metastatic-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/japanese-company-produces-fastest-vaccines-using-tobacco-leaves/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-receives-eu-approval-kovaltry-treatment-hemophilia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-begins-process-building-new-brand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-accepts-sanofi-new-drug-application-daily-fixed-ratio-combination-insulin-glargine-lixisenatide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/worlds-first-dengue-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/glyphosate-weed-killer-found-german-beers-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/potential-huntingtons-disease-drug-found-effective-mice-monkeys-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-agrees-licensing-deal-plendil-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/antidepressant-paroxetine-shows-potential-treat-hiv-linked-cognitive-impairment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lupin-plans-add-plant-japan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-roches-gazyva-treat-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/high-stress-levels-cause-cancer-spread-australian-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abortion-drug-possible-cure-breast-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tiny-bot-glows-diagnose-tuberculosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-trial-launched-test-cancer-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/dopamines-role-alcoholism-complicated-say-researchers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/google-donates-1-million-unicef-fight-zika-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/india-largest-contributor-illegally-imported-medicines-switzerland/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alzheimers-disease-caused-herpes-virus-warn-experts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/china-signals-price-cuts-cancer-drugs-imports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-merck-pull-plug-european-vaccines-venture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-industry-body-says-india-agreed-issue-compulsory-drug-licenses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/xbiotech-submits-maa-candidate-colorectal-cancer-therapy-european-medicines-agency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eli-lillys-ixekizumab-shows-promise-treatment-patients-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/generic-viagra-coming-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/getting-multiple-tattoos-can-strengthen-immune-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofis-sarilumab-beats-humira-head-head-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/european-medicines-agency-start-review-gileads-cancer-medicine-zydelig/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-biosensor-can-diagnose-cancer-diseases-spot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/herpes-virus-ebv-tackled-heart-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-bayers-kovaltry-antihemophilic-factor-recombinant-treatment-children-adults-hemophilia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-evomela/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-signs-deal-worth-2-3-billion-dice-molecules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/express-scripts-says-u-s-drug-spending-rose-5-2-percent-2015/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-confirms-generic-abraxane-patent-challenge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizers-xeljanz-rheumatoid-arthritis-drug-meets-endpoints-ulcerative-colitis-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/amgen-ucb-announce-positive-top-line-results-phase-3-study-evaluating-romosozumab-men-osteoporosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fangs-giving-snake-venom-hold-key-alzheimers-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drug-combination-shows-benefit-men-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-launches-generic-campral-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/profectus-vyriad-develop-oncolytic-rvsv-vaccines-treat-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nice-backs-use-johnson-johnsons-prostate-cancer-drug-zytiga/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/regeneron-bayer-jointly-develop-novel-combination-therapy-eye-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gilead-ordered-pay-merck-200-million-hepatitis-c-drug-patent-dispute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-cinqair-severe-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/breckenridge-announces-approval-gabapentin-oral-solution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-bayers-kovaltry-antihemophilic-factor-recombinant-treatment-children-adults-hemophilia-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bloomberg-valeants-failing-addyi-sprout-investors-say-predatory-pricing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/researchers-point-gene-responsible-sleep-deprivation-metabolic-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-drug-price-increase-coincides-calif-aid-dying-legislation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-molecular-tags-allow-mri-track-changes-body/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/shire-gets-favorable-ruling-allergan-lialda-patent-case/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/brazilian-researchers-use-nanofibre-fight-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-pitches-deadline-delays-creditors-debt-rescue-plan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/watchdog-says-u-s-big-pharma-isnt-paying-enough-breaking-law/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eli-lillys-baricitinib-study-published-new-england-journal-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/japanese-mhlw-approves-astrazenecas-tagrisso/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/glaxosmithkline-promises-reduced-drug-patents-help-worlds-poor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/europe-gives-green-light-first-gene-therapy-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/samsung-bioepis-files-uk-lawsuit-abbvie-attempts-delay-humira-biosimilars/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fridge-sized-machine-makes-prescription-drugs-demand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/janssen-receives-chmp-positive-opinion-trevicta-paliperidone-palmitate-3-monthly-injection-recommending-approval-european-union-maintenance-treatment-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tomatoes-may-combat-damaging-effects-radiation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-treasury-rules-put-pfizer-allergan-deal-question/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/worlds-smallest-diode-developed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bristol-myers-wins-positive-chmp-opinion-opdivo-combination-yervoy-treat-advanced-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scientist-almost-jailed-knowingly-publishing-fraudulent-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/two-components-type-2-diabetes-medications-may-heart-failure-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/160-billion-pfizer-allergan-inversion-scrapped/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tesaro-announces-global-prostate-cancer-collaboration-licensing-agreement-janssen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-oks-descovy-gilead-sciences-latest-combo-hiv-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/anti-oxidants-effective-elderly-skin-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-eli-lilly-study-azd3293-early-alzheimers-disease-moves-phase-iii/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/opioid-painkiller-may-new-treatment-heroin-addiction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/newphase-successfully-completed-small-mammal-pre-clinical-trials-cancer-treatment-transforms-cancer-treatable-chronic-ailment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ridding-u-s-hepatitis-b-c-public-health-problem-possible-experts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sun-pharma-obtains-us-fda-approval-bromsite/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvieroche-drug-gets-u-s-approval-rare-type-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uspstf-final-guidelines-aspirin-cvd-cancer-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/b-school-innovation-professor-discovers-pathway-diabetes-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-announces-us-launch-generic-lopressor-tablets-37-5-mg-75-mg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/traditional-chinese-herb-eyed-cancer-liver-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-panel-votes-approving-cloviss-cancer-drug-current-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tech-billionaire-donates-250-mn-cancer-moonshot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/china-says-202-detained-vaccine-scandal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/increase-coffee-consumption-provide-protective-effect-non-alcoholic-fatty-liver-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/exclusive-lonza-bid-acquire-catalent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/medivation-said-rebuffed-sanofi-takeover-approach/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-review-mercks-keytruda-head-neck-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/advent-baxter-set-submit-bids-indias-gland-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cholesterol-drug-may-fight-prostate-cancer-scientists-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/latest-battle-wipe-polio-begins-vast-vaccine-switch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/study-fast-food-comes-helping-industrial-chemicals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergans-actavis-recalls-nearly-600000-bottles-adhd-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uk-biobank-launches-worlds-biggest-body-scanning-project-shed-new-light-major-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/older-rheumatoid-arthritis-drug-effective-ms-newer-costlier-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/senate-committee-grills-valeant-ceo-pearson-9-hours-bloomberg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-invest-e300-million-expand-belgium-manufacturing-site/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-receives-breakthrough-therapy-designation-u-s-food-drug-administration-keytruda-pembrolizumab-classical-hodgkin-lymphoma-chl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/shire-building-400m-biologics-plant-adding-400-jobs-ireland/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/theranos-director-treatment-ceo-holmes-unfair/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-slips-talk-possible-7bn-bid-us-cancer-specialist/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-orphan-drug-exclusivity-evomela-melphalan-injection-indicated-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/taking-aspirin-increase-cancer-survival-20-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drug-combat-often-fatal-blood-poisoning-save-millions-lives-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/study-identifies-compound-reverses-symptoms-alzheimers-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tecfidera-data-highlights-benefit-early-treatment-relapsing-remitting-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/chinese-scientists-modify-gene-make-humans-immune-hiv-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alexion-mulls-producing-pipeline-drugs-ireland/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/dupont-expects-sec-review-dow-deal-end-june-30/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/az-hands-gout-drug-zurampic-ironwood-100m-plus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/intrexons-subsidiary-exemplar-genetics-receives-fda-approval-exegen-research-model-commercial-use-nysexon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lillys-taltz-cleared-eu-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/14-people-fatally-overdose-painkiller-california/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/singapores-manufacturing-sector-performs-better-expected-strong-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ackman-valeant-pledge-reforms-spiking-drug-prices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nurofen-maker-reckitt-benckiser-fined-australia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-agrees-buy-stemcentrx-reports-jump-earnings/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ixazomib-ups-progression-free-survival-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cost-new-oral-cancer-drugs-skyrocketed-last-decade/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/doctor-admits-falsifying-drug-trials-patients-sleeping-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/experimental-drug-may-reverse-fragile-x-syndrome-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-reports-rock-solid-quarter-sees-stronger-year-ahead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biogen-spinning-hemophilia-business-competition-heats/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sewer-sewer-buffett-ackman-butt-heads-valeant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-prosecutors-consider-charges-ex-ceo-shkreli/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-approaches-medivation-possible-takeover-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abilify-gets-potential-binge-eating-sex-urges-added-label/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nuplazid-approved-parkinsons-hallucinations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ec-approves-eribulin-treatment-advanced-liposarcoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-needs-clearer-goals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/japanese-scientists-used-skin-cells-restore-patients-vision-first-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-biotech-firm-gets-permission-conduct-groundbreaking-trial-bring-back-life-central-nervous-system-clinically-dead-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-forms-internal-committee-oversee-drug-pricing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-pharm-finalizing-asset-sales-clear-allergan-deal-source/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/high-stress-triggers-alzheimer-risk-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/soon-botanical-drug-cure-dengue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nice-gives-tentative-broad-approval-repatha-praluent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-taps-sarah-jessica-parker-rep-anaphylaxis-film-contest/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-receives-fda-approval-launch-first-generic-version-crestor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-launches-generic-version-apresoline-injection-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/baxter-close-deal-indias-gland-pharma-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nice-deems-bristol-myers-opdivo-pricey-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/top-health-official-misled-congress-obamacare-exchange-spending-house-panel-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/larry-ellison-gives-200-million-usc-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-stops-riociguat-study-safety-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-buy-anacor-4-5-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-buy-renaissance-skin-drug-unit-1-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-blocks-drugs-use-lethal-injections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bengt-sjoberg-donates-sek-2-billion-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/avanir-announces-u-s-launch-availability-onzetra-xsail/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/opdivo-approved-quickly-first-hematological-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/iran-join-insulin-producers-club-four-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/senate-approves-1-1bn-zika-fight-house-alternative-bill-provides-far-less/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/aduro-biotech-announces-phase-2b-eclipse-trial-misses-primary-endpoint-heavily-pretreated-metastatic-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alvotech-announces-acquisition-baliopharm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/atezolizumab-tecentriq-wins-fda-nod-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-makes-takeover-offer-agriculture-giant-monsanto/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/oramed-announces-positive-top-line-results-phase-iib-oral-insulin-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/osaka-university-concludes-comprehensive-collaboration-agreement-chugai-pharmaceutical-co-ltd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/deals-week-trianni-ani-pharma-merus-labs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-tecentriq-atezolizumab-urothelial-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-highlights-continued-progress-oncology-pipeline-asco-2016/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/samsung-bioepis-applies-approval-sell-remicade-biosimilar-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-panel-recommends-approval-novo-nordisk-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-moves-replace-medivation-board/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/janssens-darzalex-gets-conditional-european-commission-approval-treat-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/french-drugmaker-sanofi-step-push-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/zambon-launches-xadago-safinamide-u-k-patients-mid-late-stage-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-rejected-joint-takeover-approach-takeda-tpg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/china-regulator-launch-drug-pricing-probe-june/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/first-ever-fda-approved-buprenorphine-implant-opioid-dependence/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gsk-gets-eu-approval-first-gene-therapy-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/common-painkiller-may-slow-cancer-growth-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-investors-fret-41bn-generic-drugs-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-class-protein-treat-cancer-diseases-georgia-state-researchers-find/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-research-help-beat-jet-lag/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/jazz-pharma-buy-celator-1-5-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-fda-approves-daily-jentadueto-xr-linagliptin-metformin-hydrochloride-extended-release-tablets-adults-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-advisory-committee-recommends-approval-sanofis-type-2-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-zinbryta-treat-relapsing-forms-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-sells-eu-latam-gout-drug-rights-gruenenthal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/botswana-gets-gsks-modern-hiv-drug-largest-ever-africa-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/diabetes-drug-may-help-patients-beat-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/forgetting-may-good-memory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/shire-completes-combination-baxalta-creating-global-leader-rare-diseases-highly-specialized-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/first-dna-sequencing-space-happen-summer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-announces-fda-approval-byvalson-nebivolol-valsartan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/state-announces-grants-lure-smaller-biotechs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mercks-patent-win-gilead-reversed-false-testimony/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cancer-drug-retail-prices-vastly-different-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-launches-generic-vidaza-injection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/jj-gsk-rheumatoid-arthritis-drug-meets-goals-large-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/regulus-reveals-positive-top-line-data-hepatitis-c-virus-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fibrotic-disease-therapy-research-collaboration-established-boehringer-ingelheim-harvard-scientists/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-acquire-afferent-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/aspen-buy-anesthetics-astrazeneca-520-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biogen-continue-development-opicinumab-ms-drug-despite-failure-phase-ii-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fluoropharma-announces-letter-intent-buy-ground-fluor-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ultragenyx-takeda-partner-develop-rare-genetic-disease-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-panel-backs-approval-merck-infectious-diarrhea-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-teva-pharmaceuticals-announce-sales-suspension-zecuity-patch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/shire-license-pf-00547659-pfizer-adding-established-leading-gastrointestinal-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-regulator-says-many-drugmakers-chasing-cancer-strategy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/blood-test-detects-early-alzheimers-disease-developed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sirukumab-meets-co-primary-endpoints-rheumatoid-arthritis-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ertugliflozin-shows-significant-a1c-reductions-patients-type-2-diabetes-two-phase-3-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/can-coffee-cause-cancer-hot-says-agency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-vaccine-prevent-cholera-travelers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/return-pbr-home-regulatory-affairs-regulatory-affairs-news-fda-clears-gilotrif-late-stage-non-small-cell-lung-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-begins-construction-200-million-biologics-plant-ma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mercks-keytruda-beats-chemotherapy-lung-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-north-chicago-plant-second-fire/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bristols-opdivo-yervoy-melanoma-combo-wins-speedy-thumbs-nice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biogen-targets-cambridge-plant-285-jobs-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/congo-declares-yellow-fever-epidemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/indias-pharma-exports-may-reach-20-bn-2020-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/vitamin-d-may-great-solution-health-problems/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ariad-initiates-submission-new-drug-application-brigatinib-u-s-food-drug-administration-ahead-plan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/microbial-mass-extinctions-kicked-human-evolution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/understanding-chemical-changes-brain-affect-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-opkos-nda-rayaldee/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/experimental-zika-vaccine-approved-human-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/flu-nose-spray-doesnt-work-children-use-shots-instead-federal-expert-panel-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/impax-buys-generic-drugs-teva-allergan-586-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-life-form-discovered-saliva-linked-human-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/european-commission-grants-marketing-authorization-gileads-single-tablet-regimen-odefsey-emtricitabine-rilpivirine-tenofovir-alafenamide-treatment-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drinks-drugs-cars-trade-hit-eu-vote/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/brexit-vote-creates-new-uncertainty-uk-eu-pharma-industry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-plans-close-colorado-production-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-seals-deal-market-copy-astrazeneca-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/daiichi-sankyo-enters-agreement-servier-canada-factor-xa-inhibitor-edoxaban/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gw-pharmaceuticals-plc-announces-positive-results-phase-3-clinical-trial-investigational-medicine-epidiolex-treatment-lennox-gastaut-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/190-tries-closer-cure-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-boehringer-ingelheim-agree-25-billion-asset-swap/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-food-drug-administration-approves-gileads-epclusa-sofosbuvirvelpatasvir-treatment-genotypes-chronic-hepatitis-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-antibiotic-zavicefta-approved-european-union-patients-serious-bacterial-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tesaros-ovarian-cancer-drug-study-succeeds-shares-soar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/hungarys-richter-buys-swiss-biotech-company-finox-194-mln/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/roches-marketing-applications-review-ocrevus-ocrelizumab-two-forms-multiple-sclerosis-accepted-ema-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bind-therapeutics-files-motion-sale-assets-accepting-stalking-horse-bid-pfizer-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/home-test-malaria-cancer-may-coming-soon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/independence-good-fda-public/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/formation-melanin-discovered-opens-new-development-medicine-cosmetics-environmental-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/updated-pfizer-planning-ireland-biologics-plant-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novo-expanding-massive-denmark-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alexion-making-e100m-ireland-plant-investment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/chinese-api-maker-spanked-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/amgen-drug-appears-highly-similar-humira-fda-staff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/women-take-aspirin-sex-likely-give-birth-baby-boy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/european-commission-approves-zinbryta-treat-relapsing-forms-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sages-drug-postpartum-depression-succeeds-mid-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nichi-iko-pharmaceutical-co-ltd-acquire-sagent-pharmaceuticals-21-75-per-share-cash-transaction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-shires-xiidra-lifitegrast-ophthalmic-solution-5-treatment-indicated-signs-symptoms-dry-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/global-active-pharmaceutical-ingredients-api-market-revenues-reach-us-143-bn-2016-north-america-accounting-35-revenue-shares/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cipla-pump-89m-building-south-african-biosimilars-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-expects-allergan-deal-close-day-says-lifting-guidance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/researchers-make-advance-possible-treatments-gaucher-parkinsons-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/shares-juno-therapeutics-jump-fda-removes-clinical-hold-cancer-drug-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ge-aims-1-billion-cell-therapy-tools-business-swiss-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scientists-discovers-earliest-sign-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/phase-iii-clinical-study-promising-prostate-cancer-drug-reveals-surprising-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-sweetens-bid-monsanto-64-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drug-company-shocked-world-prices-dodged-10-billion-taxes-report-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-pharmaceuticals-shares-raises-second-quarter-estimates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alzheimers-gene-may-shrink-brain-starting-childhood/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/western-style-diet-linked-state-dependent-memory-inhibition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-compounds-defeat-multi-drug-resistant-cancer-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/evoke-pharma-reports-topline-results-evk-001-phase-3-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eisai-inc-arena-pharmaceuticals-announce-fda-approval-belviq-xr-lorcaserin-hcl-extended-release-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-fda-expands-indication-type-2-diabetes-treatment-synjardy-empagliflozinmetformin-hydrochloride-include-treatment-naive-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-adamas-announce-new-expanded-indication-namzaric-memantine-donepezil-hydrochlorides-extended-release-treatment-moderate-severe-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-offers-eu-concessions-boehringer-consumer-healthcare-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eisai-arena-pharmaceuticals-receive-regulatory-approval-venespri-mexico/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/apex-therapeutics-announces-fda-acceptance-ind-evaluate-tolerability-anti-tumor-effects-apx3330/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-kgaa-german-company-building-115-million-life-science-campus-burlington-mass/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/galenica-buy-relypsa-1-53-billion-beef-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/puma-biotechnology-submits-new-drug-application-pb272-neratinib-u-s-fda-extended-adjuvant-treatment-her2-positive-early-stage-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/amgen-allergan-biosimilar-found-effective-roche-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-sends-stern-warning-glaxo-contamination-penicillin-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sunovion-announces-results-phase-3-long-term-safety-study-showing-sun-101eflow-glycopyrrolate-well-tolerated-people-moderate-severe-chronic-obstructive-pulmonary-dise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eu-watchdog-flags-faulty-generic-drug-data-backs-sales-halt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alzheon-presents-positive-results-alz-801-clinical-studies-lead-advancement-pivotal-phase-3-study-alzheimers-patients-apoe44-homozygous-genotype/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tokai-pharmaceuticals-announces-clinical-update/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-receives-u-s-fda-approval-daily-viekira-xr-dasabuvir-ombitasvir-paritaprevir-ritonavir-treatment-genotype-1-chronic-hepatitis-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-expect-close-40-5b-allergan-generic-deal-next-week/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uk-drugs-giant-gsk-invests-275m-despite-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-drug-slows-alzheimers-progress-research-reveals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-planning-yet-another-plant-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-q2-shows-pharma-consumer-divergence-china-emerging-markets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-announces-initiation-phase-3-study-venetoclax-patients-relapsed-refractory-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cardiac-fibrosis-bile-acid-may-prevent-myocardial-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-fast-track-shires-nash-investigational-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/google-parent-glaxosmithkline-creating-715-million-bioelectronics-firm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/theranos-ceo-elizabeth-holmes-trades-new-unproven-tech-old/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-inc-wins-40-million-bid-bind-therapeutics-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cellceutix-prepares-phase-2a-ovarian-cancer-trial-kevetrin-novel-p53-modulating-drug-candidate-based-upon-phase-1-topline-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/venous-thromboembolism-therapeutics-market-set-hit-3-7-billion-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/japans-astellas-sells-u-s-plant-cmo-avara/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/chinese-company-accused-lying-fda-inspectors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/atrial-fibrillation-market-will-peak-2022-rapid-decline-4-9-billion-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/hacking-nerves-can-control-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novo-nordisk-profit-surges-19-cuts-revenue-view-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/keep-calm-spend-regeneron/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-agrees-buy-allergans-generics-distribution-unit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bristol-myers-opdivo-fails-lung-cancer-trial-shares-plunge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-plc-agn-releases-earnings-results-meets-expectations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-sues-amgen-fend-copy-blockbuster-humira-susan-decker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mesoblast-cell-treatment-shows-promise-rheumatoid-arthritis-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-drug-selumetinib-fails-lung-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-bans-third-wockhardt-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/vtv-therapeutics-announces-positive-topline-results-phase-2b-study-glucokinase-activator-ttp399-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-looks-sell-billions-assets-cut-debt-stock-soars/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-compound-shows-hope-prostate-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/53106/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/heron-therapeutics-announces-u-s-fda-approval-sustol-granisetron-extended-release-injection-prevention-chemotherapy-induced-nausea-vomiting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-criminal-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-accepts-marathon-pharmaceuticals-new-drug-applications-deflazacort-treatment-duchenne-muscular-dystrophy-grants-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novogen-submits-investigational-new-drug-ind-application-us-fda-cantrixiltm-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biogen-eisai-move-phiii-bace-inhibitor-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-sees-big-share-price-rise-ceos-making/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novel-lipid-altering-therapies-will-steer-acute-coronary-syndrome-market-beyond-12-billion-2022-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/endo-announces-opana-er-regulatory-update/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pain-reliever-eliminates-alzheimers-symptoms-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/vertex-provides-update-ongoing-phase-3-program-vx-661-combination-ivacaftor-treatment-cystic-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/agilent-technologies-build-new-facility-colorado-increasing-pharmaceutical-manufacturing-capacity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/aveo-initiates-evaluation-tivozanib-combination-bristol-myers-squibbs-opdivo-nivolumab-advanced-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/breast-cancer-common-heart-cancer-rare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ema-nails-artemis-india-plant-simvastatin-api-manufacturing-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-cuts-148-jobs-giving-ex-blockbuster-hopeful-zontivity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/casi-pharmaceuticals-provides-update-phase-2-trial-enmd-2076-fibrolamellar-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-breakthrough-therapy-designation-depression-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/hartmut-retzlaff-resigns-office/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bd-receives-fda-clearance-new-syringe-designed-administration-humulin-r-u-500-insulin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scientists-make-malaria-breakthrough/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/jj-remicade-patent-found-invalid-u-s-victory-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cerulean-announces-results-phase-2-clinical-trial-crlx101-avastin-combination-relapsed-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/turkeys-pharmaceutical-industry-set-hit-5-53-billion-2020-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nhs-patients-missing-new-cancer-treatments-available-countries-report-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/miami-beach-zika-cases-may-prompt-call-avoid-city/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/government-agency-charge-approving-drugs-gets-surprising-amount-money-companies-make/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/approval-tenecteplase-stroke-india-misguided-says-expert/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-boosts-cancer-drug-roster-14-billion-medivation-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/compound-marine-sponge-may-reduce-pancreatic-tumor-size/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-delay-sanofi-loses-head-start-diabetes-combo-med-rivalry-novo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-troxyca-er-oxycodone-hydrochloride-naltrexone-hydrochloride-extended-release-capsules-cii-abuse-deterrent-properties-management-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-lilly-receive-fda-fast-track-designation-azd3293-investigational-treatment-early-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-buy-cancer-drug-maker-14-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nice-knocks-bayers-nexavar-cdf-review-continues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/senators-press-mylan-labs-outrageous-epipen-pricing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/major-need-safer-antiarrhythmic-drugs-will-continue-plague-atrial-fibrillation-market-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-buy-antibiotics-astrazeneca-725-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-k-finds-big-issues-pfizer-hospira-plant-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/chinese-scientists-discover-molecules-repair-organs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sleep-hormone-may-suppress-breast-cancer-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pharmaceutical-company-brings-investment-greenville/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/amgen-provides-update-status-parsabiv-etelcalcetide-new-drug-application-nda-submitted-u-s-food-drug-administration-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-accepts-clovis-oncologys-new-drug-application-rucaparib-priority-review-treatment-advanced-mutant-brca-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/boosting-brain-protein-alleviates-alzheimers-symptoms-study-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-method-cancer-immunotherapy-developed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ecological-consequences-amphetamine-pollution-urban-streams/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-test-blood-donations-zika-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nichi-iko-pharmaceutical-co-ltd-announces-results-tender-offer-purchase-outstanding-shares-common-stock-sagent-pharmaceuticals-inc-nichi-iko-pharmaceutical-co-ltd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/acelrx-pharmaceuticals-presents-results-phase-3-study-arx%e2%80%9104-emergency-department-international-society-burn-injuries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-likely-get-credit-new-epipen-generic-little-late/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/folic-acid-taking/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/forensic-dna-analysis-checks-origin-cultured-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/betagenon-ab-start-phase-iia-proof-concept-clinical-trial-ampk-activator-o304-type-2-diabetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/forget-apple-time-collect-tax-dodging-gilead-tax-group-urges-u-s-treasury/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novo-nordisks-veteran-ceo-lars-rebien-sorensen-step/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/infectious-diseases-point-care-testing-market-will-rise-1-17-billion-2022-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/florida-finds-first-local-mosquitoes-zika-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/israeli-researchers-invent-mind-controlled-dna-nanobots-potential-treatment-brain-disorders-epilepsy-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drug-found-treat-rare-genetic-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-erelzi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-scores-another-win-teva-copaxone-generic-battle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-finally-ditches-osteoporosis-drug-odanacatib-stroke-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/carl-icahn-buys-2-6-million-shares-herbalife/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/clinton-offers-plan-curb-unjustified-price-hikes-life-saving-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novel-antibacterial-drug-exeporfinium-chloride-delivers-encouraging-safety-tolerability-efficacy-data-us-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-indicated-willingness-pay-one-share-monsanto-1275/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/%d0%b5xpert-reaction-paper-reporting-use-crispr-anti-cancer-therapies-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/adhd-market-reach-13-9-billion-2024-awareness-increases-drugs-improve-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cancer-drug-like-taking-panadol-developed-australia-given-fast-track-approval-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/orion-corporation-menarini-group-collaborate-budesonide-formoterol-easyhaler-combination-product-asthma-copd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/contraceptive-pills-driving-fall-ovarian-cancer-deaths/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/naldemedine-phase-iii-study-demonstrates-long-term-safety-efficacy-treatment-opioid-induced-constipation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/proclara-biosciences-announces-initiation-phase-1b-clinical-trial-npt088-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gtx-achieves-stage-1-milestone-phase-2-clinical-trial-enobosarm-erar-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/heron-therapeutics-announces-presentations-results-phase-2-clinical-trial-htx-011-hernia-repair-painweek-2016/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/foamix-announces-positive-topline-results-phase-2-trial-evaluating-fmx-103-topical-minocycline-foam-moderate-severe-papulopustular-rosacea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/horizon-pharma-buying-raptor-build-rare-disease-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/combination-therapy-glutaminyl-cyclase-qc-inhibitor-pq912-pglu-abeta-specific-antibody-pbd-c06-shows-clear-additive-effects-reducing-pglu-abeta-well-abeta-alzheimer-mouse-model/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/chemdiv-presenting-scis-event-innovation-design-supply-acquisition-compound-screening-libraries-14th-september-2016-hatfield-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ligand-initiates-phase-2-trial-lgd-6972-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayers-monsanto-acquisition-face-politically-charged-scrutiny/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/japans-takeda-prepares-15-billion-u-s-acquisitions-ft/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-buy-vitae-pharmaceuticals-639-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sugar-industry-downplayed-heart-risks-sugar-promoted-risks-fat-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-star-shaped-polymers-may-spell-end-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/aralez-announces-fda-approval-yosprala-secondary-prevention-cardiovascular-cerebrovascular-events-patients-risk-aspirin-associated-gastric-ulcersxcess-sugar-intake/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/prescription-heroin-gets-green-light-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/azs-glp-1-bydureon-sglt2-farxiga-better-together-phiii-data-show/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/information-made-public-clinical-trials-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eleven-medicines-leap-towards-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/semaglutide-reduced-major-cardiovascular-events-26-adults-type-2-diabetes-high-cardiovascular-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/johnson-johnson-buy-abbott-medical-optics-4-33-billion-cash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-buy-tobira-therapeutics-1-7-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-accelerated-approval-first-drug-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/emma-walmsley-succeed-andrew-witty-chief-executive-officer-glaxosmithkline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/stelara-wins-eu-backing-crohns-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/microsoft-will-solve-cancer-within-next-10-years-treating-like-computer-virus-says-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drugmakers-pledge-clean-antibiotic-factories-curb-overuse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sunovion-announces-results-pivotal-study-evaluating-novel-drug-candidate-dasotraline-children-adhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-announces-results-exploratory-52-week-phase-2-pride-hd-study-pridopidine-huntington-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mark-zuckerberg-priscilla-chan-pledge-2310000000-end-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/neuraltus-pharmaceuticals-initiates-confirmatory-phase-2-study-np001-patients-amyotrophic-lateral-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/turing-pharmaceuticals-ag-announces-development-new-drug-candidates-toxoplasmosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/moderna-lays-ambitious-110m-facility-clinical-supplies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lundbeck-says-alzheimers-drug-fails-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-drone-rules-set-firms-race-flight-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-fda-approves-labeling-update-rexulti-brexpiprazole-maintenance-treatment-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abbvie-presents-data-eight-week-treatment-viekirax-ombitasvirparitaprevirritonavir-tablets-exviera-dasabuvir-tablets-patients-genotype-1b-chronic-hepatitis-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uk-okays-alexion-drug-costing-2-million-wants-price-cut/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-faces-scrutiny-epipen-profit-data-shown-congress/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/orbus-therapeutics-announces-enrollment-first-patient-phase-3-trial-late-stage-brain-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/array-biopharma-pierre-fabre-announce-columbus-phase-3-study-encorafenib-plus-binimetinib-braf-mutant-melanoma-met-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-n-calls-antibiotics-food-health-crisis-par-aids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gw-pharma-attains-52-week-high-positive-epidiolex-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-abandoned-plan-split-two-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/poland-raids-major-erectile-dysfunction-drug-counterfeiter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/amgen-says-cancer-treatment-missed-endpoint-late-stage-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-medtronics-artificial-pancreas-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pivotal-phase-iii-study-started-vericiguat-patients-chronic-heart-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alcohol-shown-act-way-rapid-antidepressants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/glaxosmithkline-plc-appoints-brian-mcnamara-ceo-gsk-consumer-healthcare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/boehringer-ingelheim-co-develop-viratherapeutics-oncolytic-virus-platform-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-food-drug-administration-approves-orkambir-lumacaftorivacaftor-use-children-cystic-fibrosis-ages-6-11-two-copies-f508del-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/u-s-payer-pressures-force-novo-nordisk-cut-loose-1000-staffers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-dials-back-3-5b-brilinta-hopes-trial-data-fall-short/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ipo-puts-value-samsung-biologics-8-2b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/3-makers-worlds-smallest-machines-awarded-nobel-prize-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/asana-biosciences-announces-acceptance-third-ind-application-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-drug-safety-communication-fda-warns-risk-hepatitis-b-reactivating-patients-treated-direct-acting-antivirals-hepatitis-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/homoharringtonine-omacetaxine-mepesuccinate-adjunct-flt3-itd-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/jj-warns-diabetic-patients-insulin-pump-vulnerable-hacking/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scynexis-announces-complete-results-two-phase-2-studies-oral-scy-078-patients-candida-spp-infections-closing-15-million-term-loan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-pay-465-million-epipen-medicaid-rebate-dispute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-announces-sale-uk-ireland-actavis-assets-operations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-carnexiv-carbamazepine-injection-intravenous-short-term-replacement-therapy-certain-seizure-types/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/theranos-ditches-fingerstick-blood-tests-closing-labs-cutting-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uae-pharmaceutical-market-set-hit-5-7-billion-2020-medical-tourism-grows-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/takeda-crescendo-biologics-enter-cancer-drug-development-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/exelixis-pfizer-drugs-compete-kidney-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-clears-lundbecks-iv-epilepsy-drug-carnexiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/azd9412-clinical-trial-update/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/curis-expands-oncology-pipeline-oral-small-molecule-pd-l1tim-3-immune-checkpoint-antagonist/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/reaches-api-makers-get-prequalification-much-needed-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-cites-two-european-companies-separate-warning-letters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/major-depressive-disorder-market-will-reach-5-8-billion-2025-awareness-drugs-improve-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/generic-drugs-save-european-100-billion-euros-per-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/trevi-therapeutics-announces-positive-results-phase-2-trial-prurigo-nodularis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/panoptica-reports-positive-results-phase-12-clinical-trial-pan-90806-novel-topical-anti-vegf-eye-drop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/major-depressive-disorder-market-will-reach-5-8-billion-2025-awareness-drugs-improve-says-globaldata-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/unvaccinated-adults-cost-us-7-billion-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-receives-positive-opinion-european-medicines-agencys-committee-medicinal-products-human-use-chmp-extend-indication-trisenox-first-line-treatment-low/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/new-molecule-may-help-fight-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/adc-therapeutics-announces-closing-105-million-private-financing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/colombian-pharmaceutical-market-see-strong-market-growth-surpassing-7-billion-2020-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/canadian-ebola-vaccine-enters-new-trial-phase/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mercks-antiviral-drug-meets-main-goal-late-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gsk-exits-u-s-market-hpv-vaccine-cervarix/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/can-keytruda-beat-opdivo-full-uk-access-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/treatment-approach-used-cancer-holds-promise-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-announces-fda-acceptance-resubmitted-new-drug-application-sd-809-treatment-chorea-associated-huntington-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ema-provides-public-access-clinical-reports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ligand-partner-melinta-therapeutics-submits-baxdela-new-drug-application-hospital-treated-skin-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/boston-biomedical-initiates-canstem303c-global-phase-iii-study-investigating-cancer-stemness-inhibitor-napabucasin-patients-pretreated-advanced-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/tuberculosis-autoimmune-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-mercks-zinplava-reduce-recurrence-clostridium-difficile-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alkermes-stock-surges-depression-drugs-success/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/can-mercks-top-performers-keep-new-generics-biosims-bay/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gsk-defies-detractors-new-products-amp-q3-sales-beat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cefiderocol-novel-investigational-siderophore-cephalosporin-demonstrated-potent-activity-multi-drug-resistant-gram-negative-pathogens/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lynparza-olaparib-phase-iii-solo-2-trial-shows-significant-progression-free-survival-benefit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/viriom-announces-appointment-new-scientific-advisory-board-member/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/broccoli-reverse-signs-ageing-compound-vegetable-slows-vision-loss-middle-age-spread/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-pauses-two-cancer-drug-trials-enrolment-due-bleeding/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eisai-initiate-phase-ii-clinical-study-dual-orexin-receptor-antagonist-lemborexant-patients-irregular-sleep-wake-rhythm-disorder-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/hormonal-contraceptives-way-men/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/seasonal-influenza-vaccines-market-will-hit-4-3-billion-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/depression-drugs-sales-us-will-reach-4-6-billion-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astellas-buys-ganymed-boost-immuno-oncology-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uk-study-shows-rifaximin-%ce%b1-xifaxan-550mg-targaxan-550mg-hepatic-encephalopathy-may-reduce-costs-healthcare-systems/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ariad-announces-u-s-food-drug-administration-acceptance-nda-filing-brigatinib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/acadia-pharmaceuticals-initiates-phase-ii-study-pimavanserin-alzheimers-disease-agitation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-asks-fda-raise-bar-new-copaxone-copies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/brexit-threatens-supply-new-drugs-report-warns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lundbeck-raises-2016-financial-guidance-based-improved-sales-profitability/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-savages-chinese-api-maker-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergans-handling-q3-black-eye-dings-confidence-management-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeants-blockbuster-libido-drug-addyi-dud-shoddy-marketing-investor-lawsuit-claims/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/drugmakers-fire-suspected-us-price-fixing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pancreatic-cancer-set-become-third-biggest-cancer-killer-eu-next-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/regorafenib-bayer-submitted-health-authorities-seeking-approval-second-line-treatment-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/actelion-announces-positive-results-merit-study-macitentan-patients-chronic-thromboembolic-pulmonary-hypertension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/roches-tecentriq-based-melanoma-combos-leapfrog-pivotal-trials-promising-phib-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ketofol-alternative-deep-sedative/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/memantine-plus-sertraline-effective-major-depressive-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/discovery-cerecor-drug-candidate-cerc-611-ly3130481-published-nature-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/updated-prop-61s-defeat-drug-pricing-foes-can-forget-state-level-action/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-close-two-manufacturing-sites-uk-370-job-losses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/work-another-sanofi-drug-delayed-manufacturing-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/exclusive-pfizer-weighs-sale-spin-consumer-health-unit-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-profit-32-year-tax-gain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/mylan-profit-misses-estimates-epipen-sales-decline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/valeant-may-seek-clean-name-changing-ackman/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/haiti-launches-massive-cholera-vaccination-drive-worries-remain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/myelofibrosis-market-will-exceed-1-billion-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/roche-launches-imcore-global-network-cancer-immunotherapy-centers-excellence/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/will-trumps-election-make-pharma-ma-great/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-nod-helps-bms-opdivo-even-head-neck-cancer-score-mercks-keytruda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/crispr-gene-editing-tested-person-first-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/chemocentryx-announces-presentations-positive-results-phase-ii-anca-associated-vasculitis-trials-clear-classic-orally-administered-complement-5a-re/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/heartburn-drugs-may-increase-risk-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eiger-announces-positive-phase-2-data-american-association-study-liver-diseases-aasld-meeting-multiple-paths-forward-identified-lonafarnib-therapy-lowr-hdv-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cancer-vaccines-market-will-soar-7-5-billion-2022-says-gbi-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/last-line-antibiotics-failing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novel-tool-may-lead-zika-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-halt-bladder-cancer-drug-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gsk-files-regulatory-submission-us-daily-closed-triple-combination-therapy-ffumecvi-patients-copd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/teva-secures-european-approval-trisenox-first-line-treatment-low-intermediate-risk-acute-promyelocytic-leukemia-apl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/diabetes-proves-deadly-smokers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/adding-adhd-drug-therapy-improves-cognitive-outcomes-traumatic-brain-injury-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novel-antiretroviral-drugs-may-lower-hiv-transmission-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/alzheimers-drug-fails-many-others-still-testing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/soft-microfluidic-lab-skin-developed-sweat-analysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/non-small-cell-lung-cancer-market-gain-20-billion-value-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/il-17-inhibitors-will-drive-psoriatic-arthritis-market-12-6-billion-2025-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scientists-develop-vaccine-opioid-overdose/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/54172/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ninlarotm-%ef%bc%88ixazomib%ef%bc%89-receives-conditional-approval-european-commission-treat-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/neurotrope-completes-enrollment-randomized-double-blinded-placebo-controlled-phase-2-clinical-trial-bryostatin-patients-moderate-severe-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/world-war-one-antiseptic-may-become-21st-century-saviour/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/janssen-brings-psoriasis-therapy-guselkumab-ema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/australia-gets-first-institute-biofabrication-human-bones-tissue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/among-antidementia-drugs-memantine-associated-highest-risk-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/abe-orders-review-drug-pricing-system-year-end/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/us-speedy-review-merck-pfizers-avelumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nice-backs-anastrozole-breast-cancer-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/takeda-invest-100-million-euros-dengue-vaccine-manufacturing-plant-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/uns-ban-apologizes-people-haiti-outlines-new-plan-fight-cholera-epidemic-help-communities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/johnson-johnson-hit-1-billion-verdict-hip-implants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/astrazeneca-broad-drug-deal-bicycle-worth-1-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lyrica-pregabalin-phase-3-trial-pediatric-epilepsy-meets-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/israeli-pharmaceutical-market-set-reach-2-12-billion-2020-economy-remains-robust-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/smaller-companies-carve-sizeable-niche-future-influenza-vaccines-space-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/hedge-funds-love-opko-health-inc-opk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nice-changes-stance-gsks-asthma-drug-nucala/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/scientists-identify-pandemic-threat-viruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novel-test-can-diagnose-416-viruses-tropical-regions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novo-files-weekly-glp-1-analogue-semaglutide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cancer-drug-ibrutinib-found-helpful-treating-graft-versus-host-disease-transplant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/designer-crystals-fast-track-vaccine-development-help-doctors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cancer-cases-increase-33-2005-2015-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/arena-pharmaceuticals-completes-enrollment-ralinepag-phase-2-clinical-trial-pulmonary-arterial-hypertension-pah/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/lilly-presents-phase-ii-data-abemaciclib-early-stage-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pharmas-bad-jobs-week-gets-worse-astrazeneca-cut-700-u-s-positions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/eip-pharma-announces-positive-results-neflamapimod-vx-745-two-phase-2a-clinical-trials-patients-early-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/achaogens-lead-antibiotic-succeeds-two-key-studies-shares-soar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bayer-versant-invest-225-million-biotech-venture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/switzerlands-lonza-pay-5-billion-drug-capsule-maker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/cognition-therapeutics-initiates-us-clinical-testing-ct1812-novel-small-molecule-potential-treatment-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/sanofi-talks-actelion-sources-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/intercept-pharmas-liver-drug-wins-conditional-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/gilead-express-scripts-make-peace-hep-c-2017-formulary-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/nanobiotix-reports-positive-phase-iii-preliminary-data-feasibility-safety-nbtxr3-liver-cancers-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-eucrisa-eczema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/britain-first-country-approve-three-parent-babies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/colucid-pharmaceuticals-inc-clcd-coverage-initiated-analysts-barclays-plc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/pfizer-gets-letter-us-senators-seek-information-drug-treat-opioid-overdoses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/rd-productivity-recovery-deloitte-sees-sign-just-yet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/xtandi-cornerstone-pfizers-14b-medivation-buy-falls-short-closely-watched-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/54300/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/merck-wins-2-54-billion-hepatitis-c-drug-trial-gilead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-removes-black-box-warning-vareniclines-label/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/20-states-accuse-generic-drug-companies-price-fixing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-grants-accelerated-approval-new-treatment-advanced-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-expands-indication-continuous-glucose-monitoring-system-first-replace-fingerstick-testing-diabetes-treatment-decisions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/viiv-healthcare-announces-start-phase-iii-study-evaluating-long-acting-cabotegravir-hiv-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/flour-starch-fake-antibiotic-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/allergan-buy-acelitys-tissue-unit-lifecell-2-9-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/novel-alzheimers-drug-restores-memory-loss-prolongs-life-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/bristol-myers-squibb-selects-ceo-giovanni-caforio-new-chairman/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/biogen-board-approves-spin-hemophilia-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/updated-senate-proposes-incentivizing-generic-drugmakers-help-control-price-hikes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/billions-stake-will-biosims-finally-make-mark-u-s-2017/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ms-breakthrough-doctors-hail-discovery-landmark-drug-alters-immune-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/dipexium-shares-soar-merger-focused-aspertec-announced/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/seattle-genetics-announces-clinical-hold-several-phase-1-trials-vadastuximab-talirine-sgn-cd33a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/fda-approves-first-drug-spinal-muscular-atrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/ancient-chinese-medicine-can-help-fight-tb-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2016/single-protein-may-hold-secret-treating-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/japans-takeda-buy-u-s-cancer-drug-maker-ariad-5-2-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ipsen-buy-cancer-drugs-merrimack/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-adjust-organization-leadership-structure-better-align-growth-opportunities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/probiodrug-announces-completion-recruitment-saphir-phase-2a-study-glutaminyl-cyclase-inhibitor-pq912-early-alzheimers-disease-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/investigation-new-molecules-potentially-treat-alzheimers-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/viriom-announces-collaboration-nih-zika-major-viral-diseases-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/newvac-reports-primary-endpoint-met-phase-ii-clinical-trial-quisinostat-combination-paclitaxel-carboplatin-platinum-resistant-ovarian-cancer-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drug-meant-alzheimers-treatment-regrows-human-teeth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-enters-parkinsons-disease-option-arrangement-lysosomal-therapeutics-inc-lti-potential-first-class-breakthrough-compounds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/antioxidant-found-breast-milk-prevents-liver-disease-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/jpm-wondering-teva-overestimated-2017-sales-1b-plus-let-ceo-vigodman-explain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mits-3d-graphene-ten-times-stronger-steel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chicory-compound-reduce-alzheimers-related-memory-loss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/100-biopharma-execs-pushing-gender-diversity-industry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbvie-vows-keep-drug-price-increases-10-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-approves-gileads-hepatitis-b-therapy-vemlidy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pharma-giant-pfizer-opens-new-50m-saudi-manufacturing-hub/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/takeda-125m-maverick-t-cell-research-deal-5-year-buyout-clause/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/54434/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-biotech-opening-plant-ireland-issues-cmo-delay-glaucoma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/oral-iron-drug-found-safe-effective-treating-anemia-kidney-disease-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uncovered-spicy-indian-pepper-powerful-anti-cancer-properties/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chi-med-initiates-phase-ii-combination-study-fruquintinib-iressa-gefitinib-first-line-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/smart-drug-modafinil-helps-patients-recover-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/common-heart-drug-repurposed-treat-rare-cancer-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/study-finds-association-eating-hot-peppers-decreased-mortality/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pqq-supplementation-associated-protection-fatty-liver/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/study-reveals-first-time-talking-therapy-changes-brains-wiring/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dogfish-shark-extract-help-treat-parkinsons-disease-scientists-hope/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/malaria-drug-successfully-treated-chemotherapy-resistant-brain-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupus-market-will-reach-3-2-billion-2025-driven-new-first-class-products-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bayer-monsanto-invest-8-billion-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/green-light-sanofi-diabetes-therapy-suliqua-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/major-amendment-baricitinib-nda-sets-back-fda-review-three-months/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/global-coalition-aims-outpace-epidemics-new-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-trulance-synergy-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-receives-fda-approval-vantrelatm-er-hydrocodone-bitartrate-extended-release-tablets-cii-formulated-proprietary-abuse-deterrence-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-announces-fda-approval-rhofade-oxymetazoline-hydrochloride-cream-1-topical-treatment-persistent-facial-erythema-associated-rosacea-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-aurobindos-micardis-hct-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/statement-fda-commissioner-robert-califf-m-d-announcing-fda-oncology-center-excellence-launch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fosun-pharma-kite-unveil-plans-jv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-pony-625m-plus-keytruda-royalties-settle-bms-ono-patent-fight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/wto-ip-rules-amended-ease-poor-countries-access-affordable-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/india-court-orders-daily-tb-treatment-millions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/explain-schizophrenics-often-smoke-nicotine-helps-reduce-effects-mental-illness-groundbreaking-research-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/big-pharma-establishes-new-industry-standards-group/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/radical-ketamine-therapy-treat-alcohol-addiction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/celgene-adds-growing-portfolio-novel-immunology-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnsons-30-billion-cash-deal-finally-happening/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/seeks-new-leader-rebuild-damaged-reputation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novo-nordisk-enters-collaboration-university-oxford-type-2-diabetes-invests-gbp-115m-new-research-centre/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/shark-inspired-drug-may-help-treat-fibrosis-researchers-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/first-class-anemia-drug-passes-pivotal-clinical-tes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novel-drug-delivery-platform-brings-good-news-phase-iii-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/malaria-drugs-fail-first-time-patients-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/antibiotics-can-boost-bacterial-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/low-levels-glucose-brain-may-trigger-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/best-superfruit-benefits-nutrition-value-anti-aging-properties-pomegranate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-72-mcg-dose-linzess-chronic-idiopathic-constipation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/adapt-pharma-gets-fda-approval-2-mg-narcan-nasal-spray/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/global-branded-generics-market-expected-double-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-said-hire-jpmorgan-weigh-2-billion-portfolio-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nice-set-reject-pfizers-ibrance-high-cost/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-confirms-generic-victoza-patent-challenge-united-states/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-house-panel-take-bill-spur-generic-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-pharmaceuticals-ceo-vigodman-stepping/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-agreed-pay-96-5-million-provigil-antitrust-class-action/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-amgens-parsabiv-etelcalcetide-first-new-treatment-decade-secondary-hyperparathyroidism-adult-patients-hemodialysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/contraceptive-efficacy-intravas-injection-vasalgel-adult-male-rhesus-monkeys/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/top-5-pharmaceutical-industry-deals-2016/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mark-zuckerberg-priscilla-chan-funding-scientists-part-plan-tackle-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/academics-call-time-100000-cancer-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-emflaza-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aurobindo-pharma-open-second-u-s-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aspirin-painkiller-can-help-prevent-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drugmaker-ipsen-buy-products-sanofi-83-million-euros/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/immunomedics-licenses-cancer-drug-candidate-2-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/anti-ageing-hormone-klotho-prevent-kidney-disease-diabetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/children-may-inherit-drug-protection-fathers-nicotine-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/studies-of-potential-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tom-price-confirmed-hhs-secretary-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-announces-epoch-study-verubecestat-treatment-people-mild-moderate-alzheimers-disease-stop-lack-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/marathon-pharma-pause-muscular-dystrophy-drug-launch-criticism-6000-price-hike/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-fda-accepts-biologics-license-application-bla-mylan-biocons-proposed-biosimilar-pegfilgrastim-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-cos-hiv-drug-meets-phase-iii-trial-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-malaria-vaccine-effective-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-experts-soften-dna-editing-human-eggs-sperm-embryos/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vitamin-d-supplements-may-prevent-millions-winter-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pivotal-phase-iii-trial-hiv-mab-ibalizumab-successful/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ozanimod-shows-promise-phase-iii-ms-trial-beating-avonex/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/secret-prevent-parkinsons-disease-genes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/adding-vitamin-b3-water-boost-eye-health-help-prevent-glaucoma-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/hope-new-treatment-huntingtons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pharma-industry-reach-55-billion-three-years-says-assocham-iittm-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-clinical-data-support-durvalumab-fda-approval-bid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/shares-hit-bayer-results-pharma-growth-continues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-lonza-will-build-new-285-million-biologics-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/health-care-leaders-gather-washington/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/six-new-medicines-endorsed-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-drug-prevents-serious-infection-marrow-transplant-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/stada-recieves-3-7-billion-offer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-xermelo-carcinoid-syndrome-diarrhea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-qtern/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-perrigos-hydrocodone-bitartrate-homatropine-methylbromide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/acceras-alzheimers-trial-fails-yet-another-setback-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/juno-ends-development-high-profile-leukemia-drug-deaths/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/kite-announces-positive-topline-primary-results-axicabtagene-ciloleucel-first-pivotal-car-t-trial-patients-aggressive-non-hodgkin-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-introduces-pristiq-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-house-dust-mite-allergen-extract/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mutual-recognition-promises-new-framework-pharmaceutical-inspections-united-states-european-union/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/arix-bioscience-plc-signs-strategic-agreement-takeda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/price-drops-means-cancer-drugs-routinely-available-patients-says-nice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chugais-anti-il-31-receptor-humanized-monoclonal-antibody-nemolizumab-cim331-global-phase-ii-study-data-published-new-england-journal-medicine-online/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aids-healthcare-foundation-unveils-two-new-facilities-nigeria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-launches-digital-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/big-pharmas-top-biotechs-balk-investor-groups-push-pricing-transparency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/redheads-likely-develop-parkinsons-gene-makes-gingers-susceptible-skin-cancer-also-drives-risk-brain-disease-study-reveals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/study-reprogrammed-blood-vessels-spur-spread-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chi-med-says-cancer-drug-passed-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/celgene-agios-gain-fda-speedy-review-aml-med-enasidenib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-launches-temovate-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/french-pharmaceutical-market-stagnate-government-embraces-generics-cut-healthcare-expenditure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/biosimilars-hit-eu-pharma-warns-blanket-prescribing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-gears-european-generic-drugs-unit-sale-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-regeneron-announce-presentation-positive-data-long-term-pivotal-phase-3-chronos-study-dupixent-dupilumab-moderate-severe-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/glenmark-pharmaceuticals-receives-fda-clearance-ind-gsp-304/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bi-drug-gets-orphan-status-mds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-chooses-gottlieb-run-fda-pharma-breathes-sigh-relief/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cancer-clinic-turns-crowdfunding-boost-therapy-access/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-runs-away-pharma-brand-ad-spending-crown-nielsen-data-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ada-recommends-metformin-preferred-drug-treatment-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/indias-sun-pharma-says-u-s-fda-lift-ban-mohali-plant-exports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-ovarian-cancer-drug-slows-disease-markedly-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/otsuka-pharmaceuticals-acquires-neurovance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/top-15-pharma-companies-2016-revenue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alkermes-initiates-phase-3-gastrointestinal-tolerability-study-alks-8700-treatment-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-mercks-keytruda-adult-pediatric-patients-classical-hodgkin-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-fees-product-review-double-trump-budget/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ptc-therapeutics-buys-rights-dmd-drug-emflaza/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-uk-drug-cost-rules-leave-companies-fuming/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-opioid-painkiller-considered-high-risk-abuse-fda-panel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/second-chinese-company-found-shipping-apis-banned-manufacturer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/finland-throws-hat-ring-host-eu-drug-agency-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/circassia-strikes-deal-astrazeneca-respiratory-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-receives-china-food-drug-administration-approval-market-xeljanz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/china-considers-ways-speed-time-market-imported-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drugmakers-davos-shift-focus-chronic-diseases-poor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-releases-minastrin-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/obesity-epidemic-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novartis-heart-drug-portfolio-hit-failed-serelaxin-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nektars-opioid-painkiller-succeeds-key-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bristol-myers-expands-deal-cytomx/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/good-news-lilly-novel-breast-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/e-portal-track-sale-quality-medicines-created-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-recalls-81000-epipens-outside-u-s-reports-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/importance-modern-fda-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/akashi-therapeutics-receives-fda-clearance-resume-ht-100-clinical-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-verge-1b-plus-deal-arthritis-focused-biotech-flexion-source/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-looks-reduce-costs-every-area/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-treatment-rare-form-skin-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/da-approves-symproic-naldemedine-treatment-opioid-induced-constipation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vitamin-c-administered-high-doses-intravenous-v-infusions-can-kill-cancer-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-recommends-suspending-hundreds-drugs-tested-indian-firm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amgens-humira-biosimilar-approved-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/australia-slashes-prescription-prices-across-therapeutic-areas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-closing-illinois-plant-cutting-90-jobs-part-slim-meda-buyout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chinese-drug-approval-boosts-astrazenecas-lung-cancer-hopes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/niraparib-zejula/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-eczema-drug-dupixent-wins-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/f-d-approves-first-drug-treat-severe-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astellas-sells-16-products-ltl-pharma-181-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-mylan-silence-generic-advair-may-good-news-gsk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/post-disastrous-valeant-investment-soul-searching-ackman-reflects-lessons-learned/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vertex-shutter-canada-site-focus-3-hubs-rd-shuffle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/scientists-discover-mechanism-causes-cancer-cells-self-destruct/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/heroin-like-fish-venom-help-development-new-painkillers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/espero-pharmaceuticals-armetheon-merge-create-premier-cardiovascular-focused-biopharmaceutical-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/actelion-acquisition-close-completion-says-jj/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-says-epipen-manufacturing-partner-expand-device-recall/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/hepatitis-b-c-may-raise-risk-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astellas-buy-gpcr-specialist-ogeda-e500m-upfront/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-pay-19-8-million-claims-drug-overcharges-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/low-dose-aspirin-can-reduce-risk-death-cancer-research-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/paratek-announces-positive-phase-3-study-omadacycline-community-acquired-bacterial-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-announces-fda-approval-austedo-deutetrabenazine-tablets-treatment-chorea-associated-huntingtons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/maple-syrup-extract-may-dramatically-increase-potency-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/scientists-find-common-antibiotic-prevent-treat-ptsd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/canadian-biopharma-company-zymeworks-files-u-s-ipo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/combination-optune-standard-care-chemotherapy-temozolomide-provides-landmark-five-year-survival-rates-newly-diagnosed-glioblastoma-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-drugs-quickly-peer-agency-europe-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/takeda-gains-exclusive-global-rights-gastroenterology-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tumor-necrosis-factor-may-help-control-blood-pressure-study-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-ciplas-hiv-1-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-move-phase-iii-trials-depression-drug-thats-raising-eyebrows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uruguay-gives-pharmacies-green-light-start-selling-marijuana/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/120-million-indians-diabetic-next-20-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gilead-discloses-china-manufacturing-plans-recruitment-website/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/jazz-deal-strengthens-hikmas-hand-xyrem-generic-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/stada-accepts-5-6-billion-takeover-offer-bain-cinven/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/greek-official-thousands-people-implicated-novartis-bribery-probe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cystic-fibrosis-market-will-rocket-7-6-billion-2025-drugs-improve/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/peptidream-jj-ink-billion-dollar-drug-discovery-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/phase-iii-study-shows-roches-alecensa-improves-pfs-crizotinib-alk-positive-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bergenbio-completes-ipo-raising-49m-cancer-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/medivir-announces-positive-data-phase-ii-study-remetinostat-patients-early-stage-cutaneous-t-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-drug-treat-tardive-dyskinesia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/antiparasitic-drug-may-new-treatment-brain-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-warns-mylan-quality-concerns-india-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/asthma-drug-can-treat-skin-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/apple-reportedly-working-sensors-diabetes-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vaccine-get-rid-acne-comes-closer-reality/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pharmas-disclose-launch-prices-front-theyre-pricing-discount/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bristol-myers-license-two-drugs-biogen-roche/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/recordati-establishes-canadian-presence-launch-recordati-rare-diseases-canada-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-gets-warning-api-china-manufacturing-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/rise-prevalence-breast-cancer-will-drive-southeast-asia-market-growth-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/phase-iii-study-shows-roches-hemophilia-drug-emicizumab-prevents-bleeding-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbott-finally-agrees-buy-alere-cutting-price-4-5-billion-reuters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/another-delay-baricitinib-fda-calls-clinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/spanish-police-seize-synthetic-drug-80-times-stronger-marijuana-detain-two-brits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/retina-cells-may-help-treating-jet-lag/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/indian-government-approves-baxter-acquisition-claris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-genentechs-bladder-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lowering-diabetes-risk-water/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cannabis-based-medicine-may-cut-seizures-half-tough-treat-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tagrisso-osimertinib-receives-usfda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/boehringer-ingelheim-phase-iii-study-now-enrolling-patients-progressive-fibrosing-lung-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/motif-bio-antibiotic-hits-endpoint-skin-infection-phase-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alphabets-verily-unit-launches-study-track-health-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbvie-announces-topline-results-two-phase-3-studies-investigating-veliparib-combination-chemotherapy-treatment-patients-advanced-metastatic-squamous-non-small-cell-lun/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uks-medical-research-council-identifies-two-drugs-potential-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/knee-replacement-joints-created-3d-printer-first-time-breakthrough-us-university/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/study-demonstrates-efficacy-investigational-treatment-hepatitis-c-subgroup/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-simultaneously-launches-airduo-respiclick-authorized-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/upsher-smith-sell-generics-business-1-05b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nine-new-medicines-recommended-approval-emachmp-including-four-orphans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/becton-dickinson-acquire-bard-24-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-renflexis-infliximab-abda-biosimilar-remicade/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-announces-phase-3-monarch-3-breast-cancer-study-abemaciclib-demonstrated-superior-progression-free-survival-interim-analysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/spermidine-foods-aged-cheese-prevents-liver-damage-extends-life-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-said-seek-cutting-corporate-tax-rate-15-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-intros-prometrium-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fresenius-kabi-acquire-akorn-4-3b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-data-shows-effect-biogens-blockbuster-ms-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ovarian-cancer-market-quadruple-5-2-billion-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cheap-widely-available-drug-stop-thousands-mothers-bleeding-death/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/generic-vytorin-introduced-teva/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/hiv-market-will-see-modest-growth-22-5-billion-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-bayers-stivarga-treat-common-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/branded-thiopeta-shipped-amneal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/white-house-says-vote-healthcare-plan-may-come-weeks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-takes-action-14-companies-selling-illegal-cancer-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/beta-blocker-shows-cancer-fighting-properties/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-biomarins-batten-disease-drug-cost-per-year-702000/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-tymlos-abaloparatide-treatment-postmenopausal-women-osteoporosis-high-risk-fracture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chemotherapy-drug-shows-promise-relapsing-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-immunotherapy-wins-first-approval-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-alunbrig-brigatinib-rare-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-xatmep/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vertex-veers-upwards-reporting-rising-profits-sales/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ocrevus-thoughts-perspectives-drg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cfda-approved-hcv-treatment-bristol-myers-squibb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-scores-healthcare-victory-house/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tofacitinib-xeljanz-potential-new-treatment-option-moderate-severe-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/antibiotic-doxycycline-may-offer-hope-treatment-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/depression-3-drugs-help-treat-condition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-nih-release-final-template-clinical-trial-protocols/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-als-treatment-two-decades/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/natco-pharma-launches-generic-hepatitis-c-drug-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/usfda-inspection-strides-shasun-plant-completed-successfully/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-celebrates-grand-opening-expanded-new-jersey-facilities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nacds-hda-speak-importation-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-approves-first-immunotherapy-neuroblastoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-immuno-oncology-drug-wins-u-s-approval-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/scott-gottlieb-confirmed-lead-food-drug-administration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/array-biopharma-announces-positive-top-line-results-part-2-phase-3-columbus-study-binimetinib-encorafenib-braf-mutant-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/worried-osteoporosis-take-turmeric-indian-spice-improves-bone-density-7-study-reveal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-provides-update-stratos-1-phase-iii-trial-tralokinumab-severe-uncontrolled-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-active-biotech-announce-concerto-trial-laquinimod-rrms-meet-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-announces-positive-results-three-phase-3-studies-galcanezumab-prevention-episodic-chronic-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/will-soon-jab-prostate-cancer-experts-unveil-vaccine-provide-cure-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ardelyx-reports-positive-phase-3-data-shares-fall-hard-premarket/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uk-patients-get-early-access-abbvies-hepatitis-regimen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/genoa-pharmaceuticals-secures-62-million-series-financing-adds-leadership-team/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/postmarket-safety-events-among-novel-therapeutics-approved-us-food-drug-administration-2001-2010/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sangamo-receives-fast-track-designation-fda-sb-525-investigational-hemophilia-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/india-will-relaunch-inspections-api-facilities-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/boehringer-ingelheim-opened-biopharmaceutical-manufacturing-facility-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/european-medicines-agency-issued-2016-annual-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bayer-obtained-fda-priority-review-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-kgaa-eyes-options-splitting-divisions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/indias-drug-pricing-regulator-clamps-drug-cocktails-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-drug-medivation-deal-shows-promise-breast-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/biogen-pays-120-million-late-stage-stroke-treatment-cirara/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/shires-swelling-disorder-drug-moves-closer-u-s-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-pharmaceuticals-search-committee-recommends-foreign-ceo-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astellas-completes-800-million-euro-biotech-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/artificial-intelligence-will-reinvent-drugs-ten-times-faster-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-lupins-seroquel-xr-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-earns-fda-approval-doxil-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-hypertension-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chicago-startup-snares-65m-combat-drug-resistant-superbugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cancer-research-uk-funded-scientists-test-zika-virus-brain-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nektar-therapeutics-takeda-strike-research-parternship-oncology-compounds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/japan-bring-forward-target-increased-generic-drug-use-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/benralizumab-associated-less-use-oral-glucocorticoids-severe-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/regeneron-sanofi-announce-fda-approval-kevzara-sarilumab-treatment-moderately-severely-active-rheumatoid-arthritis-adult-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-cancer-treatment-solid-tumor-specific-genetic-feature/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/last-alternative-flu-jab-scientists-accidentally-discover-drug-treat-virus-speed-recovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gedeon-richter-drug-received-positive-opinion-chmp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-gets-booster-chinese-hpv-vaccine-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/may-24-2017-press-release-healthcare-growth-hormone-deficiency-market-grow-steadily-surpassing-2-billion-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gw-file-cannabis-drug-journal-confirms-epilepsy-success/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uk-biotech-boasts-europes-best-pipeline-brexit-threat-looms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/biogen-hemophilia-spin-acquire-true-north-825-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/inovios-nih-backed-hiv-vaccine-shows-near-100-immune-response-rate-early-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-buys-experimental-tau-antibody-teijin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/modis-generics-drugs-plan-worries-health-experts-indian-pharma-sector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-fda-commissioner-gottlieb-unveils-price-fighting-strategies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-congo-authorises-trial-experimental-ebola-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-issues-complete-response-letter-sunovions-new-drug-application-treat-copd-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-first-time-recommends-approval-biosimilar-erythropoiesis-stimulating-agent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ache-ferring-explore-nanotechnologies-brazil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bristol-myers-squibb-enters-collaboration-array-biopharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/glenmark-obtained-fda-approval-hypertension-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novartis-assets-sell-investors-wary-might-buy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/world-tobacco-day-2017-beating-tobacco-health-prosperity-environment-national-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/century-old-drug-may-provide-hope-autistic-kids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-antibiotic-packs-punch-bacterial-resistance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/meningococcal-group-b-vaccine-trumenba-gets-approval-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/statins-associated-improved-heart-structure-function/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tevas-migraine-drug-clears-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/quintilesims-institute-examines-technological-economic-growth-global-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-strattera-generics-4-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/scientists-save-beta-cells-destruction-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/acne-antibiotic-delays-development-multiple-sclerosis-small-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/global-circulating-tumor-cells-market-2017-trends-forecast-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazenecas-breast-cancer-drug-showed-positive-results-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/startup-backed-bill-gates-thats-building-early-cancer-detection-test-just-pulled-big-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novo-nordisk-innate-pharma-sign-agreement-novel-cancer-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-drug-shows-durable-efficacy-across-diverse-pediatric-adult-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-kgaa-f-star-e1bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nutrient-olive-oil-linked-brain-cancer-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/perrigo-ceo-retire/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/valeant-talks-sell-eye-surgery-assets-carl-zeiss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbvie-tops-pharma-reputation-report-pfizer-ranks-last/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/updates-essential-medicines-list-new-advice-use-antibiotics-adds-medicines-hepatitis-c-hiv-tuberculosis-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-sells-migraine-drug-302-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/actelion-antibiotic-misses-mark-one-study-hits-another/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbvies-rheumatoid-arthritis-drug-succeeds-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-psoriasis-drug-effective-three-quarters-patients-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/anti-nausea-drug-may-help-treat-people-sleep-apnoea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/compound-may-improve-balance-coordination-mice-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-requests-removal-opana-er-risks-related-abuse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/red-onions-beat-cancer-destroying-tumor-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-study-finds-2-billion-people-overweight-obese/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-pfizer-announce-investigational-sglt-2-inhibitor-ertugliflozin-met-primary-endpoint-two-phase-3-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-cancer-drug-makes-commonly-prescribed-chemo-drug-effective-given-together/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-launches-zetia-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/us-generics-industry-claims-1-7-trillion-savings/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/neglected-diabetes-candidate-may-future-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-optical-imaging-agent-visualization-malignant-tissue-gliomas-surgery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-invest-biologics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnsons-flu-drug-succeeds-mid-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-cancer-drug-makes-commonly-prescribed-chemo-drug-effective-given-together-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnsons-type-2-diabetes-drug-stellar-cardiovascular-trials-comes-catch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-gilead-said-eyeing-potential-10b-deal-prime-cancer-target-tesaro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/state-attorneys-general-probe-opioid-drug-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/intermediaries-capture-41-price-paid-drugs-usa-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novartis-verily-back-300m-medicxi-biotech-growth-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/adamis-pharmaceuticals-receives-fda-approval-epinephrine-pre-filled-syringe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gamida-cell-announces-40-million-private-financing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/world-bank-will-support-indian-biopharmaceutical-industry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gut-bacteria-might-help-slow-ageing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/glutamine-found-suppress-herpes-mice-guinea-pigs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/clovis-soars-new-round-phiii-rubraca-data-looks-promising-roci-scandal-bites-142m-settlement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/senate-republicans-release-healthcare-bill-thursday/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/worldwide-drug-sale-forecasts-fall-pricing-pressures-mount/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/corporate-ventures-fund-merck-kgaa-darmstadt-germany-creates-new-immuno-oncology-company-ionctura/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/corporate-ventures-fund-merck-kgaa-darmstadt-germany-creates-new-immuno-oncology-company-ionctura-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pamplona-capital-take-parexel-private-4-5-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/takeda-wraps-construction-new-111m-solid-dosage-plant-near-berlin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/baxdela-delafloxacin-fda-approved-us-treatment-serious-skin-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-loses-235m-patent-trial-gsk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-working-lift-barriers-generic-drug-competition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/brazils-highly-attractive-pharmaceutical-market-approach-30-billion-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pharma-industry-roi-opportunity-lies-innovative-development-market-access-strategy-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/singapores-pharmaceutical-market-set-break-1-billion-mark-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/camber-launches-micardis-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-fda-approves-mydayis-mixed-salts-single-entity-amphetamine-product-new-daily-option-adhd-symptom-control-patients-13-years-older/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/finally-drug-benefit-rare-kidney-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novo-nordisk-reports-13-8-weight-loss-people-obesity-receiving-semaglutide-phase-2-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-roche-haemophilia-drug-prevents-bleeds-questions-remain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/japan-india-deal-low-cost-vaccines-lower-income-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nigerian-pharmaceutical-industry-needs-95-million-bailout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bain-cinven-discussing-new-offer-stada-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-fda-approves-bevyxxa-betrixaban-first-anticoagulant-hospital-extended-duration-prevention-venous-thromboembolism-vte-acutely-ill-medical-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eyeing-6b-market-bavarian-nordic-posts-positive-phase-2-data-universal-rsv-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-tackles-drug-competition-improve-patient-access/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-unveils-plan-eliminate-orphan-designation-backlog/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/counter-magnesium-tablets-can-banish-blues-just-two-weeks-without-side-effects-associated-antidepressants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-introduces-generic-trilafon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/human-enzyme-may-help-find-cure-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-allows-marketing-test-aid-detection-certain-leukemias-lymphomas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/50-medicines-vaccines-development-hiv-infection-treatment-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/maximum-human-lifespan-far-exceed-115-years-new-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-accepts-bla-review-first-new-antiretroviral-10-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/newvac-presented-results-quisinostats-phase-ii-clinical-trial-asco-2017/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-hard-treat-leukemia-drug-besponsa-approved-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gsk-secured-access-exscientias-artificial-intelligence-ai-driven-drug-discovery-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/stada-arzneimittel-ag-appoints-new-chief-executive-officer-chief-financial-officer-incumbents-step-positions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uk-ministers-attempt-provide-certainty-ema-relations-post-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/japans-first-dpp-4-inhibitor-sglt2-inhibitor-combination-drug-application-approved-japan-canalia-combination-tablets-type-2-diabetes-mellitus-treatment-agent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-new-indication-amgens-vectibix/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/philips-buy-medical-device-maker-spectranetics-1-9-billion-euros/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/success-mercks-anacetrapib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gemphires-cholesterol-drug-shows-promise-phase-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/genentechs-emicizumab-demonstrates-positive-results-late-stage-studies-hemophilia-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-puts-hold-keytruda-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/celgene-signs-deal-beigene-tumor-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-intros-generic-vigamox/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/hiv-tuberculosis-hepatitis-c-ep-proposals-tackling-communicable-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/endo-pulls-opioid-u-s-seeks-tackle-abuse-epidemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/asthma-drug-shows-promise-treating-obesity-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/clementia-files-115m-ipo-fund-late-phase-trials-ex-roche-drug-ultrarare-genetic-bone-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/watching-cancer-spread-mouse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-new-treatment-sickle-cell-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-brenda-fitzgerald-named-new-cdc-director/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-endari/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lonza-completes-acquisition-capsugel-create-leading-integrated-solutions-provider-global-pharma-consumer-healthcare-industries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/simple-test-can-predict-bladder-cancer-recurrence/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-buy-vaccines-biotech-group-protein-sciences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/%d1%82eva-intros-2-new-strengths-adhd-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/arena-pharmaceuticals-reports-positive-topline-phase-2-results-ralinepag-patients-pulmonary-arterial-hypertension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/years-accelerated-approval-debacle-fda-panel-backs-pfizers-mylotarg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/daiichi-sankyo-links-german-academia-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-drug-restores-memories-brain-damaged-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/strawberries-keep-sharp-compound-fruit-prevents-age-related-mental-decline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/commercial-considerations-result-hundreds-drug-withdrawals-brazil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-slumps-report-ceo-heading-teva/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-fends-cialis-generics-new-patent-settlement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/big-pharma-backed-e-scape-bio-hits-63m-extended-series/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-fda-confirms-amicus-therapeutics-may-submit-new-drug-application-migalastat-fabry-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amgen-allergan-discuss-data-supporting-biologics-license-application-abp-215-biosimilar-candidate-avastin-bevacizumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/global-health-price-tag-371-billion-year-2030-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pascal-soriot-remain-chief-executive-astrazeneca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/deals-week-north-china-pharmaceutical-arena-pharmaceuticals-enterome-bioscience/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mas-week-sanofi-ge-healthcare-medicure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/27-phase-iii-8-phase-ii-alzheimers-drugs-track-launch-next-five-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-new-treatment-reduce-risk-breast-cancer-returning/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/china-adds-blockbuster-drugs-insurance-list-price-cuts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-vosevi-hepatitis-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-collaborates-promote-safety-quality-clinical-trials-done-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/shire-pens-bispecific-hemophilia-rd-deal-novimmune/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vertex-stock-rockets-record-boosting-market-cap-8-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/paratek-announces-phase-3-study-oral-dosing-omadacycline-met-primary-secondary-fda-ema-efficacy-endpoints-acute-bacterial-skin-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-approves-leo-pharmas-psoriasis-biologic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/4-billion-investment-4000-jobs-corning-merck-pfizer-initiative/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dompe-gains-ec-approval-rare-eye-disease-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/yemen-cholera-spread-rains-oxfam-sees-600000-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teligent-gets-fda-nod-generic-erygel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lillys-acute-migraine-drug-succeeds-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-panel-votes-approval-jj-arthritis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-idhifa-enasidenib-subset-aml-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-just-approved-first-drug-can-treat-hepatitis-c-strains-just-8-weeks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-drug-may-inhibit-cancer-cell-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/diabetes-drug-help-living-parkinsons-disease-research-reveals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/india-targeting-40-billion-domestic-biosimilars-market-2030/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-given-green-light-launch-avonza-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-intros-generic-relpax/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/perrigo-gets-tentative-fda-approval-mirvaso-gel-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-green-lights-cmp-pharmas-carospir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-gets-fda-clearance-qvar-redihaler/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/australia-vitamin-breakthrough-cut-miscarriages-birth-defects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mexico-watchdog-finds-big-pharma-faces-competition-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/humira-may-spend-tv-xeljanz-taltz-breo-notch-highest-view-rates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alzheimers-drugs-market-forecast-expand-7-5-cagr-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-plans-declare-opioid-epidemic-national-emergency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/type-1-diabetes-may-halted-experimental-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-lupins-livalo-generic-nikita/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-review-examines-link-psoriasis-psychiatric-illnesses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gm-pigs-take-step-organ-donors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cempra-melinta-announce-merger-form-leading-vertically-integrated-commercial-stage-anti-infectives-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ionis-independently-advance-inotersen-ionis-fb-l-rx/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sellas-life-sciences-galena-biopharma-plan-merger/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cheers-people-drink-glass-wine-night-live-longer-study-says-alcohol-protects-heart-cuts-risk-early-death-25/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/moles-become-melanoma-still-mystery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-natco-pharma-get-fda-approval-fosrenol-chewable-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-launches-3-hiv-generics-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/activity-us-psoriatic-arthritis-sector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/biocon-pulls-application-eu-approval-two-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/making-safer-polio-vaccines-plants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/perrigo-gets-fda-approval-generic-mycolog-ii-cream/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/study-reveals-dirty-air-wreaks-havoc-hormones-metabolism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cancer-patients-high-risk-heart-attack-diagnosis-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/potential-broad-spectrum-antiviral-discovered-herpesvirus-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/hope-breast-cancer-patients-new-imaging-technique-can-predict-deadly-disease-will-spread-lungs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/australian-researchers-make-breakthrough-finding-cure-peanut-allergy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-u-s-finalize-465-million-epipen-settlement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-mulls-change-drug-ad-rules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lynparza-receives-additional-broad-approval-us-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/wuxi-biologics-gloria-pharmaceuticals-announce-licensure-fully-human-pd-1-antibody-gls-010-arcus-biosciences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/scientists-discover-powerful-potential-pain-reliever/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/type-2-diabetes-market-reach-64-billion-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnson-announces-partnership-csir-imtech-develop-innovative-new-tuberculosis-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/samsung-bioepis-teams-takeda-develop-original-biotech-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/buyout-firms-get-german-generics-group-stada-second-try/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drugmaker-hikmas-u-s-unit-raises-medicine-prices-financial-times/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ocrevus-approved-treatment-relapsing-remitting-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bidders-line-tevas-womens-health-unit-potential-2b-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnson-hit-417m-verdict-talcum-powder-liability-losses-mount/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/topas-therapeutics-lands-option-deal-eli-lilly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/stada-says-larger-deals-cards-next-2-3-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/generics-savings-increase-fda-looks-spark-competition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-intros-generic-axiron-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/biodelivery-sciences-longtime-president-ceo-retire/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/octapharma-gets-fda-approval-new-product-strengths-nuwiq/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/high-levels-lithium-tap-water-linked-lowered-rates-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/paratek-pharmaceuticals-soars-revealing-appear-five-investor-conferences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/artificial-intelligence-system-may-help-detect-melanoma-skin-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/statins-may-help-combat-typhoid-malaria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gilead-buy-kite-promising-cancer-therapies-12-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mycosis-fungoides-sezary-syndrome-treatment-gets-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-second-humira-biosimilar-cyltezo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/first-drug-lowers-heart-attack-risks-curbing-inflammation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bayer-announces-enrollment-first-u-s-patient-phase-iii-trials-vilaprisan-uterine-fibroids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-fda-european-medicines-agency-accept-regulatory-submissions-bosulif-bosutinib-treatment-patients-newly-diagnosed-ph-chronic-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lenvatinib-significantly-improved-overall-survival-older-patients-locally-recurrent-metastatic-progressive-radioactive-iodine-refractory-differentiated-thyroid-cancer-according-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-strikes-400-million-parkinsons-drug-deal-takeda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approval-brings-first-gene-therapy-united-states/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/medicines-company-announces-fda-approval-vabomere-meropenem-vaborbactam/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eli-lilly-refile-ra-remedy-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-chemo-researchs-treatment-chagas-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-biocon-herceptin-biosimilar-delayed-fda-3-months/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/indias-mahendra-chemicals-api-plant-put-fda-import-alert-list-eric-palmer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/heptares-doses-first-subject-alzheimers-drug-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-pfizers-leukemia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/japans-daiichi-sankyo-denies-2016-takeover-bid-astrazeneca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novartis-names-drugs-chief-ceo-deliver-return-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-pfizers-leukemia-drug-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fujifilm-outlines-ambitions-healthcare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/yemens-cholera-epidemic-hits-600000-confounding-expectations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-kgaa-darmstadt-germany-prepares-strategic-options-consumer-health-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gilead-acquire-kite-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-chemo-researchs-treatment-chagas-disease-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bioverativ-bicycle-therapeutics-team-haemophilia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-acquire-rigontec-rig-therapeutics-pioneer-advancing-leadership-immuno-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/akcea-ionis-announce-submission-new-drug-application-volanesorsen-u-s-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novo-nordisk-resolves-us-federal-investigation-marketing-practices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-lay-8-percent-employees-bid-cut-costs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tezepelumab-significantly-reduced-asthma-exacerbations-broad-population-patients-severe-uncontrolled-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-launches-wellbutrin-xl-skelaxin-generics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/value-drug-acquires-specialty-pharmacy-restore-rx/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbvie-seeks-approval-market-new-drug-elagolix-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/shares-drugmaker-targets-gene-mutations-soar-positive-muscular-dystrophy-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-diagnostic-tool-finds-first-signs-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-vaccine-protects-nine-types-hpv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drugmaker-teva-hires-lundbeck-ceo-schultz-restore-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-pays-mohawk-tribe-protect-patents-challenges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-gets-fda-approval-vibra-tabs-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/immune-focused-drug-may-new-weapon-advanced-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/jj-unit-ends-hepatitis-c-drug-development-crowded-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aarp-highlights-rising-specialty-prices-fda-looks-tackle-development-costs-speed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alexion-cutting-600-jobs-moving-headquarters-major-shakeup/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sages-epilepsy-drug-fails-better-placebo-key-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amicus-abandons-wound-treatment-focus-shifts-future-trial-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/progress-global-poverty-disease-risk-gates-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/impressed-fda-panel-unanimously-recommends-gsk-shingles-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aspen-buy-remaining-astrazeneca-anesthetic-rights-766-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-sell-womens-health-assets-cvc-capital-partners-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/california-lawmakers-pass-drug-pricing-bill-opposed-phrma-sending-governor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/liquid-cats-crocodile-bets-didgeridoos-win-ig-nobel-science-prizes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/european-panel-backs-janssens-psoriasis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/easd-astrazenecas-farxiga-cuts-blood-sugar-weight-insulin-use-type-1-diabetes-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/xtandis-new-prosper-trial-win-pfizer-astellas-eyeing-bigger-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-biosimilar-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drug-industry-tenterhooks-maryland-price-gouging-law-nears/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/braeburn-announces-fda-acceptance-priority-review-new-drug-application-cam2038-buprenorphine-depot-treatment-opioid-use-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/neos-therapeutics-receives-u-s-fda-approval-adzenys-er-amphetamine-extended-release-oral-suspension-treatment-adhd-patients-6-years-older/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/plans-global-war-cholera-yemen-caseload-nears-700000/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-announces-sale-remaining-assets-specialty-global-womens-health-portfolio-1-38-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ipsen-receives-approval-european-commission-xermelo-telotristat-ethyl-treatment-carcinoid-syndrome-diarrhea-patients-inadequately-controlled-somatostatin-analogue-th/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nabriva-therapeutics-announces-positive-topline-results-global-phase-3-clinical-trial-evaluating-iv-oral-lefamulin-treatment-community-acquired-bacterial-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-trelegy-ellipta-fluticasone-furoateumeclidiniumvilanterol-treatment-copd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-symbiomix-therapeutics-solosec-secnidazole-oral-granules-treatment-bacterial-vaginosis-adult-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/world-running-antibiotics-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-perrigos-exalgo-extended-release-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aam-commissioned-report-biosimilars-can-save-cms-11-4b-2027/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-kgaa-pfizers-cancer-drug-bavencio-gets-eu-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/exclusive-africa-get-state-art-hiv-drugs-75-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-warns-korean-chinese-drugmakers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/high-low-levels-magnesium-linked-dementia-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/genetic-mutation-causes-low-blood-sugar-found/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-ai-system-can-predict-alzheimers-10-years-advance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/intercept-expect-restrictive-boxed-warning-ocaliva/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/republicans-revise-obamacare-repeal-bill-amid-tepid-support/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-drug-test-can-detect-cocaine-fingerprints-within-seconds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/montelukast-tied-psychiatric-adverse-events-kids-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/axovant-pull-plug-alzheimers-drug-key-study-fails/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/british-scientists-discover-common-asthma-drug-stop-prostate-cancer-spreading/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/springworks-therapeutics-launches-103m-series-funding-rights-four-clinical-programs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-gets-fda-approval-new-keytruda-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-relaunches-depo-provera-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupins-generic-clobex-lotion-gets-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-takes-aim-online-pharmacies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-shares-jump-3-4-2-billion-buyback-news/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-anti-inflammatory-compound-may-help-fight-alzheimers-says-study-pti/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-vows-another-healthcare-vote-next-year-eyes-executive-order/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-drugs-watchdog-staff-favor-move-amsterdam-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/jj-receives-european-approval-single-tablet-hiv-regimen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-stop-development-hepatitis-c-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-abemaciclib-verzenio-advanced-hr-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-laboratories-announces-launch-sevelamer-carbonate-tablets-u-s-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-approval-ptc-therapeutics-translarna-remains-unlikely/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/hhs-secretary-tom-price-resigns-amid-criticism-taking-charter-flights-taxpayer-expense/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nobel-prize-medicine-awarded-3-americans-work-circadian-rhythm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/belgian-biotech-ablynx-scores-big-hit-blood-disease-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-generic-vitruvias-therapeutics-sunny-pharmtech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/oxford-team-test-universal-flu-vaccine-world-first/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/daiichi-sankyo-announces-positive-top-line-results-phase-3-study-japan-esaxerenone-treatment-essential-hypertension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/newlink-genetics-announces-clinical-collaboration-evaluate-io-based-combination-therapies-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/three-biophysicists-win-2017-nobel-prize-chemistry-imaging-molecules-life/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/south-africa-watchdog-drops-charging-probe-aspen-equity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-gets-fda-nod-generic-acticlate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-surges-teva-slumps-fda-approves-copaxone-copy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-cancer-meds-havent-proved-can-improve-extend-lives-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-moneymaker-botox-grabs-another-cosmetic-approval-time-forehead-lines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/world-first-nhs-trial-universal-flu-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amgen-cytomx-therapeutics-announce-strategic-collaboration-immuno-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/obesity-linked-13-types-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/senator-mccaskill-drafts-bill-response-allergan-patent-maneuver/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/least-six-funds-interested-sanofi-european-generic-drugs-unit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-launches-humalog-junior-kwikpen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/china-accept-overseas-trial-data-bid-speed-drug-approvals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lexion-therapeutics-announces-fda-approval-zilretta-triamcinolone-acetonide-extended-release-injectable-suspension-osteoarthritis-oa-knee-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/white-house-take-executive-action-obamacare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/regulatory-updates-imfinzi-tagrisso-europe-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chemdiv-successfully-achieves-milestone-discovery-chemistry-collaboration-uc-davis-professor-gino-cortopassi-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chemdivs-executive-director-delivers-two-lectures-drug-discovery-china-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chemdiv-help-afraxis-advance-synaptic-profiling-platform-cns-drug-discovery-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnson-investing-350m-eu-biologics-operation-adding-200-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-provides-update-anacetrapib-development-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/janssen-use-mobile-platform-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupin-adds-womens-health-portfolio-buy-us-firm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/janssen-biotech-submits-nda-fda-apalutamide-treat-non-metastatic-crpc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/first-gene-therapy-fixes-hereditary-blindness-may-finally-get-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ardelyx-ardx-shares-soared-positive-phase-iii-results-tenapanor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aerie-pharmaceuticals-announces-fda-advisory-committee-vote-favor-rhopressa-netarsudil-ophthalmic-solution-0-02/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-lyrica-cr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nih-11-pharmaceutical-companies-announce-215-million-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aveo-oncology-announces-phase-1-results-tinivo-study-presented-16th-international-kidney-cancer-symposium/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nanology-announces-first-patient-enrolled-phase-2-clinical-trial-nanopac-treatment-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/impact-bags-22m-save-ex-sanofi-drug-trial-limbo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-presents-full-results-phase-2-study-next-generation-investigational-alk-inhibitor-lorlatinib-alk-positive-ros1-positive-advanced-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novo-nordisk-diabetes-drug-works-heart-risk-fda-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/chemdiv-achieves-milestone-viriom-collaboration-elsulfavirinevm1500a-long-acting-injectable-formulation-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pharma-medtech-industries-prepare-hard-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drugmakers-amneal-impax-combine-generics-push/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-curevac-announce-global-collaboration-develop-mrna-cancer-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/johnson-johnson-drops-sirukumab-fda-blow-cans-phase-3-aml-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-district-court-eastern-district-texas-issues-adverse-trial-decision-concerning-restasis-cyclosporine-ophthalmic-emulsion-0-05-patents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/kites-yescarta-axicabtagene-ciloleucel-becomes-first-car-t-therapy-approved-fda-treatment-adult-patients-relapsed-refractory-large-b-cell-lymphoma-t/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-food-drug-administration-fda-accepts-bristol-myers-squibbs-application-opdivo-nivolumab-patients-resected-high-risk-advanced-melanoma-grants-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novartis-blames-site-closure-pricing-pressure-us-generics-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/celgene-abandons-crohns-drug-trials-shares-drop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-cut-1800-u-s-sales-jobs-add-960-chronic-care/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gsk-wins-u-s-shingles-vaccine-approval-uk-nod-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bayer-makes-2-consumer-health-appointments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/us-fda-approves-new-easy-use-weekly-bydureon-bcise-injectable-medicine-patients-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-warns-meridian-violations-lead-testing-devices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-fighting-recover-fda-warning-letter-recalls-500k-heartburn-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/can-cancer-charity-efforts-roche-bristol-abbvie-boost-pharmas-reputation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lilly-powers-ahead-plant-investment-even-cuts-3500-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alector-abbvie-announce-collaboration-advance-novel-class-immune-therapies-patients-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/impax-launches-generic-renvela/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/perrigo-gets-tentative-fda-approval-picato-gel-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-launch-consumer-health-sale-november/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-declines-approve-ptcs-duchenne-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vitamin-d-supplements-improve-markers-bone-turnover-ckd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/japanese-researchers-find-alzheimers-drugs-work-lab-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/incyte-enters-900-million-deal-rights-mga012/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/first-us-patent-challenges-dispute-gileads-monopoly-hepatitis-c-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/viiv-healthcare-announces-positive-phase-3-results-brighte-study-fostemsavir-heavily-treatment-experienced-patients-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dendreon-strengthens-executive-team-key-management-appointments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/billionaire-bribed-doctors-overprescribe-powerful-opioids-solely-profit-prosecutors-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sumitomo-dainippon-gains-japan-asian-rights-imeglimin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ozanimod-ms-data-brings-relief-stumbling-celgene/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-gmg-treatment-60-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-wins-us-approval-lymphoma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alzheimers-disease-might-whole-body-problem/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gene-therapy-protects-age-related-cognitive-memory-deficits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/states-seek-expand-lawsuit-generic-drug-makers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/court-clears-tevas-application-generic-uceris-patent-infringement-suit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-3-lupin-generics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/apotex-partners-panacea-biotec-launch-first-file-effient-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/acetos-rising-pharmaceuticals-intros-generic-zoloft-oral-solution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bayer-novartis-clash-uk-doctors-use-cheap-eye-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gsk-gets-boost-early-cancer-hopes-breakthrough-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amazon-entry-pharma-looms-ceos-see-plenty-room-change-distribution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-really-want-bristol-myers-likely-says-one-analyst-whats-waiting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pmc-group-international-announces-acquisition-pharma-company-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vertex-announces-presentations-data-north-american-cystic-fibrosis-conference-demonstrate-important-progress-toward-goal-helping-people-cf/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/breakthrough-tag-gsks-multiple-myeloma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-takes-unprecedented-step-toward-efficient-global-pharmaceutical-manufacturing-inspections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/58346/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-treatment-certain-patients-erdheim-chester-disease-rare-blood-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novartis-seeks-european-approval-cell-therapy-kymriah/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/takeda-takes-sanofi-new-global-dengue-vaccine-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pancreatic-cancer-survival-linked-four-genes-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-study-explains-us-health-care-spending-increased-1-trillion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/crispr-view-sturge-weber-syndrome-coming-focus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-sun-pharmas-coreg-cr-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-drug-prophylaxis-cmv-infection-bone-marrow-transplant-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sage-soars-postpartum-depression-drug-moves-closer-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-kgaa-contacted-prospective-buyers-consumer-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-poised-nominate-ex-lilly-executive-alex-azar-top-hhs-job-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-675-million-deal-expand-multiple-sclerosis-franchise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cerenis-therapeutics-acquire-lypro-biosciences-assets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mas-week-egyptian-american-enterprise-fund-valeant-pharmaceuticals-international/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-launches-generic-vidaza-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bill-gates-makes-100-million-personal-investment-fight-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nanotech-gene-editing-used-edit-cholesterol-gene-u-s-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/california-institute-biomedical-research-excelra-knowledge-solutions-enter-database-licensing-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/kadmon-initiates-phase-2-placebo-controlled-clinical-trial-tesevatinib-autosomal-dominant-polycystic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cost-diabetes-epidemic-reaches-850-billion-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/loxo-oncology-announces-global-development-commercialization-partnership-bayer-larotrectinib-loxo-195/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/spains-almirall-warns-delay-approval-psoriasis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-introduces-generic-clolar-injection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ema-recommends-ten-drugs-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/2-warnings-2017-pharmas-ad-police-hits-historic-low/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/merck-glaxosmithkline-face-hepatitis-vaccine-shortage-amid-u-s-outbreaks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-digital-abilify-big-brother-isnt-watching-mother/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-treatment-rare-genetic-enzyme-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-genentechs-hemlibra-emicizumab-kxwh-hemophilia-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/statement-fda-commissioner-scott-gottlieb-m-d-fdas-comprehensive-new-policy-approach-facilitating-development-innovative-regenerative-medicine-products-improve-human/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-grants-marketing-authorization-first-device-use-helping-reduce-symptoms-opioid-withdrawal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-widens-scope-pfizers-sutent-kidney-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-data-show-public-support-tax-rises-fund-nhs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/health-bodies-test-digital-interventions-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cvs-health-launches-state-state-impact-dashboard/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/quotient-sciences-acquires-pharmaterials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/peptidream-announces-agreement-bayer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/science-exchange-announces-outsourced-rd-partnership-alector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-arv-drugs-early-diagnosis-key-beating-aids-epidemic-unaids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/58606/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alnylam-set-speed-patisiran-development-breakthrough-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-sell-womens-health-6b-agree-split-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/medicare-part-d-rule-change-another-win-pharmas-lobbyists-analyst-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-first-two-drug-regimen-certain-patients-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-approves-post-chemo-option-patients-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/acorda-drops-experimental-parkinsons-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/janssens-zytiga-approved-earlier-use-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-cut-25-israel-workforce-calcalist-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-glenmarks-generic-hailey-fe-120/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/ajanta-launches-generic-kapvay/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-ciplas-generic-pulmicort-respules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cytokinetics-stops-developing-tirasemtiv-failed-late-stage-als-study-trading-halted/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/innate-pharma-provides-update-lirilumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/avatars-can-help-schizophrenia-patients-control-threatening-voices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/bayer-nektars-drug-device-product-fails-improve-outcomes-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/report-singapores-pharmaceutical-market-witness-5-cagr-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/isodiol-international-inc-signs-binding-agreement-acquire-100-c3-global-biosciences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/jj-lilly-az-diabetes-medications-get-another-helping-real-world-heart-benefits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amerisourcebergen-says-civil-penalty-resolve-doj-probe-now-625m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-teva-ceo-shakes-structure-executive-ranks-major-layoffs-loom/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astrazeneca-steps-china-push-new-drug-joint-venture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/acadia-launches-parkinsons-campaign-shine-light-psychosis-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/viiv-trials-long-acting-two-drug-hiv-regimen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/glenmark-shares-fall-3-3-us-fda-warnings-baddi-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trump-obamacare-deal-pave-way-end-individual-mandate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/uk-first-country-allow-otc-sales-erectile-dysfunction-drug-viagra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/1-10-medical-products-developing-countries-substandard-falsified/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/forecast-predicts-half-u-s-children-will-obese-age-35/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/gsk-starts-big-african-study-injectable-drug-prevent-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/avelumab-fails-improve-survival-gastric-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-ferrings-clenpiq-sodium-picosulfate-magnesium-oxide-anhydrous-citric-acid-oral-solution-colonoscopy-prep/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-clears-first-medical-device-accessory-apple-watch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-biocon-win-fda-nod-herceptin-copy-move-biosim-forward-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/jjs-darzalex-success-spur-buy-partner-genmab-maybe-one-analyst-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/newfound-protein-may-prevent-viral-infection-herpes-induced-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofi-ends-development-c-difficile-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/preventing-psoriasis-vanillin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/astellas-buys-dmd-drug-450m-mitochondrial-takeover/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/researchers-identify-medication-can-prevent-migraines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/active-biotech-announce-results-arpeggio-phase-ii-trial-laquinimod-primary-progressive-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/brief-gilead-announces-public-health-initiative-combat-hivaids-southern-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/abbvies-il-23-blocker-shows-efficacy-psoriasis-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/trouble-mounts-sanofi-dengue-vaccine-safety-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mylan-aspen-launch-generic-myleran/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-breckenridges-megace-es-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amneal-launches-clolar-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/cvs-health-aetna-merge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-ozempic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-dravet-syndrome-drug-candidate-scores-phase-iii/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/nestle-buy-vitamin-maker-atrium-innovations-2-3bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/galectin-therapeutics-announces-results-phase-2b-nash-cx-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-breast-cancer-drug-superior-chemotherapy-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/philippines-seek-refund-59-million-sanofi-amid-vaccine-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/roches-latest-tecentriq-results-shed-little-light-lung-cancer-market-race-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/growth-retail-drug-spending-freefalls-along-hepatitis-c-drug-costs-analysis-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/diabetes-drug-metformin-inhibits-multidrug-resistant-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/roche-lymphoma-drug-drives-high-remission-rate-longer-survival-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-launches-generic-viagra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/tevas-job-cut-tally-touch-10k-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/promising-responses-seen-agios-leukemia-drug-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/novel-mdd-treatment-succeeds-phase-2-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-mepolizumab-churg-strauss-egpa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/currently-940-clinical-stage-immuno-oncology-agents-developed-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/otsuka-returns-us-rights-sativex/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/daiichi-sankyo-signs-two-oncology-deals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amneal-launches-generic-kenalog-40/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/china-minority-region-collects-dna-millions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/university-wollongongs-pict-3d-bioprinter-revolutionize-type-1-diabetes-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/needle-free-injection-device-moves-closer-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/sanofiregenerons-breakthrough-pd-1-hits-positive-notes-skin-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/3-stocks-focus-biotech-ma-hopes-2018-rise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/perrigo-lines-bid-mercks-consumer-health-unit-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pfizer-weighs-strategic-options-newly-fda-approved-remicade-biosim-second/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/lupins-safyral-generic-tydemy-gets-fda-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-drugs-agency-says-move-new-hq-may-take-longer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/alnylam-sanofi-cleared-resume-hemophilia-candidate-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/another-patent-challenge-gilead-time-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/parkinsons-existing-drug-halt-disease-progression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/allergan-richter-announce-positive-topline-results-phase-3-study-cariprazine-treatment-bipolar-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/aerie-pharmaceuticals-announces-u-s-fda-approval-rhopressa-netarsudil-ophthalmic-solution-0-02-lowering-elevated-intraocular-pressure-patients-open-angle-glaucoma-ocu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/canadian-cannabis-firm-licensed-produce-denmark/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/third-people-taking-prescribed-diabetes-medication-due-side-effects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/amneal-names-allergan-vet-president/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/pharmajet-invectys-enter-phase-2-cancer-vaccine-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/france-fines-jj-25-million-euros-painkiller-patch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/u-s-fda-approves-new-diabetes-drug-merck-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/drug-combo-proves-effective-pattern-hair-loss-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/new-hope-skin-cancer-form-arthritis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/study-method-proven-prevent-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-drug-treat-dangerously-low-blood-pressure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/roche-ignyta-reach-definitive-merger-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/california-court-says-novartis-can-sued-generic-drug-injuries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/whats-ahead-generics-pricing-woes-analysts-say-execs-see-better-times/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/janssen-enters-worldwide-collaboration-license-agreement-chinese-company-legend-biotech-develop-investigational-car-t-anti-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/israels-super-pharm-talks-buy-teva-pharm-plant-source/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/fda-approves-luxturna-voretigene-neparvovec-rzyl-gene-therapy-treat-patients-rare-form-inherited-vision-loss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/walmart-cvs-health-execs-address-nrf-2018-convention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/eu-follows-us-approves-chugais-alk-inhibitor-alecensa-first-line-therapy-alk-positive-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/theranos-secures-100-million-new-funding-fortress-capital/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/icers-report-vmat2-inhibitors-tardive-dyskinesia-says-vastly-overpriced/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mallinckrodt-buy-sucampo-840-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/vitamin-d-calcium-supplements-may-lower-fracture-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/mitochondrial-metabolite-linked-regulation-neurotransmission/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/martin-shkrelis-former-lawyer-convicted-federal-jury-conspiring-ex-client-defraud-investors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/dr-reddys-launches-melphalan-hydrochloride-injection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2017/teva-announces-generic-reyataz-capsules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-ends-research-new-alzheimers-parkinsons-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chemdiv-dzne-torrey-pines-investment-launch-inflammasome-discovery-program-translational-collaboration-neurodegeneration-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/atlas-venture-launches-generation-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alnylam-sanofi-enter-strategic-restructuring-rnai-therapeutics-rare-disease-alliance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/leading-pharma-gets-40-million-infusion-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lupin-launches-generic-ancobon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takeda-acquire-tigenix-630-million-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celgene-buy-impact-biomedicines-7-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/shire-cuts-2020-revenue-target-prepares-spin-adhd-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-arvinas-collaborate-protacs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-regeneron-beef-investment-immunotherapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-approvals-reached-record-high-2017/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/shires-maribavir-wins-us-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hung-dry-axovants-terrible-jpm-week/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/glaxo-ceo-replaced-50-top-managers-shakeup-spur-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/laundry-list-reasons-behind-teva-pharmaceutical-industries-48-tumble-2017/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-treatment-breast-cancer-certain-inherited-genetic-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-approves-az-biologic-fasenra-severe-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/canada-issues-safety-warning-boehringers-ofev-fatality/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cdc-flu-season-far/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drugmaker-dermapharm-gears-likely-first-german-ipo-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eisai-completes-oral-solid-dose-production-facility-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/59015/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-ceo-schwan-concedes-challenges-highly-highly-profitable-drugs-fall-biosimilar-rivals-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/aurobindo-gets-fda-approval-generic-arixtra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sun-pharma-settles-litigation-linzess-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/greenstone-launches-authorized-generic-silvadene-cream/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/59042/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-discovery-testing-new-approach-adhd-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bain-joins-bidding-germanys-stada-higher-offer-sources-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eiger-biopharmaceuticals-announces-phase-2-liberty-study-pulmonary-arterial-hypertension-meet-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celgene-discussions-buy-juno-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/argentum-pharmaceuticals-wins-patent-invalidation-trial-sole-remaining-patent-protecting-janssens-zytiga/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/59057/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/statement-fda-commissioner-scott-gottlieb-m-d-new-policy-steps-strengthening-public-warning-notification-recalls/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/exelixis-ipsen-report-positive-results-lead-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/amneal-launches-generic-entocort-ec/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/oral-contraceptive-balcoltra-gets-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/regen-biopharma-inc-s-medicinal-chemistry-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-acquire-bioverativ-11-6-billion-%e2%80%8b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celgene-corporation-acquire-juno-therapeutics-inc-advancing-global-leadership-cellular-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lupin-intros-generic-vibra-tabs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eureka-therapeutics-closes-60-million-series-d-financing-advance-proprietary-artemis-t-cell-receptor-platform-safer-t-cell-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-announces-top-line-results-phase-iii-studies-subcutaneously-administered-reslizumab-patients-severe-eosinophilic-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chemocentryx-announces-positive-overall-survival-results-ccr2-inhibitor-ccx872-locally-advancedmetastatic-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gw-pharmaceuticals-u-s-subsidiary-greenwich-biosciences-announce-publication-landmark-epidiolex-cannabidiol-study-lancet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/puma-biotechnology-sinks-europe-unlikely-ok-breast-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-develop-synthetic-bacteria-killing-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/trovagene-announces-initiation-unite-phase-2-clinical-trial-pcm-075-patients-metastatic-castration-resistant-prostate-cancer-mcrpc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-unhampered-rules-races-ahead-gene-editing-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-generics-company-emerges-unlikely-source/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/johnson-johnson-drops-race-pfizer-consumer-unit-paving-way-gsk-reckitt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/brands-matter-pharma-much-outcomes-patients-say-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lutathera-marks-first-fda-approval-peptide-receptor-radionuclide-therapy-prrt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/senate-confirms-trump-nominee-alex-azar-health-secretary/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/synergy-pharmaceuticals-announces-fda-approval-trulance-plecanatide-treatment-irritable-bowel-syndrome-constipation-ibs-c-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/barry-honey-sherman-deaths-targeted-double-homicide-police-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/overlooked-antibiotic-re-enlisted-fight-drug-resistant-superbugs-medical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/seven-new-meds-recommended-approval-including-one-orphan-emachmp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/brief-eu-approval-follows-us-nod-prevymis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ciplas-generic-viread-approved-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-bags-breakthrough-status-autism-hope-balovaptan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/trump-urges-u-s-congress-back-right-try-terminally-ill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/amazon-warren-buffett-create-reasonable-cost-healthcare-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ab-biosciences-shire-enter-agreement-development-commercialization-ab-biosciences-prim-program-potential-treatment-autoimmune-diseases-immune-mediated-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/multiple-sclerosis-guardian-molecule-may-lead-new-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alzheimers-blood-test-promises-detection-years-symptoms-develop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-discover-method-put-cancer-cells-hibernation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/seattle-genetics-acquire-cascadian-therapeutics-adding-late-stage-breast-cancer-program-oncology-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cdc-director-brenda-fitzgerald-resigns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/brief-heads-china-fda-britains-mhra-discuss-cooperation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/capricor-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation-duchenne-muscular-dystrophy-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/amneal-launches-generic-concerta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pivotal-phase-3-checkmate-227-study-demonstrates-superior-progression-free-survival-pfs-opdivo-plus-yervoy-combination-versus-chemotherapy-first-line-non-small-cell-lung-cancer-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-announces-positive-top-line-phase-3-results-ubrogepant-oral-cgrp-receptor-antagonist-acute-treatment-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/apalutamide-delays-metastasis-2-years-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bostons-intarcia-pink-slips-60-employees-terminates-two-late-stage-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/array-excitement-combos-comparison-roche-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/just-two-drugmakers-left-bidding-sanofis-european-generics-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sage-therapeutics-receives-fda-breakthrough-therapy-designation-sage-217-treatment-major-depressive-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/biogen-reports-top-line-results-phase-2b-study-natalizumab-acute-ischemic-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-food-drug-administration-approves-gileads-biktarvy-bictegravir-emtricitabine-tenofovir-alafenamide-treatment-hiv-1-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/verastem-seeks-approval-duvelisib-patients-relapsed-refractory-cllsll-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-warns-2018-profit-may-face-migraine-drug-delays/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breakthrough-therapy-designation-market-worth-144-6-billion-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/primitive-human-eggs-matured-lab-first-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/madrigals-mgl-3196-achieves-primary-endpoint-patients-heterozygous-familial-hypercholesterolemia-hefh/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cvs-health-improves-wages-benefits-alongside-earnings-david-salazarfebruary-8-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cea-report-reforming-biopharmaceutical-pricing-home-abroad/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/oxycontin-maker-stops-promoting-opioids-cuts-sales-staff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-develop-first-urine-producing-human-kidney-tissue-within-living-organism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/israeli-co-polypid-files-86m-nasdaq-ipo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-symdekotm-tezacaftorivacaftor-ivacaftor-treat-underlying-cause-cystic-fibrosis-people-ages-12-older-certain-mutations-cftr-gene/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roivant-poxel-announce-strategic-agreement-development-commercialization-imeglimin-u-s-europe-additional-countries-worldwide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/phase-ii-data-support-potential-roches-novel-anti-vegfanti-angiopoietin-2-bispecific-antibody-rg7716-people-diabetic-macular-edema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/tetraphases-antibiotic-fails-late-stage-study-shares-plummet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/japanese-company-claims-experimental-drug-kills-flu-virus-single-day/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-scraps-another-late-stage-alzheimers-drug-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cambers-generic-viread-launches/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-kgaa-darmstadt-germany-pfizer-provide-update-phase-iii-javelin-lung-200-trial-avelumab-monotherapy-previously-treated-patients-advanced-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-apalutamide-nonmetastatic-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/camber-launches-generic-celexa-oral-solution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-buy-flatiron-health-1-9-billion-expand-cancer-care-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/reversal-fortunes-judge-voids-order-gilead-must-pay-2-5b-merck-patent-dispute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/icer-declares-costs-approved-car-t-therapies-aligned-clinical-benefit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/rheumatoid-arthritis-drugs-market-will-grow-30-4-billion-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-identify-molecule-kills-tumour-cells-may-help-fight-cancer-pti/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vical-initiates-phase-2-trial-vl-2397-antifungal-invasive-aspergillosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sofpironium-bromide-demonstrates-promising-potential-safe-effective-first-line-treatment-primary-axillary-hyperhidrosis-excessive-underarm-sweating/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/h3-biomedicine-preclinical-proof-concept-data-first-class-spliceosome-modulator-therapy-genomically-identified-patients-hematological-cancers-published-nature-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-osmotica-pharmaceuticals-daily-osmolex-er-amantadine-extended-release-tablets-treatment-parkinsons-disease-drug-induced-extrapyramidal-rea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/voyager-therapeutics-abbvie-announce-global-strategic-collaboration-develop-potential-new-treatments-alzheimers-disease-tau-related-neurodegenerative-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/wave-life-sciences-takeda-form-global-strategic-collaboration-advance-therapies-central-nervous-system-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/aimmune-therapeutics-pivotal-phase-3-palisade-trial-ar101-meets-primary-endpoint-patients-peanut-allergy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/impax-launches-authorized-solodyn-generic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/heres-much-calcium-may-lead-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gout-drug-help-treat-heart-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/anti-bacterial-kitchen-sprays-wipes-waste-money-claims-tv-doctor-experiment-reveals-poisonous-bugs-return-within-hour/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/aspirin-just-good-rivaroxaban-preventing-clots-hip-knee-surgery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-co-buys-australian-o-firm-viralytics-394-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/selumetinib-granted-orphan-drug-designation-u-s-fda-neurofibromatosis-type-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novo-nordisk-successfully-completes-first-phase-3a-trial-pioneer-1-oral-semaglutide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/watch-antibiotic-heart-disease-fda-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/obseva-sa-reports-positive-topline-results-implant2-phase-3-clinical-trial-nolasiban-ivf/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/arca-biopharma-reports-topline-phase-2b-results-genetic-af-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/first-medicine-treat-neonatal-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/kyowa-kirin-ultragenyx-announce-crysvita-burosumab-receives-conditional-marketing-authorization-europe-treatment-x-linked-hypophosphatemia-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celgene-stumbles-fda-declines-review-multiple-sclerosis-drug-critical-company-future/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/today-rare-disease-day-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/party-drug-ketamine-prevent-depression-ptsd-women-first-study-female-rats-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-face-502m-bill-comes-short-u-k-patent-appeal-lyrica/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-sorrentos-non-opioid-painkiller-patch-shares-jump/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/big-pharma-big-data-drugmakers-want-health-records/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bial-whanin-signed-exclusive-licensing-agreement-zebinix-south-korea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/idera-pharmaceuticals-announces-launch-global-phase-3-trial-evaluating-imo-2125-combination-ipilimumab-treatment-anti-pd-1-refractory-melanoma-illuminate-301/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ionis-htt-rx-rg6042-top-line-data-demonstrate-significant-reductions-disease-causing-mutant-huntingtin-protein-people-huntingtons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vividion-therapeutics-announces-strategic-research-collaboration-celgene-corporation-discover-therapies-transformative-first-class-targets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/management-board-initiates-building-approval-process-ema-premises-amsterdam/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-launch-2-hiv-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/santhera-reports-outcome-exploratory-trial-idebenone-ppms-conducted-nih/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/clearside-biomedical-announces-positive-topline-results-pivotal-phase-3-clinical-trial-cls-ta-macular-edema-associated-non-infectious-uveitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/experimental-hiv-antibody-successfully-suppresses-virus-six-months-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/diabetes-grouped-five-types-rather-two-tailor-early-treatment-researchers-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/prescription-opioids-fail-rigorous-new-test-chronic-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-direct-consumer-test-breast-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/europes-medicines-regulator-calls-recall-biogen-abbvie-multiple-sclerosis-drug-reuters-staff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-may-seek-u-s-approval-dengvaxia-despite-philippines-outrage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/endocrinology-drugs-market-depth-analysis-including-key-players-novo-nordisk-sanofi-merck/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-trogarzo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-sees-pivotal-lung-cancer-trial-results-later-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/newer-gout-drug-poses-risk-heart-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eisai-co-ltd-merck-enter-global-strategic-oncology-collaboration-lenvima-lenvatinib-mesylate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sagent-issues-voluntary-recall-injectable-anti-inflammatory-due-impurities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-sends-hikma-back-clinic-generic-advair/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/acc-waiting-fdas-heart-helping-verdict-jj-shares-positive-cv-data-invokana/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-health-spending-twice-countries-worse-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-stops-dangerous-bleeding-patients-taking-factor-xa-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/intec-pharma-lts-manufacture-drug-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/theranos-chief-executive-elizabeth-holmes-charged-massive-fraud/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/positive-topline-results-second-phase-3-study-evaluating-investigational-elagolix-women-uterine-fibroids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alexions-second-rare-blood-disorder-drug-fortify-future-revenue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/experimental-drug-reduces-hot-flushes-connected-menopause/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cancer-drug-prescribed-autism-patients-scientists-discover-reverses-anti-social-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lundbeck-buy-parkinsons-drug-developer-potential-1-1-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/high-blood-glucose-levels-effect-rather-cause-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/statement-fda-commissioner-scott-gottlieb-m-d-pivotal-public-health-step-dramatically-reduce-smoking-rates-lowering-nicotine-combustible-cigarettes-minimally-non-addictive-le/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cigna-take-express-scripts-67-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/erdafitinib-granted-breakthrough-therapy-designation-fda-urothelial-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/certain-breast-cancer-patients-find-endocrine-therapy-ideal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/viagra-may-cancer-prevention-properties-clinical-trials-required-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breakthrough-new-daily-male-contraceptive-pill-found-safe-effective/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lsd-blurs-boundaries-experience-self/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/metformin-lowers-risk-late-miscarriage-preterm-birth-pregnant-women-pcos/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/smart-software-can-diagnose-prostate-cancer-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/britains-use-copycat-biotech-drugs-takes-u-s-lags/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/longtime-u-s-aids-researcher-picked-run-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-advances-pfizer-consumer-health-auction-reckitt-quits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/high-omega-6-levels-can-protect-premature-death/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/experimental-obesity-drug-may-prevent-kidney-stones-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sun-pharma-announces-u-s-fda-approval-ilumya-tildrakizumab-asmn-treatment-moderate-severe-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/phase-iii-impower131-study-showed-roches-tecentriq-atezolizumab-plus-chemotherapy-carboplatin-abraxane-reduced-risk-disease-worsening-death-initial-treatment-peopl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/world-tuberculosis-day-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsks-two-drug-hiv-regimen-wins-european-panel-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/purple-day-2018-monday-26-march/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/israel-launch-big-data-health-project/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-pulls-20-billion-race-pfizer-consumer-assets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/arena-pharmaceuticals-reports-positive-phase-2-results-oasis-trial-etrasimod-patients-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-reaches-agreement-novartis-acquire-full-ownership-consumer-healthcare-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/300-million-hepatitis-b-sufferers-one-20-treated-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/biohaven-shares-drop-23-migraine-drug-trial-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-use-synthesized-antibiotic-treat-bacterial-infection-mice-first-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/newly-discovered-human-organ-may-help-explain-cancer-spreads/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alzheimers-solution-requires-prescription-doctor-painkiller-ibuprofen-eliminate-disease-reveal-scientists/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-drug-significantly-reduces-smoking-habit-heart-attack-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drugmaker-shire-soars-japans-takeda-considers-bid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-compound-shows-promise-rheumatoid-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/phase-iii-impower150-study-showed-roches-tecentriq-atezolizumab-avastin-bevacizumab-plus-carboplatin-paclitaxel-helped-people-advanced-lung-cancer-live-longer-compared-ava/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/protagonist-therapeutics-discontinues-phase-2b-propel-trial-ptg-100-treatment-ulcerative-colitis-following-interim-analysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/israel-aims-100000-people-volunteer-health-database/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/shire-reports-regulatory-milestones-investigational-hereditary-angioedema-hae-treatment-lanadelumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-inc-announced-tafamidis-phase-3-transthyretin-cardiomyopathy-study-evaluating-tafamidis-treatment-transthyretin-cardiomyopathy-met-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-blincyto-blinatumomab-treat-minimal-residual-disease-positive-b-cell-precursor-acute-lymphoblastic-leukemia-adults-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bluebird-celgene-share-u-s-costs-profits-lead-cancer-car-t/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-large-scale-trial-results-show-stiolto-respimat-prevents-copd-exacerbations-better-spiriva-respimat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/genentech-offers-hemlibra-update/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-drug-attacks-cancer-causing-genes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dangerous-antibiotic-resistant-gene-spread-world-now-know-started/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/senators-launch-probe-price-cancer-drug-increased-1400-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/harvard-researchers-look-fetus-better-wound-healing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-signs-deal-allogene-develop-cancer-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/high-flying-biotech-loxo-tempers-bullish-view-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celgene-corporation-announces-departure-president-chief-operating-officer-scott-smith/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-rejects-alkermes-depression-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-gets-fda-nod-cost-saving-hiv-combo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/compugen-astrazeneca-unit-cancer-drug-development-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/low-dopamine-may-indicate-early-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lilly-announces-cyramza-ramucirumab-phase-3-reach-2-study-second-line-hepatocellular-carcinoma-patients-met-overall-survival-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ucb-strengthens-research-capabilities-acquisition-element-genomics-duke-university-biotech-spin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-green-light-chiesis-lamzede/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/boehringer-ingelheim-ose-immunotherapeutics-announce-global-immuno-oncology-partnership-develop-pioneering-checkpoint-inhibitor-treatment-advanced-solid-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/reviews-start-pfizers-wildcard-lung-cancer-drug-dacomitinib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-industry-standards-group-launched/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/settlement-clears-path-biogen-samsungs-humira-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novartis-enters-agreement-acquire-avexis-inc-usd-8-7-bn-transform-care-sma-expand-position-gene-therapy-neuroscience-leader/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mercks-keytruda-helps-lung-cancer-patients-live-longer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novo-nordisk-obtains-exclusive-worldwide-licence-epidestinys-sickle-cell-disease-programme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/incyte-merck-provide-update-phase-3-study-epacadostat-combination-keytruda-pembrolizumab-patients-unresectable-metastatic-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/upadacitinib-demonstrates-positive-rheumatoid-arthritis-results-select-compare-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-pushes-elagolix-pdufa-date-q3-april-10-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/epilepsy-drugs-increase-peoples-risk-dementia-60-breaking-brain-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alexion-acquire-wilson-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-shut-ashdod-plant-within-year-loss-175-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-may-found-new-weapon-tackle-flu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-invest-e350-million-canadian-vaccine-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-remove-tariffs-imported-cancer-drugs-may-1-state-media/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-hands-rare-disease-gene-therapies-orchard/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dow-jones-component-pfizer-pfe-interest-acquiring-bristol-myers-squibb-bmy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eating-berries-may-prevent-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/us-fda-approves-first-ai-device-detect-diabetic-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/good-cholesterol-may-increase-risk-gastro-pneumonia-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hanmi-pharma-gives-development-lung-cancer-drug-olita/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/shire-sells-cancer-drugs-servier-2-4-billion-takeda-circles/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-seeks-deal-german-mercks-consumer-products-unit-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vtv-therapeutics-announces-topline-results-first-steadfast-phase-3-study-evaluating-azeliragon-people-mild-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/karyopharms-selinexor-receives-fast-track-designation-fda-treatment-patients-penta-refractory-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/world-hemophilia-day-2018-sharing-knowledge-makes-us-stronger/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/advent-international-enters-exclusive-negotiations-acquire-zentiva-sanofis-european-generics-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gates-backs-gene-technologies-fight-end-malaria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-therapy-rare-inherited-form-rickets-x-linked-hypophosphatemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/rigel-announces-fda-approval-tavalisse-fostamatinib-disodium-hexahydrate-chronic-immune-thrombocytopenia-itp-adult-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergans-interest-raises-stakes-pursuit-drugmaker-shire/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pg-acquire-german-mercks-consumer-health-business-4-21-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-report-shows-500-medicines-development-neurological-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gw-pharma-gets-fda-panel-nod-first-cannabis-based-drug-nearing-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/biogen-boosts-investment-neurology-1-billion-ionis-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/shire-rejects-43bn-offer-japans-takeda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/good-news-glaxo-novartis-advair-copy-definitely-wont-see-market-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/relapsing-ms-patients-switched-aubagio-teriflunomide-reported-increased-treatment-satisfaction-two-clinical-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-declines-approve-pfizer-biosimilar-roches-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/prostate-cancer-breakthrough-scientists-invent-new-ultra-accurate-non-invasive-test-killer-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/two-new-lung-cancer-medicines-offer-hope/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/jilted-akorn-sues-fresenius-deal-termination/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/uk-bans-sanofi-epilepsy-drug-without-pregnancy-prevention-plan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/squeezed-mylan-axing-500-jobs-west-virginia-right-size-massive-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-hits-hong-kong-otc-drugmaker-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/otsukas-jynarque-tolvaptan-approved-u-s-fda-first-treatment-slow-kidney-function-decline-adults-risk-rapidly-progressing-autosomal-dominant-polycystic-kidney/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-advisory-committee-recommends-approval-baricitinib-2mg-4mg-treatment-moderately-severely-active-rheumatoid-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-akynzeo-injection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dna-commonly-found-well-known-double-helix-shape-new-research-shows-can-take-another-form/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/availability-orphan-medicines-varies-european-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/neurocrine-presents-positive-analysis-phase-iii-ingrezza-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ctg-catapult-opens-new-unique-cell-gene-therapy-plant-u-k/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/twice-rejected-lilly-adocia-mounts-recovery-diabetes-drug-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-study-shows-life-saving-outcomes-using-3-d-printing-models-heart-valve-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/global-study-finds-44-genetic-risk-factors-major-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vitamin-derivative-cure-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cancer-drug-helps-treat-tuberculosis-restoring-leaky-blood-vessels/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/united-therapeutics-acquire-steadymed-ltd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/kymriah-tisagenlecleucel-first-class-car-t-therapy-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/painkillers-cortisone-injections-scientists-rank-five-effective-treatments-knee-osteoarthritis-r/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/common-diabetes-drug-prevent-cocaine-relapse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/benevir-bought-janssen-1-04-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-reports-jump-first-quarter-earnings-raises-guidance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-hits-mexican-drugmaker-degasa-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-rebuff-celgene-track-refile-ozanimod-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celgene-reports-first-quarter-2018-operating-financial-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/back-u-s-fda-approves-portola-pharmaceuticals-andexxa-first-antidote-reversal-factor-xa-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sarepta-therapeutics-announces-first-quarter-2018-financial-results-recent-corporate-developments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bayer-sells-covestro-stake-2-2-billion-euros/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/japans-takeda-clinches-62-billion-deal-buy-drugmaker-shire/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/aurobindo-bids-1-6b-novartis-u-s-dermatology-generics-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/south-africas-aspen-opens-80m-high-potency-site-adding-500-workers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/portolas-andexxa-bleeding-antidote-wins-fda-nod-will-see-limited-release/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lilly-announces-agreement-acquire-armo-biosciences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/daiichi-sankyo-announces-single-agent-quizartinib-significantly-prolongs-overall-survival-compared-chemotherapy-patients-relapsedrefractory-aml-flt3-itd-mutations-quantum-r-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/valeant-will-become-bausch-health-companies-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/janssen-announces-darzalex-daratumumab-u-s-fda-approval-newly-diagnosed-patients-multiple-myeloma-transplant-ineligible/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofis-shift-robots-digital-twins-u-s-biologics-site-costs-95-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-canada-announces-launch-teva-cyclosporine-ophthalmic-emulsion-first-generic-version-restasis-canada-treatment-dry-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/calls-trans-fats-eliminated-within-five-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-consider-expanding-medicare-drug-price-negotiation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/medigene-1-5-billion-broader-pact-bluebird-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazenecas-respiratory-rivalry-glaxosmithkline-takes-hit-fasenras-phase-3-fail/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gets-approval-use-ebola-vaccine-democratic-republic-congo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizers-biosimilar-anemia-treatments-gets-fda-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/deadly-brain-cancer-stopped-new-compound/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/jet-lag-supplement-may-combat-obesity-melatonin-burns-calories-reduces-fat-storage-around-midriff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/reversing-atherosclerosis-one-shot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/injection-thin-blood-can-also-help-breathe-easily/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/causes-pcos-scientists-might-found-answer-big-implications-treat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gilead-build-eu-car-t-manufacturing-facility-amsterdam-airport/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lillys-galcanezumab-meets-primary-endpoint-phase-3-study-evaluating-galcanezumab-prevention-episodic-cluster-headache/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/early-test-inovios-hiv-vaccine-delivered-immune-responses-lasted-least-6-months/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-non-opioid-treatment-management-opioid-withdrawal-symptoms-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsks-blockbuster-hiv-drug-linked-birth-defects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/reuters-johnson-johnson-said-stop-mid-stage-trials-testing-experimental-alzheimers-drug-observing-safety-issues-latest-drugmaker-abandon-developing-treatmen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-drug-dramatically-reduces-bleeds-key-hemophilia-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/protein-found-tobacco-plant-potential-fight-life-threatening-infectious-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/statement-fda-commissioner-scott-gottlieb-m-d-trump-administrations-plan-lower-drug-prices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-doptelet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/toothpaste-ingredient-may-combat-severe-lung-disease-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/study-finds-old-drug-may-help-treat-hereditary-motor-neuron-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/spark-therapeutics-pfizer-announce-data-15-participants-hemophilia-b-showing-persistent-sustained-factor-ix-levels-serious-adverse-events/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novo-nordisk-sees-clinical-studies-stem-cell-based-therapies-type-1-diabetes-next-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/estonia-map-dna-10-population/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/former-gilead-sciences-rd-chief-norbert-bischofberger-named-ceo-kronos-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-hopes-launch-migraine-drug-soon-september/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/humans-may-influence-cancer-many-species-planet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/rare-virus-without-cure-emerged-india-killing-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/can-drinking-much-water-harm-cause-brain-swelling-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-stalls-eisai-new-partner-merck-quest-widen-cancer-med-lenvimas-reach/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/antidepressants-may-lead-weight-gain-british-study-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/glaxosmithkline-veteran-zhi-hong-launches-brii-biosciences-260m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/grails-third-vc-round-brings-funding-total-1-5b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/biomarin-provides-2-years-clinical-data-6e13-vgkg-dose-ongoing-phase-12-study-valoctocogene-roxaparvovec-gene-therapy-severe-hemophilia-world-federation-hemophilia-2018-wor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/biomarin-receives-standard-approval-palynziq-pegvaliase-pqpz-injection-treatment-adults-phenylketonuria-pku-rare-genetic-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pivotal-bioventure-partners-debuts-150m-china-focused-biotech-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-makes-easier-companies-produce-generic-medicines-export/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/india-steps-hunt-origin-mysterious-brain-damaging-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-ai-algorithm-help-doctors-diagnose-fractures-faster/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/walk-chew-gum-stay-thin-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/european-cancer-vaccine-startup-nouscom-poaches-pfizer-o-executive/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/talc-mesothelioma-case-south-carolina-ends-mistrial-johnson-johnson/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/deep-brain-stimulation-found-improve-diabetes-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/timing-chemotherapy-drugs-patients-personal-biological-clock-make-treatment-effective-research-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-sell-womens-health-infectious-disease-units/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/trump-says-drug-companies-unveil-price-cuts-two-weeks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/asgct-2018-electroporation-mediated-gene-delivery-coronary-artery-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vtv-therapeutics-announces-licensing-agreement-newsoara-biopharma-co-ltd-rights-vtvs-pde4-inhibitor-china-pacific-rim-territories/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-inc-announced-fda-approved-xeljanz-tofacitinib-treatment-patients-moderately-severely-active-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ucb-announces-approval-cimzia-certolizumab-pegol-moderate-severe-plaque-psoriasis-representing-important-new-option-patients-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/oral-semaglutide-shows-superior-improvement-hba1c-vs-empagliflozin-pioneer-2-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/french-drug-maker-announces-lyme-disease-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/might-baking-soda-boost-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pill-commonly-used-treat-fungal-nail-infections-cure-bowel-cancer-research-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/parkinsons-disease-hope-study-finds-arthritis-asthma-medication-reduces-risk-condition-one-third-pave-way-new-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ab-science-provides-update-eu-marketing-authorization-application-masitinib-treatment-amyotrophic-lateral-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/madrigals-mgl-3196-shows-sustained-benefit-mid-stage-nash-study-shares-40-premarket/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-artificial-iris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-announces-u-s-fda-approves-xeljanz-tofacitinib-treatment-moderately-severely-active-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-stops-olesoxime-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/updated-results-ongoing-multicenter-phase-study-bb2121-anti-bcma-car-t-cell-therapy-continue-demonstrate-deep-durable-responses-patients-late-stage-relapsedrefractory-multiple/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/tricida-announces-positive-pivotal-phase-3-clinical-trial-results-trc101-ckd-patients-metabolic-acidosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/results-phase-iii-relevance-study-comparing-revlimid-plus-rituximab-r%c2%b2-versus-rituximab-plus-chemotherapy-patients-previously-untreated-follicular-lymphoma-presented-asco-20/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/phase-ii-clinical-study-elenbecestat-demonstraytes-safety-tolerability-mci-mild-moderate-alzheimers-disease-18-months/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/study-diuretic-effective-antibiotics-treat-womens-acne/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/artificial-bone-marrow-take-fight-diseases-blood/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/human-trials-set-experimental-hiv-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-warns-websites-stop-illegal-online-opioid-sales/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/missouri-jj-faces-biggest-trial-yet-alleging-talc-caused-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/trembling-cursor-struggling-scroll-online-early-signs-parkinsons-alzheimers-reveal-scientists-microsoft-duke-university-analysed-online-activity-31-million-americans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/blood-test-pregnant-women-can-predict-premature-birth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-files-parp-inhibitor-breast-cancer-us-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vertex-presents-real-world-data-highlighting-benefit-cf-drug-kalydeco/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/update-phase-iii-clinical-trials-lanabecestat-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/galmeds-600-mg-aramchol-achieved-regulatory-approvable-endpoint-showing-nash-resolution-without-worsening-fibrosis-nash-patients-global-phase-2b-arrest-52-week-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ten-thousand-bursting-genes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/abbvie-announces-u-s-fda-approval-venclexta-venetoclax-tablets-combination-rituximab-fixed-duration-treatment-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-pa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/aussie-researchers-develop-new-blood-test-better-predict-heart-attacks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/decades-old-asthma-drug-reversed-brain-damage-dementia-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/parkinsons-linked-bacteriophages/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lillys-lupus-treatment-succeeds-mid-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/viiv-healthcare-reports-landmark-phase-iii-studies-dolutegravir-lamivudine-demonstrating-ability-control-hiv-two-drug-regimen-treatment-naive-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vtvs-alzheimers-drug-azeliragon-flops-phase-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/despite-fda-hold-epizymes-tazemetostat-posts-positive-interim-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/modern-alchemists-making-chemistry-greener/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/orion-biotechnology-canada-acquires-k2biomedical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ms-new-findings-may-prevent-future-loss-brain-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/large-international-study-links-blood-vitamin-d-levels-colorectal-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-pulls-fremanezumab-cluster-headaches-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-national-drug-administration-approves-countrys-first-immuno-oncology-agent-opdivo-nivolumab-injection-previously-treated-non-small-cell-lung-cancer-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/tg-therapeutics-inc-announces-updated-results-ongoing-phase-2-study-ublituximab-patients-multiple-sclerosis-4th-congress-european-academy-neurology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-pays-2-4-billion-rest-cancer-expert-foundation-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-declines-approve-valeants-plaque-psoriasis-lotion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novo-kallyope-link-develop-obesity-diabetes-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/speedy-genetic-tool-might-soon-let-scientists-create-new-genes-overnight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novos-pioneering-diabetes-pill-beats-victoza-januvia-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/geron-posts-positive-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-kgaa-partners-alibaba-health-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/caffeine-four-cups-coffee-protects-heart-help-mitochondria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/repurposing-promising-cancer-drugs-may-lead-new-approach-treating-tb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gene-silencing-alleviates-machado-joseph-disease-study-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-discover-potential-disease-fighting-warheads-bacteria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sarepta-therapeutics-announces-first-rd-day-jerry-mendell-m-d-presented-positive-preliminary-results-first-three-children-dosed-phase-12a-gene-therapy-micro-dystrophin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizers-breast-cancer-drug-combo-falls-short-survival-goal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dementia-venture-fund-raises-350-million-hunt-new-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-discover-new-antiviral-gene-prevent-virus-clone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eye-pharma-lupin-announces-distribution-agreement-etanercept-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merrimack-announces-top-line-results-randomized-phase-2-trial-mm-141-front-line-metastatic-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/clamor-gsk-shingles-shot-points-bigger-profits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/spectrum-pharma-weighing-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/basf-shuts-ibuprofen-production-u-s-plant-due-technical-problem/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/good-news-bad-news-fda-approval-achaogens-powerful-antibiotic-zemdri/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ada-lillys-trulicity-bests-novos-victoza-azs-bydureon-real-world-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-gives-biocon-biosimilars-plant-clean-bill-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/antidepressants-can-kill-patients-lung-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/modified-polio-vaccine-may-help-extend-life-brain-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/root-violence-mice-become-mean-injected-antibody-taken-blood-human-murderers-rapists-gang-members/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/copper-reducing-molecule-help-wilsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-cancer-drugs-halt-autism-symptoms-prevent-onset-blocking-protein-linked-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-advent-finally-shake-hands-2-2b-european-generics-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/facial-recognition-ramped-across-british-borders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-discover-effective-treatment-fight-tb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/good-news-heavy-coffee-drinkers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cvc-capital-revs-rare-disease-ambitions-3-5b-recordati-buyout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/conatus-pharmaceuticals-pan-caspase-inhibitor-emricasan-improves-survival-portal-hypertension-mouse-model-cirrhosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-focus-china-develops-smart-vest-monitor-heart-prevent-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/experimental-drug-stops-parkinsons-disease-progression-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/virus-may-boost-immune-system-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/abivax-releases-positive-top-line-data-abx464-005-phase-2a-study-hiv-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/europe-recalls-generic-heart-drug-made-china-cancer-fears/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-judge-tosses-140-million-verdict-abbvie-androgel-case/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ex-millennium-chief-deborah-dunsire-looks-pipeline-growth-lundbecks-ceo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-diabetes-drug-can-help-reverse-fatal-lung-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alkermes-receives-50-million-payment-biogen-following-review-preliminary-gastrointestinal-tolerability-data-ongoing-biib098-clinical-development-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/biogen-eisais-alzheimers-drug-succeeds-mid-stage-trial-shares-soar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/study-reveals-potential-approach-treat-dementia-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alzheimers-aspirin-may-reduce-toxic-plaque/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bristol-myers-squibb-looks-sell-french-otc-unit-bring-1-8b-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/species-specific-activity-antibacterial-drug-combinations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cti-biopharmas-cancer-drug-fails-late-stage-trial-shares-tumble/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/orion-started-phase-iii-trial-develop-drug-als-patient-recruitment-begun/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/results-phase-iii-pix306-trial-evaluating-progression-free-survival-pixuvrir-pixantrone-combined-rituximab-patients-aggressive-b-cell-non-hodgkin-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-adds-central-nervous-system-portfolio-launch-generic-exelonr-patch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-closing-plant-france-pollution-complaint-filed-government/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ai-system-can-predict-side-effects-drug-combinations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-giant-pfizer-split-three-units-including-new-hospital-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gala-therapeutics-receives-fda-ide-approval-us-early-feasibility-study-rheoxtm-system-treat-chronic-bronchitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alphabet-resmed-spinning-start-solve-sleep-apnea-hidden-health-crisis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/amazon-start-xealth-planning-pilot-doctors-prescribe-products-delivered-patients-leave-hospital/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novartis-exits-antibiotics-research-cuts-140-jobs-bay-area/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/jury-orders-jj-pay-4-7-billion-missouri-asbestos-cancer-case/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-court-denies-jazz-pharma-bid-revive-narcolepsy-drug-patents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/saturated-fats-yoghurt-cheese-butter-increase-risk-heart-disease-may-actually-prevent-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cms-proposes-change-drug-payment-amount-medicare-part-b-reuters-staff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-pushes-lower-cancer-drug-prices-xinhua/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breaking-crispr-causing-extensive-mutations-genetic-damage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-blood-test-can-detect-deadly-skin-cancer-better-biopsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-filled-nanobubbles-triggered-x-rays-aim-cancer-treatment-aussie-researchers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-signs-u-s-license-deal-humira-abbvie/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/anti-obesity-drug-derived-chili-peppers-shows-promise-animal-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/study-links-adhd-symptoms-teens-frequent-gadget-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bill-gates-backs-30-million-push-early-alzheimers-diagnostics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ibm-extends-deal-using-watson-support-veterans-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-stockpile-drugs-brexit-safety-net/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/common-type-2-diabetes-drug-mixed-vitamin-b-stop-medication-causing-nausea-vomiting-finds-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-focus-chinas-new-alzheimers-drug-completes-phase-3-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astellas-considering-selling-europe-assets-raise-cash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/selective-neuronal-silencing-using-synthetic-botulinum-molecules-alleviates-chronic-pain-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-lowers-prices-drugs-trump-calls-industry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-lilly-pain-drug-meets-late-stage-trial-goals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-targeted-treatment-patients-relapsed-refractory-acute-myeloid-leukemia-certain-genetic-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/apollo-buy-lifepoint-latest-private-equity-bet-healthcare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/swiss-german-drugmakers-join-u-s-price-freeze/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/patient-death-prompts-fda-hold-mersanas-lead-cancer-adc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-tafenoquine-prevent-malaria-relapse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cannabis-may-boost-immune-system-fight-cancer-scientists-claim/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/adding-just-two-half-teaspoons-sugar-tea-daily-increases-risk-alzheimers-54-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breakthrough-will-soon-end-diabetes-new-implant-tackle-cause-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/abbvies-new-endometriosis-drug-cost-10k-per-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/two-drug-hiv-regimen-gsk-bolstered-phase-3-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-joins-u-s-drug-price-freeze-rest-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-panel-votes-approval-gsks-lung-disease-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ibm-watson-reportedly-recommended-cancer-treatments-unsafe-incorrect/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-identify-gene-linked-people-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takedas-alunbrig-beats-pfizers-xalkori-pfs-alk-positive-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bristol-myers-surprise-threatened-o-drug-opdivo-stands-ground-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-shut-bangladesh-drug-making-factory-end-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takeda-signs-antibody-therapy-deal-hifibio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-declines-approve-insys-therapeutics-opioid-painkiller/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-presents-promising-results-new-wet-amd-product/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-treatment-rare-adrenal-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novartis-migraine-drug-gets-ema-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/experimental-drug-reverses-hair-loss-skin-damage-linked-fatty-diet-shows-new-study-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ec-approves-pfizers-herceptin-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-ai-system-can-design-drugs-scratch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-lusutrombopag-thrombocytopenia-adults-chronic-liver-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bayer-sells-prescription-dermatology-brands-denmarks-leo-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-sues-pfizer-costs-opioid-litigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-sees-one-5000-cancer-risk-tainted-china-heart-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/celtaxsys-cystic-fibrosis-drug-reduces-key-symptom-mid-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/spains-almirall-buy-u-s-dermatology-portfolio-allergan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-reports-first-african-swine-fever-outbreak-culls-1000-hogs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cocaine-relapse-reversed-bdnf-microinjections-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/best-worlds-basic-acidic-flash-switching-organic-synthesis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-bets-biotech-flu-vaccine-425-million-biontech-alliance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/clock-gene-expression-locomotor-activity-predict-death-last-days-life-drosophila-melanogaster/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/research-shows-possible-reverse-damage-caused-aging-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/weaponizing-oxygen-kill-infections-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gps-inside-body/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/american-scientists-develop-gene-therapy-blinding-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/humble-cabbage-can-stop-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-health-secretary-says-agency-can-eliminate-drug-rebates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/nih-starts-phase-l-trial-rzikvd4%ce%b430-713-zika-virus-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/measles-epidemic-europe-hits-record-high-world-health-organisation-warns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/toxin-heart-drug-recall-shows-holes-medical-safety-net/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/candidate-universal-flu-vaccine-protects-multiple-strains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-drug-neurotrophic-keratitis-rare-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novo-nordisk-acquires-ziylo-ltd-accelerate-development-glucose-responsive-insulins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/life-expectancy-declines-seen-u-s-high-income-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-way-tackle-aging-potential-upend-20-billion-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-signs-inclacumab-deal-gbt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/shires-hae-drug-takhzyro-gets-green-light-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-astellas-amend-clinical-research-protocols-two-phase-3-trials-enzalutamide-patients-hormone-sensitive-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pharmaceutical-companies-warn-saudi-disputes-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-discover-immune-system-micro-organs-remember-fight-infections-appear-someone-ill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-discover-first-treatment-improve-survival-rare-heart-condition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cardiovascular-safety-lorcaserin-overweight-obese-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bayer-jjs-heart-drug-xarelto-fails-trial-widen-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-tetraphase-pharmas-antibiotic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-seeks-mid-sept-bids-4b-horlicks-unit-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/math-malaria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chest-pain-drug-falls-short-preventing-first-episode-ventricular-arrhythmia-death/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cochrane-review-looks-accuracy-xpert-diagnosis-extrapulmonary-tb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-recalls-childrens-advil-product-measuring-cup-confused-milliliters-teaspoons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-affimed-us5bn-cancer-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/measuring-tension-cell-fluorescent-molecule/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/natural-sugar-defends-metabolic-syndrome-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-warns-serious-genital-infection-linked-certain-diabetes-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-take-big-step-toward-finding-non-addictive-painkiller/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bayers-hemophilia-treatment-gets-u-s-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/emergent-biosolutions-buy-narcan-maker-adapt-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cadila-healthcare-ltds-subsidiary-gets-5-observations-us-fda-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sotio-ppf-complete-acquisition-cytune-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pharma-nord-helps-climber-conquer-worlds-second-highest-mountain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/potential-acne-vaccine-just-passed-important-early-test-cant-come-soon-enough/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/matcha-green-tea-used-treat-cancer-striking-results-show-kills-cancer-cells-stopping-refuelling/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novartis-gileads-car-ts-alnylams-onpattro-others-rack-eu-approvals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-approved-sanofis-cablivi-caplacizumab-first-antibody-therapeutic-treat-acquired-thrombotic-thrombocytopenic-purpura-attp-friday/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/peter-goldschmidt-succeed-claudio-albrecht-stadas-ceo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-ends-two-duchenne-muscular-dystrophy-drug-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/80-risk-early-death-aged-heart-warns-phe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/huntingtons-disease-starts-childhood/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chinese-scientists-develop-new-wound-dressing-material/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/blood-testing-firm-theranos-dissolve/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/judge-tosses-lawsuit-california-drug-price-law/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-find-new-way-understand-odors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/brexit-costs-mount-pfizer-estimates-100m-adapt-supply-chain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-drops-development-laquinimod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novartis-unloads-u-s-assets-loss-bargain-hunting-aurobindo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/walking-20-minutes-day-cuts-womens-heart-failure-risk-25-first-ever-study-topic-reveals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/glaxosmithkline-cut-650-us-jobs-reinvest-r-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gilead-galapagos-filgotinib-succeeds-phii-ankylosing-spondylitis-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/btg-buys-irish-med-device-group-novate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/itf-pharma-announces-fda-approval-tiglutik-riluzole-oral-suspension-treatment-amyotrophic-lateral-sclerosis-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vertex-completes-enrollment-two-phase-3-studies-vx-659-triple-combination-tezacaftor-ivacaftor-treatment-cystic-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/perrigos-otc-version-diarrhea-drug-imodium-gets-fda-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chinese-researchers-identify-potential-new-antibiotic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazenecas-first-breakthrough-therapy-designation-respiratory-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-says-u-s-fda-wants-information-pulmonary-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/body-clock-study-pave-way-new-asthma-treatment-uk-expert/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cdmo-hit-fda-warning-shutters-plants-files-bankruptcy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cadila-manufacturing-facility-india-gets-fda-form-483-5-observations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-kgaa-pfizers-immuno-drug-shown-alleviate-kidney-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-grants-priority-review-keytruda-pd-l1-positive-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/florence-approaches-pfizer-pauses-operations-north-carolina-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bristol-myers-plaque-psoriasis-drug-shows-promise-mid-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/skin-cancer-breakthrough-new-vaccine-100-percent-effective-beating-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/turning-brains-pain-center-finally-bring-relief-millions-chronic-nerve-pain-suffers-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/traces-32-pharmaceuticals-detected-rivertagus-researchers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-use-bear-saliva-rapidly-test-antibiotics-super-fast-screening-technology-help-discover-new-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cancer-drug-antidepressants-provide-clues-treating-brain-eating-amoeba-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/oehringer-ingelheim-buys-austrian-firm-viratherapeutics-e210m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/immunotherapy-firm-oncoresponse-secures-40m-series-b-financing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ironwood-secures-fda-fast-track-designation-heart-drug-praliciguat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-snaps-bonti/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/tevas-anti-cgrp-drug-ajovy-cleared-migraine-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/az-file-triple-combination-therapy-copd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/daily-low-dose-aspirin-found-effect-healthy-life-span-older-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/macron-announces-changes-frances-health-care-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takeda-gets-chinas-approval-62-billion-shire-purchase/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/clovis-oncology-execs-pay-20-million-settle-sec-charges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/phase-iii-trial-results-pt010-combination-therapy-copd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/almirall-steps-psoriasis-market-ilumetri-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/actelions-opsumit-shows-promise-portopulmonary-hypertension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cochrane-collaboration-expels-cofounder-prompts-resignations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-sosei-suspend-clinical-development-dementia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-approves-fifth-copy-abbvies-18-billion-drug-humira/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astellas-announces-positive-topline-results-global-phase-3-trial-roxadustat-chronic-kidney-disease-ckd-patients-anemia-dialysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/diabetes-drugs-less-affordable-less-available-lower-income-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cambrex-closes-425m-deal-dosage-form-cdmo-halo-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lilly-migraine-drug-wins-european-panel-thumbs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/molecular-templates-announces-agreement-takeda-joint-development-protein-based-oncology-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-plans-center-pudong-boost-medical-rd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/worlds-largest-alzheimers-survey-reveals-adults-believe-cure-will-developed-lifetime/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alcohol-abuse-kills-3-million-year-men/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-diabetes-drug-cuts-heart-risks-major-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-blood-test-roche-dives-deeper-personal-cancer-care/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gtx-announces-top-line-results-placebo-controlled-astrid-trial-enobosarm-women-stress-urinary-incontinence/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/amicus-therapeutics-acquires-gene-therapy-portfolio-ten-clinical-pre-clinical-stage-aav-programs-neurologic-lysosomal-storage-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/opiant-pharmaceuticals-announces-contract-biomedical-advanced-research-development-authority-4-6-million-accelerate-development-opnt003-nasal-nalmefene-treatment-opi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gilead-launch-generic-versions-hepatitis-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novartis-cut-2550-jobs-switzerland-uk-profit-push/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-considering-banning-online-sales-e-cigarettes-gottlieb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-vaccine-success-milestone-tb-room-improvement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/malaria-breakthrough-disease-carrying-mosquitoes-wiped-major-lab-experiment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takedas-alunbrig-shows-promise-first-line-alk-nsclc-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alexion-acquire-syntimmune/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-cuban-biotech-venture-created-bring-new-cancer-therapies-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lillys-snaps-chugais-experimental-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/janssen-hands-back-rights-imetelstat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/inhibitor-gsk3b-hdacs-kills-pancreatic-cancer-cells-slows-pancreatic-tumor-growth-metastasis-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ten-minutes-exercise-day-might-improve-memory-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chronic-illnesses-un-stands-stop-41-million-avoidable-deaths-per-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-fda-approves-lilly-migraine-drug-price-rivals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/two-scientists-won-nobel-prize-medicine-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/generic-cialis-win-teva-eli-lillys-worst-nightmare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/1-october-international-day-older-persons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-fda-approved-vizimpro-vih-zim-pro-dacomitinib-kinase-inhibitor-first-line-treatment-patients-metastatic-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/nobel-prize-physics-shared-woman-first-55-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-replace-longtime-ceo-read-veteran-bourla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hivaids-china-reports-14-surge-new-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/us-oks-sanofi-regenerons-new-skin-cancer-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/nobel-prize-chemistry-awarded-3-scientists-using-evolution-design-molecules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/juul-fdas-sights-u-s-rethinks-position-e-cigarettes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/suffering-chronic-pain-science-says-drink-coffee/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dr-reddys-unloads-antibiotics-plant-abu-dhabi-based-neopharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roche-unveils-phiii-data-flu-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dutch-study-estimates-1-2-women-1-3-men-set-develop-dementiaparkinsonismstroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pepsico-joins-coca-cola-exploring-cannabis-drinks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/jivi-launches-bayer-cuts-227-workers-u-s-plant-produces-hemophilia-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/beat-kymriah-gilead-strikes-discount-yescarta-deal-nhs-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/roches-fast-moving-hemlibra-breaks-wider-hemophilia-market-blockbuster-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/us-nod-akceaionis-tegsedi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bausch-healths-plaque-psoriasis-lotion-gets-tentative-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-antibiotic-ciprofloxacin-destroys-dna-cells-human-body/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/rare-polio-like-condition-appears-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/swedish-startup-mulls-listing-abbvie-parkinsons-challenge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/veracyte-present-data-demonstrating-potential-envisia-genomic-classifier-improve-ild-diagnosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/change-short-term-beliefs-related-dopamine-function-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/glaxosmithkline-taps-publicis-platformgsk-setup-1-5b-media-account/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/china-approves-17-anti-cancer-drugs-medical-insurance-coverage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-reviewers-endorse-celltrions-rituxan-biosimilar-ahead-panel-vote/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/uk-clinical-trials-fall-brexit-clouds-drug-approval-process/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dose-stelara-ustekinumab-induces-clinical-remission-response-adults-moderate-severe-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/jjs-stelara-succeeds-chronic-bowel-disease-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bristol-myers-invest-compugen-collaborate-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gdp-l-fucose-synthase-cd4-t-cell-specific-autoantigen-drb30202-patients-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-establishes-executive-team-support-new-ceo-albert-bourla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allogene-therapeutics-announces-pricing-initial-public-offering/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/uk-doctors-allowed-prescribe-medical-cannabis-november/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/promis-neurosciences-identifies-novel-antibody-drug-candidates-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drug-promises-ease-progressive-multiple-sclerosis-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/irregular-heartbeat-may-increased-risk-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/anti-psychotic-drug-treat-aggressive-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-places-chinas-zhejiang-huahai-increased-supervision/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mit-opening-1bn-ai-college/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sanofi-regenerons-dupixent-shines-rhinosinusitis-nasal-polyps-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-test-rapidly-identifies-antibiotic-resistant-superbugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/nhs-trafford-ccg-placing-team-pharmacists-care-homes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/61237/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-talzenna-gbrcam-her2-breast-ca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-advisory-committee-recommends-approval-dsuvia-treatment-moderate-severe-acute-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dr-reddys-laboratories-announces-sale-api-manufacturing-business-unit-jeedimetla-hyderabad/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/jjs-strong-pharma-unit-sales-offset-currency-rate-woes-q3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cost-blood-pressure-drug-surges-u-s-recall/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chinese-pharmacists-fined-1-3-billion-fake-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/omega-3-fatty-acids-health-benefits-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sweat-required-team-finds-hypertension-treatment-mimics-effect-exercise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/molecule-level-ct-scans-lead-faster-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/phase-ii-trial-capmatinib-demonstrates-positive-results-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-scientists-create-new-drug-sustain-oxygen-starved-hearts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takeda-buys-stake-enteromes-microbiome-crohns-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-digs-deeper-cancer-innate-stake/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/abbvie-rheumatoid-arthritis-drug-succeeds-late-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/consumer-deal-fever-hits-johnson-johnson-2-1b-deal-buy-japans-ciz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-lilly-non-opioid-drug-helps-reduce-osteoarthritis-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/amgen-cuts-price-cholesterol-drug-repatha-60-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/scientists-reveal-new-details-naturally-occurring-hormone-can-boost-memory-aging-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-study-bolsters-hypothesis-herpes-virus-causes-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-new-flu-drug-nearly-20-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-discover-drug-combat-brain-cell-death-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allopurinol-linked-reduced-risk-ckd-stage-%e2%89%a53-gout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gene-therapy-parkinsons-symptoms-shows-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/lundbeck-updates-clinical-phase-iii-study-lu-af35700-treatment-resistant-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gilead-raises-outlook-despite-dip-revenue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eisai-biogen-alzheimers-data-fails-convince-skeptics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-refuses-approve-regenerons-eylea-pre-filled-syringe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takeda-tags-another-shire-drug-sale-win-key-nod-62b-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/careful-reps-doctors-watching-fda-promo-polices-latest-rebuke-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-explain-lsd-changes-perception/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/common-blood-pressure-medication-linked-greater-lung-cancer-risk-study-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/long-lasting-hiv-injection-step-closer-second-gsk-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/secrets-mighty-cancer-killing-virus-unlocked-otago-researchers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/90-worlds-children-breathe-toxic-air-every-day/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/drugmakers-tout-new-medicines-eye-disease-battle-intensifies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/viiv-healthcare-reports-positive-48-week-results-second-phase-iii-study-novel-long-acting-injectable-hiv-treatment-regimen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-mercks-keytruda-pembrolizumab-combination-carboplatin-either-paclitaxel-nab-paclitaxel-first-line-treatment-patients-metastatic-squamous/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-approves-vertex-cystic-fibrosis-combo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/green-light-roches-chemo-free-cll-treatment-combo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/salt-can-trigger-inflammation-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/long-term-prognosis-chagas-patients-improved-anti-parasite-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-weighing-sale-2-billion-womens-health-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/116-countries-859-arrests-interpol-makes-grand-seizure-500-tonnes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fat-thin-can-cost-four-years-life/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-seeks-break-streak-post-earnings-stock-losses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gilead-present-latest-scientific-research-hematologic-malignancies-solid-tumors-ash-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-identify-possible-botulism-antidote/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-pfizers-treatment-certain-lung-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cannabis-tied-serious-type-1-diabetes-complications-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/morning-people-lower-breast-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-nixes-texas-plant-expansion-restasis-generics-loom/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eylea-crosses-quarterly-u-s-blockbuster-line-regeneron-dupixent-nears-new-fda-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-overhaul-west-virginia-plant-ways-go/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mallinckrodts-niemann-pick-type-c-drug-fails-hit-trial-target/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/az-books-sales-growth-third-quarter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hikma-produce-injectables-vietnam-deal-medlac-pharma-italy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/recro-pharma-expands-cdmo-business-georgia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/first-human-clinical-trial-hiv-drug-gammora-offers-potential-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fluorescent-marker-can-help-guide-surgeons-remove-dangerous-brain-tumour-cells-accurately/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-drug-options-risk-factors-added-u-s-heart-guidelines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mylan-theravances-copd-treatment-gets-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/farxiga-significantly-reduced-hospitalisation-heart-failure-cv-death-broad-patient-population-type-2-diabetes-landmark-declare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/report-surveillance-antibiotic-consumption-2016-2018-early-implementation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-mercks-lynparza-scores-speedy-review-blockbuster-ovarian-cancer-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/turning-words-art-merck-kgaa-launches-campaign-bring-ms-insights-life/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-divest-us-synagis-rights-sobi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/61446/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pfizer-loses-blockbuster-drug-patent-fight-uk-supreme-court/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/german-health-minister-calls-faster-adoption-biosimilar-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/theragen-agrees-transfer-technology-j2h/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eisai-launches-lenvima-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hope-parkinsons-patients-scientists-discover-destroy-prevent-build-toxic-clumps-brains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/tens-thousands-die-africa-year-due-fake-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hungary-becomes-one-worlds-top-20-pharmaceutical-exporters-minister/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chinese-pharmaceutical-companies-boost-exports-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pets-can-double-asthma-antidote/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ema-recommends-fexinidazole-first-oral-treatment-sleeping-sickness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/repeat-violations-stack-dr-reddys-cancer-drug-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/abbvies-mavyret-shortens-treatment-period-hep-c-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/torrey-pines-investments-i2020-accelerator-advance-snap-bios-selective-kinase-inhibitor-platform-treatment-endodermal-cancers-autoimmune-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eli-lilly-weighs-200m-plus-sale-declining-china-drug-portfolio-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-treatment-protect-people-peanut-allergies-ready-fda-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breakthrough-understanding-flu-viruses-infect-humans-powers-anti-influenza-drugs-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/boston-scientific-builds-medical-technology-4-2-billion-btg-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-court-allows-generic-version-indivior-opioid-abuse-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/hackers-main-cause-health-data-breaches/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/suicide-gene-scientists-find-hundreds-genetic-links-family-members-killed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/european-commission-approves-lillys-emgality-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/estimation-global-insulin-use-type-2-diabetes-2018-30-microsimulation-analysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/glasdegib-granted-fda-approval-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/35-kidney-genes-linked-chronic-kidney-disease-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/low-cost-drugs-may-effective-cancer-prevention-tools-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/congo-approves-clinical-trials-ebola-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vectura-drops-severe-asthma-treatment-poor-trial-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/generation-z-expect-technology-revolution-nhs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-oncology-drug-targets-key-genetic-driver-cancer-rather-specific-type-tumor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sun-pharma-buys-japanese-company-1m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-seeks-revamp-medical-devices-approvals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/eu-court-sides-merck-endoceutics-trademark-appeal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ge-healthcare-open-uk-biotech-manufacturing-centre/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/novo-nordisk-launches-type-ii-diabetes-awareness-campaign/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bayer-looks-options-consumer-brands-animal-health-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vertex-two-phase-3-studies-vx-659-triple-combination-met-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/xospata-gilteritinib-approved-u-s-fda-adult-patients-relapsedrefractory-acute-myeloid-leukemia-aml-flt3-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-raised-prices-five-drugs-including-keytruda-november/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/triple-combination-cancer-immunotherapy-improves-outcomes-preclinical-melanoma-model/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/weight-cycling-associated-higher-risk-death/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/world-aids-day-december-1-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/bayer-cut-loose-animal-health-consumer-brands-12000-jobs-huge-shakeup/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/calling-quits-biosims-outside-u-s-boehringer-bets-big-humira-patent-fight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/chinese-heparin-maker-banned-ema-contamination-risks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gsk-reaches-agreement-acquire-tesaro-oncology-focused-biopharmaceutical-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/pg-completes-acquisition-merck-kgaas-otc-divisionno-logogeorge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-meridian-biosciences-test-herpes-newborns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alkermes-announces-positive-topline-results-enlighten-2-phase-3-study-alks-3831-patients-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-first-treatment-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-grants-breakthrough-device-designation-artificial-intelligence-software-cteph-pattern-recognition-bayer-msd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/cancer-drug-may-help-treat-human-papillomavirus-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-parkinsons-disease-drug-target-revealed-study-fatty-acids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gbt-announces-u-s-fda-agrees-proposal-relating-accelerated-approval-pathway-voxelotor-treatment-sickle-cell-disease-gbt-plans-submit-new-drug-application-nda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dextenza-dexamethasone-ophthalmic-insert-first-intracanalicular-insert-drug-delivery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/takeda-shareholders-agree-60-bil-shire-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ucb-invest-1bn-uk-life-sciences-sector-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/johnson-johnson-pays-300m-develop-cusatuzumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/working-friday-means-can-lounge-around-weekend-without-gaining-weight-effects-exercise-last-two-days-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/company-focus-science-join-us-novartis-announces-fda-filing-acceptance-priority-review-avxs-101-one-time-treatment-designed-address-genetic-root-cause-sma-type-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/oxybutynin-decreased-frequency-hot-flashes-improved-qol-breast-cancer-survivors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazenecas-imfinzi-fails-meet-main-goals-head-neck-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/overall-us-healthcare-spending-growth-slowed-second-year-cms-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-approves-roches-tecentriq-combination-avastin-chemotherapy-initial-treatment-people-specific-type-metastatic-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/gilead-sciences-names-daniel-oday-chairman-chief-executive-officer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mit-engineers-repurpose-wasp-venom-antibiotic-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/non-insulin-therapies-diabetes-market-register-hugh-growth-healthcare-industry-2026-astrazeneca-boehringer-ingelheim-gmbh-bristol-myers-squibb-eli-lilly-company-glaxosmithk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/vitamin-c-good-lungs-babies-whose-mothers-smoke-pregnancy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/australian-scientists-develop-10-minute-cancer-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-phase-3-data-demonstrate-superiority-tremfya-guselkumab-vs-cosentyx-secukinumab-delivering-pasi-90-responses-treatment-moderate-severe-plaque-psoriasis-week-4/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/ac-immune-lilly-announce-license-collaboration-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/entera-bio-amgen-enter-strategic-research-collaboration-inflammatory-disease-serious-illnesses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/risk-dementia-increased-among-female-veterans-tbi-ptsd-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/mcdonalds-curbing-use-antibiotics-meat-supply-effort-curb-spread-drug-resistant-superbugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/axovant-reports-results-exploratory-phase-2-clinical-study-nelotanserin-lewy-body-dementia-patients-experiencing-rem-sleep-behavior-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/neurocrine-biosciences-announces-topline-data-phase-iib-t-force-gold-study-demonstrating-valbenazine-meet-primary-endpoint-pediatric-patients-tourette-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/new-understanding-mysterious-hereditary-swelling/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/us-flu-activity-low-right-now-rising-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/johnson-johnson-shares-plunge-report-asbestos-baby-powder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/supernus-announces-positive-results-two-phase-iii-studies-spn-812-children-adhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/artificial-intelligence-future-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/teva-will-lease-new-17-floor-tel-aviv-hq-vitania/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazeneca-provides-update-phase-iii-mystic-trial-imfinzi-tremelimumab-stage-iv-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/neurons-good-housekeeping-protected-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/diabetes-related-lower-limb-amputations-jump-nearly-20/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/taisho-nears-1-6-billion-deal-bristol-myers-unit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-panel-votes-prescribing-naloxone-opioids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/advil-meet-excedrin-pfizer-gsk-merging-consumer-healthcare-businesses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/secret-womens-longevity-genes-two-x-chromosomes-promotes-survival-study-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/skin-creams-can-lead-fire-deaths/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/sophiris-bio-provides-updates-phase-2b-localized-prostate-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/allergan-stops-sale-textured-breast-implants-europe-shares-sink/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/astrazenecas-ovarian-cancer-drug-gets-fda-nod-maintenance-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/dengvaxia-approved-dengue-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/nice-recommends-lenvima-advanced-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/imperial-bayer-use-ai-heart-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/molecule-discovery-shows-promise-psoriasis-gene-therapies-21st-december-2018-image-anna-smith-scientists-university-birmingham-announced-discovery-protein-coul/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/acorda-therapeutics-inbrija-parkinsons-disease-treatment-gets-fda-ok/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/alzheimers-vaccine-shows-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/glial-cell-maturation-severely-impaired-patients-huntingtons-disease-download-pdf-copy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/merck-kgaa-pfizer-end-late-stage-ovarian-cancer-treatment-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/past-present-imaging-modalities-used-prostate-cancer-diagnosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breast-cancer-drug-impairs-brain-function/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/brussels-sprouts-drug-treat-alzheimers-supercharging-vitamin-found-christmas-vegetable-may-stop-dementia-tracks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/israeli-lawmakers-approve-medical-cannabis-exports-law/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/opioid-abuse-people-need-heart-surgery-increasing-risk-complications/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/breast-cancer-drugs-help-treat-resistant-lung-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/fda-warns-increased-risk-ruptures-tears-aorta-blood-vessel-fluoroquinolone-antibiotics-certain-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/u-s-opioid-addiction-crisis-top-health-story-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2018/researchers-discover-kidney-disease-gene-affects-populations-previously-thought/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eli-lilly-buy-loxo-oncology-8-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bristol-myers-squibbs-74-billion-acquisition-celgene-combine-two-troubled-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/23andme-will-add-weight-loss-advice-dna-testing-services/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/akorn-gets-fda-warning-letter-illinois-plant-2-min-read/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/drugmaker-eli-lilly-start-publishing-list-prices-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/takedas-ceo-says-needs-sell-assets-quickly-cut-debt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ema-sees-approval-numbers-rise-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/canadas-legal-cannabis-drives-prices-17-govt-stats-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-shut-two-manufacturing-plants-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fund-battling-aids-tb-malaria-seeks-14-billion-invigorate-fight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-sets-records-approving-new-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/axsome-therapeutics-announces-axs-05-achieves-primary-endpoint-phase-2-trial-major-depressive-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eli-lilly-cut-250-jobs-france-plant-voluntary-redundancy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/millions-prescription-sleeping-pills-sleep-fire-alarm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/big-pharma-shells-20b-year-schmooze-docs-6b-drug-ads/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/statins-metformin-used-treat-schizophrenia-bipolar-disorder-remarkable-study-finds-pills-taken-millions-reduce-risk-self-harm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-lawmaker-launches-investigation-pharma-drug-pricing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/painless-microneedle-patch-provides-month-long-contraception/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/aslan-pharmaceuticals-announces-study-results-phase-2-study-varlitinib-first-line-gastric-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/verona-pharma-reports-encouraging-top-line-data-three-day-phase-2-trial-evaluating-nebulized-ensifentrine-rpl554-top-dual-bronchodilator-therapy-copd-maintenance-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/walgreens-microsoft-partner-develop-digital-healthcare-services/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgens-postmenopausal-osteoporosis-drug-wins-fda-panel-backing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/researchers-successfully-turn-breast-cancer-cells-fat-stop-spreading/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/beigene-receives-u-s-fda-breakthrough-therapy-designation-zanubrutinib-mantle-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/spectrum-pharmaceuticals-sells-marketed-portfolio-acrotech-biopharma-l-l-c-focus-new-innovative-therapies-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ascletis-alphamab-announce-strategic-collaboration-licensing-agreement-anti-pd-l1-treat-hepatitis-b-viral-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-partners-medochemie-make-drugs-vietnam/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-recalls-inspectors-shutdown-drags-gottlieb-calls-pdufa-vulnerable/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lilly-cancer-drug-fails-key-trial-will-longer-prescribed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-panel-tie-vote-new-type-1-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ertugliflozin-seems-safe-effective-type-2-diabetes-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/first-generic-version-epilepsy-drug-sabril-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/viriom-china-wins-award-2018-zhongguancun-international-frontier-science-technology-innovation-competition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/drugs-may-one-day-delivered-robots-swallow-scientists-create-ingestible-gadget-swims-body-diseased-tissue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/takeda-mulls-sale-3-billion-emerging-market-assets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chinese-scientist-gene-edited-babies-fired-university/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/glaxosmithkline-chairman-philip-hampton-bows-company-preps-split/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/blood-test-spot-risk-alzheimers-disease-16-years-symptoms-arise-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/johnson-johnson-abbvie-superstar-imbruvica-flunks-pancreatic-cancer-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/alphabet-cfo-ai-good-can-detect-breast-cancer-less-data-ever/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/genetic-study-reveals-possible-new-osteoarthritis-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ozempic-launched-type-ii-diabetes-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/drug-prices-took-daily-fire-last-year-phrma-racked-record-lobbying-bill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ema-cites-slovakian-sterile-drugmaker-says-meds-recalled/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cause-alzheimers-coming-inside-mouth-study-claims/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chinese-scientists-cloned-genetically-altered-primate-first-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/looks-like-common-vaccine-unintentionally-helping-prevent-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/antimicrobial-resistance-uk-launches-5-year-action-plan-20-year-vision/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cystic-fibrosis-drug-combo-found-safe-effective-2-5-year-olds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/harvard-researchers-report-positive-trial-results-artificial-pancreas-smartphone-app/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/profit-offer-20-generic-drugs-2019-alleviate-shortages/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/alexion-announces-positive-top-line-results-phase-3-study-ultomiris-ravulizumab-cwvz-complement-inhibitor-naive-patients-atypical-hemolytic-uremic-syndrome-ahus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abbvie-announces-u-s-fda-approval-imbruvica-ibrutinib-plus-obinutuzumab-gazyva-first-chemotherapy-free-anti-cd20-combination-regimen-approved-chronic-lymphocytic-leukemiasm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/israeli-cabinet-approves-law-allow-medical-cannabis-exports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biogen-beats-estimates-multiple-sclerosis-drugs-sales/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/global-medicine-spend-forecast-exceed-1-5-trillion-2023/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/takedas-dengue-vaccine-candidate-meets-primary-endpoint-pivotal-phase-3-efficacy-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novo-nordisk-stockpiling-double-usual-amount-ahead-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-inaugurates-pay-performance-china-money-back-ibrance-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/1-5million-investment-parkinsons-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/samsung-biologics-sees-sales-rise-profit-fall-continues-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizers-xtandi-blows-johnson-johnsons-erleada-hot-start-new-prostate-cancer-field/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eat-impact-brain-memory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/janssen-enters-worldwide-collaboration-license-agreement-meiragtx-develop-gene-therapy-programs-inherited-retinal-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ec-leaders-request-information-skyrocketing-cost-insulin-pharmaceutical-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/blood-test-specific-metabolites-reveal-blocked-arteries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/exploring-dark-side-genome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/neurocrine-biosciences-voyager-therapeutics-form-strategic-development-commercialization-collaboration-parkinsons-disease-friedreichs-ataxia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-lilly-announce-top-line-results-second-phase-3-study-tanezumab-osteoarthritis-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sen-bernie-sanders-asks-low-cost-drug-now-costs-375000/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/vaccine-group-back-critical-cervical-cancer-shots/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/smoking-hawaii-lawmaker-wants-say-goodbye-cigarettes-forever/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tevas-migraine-drug-ajovy-looks-set-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/grassley-wyden-invite-7-major-pharmaceutical-companies-drug-pricing-hearing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-bolts-immuno-oncology-candidate-e3-7bn-merck-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/graphene-biosensor-provide-early-lung-cancer-diagnosis-research-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/review-finds-antibiotic-development-increased-insufficient/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/endocannabinoid-system-target-improve-cognitive-disorders-models-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/whole-bacterial-pneumonia-vaccine-approaches-human-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biomimetic-micromotor-enables-active-delivery-antigens-oral-vaccination/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cablivi-gets-fda-ok-blood-clotting-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lemborexant-hits-phase-iii-targets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/duchenne-study-causes-solid-biosciences-shares-fall/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-explores-using-blockchain-track-drug-supplies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/geneticists-identify-molecular-pathway-autism-related-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sanofi-regeneron-cut-list-price-cholesterol-drug-60-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dr-reddys-bachupally-plant-version-fda-deja-vu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-announces-topline-data-phase-3-stellar-4-study-selonsertib-compensated-cirrhosis-f4-due-nonalcoholic-steatohepatitis-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/large-study-fails-link-phthalates-increased-breast-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/yescarta-rejected-among-smc-decisions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/progenics-buys-manufacturing-facility-orphan-radiotherapeutic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/teva-ceo-content-23-access-payers-migraine-drug-ajovy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/turkey-increase-fixed-exchange-rate-pharma-products-26-4-percent-ntv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mckesson-called-fdas-gottlieb-opioid-tampering/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-astellas-chase-new-xtandi-nod-big-survival-numbers-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/johnson-johnson-buy-surgical-robotics-firm-auris-3-4-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-study-keytruda-prostate-cancer-early-success/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/researchers-discover-weakness-rare-cancer-exploited-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/can-repair-brain-promise-stem-cell-technologies-treating-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/experimental-nano-painkiller-effective-morphine-low-addiction-risk-scientists-discover/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lundbeck-otsuka-report-phase-iii-data-evaluating-brexpiprazole-treatment-manic-episodes-associated-bipolar-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nektar-bristol-combo-drug-shows-signs-tumor-reduction-bladder-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/swayed-discounts-nice-finally-backs-roches-perjeta-postsurgery-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/darolutamide-shows-promise-treatment-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/innovate-uk-awards-aklrd-675000-osteoarthritis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/neuromelanin-sensitive-mri-identified-potential-biomarker-psychosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/physicists-pinpoint-simple-mechanism-makes-bacteria-resistant-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/experimental-anti-aging-treatment-kills-old-cells-passed-first-human-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/intercept-announces-positive-topline-results-pivotal-phase-3-regenerate-study-obeticholic-acid-patients-liver-fibrosis-due-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/japan-approves-world-first-trial-using-ips-cells-treat-spinal-cord-injuries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ireland-urges-people-stockpile-medicines-ahead-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/flavonoid-44%e2%80%b2-dimethoxychalcone-promotes-autophagy-dependent-longevity-across-species/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/medimmune-brand-retired-biologics-integrate-astrazenecas-new-rd-structure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-provides-update-keynote-240-phase-3-study-keytruda-pembrolizumab-previously-treated-patients-advanced-hepatocellular-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/former-astrazeneca-uk-plant-back-sale-putting-270-jobs-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gene-therapy-womb-cure-rare-untreatable-brain-disorder-causes-seizures-memory-loss-lack-speech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nhs-implements-new-ai-code-conduct/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-aims-strengthen-sunscreen-rules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-links-diabetes-back-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/oral-antifungals-used-treat-yeast-infections-lead-miscarriage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pembrolizumab-combination-erlotinib-gefitinib-first-line-therapy-advanced-nsclc-sensitizing-egfr-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eu-measures-support-generic-pharmaceuticals-producers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/smart-drug-shows-promise-metastatic-triple-negative-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/first-time-scientists-made-synthetic-dna-4-additional-letters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientist-identifies-gene-responsible-spread-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/discovery-improves-understanding-lou-gehrigs-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/rare-cancers-growing-focus-early-stage-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/karyopharm-40-ad-com-briefing-docs-selinexor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloric-febuxostat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/brilintas-phase-iii-themis-trial-met-primary-endpoint-patients-established-coronary-artery-disease-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ipsen-acquire-clementia-pharmaceuticals-significantly-boost-rare-disease-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-steps-gene-therapy-4-3-billion-spark-bet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-senators-tell-drug-company-executives-pricing-morally-repugnant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/diabetes-tied-risk-advanced-aggressive-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazenecas-lynparza-meets-main-goal-late-stage-pancreatic-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/blackstone-life-sciences-novartis-launch-anthos-therapeutics-develop-innovative-medicines-cardiovascular-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sarepta-exercises-option-acquire-myonexus-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nhs-pilot-new-diabulimia-service/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tremfya-gets-fda-approval-moderate-severe-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/wireless-patches-can-comfortably-monitor-sick-babies-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/horizons-teprotumumab-hits-major-rd-milestone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/poor-quality-sleep-raises-risk-alzheimers-even-get-eight-hours-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/radical-parkinsons-treatment-tested-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novavax-announces-topline-results-phase-3-preparetm-trial-resvax-prevention-rsv-disease-infants-via-maternal-immunization/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/immunogen-announces-top-line-results-phase-3-forward-study-mirvetuximab-soravtansine-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/philippines-charge-officials-sanofi-government-dengue-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/kids-eczema-may-sleep-poorly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-help-hiv-patients-age-positively-17-6m-grants-30-groups/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-pays-ceo-soriot-nearly-15m-2018s-return-growth-will-investors-push-back/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/breaking-fda-chief-scott-gottlieb-steps-leaving-pet-projects-behind/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biogen-strikes-877m-nightstar-gene-therapy-buyout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-esketamine-first-major-depression-treatment-reach-u-s-market-decades/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/wired-walls-voice-recognition-system-promises-automate-data-entry-office-visits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ten-years-berlin-patient-doctors-announce-second-person-effectively-cured-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/protein-inhibitor-may-help-cure-liver-cancer-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lnylam-reports-positive-topline-results-envision-phase-3-study-givosiran-acute-hepatic-porphyria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ozempic-superior-lowering-blood-sugar-weight-vs-placebo-combination-sglt-2-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-announces-2019-second-quarter-dividend/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/syndax-pharmaceuticals-reports-fourth-quarter-2018-financial-results-provides-clinical-business-update/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/clinical-trials-allergans-antidepressant-rapastinel-fail/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-announces-data-demonstrating-non-inferiority-daily-descovy-vs-daily-truvada-prevention-hiv-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/axovant-reports-positive-interim-results-first-cohort-sunrise-pd-phase-2-trial-axo-lenti-pd-gene-therapy-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/correcting-replacing-two-phase-3-studies-triple-combination-vx-445-tezacaftor-ivacaftor-met-primary-endpoint-improvement-lung-function-ppfev1-people-cystic-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/french-biotech-cellectis-picks-u-s-commercial-car-t-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lillys-combo-therapy-succeeds-late-stage-lung-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/flurotech-advances-cannabis-biomarker-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/vedolizumab-entyvio-achieves-superior-rates-clinical-remission-vs-adalimumab-humira-first-ever-head-head-biologic-clinical-study-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ema-now-operating-amsterdam-share/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/uk-will-less-attractive-clinical-research-post-brexit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/aerie-pharmaceuticals-announces-u-s-fda-approval-rocklatan-netarsudil-latanoprost-ophthalmic-solution-0-020-005-reduction-intraocular-pressure-patients-open-angl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/national-cancer-chief-ned-sharpless-named-f-d-s-acting-commissioner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/servier-oncodesign-partner-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ec-extends-license-rochechugais-hemlibra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-kgaa-iktos-enter-ai-discovery-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pill-good-statins-benefit-hundreds-thousands-patients-works-without-side-effects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/long-term-exposure-pm2-5-increases-risk-diabetes-chinese-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-warns-jubilant-tablet-plant-india-repeat-mistakes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-drops-warning-letter-lupin-sterile-drug-operations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/zentiva-siyiara-enterprises-acquire-romanian-pharma-firm-solacium/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/hepatitis-b-vaccination-preadolescents-lowers-disease-incidence-rate-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-finds-test-protein-levels-eye-potential-predictor-future-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/diabetes-drug-effective-heart-failure-wide-spectrum-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/second-u-s-jury-finds-bayers-roundup-caused-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/canada-create-national-drug-agency-help-cut-cost-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/health-secretary-wants-nhs-roll-genetic-tests-detect-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-roches-tecentriq-combination-chemotherapy-initial-treatment-adults-extensive-stage-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-pfizer-pull-plug-ovarian-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/us-approves-first-treatment-post-partum-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biogen-eisai-discontinue-phase-3-engage-emerge-trials-aducanumab-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-secures-exclusive-option-acquire-gene-therapy-company-vivet-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/servier-harvard-partner-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/flamma-completes-successful-cfda-inspection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/world-tuberculosis-day-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/world-syndrome-day-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/forxiga-approved-europe-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/geneuros-angel-ms-phase-2b-extension-study-confirms-extends-neuroprotective-effects-temelimab-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/data-garnet-study-indicates-robust-activity-dostarlimab-patients-advanced-recurrent-endometrial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/clinical-benefit-anticancer-drugs-approved-fda-gastrointestinal-malignancies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/early-test-male-birth-control-pill-shows-safety-problems/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/775-million-u-s-dollars-bayer-reaches-settlement-resolve-xarelto-litigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/can-fite-announces-phase-ii-advanced-liver-cancer-top-line-results-orphanfast-track-drug-namodenoson/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/parasitic-worms-cause-cancer-help-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approval-mayzent-siponimod-first-oral-drug-treat-secondary-progressive-ms-active-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/aldeyra-therapeutics-announces-positive-top-line-results-phase-3-alleviate-trial-patients-allergic-conjunctivitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/brain-stem-cells-age-faster-multiple-sclerosis-patients-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/big-pharma-accused-endless-talk-action-antibiotic-threat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/seattle-genetics-astellas-announce-positive-topline-results-pivotal-trial-enfortumab-vedotin-locally-advanced-metastatic-urothelial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/proteostasis-therapeutics-announces-broad-new-dataset-proprietary-combination-add-cftr-modulator-studies-cystic-fibrosis-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-pharma-azadyne-raises-1-5m-autoimmune-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/number-prescription-rises-cost-falls/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-treatment-patients-type-inflammatory-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/first-gene-therapy-treat-rare-blood-disease-nears-european-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-pays-6-9-billion-daiichi-sankyo-cancer-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/3d-printed-tissues-may-keep-athletes-action/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/state-new-york-accuses-six-pharmaceutical-companies-fraudulent-marketing-opioid-analgesics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilteritinib-improves-survival-patients-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/party-drug-linked-new-treatment-sleep-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/next-generation-single-dose-antidotes-opioid-overdoses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/depression-obesity-chronic-pain-treated-targeting-key-protein-neuroscience-newsneuroscience-newsapril-1-2019-featuredgeneticsneurologyneurosciencepsychology4-min-read-summary/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/vitamins-carotenoids-associated-lower-risk-cataract/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cholera-kills-two-infects-1400-cyclone-hit-mozambique/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-warns-homeopathic-firms-putting-patients-risk-significant-violations-manufacturing-quality-standards/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/puma-biotechnology-pierre-fabre-enter-exclusive-license-agreement-develop-commercialize-nerlynx-neratinib-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/phase-3-admiral-trial-data-show-xospata-gilteritinib-significantly-prolongs-overall-survival-adult-patients-flt3-mutation-positive-relapsedrefractory-acute-myeloid-leukemia-compared-w/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/apexigen-announces-new-clinical-data-apx005m-combination-therapy-pancreatic-cancer-aacr-annual-meeting-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chinese-scientists-find-new-target-gene-therapy-osteoarthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/adding-savolitinib-osimertinib-beneficial-certain-pretreated-lung-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roches-ipatasertib-combination-tecentriq-chemotherapy-shows-promising-anti-tumour-activity-triple-negative-breast-cancer-early-phase-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/hospital-viruses-fake-cancerous-nodes-ct-scans-created-malware-trick-radiologists/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-asceniv-novel-intravenous-immune-globulin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/world-health-day-history/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/drugmakers-pay-123-million-resolve-us-charity-kickback-probe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/isracann-biosciences-invest-israels-first-cannabis-pure-play-public-offering/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/telemedicine-tied-antibiotics-kids-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/five-australian-patients-trial-new-brain-reading-device-help-speech-movement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/regeneron-forays-gene-silencing-therapies-alnylam-tie/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cancer-vaccine-shows-promise-human-trial-lymphoma-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/money-science-tech-lifestyle-health-policy-public-interest-people-culture-merrimack-discontinues-development-mm-310/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/us-fda-approves-viiv-healthcares-dovato-dolutegravirlamivudine-first-daily-single-tablet-two-drug-regimen-treatment-naive-hiv-1-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/united-theraputics-ends-esuberaprost-trial-early/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/boehringer-ingelheim-enhances-oncology-rd-novel-macrodel-delivery-technology-via-acquisition-icd-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-charges-pummel-drugmaker-indivior-hurt-reckitt-justin-george-varghese-martinne-geller/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/aussie-pill-hold-cure-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dogs-can-smell-cancer-blood-offering-new-cancer-screening-way/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/concerto-inks-second-ai-collaboration-week-teams-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/four-million-new-child-asthma-cases-linked-traffic-pollution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/large-study-ties-ptsd-acute-stress-cardiovascular-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/french-court-finds-bayers-monsanto-liable-farmers-sickness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/intercept-reports-additional-positive-data-regenerate-first-successful-phase-3-study-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-issues-final-rule-safety-effectiveness-consumer-hand-sanitizers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-evenity-romosozumab-aqqg-treatment-osteoporosis-postmenopausal-women-high-risk-fracture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-dovato-dolutegravirlamivudine-hiv-1-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ilc-2019-first-class-entry-inhibitor-bulevirtide-myrcludex-b-effective-well-tolerated-combination-peg-ifn-phase-2b-study-involving-individuals-chronic-hepatitis-bd-virus-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/alnylam-presents-positive-complete-results-envision-phase-3-study-givosiran-investigational-rnai-therapeutic-treatment-acute-hepatic-porphyria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/az-finds-lack-lung-cancer-info-available-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/data-show-jjs-invokana-may-slow-prevent-ckd-diabetes-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/catalent-acquire-gene-therapy-leader-paragon-bioservices-inc-1-2-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/clovis-oncology-inc-discontinuing-sponsored-phase-2-open-label-monotherapy-clinical-trial-evaluating-rucaparib-recurrent-metastatic-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/big-spending-abbvie-pfizer-pushes-pharmas-2018-ad-spend-6-5b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-targeted-therapy-metastatic-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/avexis-data-reinforce-effectiveness-zolgensma-treating-spinal-muscular-atrophy-sma-type-1-apr-16-2019-ph-3-str1ve-data-show-prolonged-event-free-survival-early-rapid-increases-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/use-multiple-sclerosis-medicine-lemtrada-restricted-ema-review-ongoing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/april-17-world-hemophilia-day-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/teva-ceo-kare-schultz-nabs-whopping-33m-first-full-year-helm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/johnson-johnson-q1-adjusted-earnings-2-10-per-share-rttnews/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/medicinova-announces-plans-move-forward-phase-3-trial-mn-166-ibudilast-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/measles-cases-rose-nearly-four-fold-first-quarter-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nice-final-guidance-published-cimzia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/170-years-ago-finally-know-general-anesthesia-works/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bioatla-beigene-enter-collaboration-develop-bioatlas-ba3071-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/vitamin-d-may-help-fight-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amg-420-novel-bite-shows-impressive-responses-heavily-treated-patients-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-marketing-first-device-treat-adhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-york-outbreaks-drive-us-measles-count-626/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/promise-liquid-biopsy-cancer-biomarker-detection-prenatal-screening/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-suggests-overdiagnosis-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-pembrolizumab-plus-axitinib-advanced-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/first-time-pharmaceutical-distributor-faces-federal-criminal-charges-opioid-crisis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-lilly-announce-top-line-results-long-term-phase-3-study-tanezumab-patients-osteoarthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nemolizumab-achieves-primary-endpoint-phase-3-clinical-study-comparative-study-japan-treatment-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/massive-roll-worlds-first-malaria-vaccine-commences-africa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-nanomedicine-slips-cracks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lilly-announces-positive-top-line-results-coast-x-52-week-placebo-controlled-study-taltz-ixekizumab-patients-non-radiographic-axial-spondyloarthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/researchers-use-machine-learning-system-diagnose-genetic-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-announces-topline-data-phase-3-stellar-3-study-selonsertib-bridging-fibrosis-f3-due-nonalcoholic-steatohepatitis-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/autolus-therapeutics-receives-fda-orphan-drug-designation-auto3-treatment-acute-lymphoblastic-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abbvies-skyrizi-drug-treat-psoriasis-wins-u-s-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayer-says-looking-established-drugs-strategy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/glaxo-invest-usd100-million-us-vaccine-manufacturing-site/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-plant-make-merck-kgaa-drugs-opens-iran/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pharma-healthcares-digital-ad-spend-reach-10b-next-year-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-bausch-healths-duobrii-halobetasol-propionate-tazarotene-lotion-0-010-045-plaque-psoriasis-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/zynquista-approved-eu-certain-patients-type-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novo-nordisks-victoza-found-cut-blood-sugar-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/praulent-gets-fda-nod-heart-attack-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-talzenna-leads-latest-chmp-highlights/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pioneering-breakthrough-university-marylands-schools-medicine-engineering-first-use-unmanned-aircraft-successfully-deliver-kidney-transplant-university-maryland-medical-cen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lifetime-flu-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/transgene-astrazeneca-enter-collaboration-exclusive-license-option-agreement-innovative-invir-iotm-based-armed-oncolytic-immunotherapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/world-first-breakthrough-improves-pasteurization-keeps-milk-fresh-90-days/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/anti-crispr-molecules-discovered-can-block-gene-editing-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chinese-scientists-develop-new-catalyst-turn-co2-clean-liquid-fuel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/jj-agrees-pay-1-billion-resolve-hip-implant-lawsuits-bloomberg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/wearable-lab-body/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/space-experiment-looks-slow-aging-process-using-nanoparticles/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biological-barrier-keep-cancer-metastasizing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-daiichi-breast-cancer-treatment-shows-promise-latest-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gw-pharmas-epilepsy-drug-meets-main-goal-late-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-shows-new-drug-effective-overcoming-ibrutinib-resistance-mantle-cell-lymphona/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novartis-buys-dry-eye-drug-takeda-5-3-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/3ms-6-725-billion-acquisition-acelity-kci-subsidiaries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/need-know-u-s-measles-outbreak/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nhs-tackle-elderly-medication-200-new-pharmacists/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/california-jury-hits-bayer-2-billion-award-roundup-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-finds-testing-issues-torrent-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-pushes-back-spark-tender-third-time-will-close-deal-time-ever/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/disappointing-nerlynx-sales-shows-pierre-fabre-timing-everything/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-eylea-aflibercept-injection-diabetic-retinopathy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approval-bavencio-combo-advanced-rcc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/artificial-intelligence-selecting-grant-reviewers-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/takeda-addressing-gammagard-liquid-supplies-says-will-take-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/thermo-fisher-snaps-gsk-site-ireland-part-expansion-campaign/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/b-braun-commits-1b-expand-face-iv-fluid-shortages/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizers-atopic-dermatitis-treatment-meets-goals-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/johnson-johnson-submit-applications-least-10-new-drugs-2023/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/brain-cancer-halted-mice-using-antihistamine-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-novartis-liniment-marketing-misled-australian-consumers-court/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-anticoagulant-blood-thinner-pediatric-patients-treat-potentially-life-threatening-blood-clots/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/phase-1-study-evaluating-safety-tolerability-pharmacokinetics-pk-efficacy-amg-510-novel-small-molecule-krasg12c-inhibitor-advanced-solid-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roches-personalised-medicine-entrectinib-shrank-tumours-harbouring-ntrk-ros1-alk-gene-fusions-children-adolescents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/az-symbicort-reduces-rate-asthma-attacks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/owlstone-medical-actelion-team-pulmonary-hypertension-detection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/potential-new-treatment-targets-root-cause-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-supports-effectiveness-new-fast-acting-antidepressant-esketamine-nasal-spray/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/heart-failure-patients-uk-receive-long-term-care-need/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/artificial-intelligence-diagnoses-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/five-foods-arent-healthy-think/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cegedim-sanofi-enter-healthcare-improvement-rwd-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nintedanib-hits-targets-rare-lung-disease-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-acquire-peloton-therapeutics-bolstering-oncology-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/early-antiretroviral-treatment-may-preserve-key-immune-responses-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-buy-copenhagen-based-nuevolution-167-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsks-shingles-vaccine-approved-use-china-adults-aged-50/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/wuxi-build-dedicated-vaccine-facility-whos-client/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/jjs-invokana-closes-badly-needed-kidney-disease-nod-fda-priority-boost/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/indias-biggest-drugmaker-plans-start-developing-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cirrhosis-cancer-risks-higher-fatty-liver-especially-diabetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/daiichi-sankyo-looking-sell-otc-business-900m-correct-says-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dendreon-commits-prostate-cancer-vaccine-provenge-new-lease-manufacturing-site/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/british-columbia-first-canadian-province-switch-patients-biosimilars/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/antibiotic-concentrations-worlds-rivers-exceed-safe-limits-finds-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/counts-africa-polio-clock-despite-fears-new-outbreak/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/first-pi3k-inhibitor-approved-metastatic-advanced-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/iovance-biotherapeutics-adds-cell-therapy-manufacturing-boom/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/regulators-hit-italian-drugmaker-warning-manufacturing-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/emcure-injected-schizophrenia-drug-recalled-contamination-detected/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lupin-plant-goa-may-face-fda-action/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/synthetic-version-cbd-treats-seizures-rats/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-technology-can-speed-chemical-reactions-10000-times-faster-current-reaction-rate-limit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-jakafi-ruxolitinib-treatment-patients-acute-graft-versus-host-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/five-year-survival-data-mercks-keytruda-pembrolizumab-advanced-non-small-cell-lung-cancer-nsclc-first-keynote-trial-2019-asco-annual-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/allergan-recall-textured-breast-implants-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/az-reports-stellar-results-lynparza-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/janssen-presents-positive-darzalex-results-asco/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/water-filters-efficient-cookstoves-improve-health-vulnerable-rwandan-populations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/diabetes-drug-alleviates-anxiety-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sanofi-loses-german-patent-case-amgen-cholesterol-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/viriom-files-market-authorization-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/australian-gardener-sues-bayers-monsanto-cancer-link/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-make-easier-doctors-get-unapproved-cancer-drugs-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/stalk-antibodies-provide-flu-protection-humans-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-treatment-episodic-cluster-headache-reduces-frequency-attacks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/india-third-largest-pharma-exporter-world/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/poultry-bad-red-meats-cholesterol-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/drug-makes-tumors-susceptible-chemo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-psoriatric-arthritis-mouse-model-developed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/motif-bio-announces-path-forward-iclaprim-following-receipt-fda-meeting-minutes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/paul-hudson-succeed-olivier-brandicourt-chief-executive-officer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-announces-first-clinical-data-evaluating-novel-investigational-krasg12c-inhibitor-amg-510-asco-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/seattle-genetics-astellas-announce-antibody-drug-conjugate-enfortumab-vedotin-produced-tumor-response-rate-44-percent-patients-common-type-advanced-urothelial-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/experimental-drug-delays-type-1-diabetes-onset-mid-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mexican-scientists-create-skin-patch-diabetic-foot-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-buys-tilos-773-million-expand-oncology-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/los-angeles-county-emerges-californias-third-biotech-hub-report-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/insys-files-bankruptcy-heels-225m-kickback-settlement-feds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pharma-plant-explosion-india-kills-3-workers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ada-sanofis-toujeo-tops-novo-nordisks-tresiba-tough-treat-diabetes-subgroup/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abbvie-pads-humira-follow-skyrizis-blockbuster-potential-positive-2-year-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dassault-systemes-targets-life-sciences-5-8-billion-medidata-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-buy-biopharmaceutical-firm-tilos-therapeutics-608m-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abuse-vitamin-d-leads-destruction-kidney/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/locking-arthritis-drug-may-key-improving/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gut-bacteria-can-eat-medication-keep-drugs-jobs-study-reveals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/acne-drug-prevent-deadly-heart-attacks-strokes-scientists-accidentally-discover-antibiotic-targets-spots-also-stops-arteries-hardening/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-finds-nearly-400-medical-devices-procedures-practices-ineffective/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-think-finally-know-happens-skin-eczema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/breakthrough-paves-way-new-lyme-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/antioxidant-puts-fight-loses-battle-protein-linked-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/french-drugmaker-sanofi-google-use-data-tech-innovations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-wins-japan-approval-personalized-cancer-drug-rozlytrek/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayer-asks-trial-judge-reverse-2-billion-roundup-jury-verdict/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/provisions-usmca-change-u-s-pharmaceutical-patent-laws-lighthizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/harvard-scientists-make-landmark-discovery-synthesizing-anti-cancer-molecules-found-sea-sponges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/machine-learning-predicts-psychosis-93-accuracy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-victoza-injection-children-10-years-older/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sickle-cell-drug-showing-promise-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/breztri-aerosphere-pt010-approved-japan-patients-chronic-obstructive-pulmonary-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/daiichi-sankyos-vanflyta-receives-approval-japan-treatment-relapsedrefractory-flt3-itd-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-discover-new-method-developing-tracers-used-medical-imaging-advance-medical-imaging-scientists-university-north-carolina-lineberger-comprehensive-cancer-center-h/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/france-plans-legalize-cannabis-recreational-use-minister/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-nurix-establish-strategic-collaboration-develop-novel-therapies-cancer-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-declines-approve-daiichi-sankyos-blood-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tetrodotoxin-fugu-pufferfish-can-cause-deadly-poisoning-delivered-properly-becomes-potent-local-anesthetic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-drug-target-chemically-induced-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-symdeko-tezacaftorivacaftor-ivacaftor-treat-underlying-cause-cf-children-ages-6-11-years-certain-mutations-cftr-gene/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sanofi-regeneron-successful-phase-ii-asthma-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/talzenna-bags-eu-approval-gbrca-mutated-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/phenols-cocoa-bean-shells-may-reverse-obesity-related-problems-mouse-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abbvie-looks-beyond-humira-63-billion-deal-botox-maker-allergan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amag-pharmaceuticals-announces-fda-approval-vyleesi-bremelanotide-injection-hypoactive-sexual-desire-disorder-hsdd-premenopausal-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/progress-suns-halol-india-plant-tarnished-new-fda-findings/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/glenmark-wind-knocked-nda-respiratory-drug-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/san-francisco-bans-sales-e-cigarettes-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/china-announces-generic-drug-list-reduce-pharmaceutical-costs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-reported-started-sale-1-2-billion-consumer-health-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/commonly-prescribed-drugs-increase-risk-dementia-says-new-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/growing-evidence-suggests-parkinsons-disease-starts-gut-research-shows-key-proteins-disease-can-spread-gastrointestinal-tract-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pathway-discovered-prevents-buildup-alzheimers-protein/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-treatment-chronic-rhinosinusitis-nasal-polyps/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/improved-vaccine-bacterial-meningitis-bloodstream-infections-american-society-microbiology-gram-stain-meningococci-culture-showing-gram-negative-pink-bacteria-often/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/soliris-approved-treat-neuromyelitis-optica-spectrum-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-connects-low-social-engagement-amyloid-levels-cognitive-decline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/blast-water-shrink-enlarged-prostate-effectively-surgery-fewer-side-effects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/elizabeth-holmes-will-officially-go-trial-next-summer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-australian-flu-vaccine-developed-ai-undergo-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/another-biotech-plant-explosion-china-kills-six/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mans-best-friend-robot-dog-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/karyopharm-therapeutics-prices-blood-cancer-treatment-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pharma-company-sues-fda-requiring-deadly-tests-dogs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/viiv-secures-eu-nod-hiv-therapy-dovato/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/janssen-hands-back-rights-hanmis-diabetesobesity-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eu-approval-alexions-pnh-drug-ultomiris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/viriom-signed-licensing-agreement-indonesia-p-t-lloyd-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/marijuana-affects-different-people-differently/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/killing-seeds-cancer-new-finding-shows-potential-destroying-cancer-stem-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-find-urine-test-offer-non-invasive-approach-diagnosis-irritable-bowel-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-spanking-biocon-mylan-face-new-hurdle-lantus-challenger/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-opens-95m-continuous-production-operation-singapore/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/natural-antioxidant-helps-improve-immune-based-therapies-modulating-t-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/france-will-end-healthcare-refunds-homeopathic-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/flaws-hospital-anesthesia-respiratory-devices-allow-remote-tampering/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/larger-drug-trials-intervene-earlier-needed-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-discover-previously-unknown-subtypes-liver-cells-health-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-advances-arthritis-candidate-phase-iii-triggering-e22m-milestone-payment-morphosys/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-set-review-sanofis-isatuximab-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bmj-data-suggests-link-sugary-drinks-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/indiviors-former-parent-ponies-whopping-1-4b-settle-suboxone-marketing-probe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/hits-keep-coming-apotex-loses-31-drug-approvals-fda-cites-plants-inadequate-controls/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/flu-deaths-prevented-drug-used-wwii-researchers-find/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eu-invests-35-mln-euros-ai-based-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/johnson-johnson-test-experimental-hiv-vaccine-u-s-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazenecas-farxiga-fails-get-u-s-approval-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cholesterol-lowering-drugs-prescribed-prevention-atherosclerotic-cardiovascular-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cannabis-treatment-counters-addiction-first-study-kind/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-snares-ex-novartis-astrazeneca-cfo-symonds-chairman-reports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gileads-kite-builds-cell-therapy-manufacturing-quickly-even-yescarta-sales-grow-slowly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/indoco-caught-maelstrom-fda-concerns-plant-hit-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/evoke-taps-new-president-north-america-continues-talent-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-invests-5-billion-deepen-ties-biotech-galapagos/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/us-eu-enter-mutual-recognition-agreement-drug-manufacturing-inspections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-new-treatment-complicated-urinary-tract-complicated-intra-abdominal-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sharks-aid-parkinsons-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-research-identifies-gene-hides-cancer-cells-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dermal-tattoo-sensors-detection-blood-ph-change-metabolite-levels/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dosing-regimen-old-cancer-drug-shows-new-promise-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/boost-bee-sting-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/robots-help-produce-new-class-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayer-bms-ono-team-investigate-stivarga-opdivo-combo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abbvie-enhances-early-stage-oncology-pipeline-acquisition-mavupharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pharmacies-take-drug-disposal-effort-big-pharma-fought/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/toxin-responsible-legionella-growth-identified/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biohavens-treatment-lou-gehrigs-disease-fails-win-fda-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amarins-400m-plus-offering-put-investors-edge-buyout-table/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-develop-promising-drug-treating-ovarian-pancreatic-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/still-cash-raising-spree-takeda-shops-e1-5b-european-drug-sale-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chinese-cdmo-genscript-takes-steps-player-chinas-gene-cell-therapy-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/resistant-malaria-spreading-south-east-asia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chemical-found-breast-milk-breaks-tumours-tiny-fragments-cancer-patients-can-pass-urine-without-damaging-healthy-tissue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/promising-early-data-msds-investigational-hiv-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizers-rituxan-biosimilar-bags-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/first-uk-medical-cannabis-clinic-launched-specialist-doctors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ai-used-help-diagnose-treat-birdshot-uveitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-treatment-severe-hypoglycemia-can-administered-without-injection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayer-offloads-dr-scholls-foot-care-brand-585m-major-revamp-presses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tiny-implant-currently-trialled-long-term-protection-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-like-bayer-hit-winnti-cyberattack/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/world-hepatitis-day-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-hadlima/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/european-panel-okays-gw-pharma-cannabis-drug-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roundup-case-u-s-judge-cuts-2-billion-verdict-bayer-86-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-records-16-new-measles-cases-outbreak-shows-signs-slowing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/janssens-ponesimod-holds-aubagio-late-stage-trial-29th-july-2019-image-anna-smith-janssen-announced-positive-top-line-results-phase-iii-optimum-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/antibiotic-resistant-genes-found-londons-rivers-canals-ponds-including-hyde-parks-serpentine-lake-scientists-say-spread-treated-sewage-water/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pfizer-spinoff-merge-patent-drugs-unit-mylan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/exclusive-two-powerful-canadian-provinces-argued-federal-drug-price-crackdown/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-novartis-cancer-therapies-losing-patients-experimental-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chimerix-announces-exclusive-worldwide-license-phase-3-ready-cx-01-development-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/aclaris-therapeutics-announces-phase-2-clinical-trial-ati-501-oral-patients-alopecia-areata-met-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-bayers-nubeqa-darolutamide-new-treatment-men-non-metastatic-castration-resistant-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fatality-phase-clinical-study-e2082/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-fedratinib-treatment-myelofibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sarepta-stumbles-fda-rejection-new-drug-treat-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-wakix/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roches-personalized-cancer-treatment-wins-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-buy-celgenes-otezla-13-4bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lillys-atopic-dermatitis-drug-hits-endpoints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/oxycontin-maker-negotiating-settlement-worth-reported-12b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-ixekizumab-ankylosing-spondylitis-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-judge-rules-regeneron-sanofi-amgen-cholesterol-drug-patent-fight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-flags-risks-abbvie-gilead-merck-hepatitis-c-drugs-certain-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-lupus-drug-shows-promise-set-back-last-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/veeva-introduces-quality-risk-management-vault-qms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-finds-moderate-red-wine-drinking-may-good-gut-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-green-light-fasenra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-researchers-develop-new-skin-patch-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mit-engineers-create-robotic-thread-break-blockages-brains-blood-vessels/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ajinomoto-bio-pharma-services-acquires-remaining-interest-granules-omnichem-joint-venture-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/glenmark-pharmaceuticals-receives-anda-approval-pimecrolimus-cream-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/china-expands-drug-bulk-buy-program-puts-pressure-pharma-firms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-records-19-new-cases-measles-last-week/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/patent-court-review-alexions-soliris-patents-amgen-challenge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fewer-cardiovascular-events-seen-diabetics-weight-loss-surgery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-drug-revolutionize-treatment-neurological-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mylan-generic-lung-cancer-drug-alimta-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/endo-allergan-settle-opioid-case-ahead-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/blood-test-predict-heart-disease-early-death-risks-40-years-advance-study-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/daily-cocaine-use-changes-genes-brain-fuels-addiction-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/allergan-receives-fda-approval-juvederm-voluma-xc-mid-face-injection-via-cannula/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-singles-9-drug-substances-compounding/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/israeli-researchers-develop-antibacterial-coating-implants-prevent-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tricida-announces-submission-new-drug-application-veverimer-treatment-metabolic-acidosis-patients-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tuberculosis-mutation-discovery-paves-way-better-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/uta-scientist-explores-using-nanoparticles-reduce-size-deep-seated-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cancer-drugs-share-new-fda-approvals-doubled-decade-thanks-smarter-rd-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/trump-administration-announces-1-8-billion-funding-states-continue-combating-opioid-crisis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/63414/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/takeda-recalls-eye-drug-natpara-warns-patients-abruptly-stop-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/unsafe-levels-antibiotics-found-rivers-72-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-ofev-first-therapy-slow-rate-decline-pulmonary-function-patients-systemic-sclerosis-associated-ild/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/malaria-can-eradicated-2050-say-global-experts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/juul-warned-fda-marketing-practices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/chicago-biotech-company-3d-prints-mini-human-heart/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-grants-amg-510-fast-track-designation-kras-g12c-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novo-nordisk-cut-insulin-prices-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/spepharm-ag-wins-case-eisai-inc-united-states-district-court-district-delaware/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sanofi-pay-lexicon-260-million-terminated-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/xeris-pharmaceuticals-receives-u-s-fda-approval-gvoke-glucagon-first-ready-use-stable-liquid-glucagon-severe-hypoglycemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-drug-protect-alzheimer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/purdue-inks-multibillion-dollar-opioid-deal-thousands-local-governments-20-states-reports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/israels-healthy-io-raises-60-million-gets-fda-ok-urine-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tocagen-reports-results-toca-5-phase-3-trial-recurrent-brain-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-generic-drug-approvals-reach-record-high-in-fiscal-year-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/alexion-acquiring-achillion-to-expand-reach-into-rare-immune-related-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/trump-urges-quicker-action-to-allow-imported-drugs-from-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/a-new-theory-on-depression-its-a-disease-caused-by-the-bodys-immune-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biogen-surges-42-after-stunning-reversal-sees-it-revive-plans-for-alzheimers-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/researchers-identify-a-new-way-to-target-treatment-resistant-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-new-drug-for-most-common-form-of-cystic-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/researchers-grow-muscle-cells-on-edible-fibers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/drugstore-drones-ups-will-fly-cvs-prescriptions-to-u-s-customers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tevas-proposed-opioid-settlement-could-cost-drugmaker-pennies-on-the-dollar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eli-lilly-to-target-cancer-drug-developers-for-deals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-niraparib-for-hrd-positive-advanced-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-create-new-test-that-can-tell-doctors-in-just-45-minutes-whether-a-patient-is-battling-a-superbug-or-one-that-may-respond-to-antibiotics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-again-raises-sales-estimates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/wuxi-biologics-doubles-down-on-ireland-will-build-vaccine-plant-there/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-ups-challenge-against-az-mercks-lynparza-with-expanded-zejula-ovarian-cancer-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-escalates-pcsk9-pricing-war-with-permanent-60-price-cut-on-repatha/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/forget-ambulances-drones-are-quicker-study-of-rush-hour-traffic-in-new-york-reveals-the-gadgets-get-to-patients-32-quicker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-botox-onabotulinumtoxina-for-pediatric-patients-with-lower-limb-spasticity-excluding-spasticity-caused-by-cerebral-palsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/avrobio-receives-orphan-drug-designation-from-the-u-s-fda-for-avr%e2%80%91rd%e2%80%9102-for-the-treatment-of-gaucher-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/schizophrenia-biomarker-hydrogen-sulfide-in-human-hair/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/allergan-settles-alzheimers-therapy-lawsuit-for-750-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mirati-drug-shrinks-tumors-in-some-cancer-patients-in-early-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cannabis-not-proven-in-mental-health-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-divests-rights-to-seroquel-and-seroquel-xr-in-europe-and-russia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/morphosys-novartis-galapagos-abandon-experimental-mor106/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gilead-glympse-bio-to-explore-biomarker-use-in-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/with-2-failed-trials-cyclerion-announces-plans-to-cut-30-out-of-135-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/liver-damage-from-drinking-may-one-day-be-reversible-scientists-are-developing-a-drug-to-undo-tissue-scarring-in-lung-and-liver-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/common-early-sign-of-cardiovascular-disease-also-may-indicate-cancer-risk-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-vumerity-diroximel-fumarate-for-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bio-techne-investing-up-to-50m-in-new-plant-for-recombinant-proteins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-enters-into-strategic-collaboration-with-beigene-to-expand-oncology-presence-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dicerna-enters-alliance-to-develop-hepatitis-b-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-28-31-october-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novartis-zolgensma-study-halted-by-fda-amid-safety-questions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/president-trump-to-nominate-dr-stephen-hahn-as-new-fda-commissioner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-alzheimers-drug-fast-tracked-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/redhill-biopharma-announces-fda-approval-of-talicia-for-treatment-of-h-pylori-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-fluzone-high-dose-quadrivalent-influenza-vaccine-for-adults-65-years-of-age-and-older/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/seasonal-influenza-vaccine-market-to-be-worth-6-5bn-by-2028/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/pandion-astellas-sign-795m-deal-for-pancreas-targeted-immunomodulators/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/japans-takeda-opens-dengue-vaccine-manufacturing-facility-in-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-tops-the-first-pharmaceutical-invention-index/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayer-completes-sale-of-dr-scholls-brand-to-yellow-wood-partners/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cytel-acquires-mtek-sciences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ups-drone-makes-first-home-prescription-deliveries-for-cvs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/predictimmune-announces-predictsure-ibd-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/britains-astrazeneca-launches-1-billion-china-investment-fund-with-cicc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/say-hello-to-roches-worst-case-scenario-tevas-rituxan-biosim-set-to-launch-in-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/the-online-user-experience-that-can-drive-action-for-your-brand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/britains-astrazeneca-to-distribute-sun-pharma-cancer-drugs-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-therapy-to-treat-patients-with-rare-blood-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/brain-implants-used-to-fight-drug-addiction-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novo-nordisk-obtains-exclusive-worldwide-licence-to-potential-nash-candidate-ud-014-from-ube-industries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-discontinues-trial-of-duchenne-muscular-dystrophy-drug-rg6206/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-grants-priority-review-to-opdivo-yervoy-combo-in-advanced-hcc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/vaccine-against-ebola-commission-grants-first-ever-market-authorisation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-reports-pooled-cardiovascular-safety-and-efficacy-analyses-of-roxadustat-in-p-iii-program-for-ckd-patients-with-anaemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roches-risdiplam-meets-primary-endpoint-in-pivotal-sunfish-trial-in-people-with-type-2-or-3-spinal-muscular-atrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/microsoft-ai-helps-diagnose-cervical-cancer-faster/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/worlds-first-robot-assisted-brain-aneurysm-surgery-performed-in-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fingerprint-test-can-distinguish-between-those-who-have-taken-or-handled-heroin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-plans-2020-filing-for-anifrolumab-in-lupus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/coi-pharmaceuticals-announces-acquisition-of-calporta-by-merck/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/israeli-firm-announces-successful-trials-of-oral-insulin-drug-for-treating-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-panel-votes-against-lilly-boehringer-ingelheims-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/apple-launches-app-to-let-users-enroll-in-health-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/shionogi-gets-fda-approval-for-cuti-drug-fetroja/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-buys-u-s-drugmaker-promedior-for-up-to-1-4-billion-to-get-lung-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/jazz-pharmas-sleep-disorder-drug-gets-european-panel-backing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-orders-cadila-to-clean-up-its-act-at-sterile-plant-in-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/china-records-third-case-of-deadly-bubonic-plague/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/the-plaster-that-could-tell-if-your-mole-is-cancerous-or-not-and-spell-an-end-to-traditional-biopsies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/researchers-develop-an-ai-system-with-near-perfect-seizure-prediction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/google-almost-made-100000-chest-x-rays-public-until-it-realized-personal-data-could-be-exposed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nhs-patients-may-have-to-split-tablets-in-half-to-cope-with-drugs-shortage-as-leaked-document-reveals-health-service-is-short-of-86-medications-including-those-to-treat-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/janssen-says-the-design-will-reimagine-drug-development-and-is-the-next-evolution-of-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ketamine-could-help-men-suffering-from-alcohol-use-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/milestone-reached-in-new-leukemia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/crispr-therapeutics-and-vertex-announce-positive-safety-and-efficacy-data-from-first-two-patients-treated-with-investigational-crispr-cas9-gene-editing-therapy-ctx001-for-severe-hemoglobinopathi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-and-bayers-heart-drug-meets-main-goal-of-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/alnylams-rare-genetic-disorder-drug-priced-at-575000-per-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-contact-lens-to-slow-childhood-nearsightedness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/successful-study-of-swedish-vaccine-candidate-against-diarrhea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/74bn-bms-celgene-merger-finally-cleared-by-competition-regulators/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/abbvie-signs-potential-2-4bn-cancer-immunotherapy-deal-with-harpoon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/allergan-builds-case-for-migraine-drug-ubrogepant-as-fda-verdict-nears/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-treatment-for-inherited-rare-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/mylan-pfizer-announce-viatris-as-the-new-company-name-in-planned-mylan-upjohn-combination/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/q-biomed-announces-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-abrilada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/zoetis-acquires-znlabs-a-nationwide-veterinary-reference-laboratory-to-further-strengthen-its-comprehensive-diagnostics-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amgen-boosts-full-year-outlook-after-wrapping-up-13-4-billion-purchase-of-celgenes-otezla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/toshiba-blood-test-detects-cancer-in-hours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-aquestives-als-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/newron-receives-fda-rare-pediatric-disease-designation-for-sarizotan-for-the-treatment-of-rett-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/blackstone-to-invest-400-million-in-gene-therapy-venture-with-ferring/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/using-artificial-intelligence-to-determine-whether-immunotherapy-is-working/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-migraine-medications-could-endanger-patients-with-high-blood-pressure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/activation-of-opioid-receptor-uncovered/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/teva-partners-with-israeli-institutes-for-early-stage-drug-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/asahi-kasei-unveils-deal-to-buy-veloxis-for-1-3-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/one-shot-of-ketamine-could-reduce-problem-drinking/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-accepts-incytes-nda-for-priority-review-of-pemigatinib-to-treat-cholangiocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/popular-heartburn-drugs-may-up-odds-of-stomach-bug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/in-a-first-for-cell-biology-scientists-observe-ribosome-assembly-in-real-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/home-urine-test-could-revolutionise-prostate-cancer-diagnosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazenecas-imfinzi-gets-speedy-fda-review-for-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biocon-gets-us-fda-approval-for-new-facility-in-bengaluru/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/screening-tech-advances-early-detection-of-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/biosensor-equipped-glasses-could-monitor-diabetes-through-tears/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/think-you-are-allergic-to-penicillin-there-is-a-90-per-cent-chance-you-may-not-be-anymore/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/the-theme-of-this-years-world-aids-day-is-communities-make-the-difference/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lexicon-pharma-shares-plummet-after-fda-denies-appeal-against-drug-rejection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amazon-transcribe-medical-real-time-automatic-speech-recognition-for-healthcare-customers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/verrica-pharmaceuticals-announces-fda-filing-acceptance-of-new-drug-application-for-vp-102-for-the-treatment-of-molluscum-contagiosum/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/lynparza-shows-benefits-in-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/senate-committee-advances-hahn-for-fda-commissioner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sanofi-agrees-to-sell-seprafilm-to-baxter-for-350-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/nice-approves-breast-cancer-treatment-through-cancer-drugs-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/world-first-as-artificial-neurons-developed-to-cure-chronic-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ardelyx-drug-reduces-elevated-phosphate-levels-late-stage-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astellas-inks-3b-audentes-buyout-to-expand-in-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/acadias-nuplazid-could-hit-blockbuster-heights-after-strong-psychosis-data-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/diabetes-drug-has-unexpected-broad-implications-for-healthy-aging/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bristol-myers-squibb-gets-fda-breakthrough-therapy-status-for-orencia-to-prevent-gvhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/study-aspirin-anti-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-discover-molecule-that-destroys-pancreatic-cancer-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/a-step-toward-an-alzheimers-treatment-new-ultrasound-can-cuts-through-the-blood-brain-barrier-to-target-dementia-linked-plaques/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/sanofi-to-acquire-synthorx-to-bolster-its-immuno-oncology-pipeline-for-2-5-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/viriom-launches-reproductive-toxicity-studies-for-elpida-elsulfavirine-once-weekly-oral-formulation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-expands-use-of-insulin-glargine-to-childhood-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/scientists-create-a-new-kind-of-artificial-flesh-that-heals-itself-like-the-real-thing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/zotiraciclib-granted-orphan-drug-designation-by-fda-and-ema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/research-shows-the-pharma-industry-believes-ai-will-likely-optimise-rd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ema-update-on-metformin-diabetes-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-sends-warning-to-companies-for-offering-unapproved-umbilical-cord-blood-products-that-may-put-patients-at-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-issues-warning-letter-to-alkermes-over-opioid-addiction-treatment-ad/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-daiichi-drug-halts-cancer-for-months-in-first-readout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/can-sanofi-and-regenerons-dupixent-steal-half-of-a-21b-eczema-market-not-so-fast-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayers-7-6b-bid-to-offload-animal-health-to-elanco-draws-extra-ftc-antitrust-attention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/dermira-secures-fda-fast-track-status-for-lebrikizumab-in-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/amneal-to-buy-generic-pharmaceuticals-provider-avkar-for-340m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-underscores-that-consumers-should-not-use-drugs-dietary-supplements-and-devices-recalled-from-basic-reset-and-biogenyx-following-consent-decree-for-federal-violations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/senate-confirms-stephen-hahn-as-new-fda-chief/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-changes-course-on-sareptas-once-rejected-muscular-dystrophy-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/the-nhs-robots-performing-major-surgery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/az-daiichis-targeted-breast-cancer-therapy-on-target/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/u-s-government-extends-deadline-to-sign-up-for-obamacare-insurance-plans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bayer-asks-u-s-appeals-court-to-reverse-25-million-roundup-verdict/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gileads-nash-combination-treatment-fails-mid-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/novartis-drops-asthma-drug-fevipiprant-after-trial-failures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/phase-1-clinical-trials-for-psilocybin-show-no-adverse-effects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-animal-model-shows-effective-treatment-for-latent-tuberculosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/malaria-under-arrest-new-drug-target-prevents-deadly-transmission/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ai-improves-breast-cancer-risk-prediction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-insights-to-development-of-major-diseases-discovered-by-aussie-researchers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/3m-to-divest-substantially-all-of-its-drug-delivery-business-to-altaris-capital-partners/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/charles-river-laboratories-to-buy-hemacare-for-380m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/organovo-and-tarveda-therapeutics-announce-definitive-merger-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/merck-animal-health-completes-acquisition-of-vaki-to-further-broaden-its-leadership-position-in-aquaculture-to-advance-fish-health-and-welfare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/cancer-drug-shows-promise-in-parkinsons-disease-safety-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-grants-accelerated-approval-for-astellas-seattle-genetics-bladder-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-issues-its-first-approval-for-an-ebola-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/trump-administration-takes-historic-steps-to-lower-u-s-prescription-drug-prices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-padcev-for-treatment-of-advanced-urothelial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/australian-new-gel-boosts-cell-revival-in-damaged-brain-tissue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/eisai-inc-announces-u-s-approval-for-insomnia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/alcoholism-is-linked-to-brain-pathways-suggests-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/roche-enters-licensing-agreement-with-sarepta-therapeutics-to-improve-the-lives-of-patients-living-with-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/australian-new-gel-boosts-cell-revival-in-damaged-brain-tissue-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/new-study-shows-chemical-compound-in-essential-oils-helps-wound-healing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/tweaking-dna-fragments-before-inserting-yields-highest-efficiency-rates-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/allergan-signs-750-million-settlement-with-purchasers-of-alzheimers-drug-namenda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/correvios-heart-drug-fails-to-get-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/bavarian-nordic-announces-the-sale-of-priority-review-voucher/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/skin-lightening-cream-could-cause-nerve-damage-cdc-report-warns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/a-better-testing-method-for-patients-with-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/ucb-to-build-e300m-biologics-plant-add-150-workers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astrazeneca-daiichi-notch-blockbuster-fda-nod-for-breast-cancer-med-enhertu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/fda-approves-first-generics-of-eliquis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/gsk-puts-faith-in-ai-to-make-more-successful-drugs-more-quickly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/astellas-strengthens-immuno-oncology-pipeline-with-acquisition-of-xyphos-biosciences-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/china-regulator-approves-imports-of-jjs-tremfya/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2019/antibiotics-maker-melinta-files-for-chapter-11-bankruptcy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/artificial-intelligence-programme-detects-breast-cancer-better-than-experts-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-to-offer-free-insulin-to-u-s-patients-in-immediate-need/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/more-january-u-s-price-hikes-take-2020-tally-to-over-330-drugs-with-higher-cost/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-uva-developed-artificial-pancreas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-bms-gilead-abbvie-and-others-hike-prices-on-hundreds-of-meds-to-ring-in-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/in-china-44-people-became-ill-with-an-unknown-form-of-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/totally-bummed-nobel-prize-winner-admits-a-painful-mistake/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/with-cancer-kickoff-amgen-bets-on-beigenes-fast-growing-chinese-sales-force/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cdmo-wuxi-sta-opens-manufacturing-facility-to-produce-oligonucleotides/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/towa-adds-eu-production-in-deal-for-spanish-generics-maker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-squibb-completes-divestment-of-manufacturing-facility-in-anagni-italy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/avacta-and-daewoong-pharmaceutical-form-immunotherapy-focused-joint-venture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/boehringer-ingelheims-bet-on-chinese-cdmo-market-pays-off-with-beigenes-mab-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mercks-keytruda-wins-u-s-fda-approval-for-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutica/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-anti-cancer-treatment-developed-by-hong-kong-researchers-significantly-reduces-tumour-size/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/israeli-researchers-develop-decoy-molecule-against-deadly-animal-to-human-viruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/spains-esteve-sells-a-plant-then-buys-one-as-it-refocuses-on-specialty-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/almirall-strikes-option-deal-to-buy-bioniz-and-dermatology-drug-bnz-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/hikma-and-arecor-announce-exclusive-agreement-to-develop-and-commercialise-ready-to-use-medicine-using-arestat-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-the-first-targeted-therapy-to-treat-a-rare-mutation-in-patients-with-gastrointestinal-stromal-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/celgene-backs-out-of-55m-class-action-settlement-on-claims-it-blocked-copycats-to-revlimid-thalomid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ai-specialist-exscientia-signs-drug-discovery-tie-up-with-bayer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lilly-announces-agreement-to-acquire-dermira/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-hospital-cures-patients-with-3d-printed-implants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biogen-to-buy-early-stage-potential-alzheimers-parkinsons-treatment-from-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eli-lilly-to-launch-half-priced-versions-of-two-more-insulin-products/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-pneumonia-outbreak-not-spreading-at-present-who/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/governor-of-california-proposes-state-run-drug-label/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/phase-iii-strength-trial-for-epanova-in-mixed-dyslipidaemia-will-close/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/swinging-for-the-fences-alexion-to-test-ultomiris-in-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/uk-cell-and-gene-clinical-trials-up-45-from-2018/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cyber-attacks-hit-more-than-half-of-healthcare-orgs-in-last-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/horizon-enlists-mammoth-in-crispr-move/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/heres-why-rigel-pharmaceuticals-is-erupting-this-week/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nektar-withdraws-application-for-opioid-painkiller-after-fda-panels-vote/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/german-drug-assessment-body-not-convinced-by-bayers-cancer-drug-vitrakvi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/wuxi-biologics-and-bayer-enter-into-an-acquisition-agreement-on-a-drug-product-plant-in-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/valtoco-is-approved-by-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/this-ai-can-detect-low-blood-sugar-from-ecg-readings/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/celltrion-to-build-plant-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/judge-slashes-8-billion-risperdal-award-against-johnson-johnson-to-6-8-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-counts-sharp-rise-in-coronavirus-cases-2-in-beijing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-scientists-identify-mosquito-protein-related-to-virus-transmission/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-warns-of-surgical-gowns-that-may-not-be-sterile/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/heart-failure-market-could-surpass-22bn-by-2028/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-clears-roches-polivy-for-certain-lymphomas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/as-pipeline-fattens-lilly-commits-470-million-for-new-plant-with-460-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-gets-1st-case-of-mysterious-new-chinese-illness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/treatment-for-depression-must-also-restore-proper-functioning-of-the-blood-brain-barrier/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cyclerion-drugs-4-pronged-cracking-of-neurodegenerative-diseases-passes-early-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-federal-researchers-kick-off-vaccine-work-against-deadly-new-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/horizon-notches-blockbuster-fda-approval-for-rare-eye-disease-med-tepezza/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jpm-gilead-leans-on-data-focus-to-launch-filgotinib-into-jam-packed-ra-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-suggest-a-less-traditional-assessment-could-help-flag-dementia-earlier/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-battle-with-the-wuhan-coronavirus-is-shackled-by-a-toxic-relationship-with-information/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/surprise-discovery-shakes-up-our-understanding-of-gene-expression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/blues-health-insurers-put-up-55-million-to-take-on-generic-drug-makers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma-first-and-only-ezh2-inhibitor-approved-by-the-u-s-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/johnson-johnson-named-a-2020-fortune-worlds-most-admired-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-research-shows-more-people-knowingly-use-fentanyl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/parkinsons-disease-may-start-before-birth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-cdc-says-no-new-confirmed-cases-of-coronavirus-110-under-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/first-human-trial-of-monoclonal-antibody-to-prevent-malaria-opens/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/krystal-biotech-investing-up-to-90m-on-facility-for-its-gene-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/success-for-enhertu-in-phase-ii-gastric-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/brilinta-hits-endpoint-in-late-stage-stroke-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-coronavirus-rising-death-toll-global-impact/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novel-molecules-display-potent-and-selective-action-against-ovarian-tumor-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-trijardy-xr-for-type-2-diabetes-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/johnson-johnson-pretty-confident-it-can-develop-coronavirus-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/quality-of-life-extended-with-atezolizumab-and-bevacizumab-in-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-faults-biocon-small-molecule-api-facility-during-preapproval-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/wuxi-biologics-enables-development-of-multiple-neutralizing-antibodies-for-novel-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/accelerons-pulmonary-hypertension-treatment-meets-main-goal-shares-soar-79/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nanoparticle-helps-eat-away-deadly-arterial-plaque/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-drug-candidate-created-by-ai-in-world-first/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-declares-coronavirus-outbreak-a-global-health-emergency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-to-sell-nearly-new-shire-plant-with-200-employees/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-identify-possible-new-combination-treatment-for-advanced-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-wins-eu-recommendation-for-prostate-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-drug-for-treatment-of-peanut-allergy-for-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-climbs-as-coronavirus-drug-shows-efficacy-starts-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/uk-withdrawal-from-the-eu-on-31-january-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/insmed-announces-positive-top-line-results-from-phase-2-willow-study-of-ins1007-in-patients-with-non-cystic-fibrosis-bronchiectasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/resverlogix-receives-us-fda-breakthrough-therapy-designation-for-apabetalone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-announces-more-coronavirus-cases-details-quarantine-plans-for-returning-travelers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-investigated-over-epilepsy-drug-linked-to-birth-defects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-to-slim-down-with-asset-spinoff-focus-on-keytruda-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-design-proteins-that-can-be-utilized-to-combat-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/64495-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-grants-emergency-nationwide-use-to-cdcs-coronavirus-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genentechs-risdiplam-showed-significant-improvement-in-motor-function-in-people-aged-2-25-with-type-2-or-3-spinal-muscular-atrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-may-delay-annual-meeting-of-parliament-due-to-virus-outbreak-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biogen-shares-soar-32-on-ms-drug-patent-win-over-mylan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/zynerba-pharmaceuticals-announces-achievement-of-patient-screening-target-for-pivotal-trial-of-zygel-in-fragile-x-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gsk-cutting-720-jobs-in-manufacturing-rd-and-support-functions-at-massive-belgian-vaccine-hub/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-investing-117-4m-in-manufacturing-site-in-denmark/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-expanding-again-in-australia-pledging-133m-investment-at-sydney-site-and-adding-250-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dupixent-sales-of-e10b-were-on-track-sanofi-ceo-hudson-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/advance-team-of-who-experts-arrives-in-china-to-probe-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/testosterone-study-finds-differing-disease-links-in-men-and-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roche-experimental-drug-flops-in-early-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cancer-vaccine-could-boost-immunotherapy-effectiveness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lillys-solanezumab-flunks-latest-alzheimers-study-shares-down-4-premarket/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novel-coronavirus-vaccine-starts-animal-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-invests-dkk-800-million-in-upgrading-and-expanding-production-facilities-in-kalundborg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-speeds-up-examination-of-5-drugs-with-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/judge-drops-some-charges-against-elizabeth-holmes-wire-fraud-remains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-technique-to-improve-melanoma-detection-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/experts-fear-china-reluctant-to-accept-who-ground-mission/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/keytruda-hits-endpoints-in-triple-negative-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/under-the-gun-acorda-slashes-inbrija-sales-forecast-amid-lackluster-launch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gbt-takes-a-page-from-hiv-playbook-as-it-embarks-on-oxbryta-launch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ai-helps-predict-heart-attacks-and-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/wockhardt-selling-plant-and-piece-of-its-business-to-dr-reddys-for-260m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/interim-data-shows-stelara-promise-in-crohns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/verona-unveils-phase-ii-copd-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/subcutaneous-entyvio-hits-crohns-primary-endpoint-misses-secondary/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eisais-weight-loss-drug-belviq-pulled-from-u-s-market-over-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-astellas-seattle-genetics-padcev-combo-data-spark-5-8b-sales-hopes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/concern-for-drug-shortages-grows-as-covid-19-outbreak-drags-on/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/parkinsons-disease-protein-structure-solved-inside-cells-using-novel-technique/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/most-coronavirus-infections-are-mild-says-chinese-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/how-malaria-detects-and-shields-itself-from-approaching-immune-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gsk-to-close-u-s-consumer-plant-eliminating-260-jobs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-largest-study-suggests-elderly-and-sick-are-most-at-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/joint-effort-of-fda-and-india-intercepts-illegally-shipped-opioids-cancer-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bluebird-cleared-for-zynteglo-launch-aims-to-dose-first-patients-soon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/medtech-conglomerate-medtronic-purchases-digital-surgery-in-bid-to-expand-their-surgical-robotics-arm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mit-algorithm-discovers-antibiotic-that-can-fight-drug-resistant-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roches-tecentriq-bags-priority-review-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scientists-strongly-condemn-rumors-and-conspiracy-theories-about-origin-of-coronavirus-outbreak/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-divests-allergopharma-to-dermapharm-holding-se/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/audentes-therapeutics-announces-plans-to-build-new-state-of-the-art-gene-therapy-manufacturing-facility-in-sanford-north-carolina/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/tevas-austedo-flunks-in-late-stage-paediatric-tourette-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/opdivo-yervoy-continues-to-impress-in-kidney-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/a-better-diagnosis-of-rare-diabetes-to-adapt-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-crispr-base-editing-technology-slows-als-progression-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/record-high-two-million-people-at-type-ii-diabetes-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biocon-confident-of-approval-for-lantus-copy-after-malaysia-plant-inspected-by-fda-a-third-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/empty-astrazeneca-plant-sized-up-by-cdmo-which-may-or-may-not-be-agc-biologics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-to-create-new-industry-leading-european-company-to-provide-active-pharmaceutical-ingredients-api/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/smart-watches-for-alzheimers-discussed-as-numbers-set-to-double-by-2050/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-spanks-kvk-tech-over-impurities-in-adhd-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-authorizes-marketing-of-the-first-genetic-test-to-aid-in-the-diagnosis-of-fragile-x-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-generic-of-proair-hfa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-heparin-maker-tried-to-sneak-proof-of-its-unapproved-apis-out-the-back-door/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-starts-two-late-stage-studies-to-test-drug-for-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-study-allows-brain-and-artificial-neurons-to-link-up-over-the-web/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-health-secretary-says-at-least-40-labs-can-currently-test-for-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/stada-becomes-a-major-consumer-healthcare-player-by-acquiring-15-well-established-gsk-brands/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-acquires-pvp-biologics-following-results-of-a-phase-1-study-of-tak-062-kuma062-for-the-treatment-of-celiac-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fujifilm-diosynth-biotechnologies-expands-north-carolina-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-and-amcm-eos-cooperate-in-3d-printing-of-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biogen-and-sangamo-announced-global-licensing-collaboration-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/glaxosmithkline-reportedly-looking-to-sell-select-antibiotic-brands/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-to-acquire-forty-seven-for-4-9-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/two-new-medicines-recommended-for-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-generic-of-daraprim/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-new-therapy-for-patients-with-previously-treated-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roche-pushes-to-kick-start-lung-therapy-esbriet-after-big-writedown/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coordination-chemistry-and-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/boehringer-launches-digital-platform-to-raise-awareness-about-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-picks-up-350m-after-selling-hypertension-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gene-variants-may-increase-susceptibility-to-accumulate-alzheimers-protein-tau/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/hydrogen-sulfide-heightens-disease-in-tuberculosis-suggesting-a-new-therapeutic-target/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/global-supplier-india-curbs-drug-exports-as-coronavirus-fears-grow/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-turns-roche-arthritis-drug-actemra-against-covid-19-in-new-treatment-guidelines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-pushes-doptelet-for-pre-surgery-liver-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/orphan-drugs-face-uphill-battle-in-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/hikma-halts-production-of-pain-drug-because-of-gelatinous-particles-in-vials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dirty-disposable-socks-cipla-sterile-injectables-plant-hit-with-fda-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/imfinzi-cancer-combo-falls-short-in-danube-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/urovant-sciences-announces-us-fda-acceptance-of-nda-for-vibegron-to-treat-overactive-bladder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/thermo-fisher-scientific-to-acquire-qiagen-n-v/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-requires-stronger-warning-about-risk-of-neuropsychiatric-events-associated-with-asthma-and-allergy-medication-singulair-and-generic-montelukast/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/world-vaccines-market-outlook-to-2030-major-players-are-astrazeneca-emergent-biosolutions-glaxosmithkline-merck-and-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pharming-gets-fda-approval-for-new-facility-to-make-hae-drug-ruconest/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-treatment-for-group-of-progressive-interstitial-lung-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/advanz-pharma-corp-limited-announces-definitive-agreement-to-acquire-the-rights-to-a-portfolio-of-alprostadil-products-from-ucb-s-a-for-approximately-84-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-figures-show-3-5-million-unlicensed-erection-pills-seized-in-2019/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-new-treatment-for-adults-with-cushings-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gates-funded-project-to-offer-home-testing-kits-for-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bora-pharmaceuticals-to-acquire-gsk-mississauga-based-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-researchers-find-key-neuron-of-stress-coping-strategies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-declares-the-coronavirus-outbreak-a-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biogen-signs-on-to-manufacture-clinical-supplies-for-virs-covid-19-antibodies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/look-for-novel-coronavirus-treatments-first-experts-say-and-vaccines-are-farther-off-than-you-think/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-coronavirus-test-10-times-faster-is-fda-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/venclyxto-gains-approval-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-merck-kgaas-bavencio-skewered-by-javelin-in-head-and-neck-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/after-kymeras-raise-nurix-nabs-120m-as-it-too-hones-in-on-clinical-work/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/boehringer-eli-lilly-get-fda-fast-track-status-for-jardiance-to-treat-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-clears-first-clinical-study-for-a-polymicrobial-phage-library-based-treatment-for-antibiotic-resistant-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-scanner-can-improve-the-detection-of-cancer-tissue-and-brain-disease-diagnoses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/polyps-and-colorectal-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-cancels-haemophilia-drug-phase-iii-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-19-sanofi-moderna-biontech-give-updates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/affordable-versions-of-hepatitis-c-medicine-daclatasvir-soon-available-in-additional-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/regeneron-aims-to-have-coronavirus-antibody-treatment-ready-for-human-testing-by-early-summer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/higher-dose-of-gefapixant-hits-endpoints-in-chronic-cough-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oxford-biomedica-to-license-lentivector-to-juno/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizers-abrocitinib-hits-endpoints-in-late-stage-atopic-dermatitis-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nhs-data-shows-gap-in-care-for-heart-failure-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cipla-slammed-with-fda-warning-letter-for-sterile-injectables-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/soligenixs-stock-climbs-as-phase-3-lymphoma-trial-hits-goal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/two-generic-drugs-being-tested-in-u-s-in-race-to-find-coronavirus-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-oks-gileads-paediatric-hep-c-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/janssen-sends-off-nda-for-new-multiple-sclerosis-drug-ponesimod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/epizyme-hires-kutok-as-cso-to-find-new-uses-for-tazverik/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/viiv-healthcare-announces-first-global-regulatory-approval-of-cabenuva-the-first-complete-long-acting-regimen-for-the-treatment-of-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/using-cannabinoids-to-treat-acute-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oncomx-knowledgebase-enables-research-of-cancer-biomarkers-and-related-evidence/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-dismisses-jardiance-for-type-i-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/crumpled-graphene-makes-ultra-sensitive-cancer-dna-detector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/telemedicine-reduces-mental-health-burden-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/five-year-zolgensma-data-shows-sma-benefit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/venclexta-venclyxto-combo-extends-myeloid-leukaemia-survival/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/india-bans-export-of-drug-being-tested-for-coronavirus-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/qiagen-releases-qiastat-dx-test-kit-to-the-u-s-as-first-syndromic-test-for-detection-of-sars-cov-2-coronavirus-under-new-fda-policy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-enlists-curadev-in-sting-antagonist-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/labeling-of-cannabidiod-products-becoming-a-public-health-concern/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jefferies-pumping-10m-into-apiject-and-hhs-national-syringe-surge-network/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/beigenes-supply-of-bristol-myers-squibbs-abraxane-freezes-in-china-amid-fresenius-kabi-plant-woes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-food-and-drug-administration-approves-bristol-myers-squibbs-zeposia-ozanimod-a-new-oral-treatment-for-relapsing-forms-of-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-cansino-bio-advances-covid-19-vaccine-into-phase-2-on-preliminary-safety-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/johnson-johnson-posts-temporary-tylenol-shortage-amid-heightened-demand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mylan-prepares-hydroxychloroquine-giveaways-after-production-ramp-up/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/belgian-scientists-identify-atp10b-as-novel-risk-gene-for-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-reveals-how-high-salt-diet-blocks-tumor-growth-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-researchers-identify-biomarker-for-early-detection-of-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-generic-of-a-commonly-used-albuterol-inhaler-to-treat-and-prevent-bronchospasm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-covid-19-update-fda-authorizes-blood-purification-device-to-treat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-therapy-for-children-with-debilitating-and-disfiguring-rare-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/the-coronavirus-spreads-at-least-13-feet-travels-on-shoes-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-rutgers-saliva-test-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/retail-scripts-of-vaccines-acute-drugs-decline-sharply-amid-covid-19-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/smc-accepts-four-medicines-for-nhs-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genetic-alliance-uk-launches-covid-19-advice-hub/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lilly-to-test-olumiant-ly3127804-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-therapy-for-treatment-of-low-grade-upper-tract-urothelial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/exclusive-india-agrees-to-sell-hydroxychloroquine-to-malaysia-to-help-fight-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/temple-treats-first-patient-in-the-u-s-in-clinical-trial-of-gimsilumab-for-patients-with-covid-19-and-acute-respiratory-distress-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aid-groups-ask-uk-gov-to-stop-pharma-profiteering-from-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/when-damaged-the-adult-brain-repairs-itself-by-going-back-to-the-beginning/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chi-meds-surufatinib-bags-us-fast-track-designations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-data-back-long-term-use-of-novartis-aimovig-in-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cancer-drug-resistance-study-raises-immune-red-flags/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/kaneka-agrees-to-supply-active-pharmaceutical-ingredients-for-avigan-tablet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cannabis-formulation-for-the-treatment-of-colon-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dont-count-on-a-covid-19-vaccine-for-at-least-5-years-says-ai-based-forecast/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genentech-novo-nordisk-and-abbvie-top-the-list-of-best-workplaces-in-biopharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-new-drug-under-international-collaboration-a-treatment-option-for-patients-with-her2-positive-metastatic-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-targeted-treatment-for-patients-with-cholangiocarcinoma-a-cancer-of-bile-ducts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astellas-announces-acquisition-of-nanna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-kgaa-amps-up-in-gene-therapy-with-110m-viral-vector-manufacturing-boost/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-19-lockdown-in-india-hub-leaves-pharmas-scrambling-to-keep-up-supply/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-backs-nhs-use-of-bayers-vitrakvi-via-the-cdf/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-new-therapy-for-triple-negative-breast-cancer-that-has-spread-not-responded-to-other-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-saint-lukes-begin-testing-farxiga-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ec-nod-for-merger-of-mylan-and-pfizers-upjohn-division/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/designer-virus-is-first-new-oral-polio-vaccine-in-50-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-approves-sanofis-meningococcal-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scancell-kicks-off-covid-19-vaccine-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-develop-breakthrough-antibody-test-for-covid-19-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/higher-levels-of-nets-in-blood-associated-with-more-severe-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-mercks-lynparza-gets-an-edge-over-clovis-rubraca-with-prostate-cancer-survival-win/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-warns-that-hyped-covid-19-drug-hydroxychloroquine-is-too-risky-outside-the-hospital/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/no-evidence-people-with-coronavirus-are-immunised-who/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/herpes-virus-decoded/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/east-china-city-to-build-chinese-pharma-valley/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mixed-results-for-sanofis-kevzara-covid-19-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/neurocrine-gets-u-s-nod-for-parkinsons-therapy-covid-19-delays-launch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ec-approves-shionogis-new-antibiotic-fetcroja/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bemcentinib-first-candidate-to-be-tested-in-unique-accord-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/after-horlicks-sale-gsk-plans-to-offload-3-7b-stake-in-unilever-india-bloomberg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/richter-entered-into-an-asset-purchase-agreement-with-mycenax-for-the-biosimilar-tocilizumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/indian-pharmas-call-on-fda-to-perform-virtual-facility-checks-during-covid-19-inspection-lockdown/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fujifilm-grants-production-space-to-gates-funded-covid-19-effort/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/catalent-signs-agreement-with-johnson-johnson-to-be-u-s-manufacturing-partner-for-lead-covid-19-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chmp-puts-eight-new-medicines-forward-for-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-grants-gileads-remdesivir-emergency-authorization-for-covid-19-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/vicore-pharma-bags-mhra-nod-for-covd-19-trial-in-record-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-approves-label-update-for-az-lokelma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/menarini-to-buy-stemline-for-up-to-677-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/newron-drops-development-of-sarizotan-in-rett-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/crescendo-links-with-cruk-to-progress-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/alexion-to-buy-portola-in-1-4-billion-effort-to-diversify/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-oks-az-farxiga-for-heart-failure-with-reduced-ejection-fraction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-working-on-its-own-remdesivir-ramp-up-scouts-licensing-partners-for-global-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/with-the-world-waiting-roche-socks-459m-into-covid-19-antibody-test-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/avrobio-taps-magentas-adc-in-ongoing-quest-to-improve-gene-therapy-conditioning/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/janssen-promotes-rd-exec-into-newfound-data-science-role/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fresenius-kabi-recalls-anti-inflammation-drug-ketorolac-after-finding-particles-in-vials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novartis-gets-fda-nod-for-tabrecta-to-treat-metastatic-nsclc-with-metex14/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/laurent-pharmaceuticals-receives-health-canadas-approval-to-initiate-covid-19-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/daiichi-sankyo-submits-snda-for-trastuzumab-deruxtecan-in-japan-for-her2-positive-metastatic-gastric-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/certara-and-dmtc-announce-research-collaboration-to-study-preventative-use-of-chloroquine-in-health-care-workers-at-high-risk-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cadila-shutters-indian-ingredients-plant-after-26-workers-test-positive-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/vitamin-d-levels-appear-to-play-role-in-covid-19-mortality-rates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-mercks-lynparza-wins-bid-to-challenge-gsks-zejula-in-wider-ovarian-cancer-pool/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-hit-with-iranian-cyberattack-for-role-in-covid-19-response-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/apotex-admits-to-generic-price-fixing-agrees-to-pay-24m-criminal-fine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-therapy-for-patients-with-lung-and-thyroid-cancers-with-a-certain-genetic-mutation-or-fusion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/zydus-cadila-launches-enzalutamide-drug-to-treat-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/abbvie-completes-transformative-acquisition-of-allergan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-covid-19-update-fda-authorizes-first-antigen-test-to-help-in-the-rapid-detection-of-the-virus-that-causes-covid-19-in-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/experimental-two-in-one-shot-may-give-diabetics-a-better-way-to-control-their-blood-sugar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-final-guidance-backs-pfizers-lorviqua/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-reveals-key-gene-related-to-primate-arterial-aging/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-backs-use-of-roches-gazyvaro-with-bendustamine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-technology-transforms-tap-water-into-powerful-disinfectant-against-viruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jjs-erleada-extends-lives-by-14-months-in-nonmetastatic-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/exvastat-wins-3-6m-euro-grant-for-covid-19-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nantkwest-and-immunitybio-to-initiate-a-phase-2-study-of-immunotherapy-for-metastatic-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-snags-pomalyst-green-light-in-rare-aids-related-skin-lesions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-nabs-speedy-review-of-sutimlimab-aiming-for-a-november-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/los-angeles-offers-virus-tests-to-all-still-has-unused-kits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/blueprints-ayvakit-gets-fda-no-go-in-new-stomach-cancer-use-but-presses-ahead-in-blood-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/using-telehealth-to-transition-diabetes-inpatients-to-virtual-care-during-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/no-spike-in-coronavirus-in-places-reopening-u-s-health-secretary-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/israels-teva-gets-china-approval-for-huntingtons-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-in-talks-with-other-governments-to-replicate-uk-vaccine-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/over-100-million-in-chinas-northeast-face-renewed-lockdown/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-finds-that-aging-neurons-accumulate-dna-damage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/people-with-diabetes-at-higher-risk-of-amid-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roche-partners-with-vividion-on-novel-e3-ligases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/online-health-diagnosis-tools-only-accurate-around-36-pct-of-the-time-aussie-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/first-clinical-trial-with-genetically-modified-malaria-vaccine-completed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/beximco-pharma-introduces-worlds-first-generic-remdesivir-for-covid-19-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cansino-adds-mrna-to-covid-19-vaccine-efforts-with-precision-nanosystems-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/govt-unveils-coronavirus-antibody-testing-scheme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gsk-partners-with-samsung-to-expand-biopharma-manufacturing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/amarins-vascepa-loses-one-more-shield-with-hikmas-generic-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genentech-posts-long-term-data-on-near-approval-soliris-rival/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/when-developing-vaccines-against-covid-19-fast-is-slow-and-slow-is-fast/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nautilus-biotechnology-raises-76m-in-series-b-funding-to-be-first-to-quantify-human-proteome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/first-signs-if-a-covid-19-vaccine-works-possible-in-autumn-gavi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sunovion-announces-u-s-fda-approval-of-kynmobi-apomorphine-hydrochloride-sublingual-film-for-the-treatment-of-parkinsons-disease-off-episodes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/arginine-is-a-potential-disease-modifying-drug-for-polyglutamine-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-to-sell-stake-in-regeneron/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-us-approval-for-takedas-alunbrig/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-pauses-hydroxycholoroquine-arm-in-covid-19-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-treatment-for-a-form-of-bladder-dysfunction-in-pediatric-patients-as-young-as-2-years-of-age/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pharma-exports-a-rare-bright-spot-for-singapore-economy-as-pandemic-drives-demand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-launches-social-responsibility-strategy-for-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/antibody-drug-tech-firm-abcellera-raises-105-million-as-it-works-on-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-fda-finds-high-levels-of-carcinogen-in-diabetes-drug-metformin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dementia-gene-raises-risk-of-severe-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-develop-ai-tool-able-to-predict-cancer-relapse-28th-may-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-19-sun-pharma-gets-dcgi-nod-for-nafamostat-clinical-trial-in-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/emas-human-medicines-committee-chmp-recommended-eight-medicines-for-approval-at-its-may-2020-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/tagrisso-shows-unprecedented-disease-free-survival-in-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-vaccine-could-be-ready-by-year-end-government-body-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/taiwan-approves-gileads-remdesivir-to-treat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/government-has-decided-to-disinvest-in-certain-pharma-psus-piyush-goyal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-pushes-metformin-recalls-for-5-drugmakers-after-carcinogen-contamination/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/emergent-biosolutions-barda-reach-628m-deal-to-manufacture-covid-19-vaccine-hopefuls/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-new-indication-for-astrazenecas-heart-disease-drug-brilinta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-treatment-succeeds-in-late-stage-bowel-disease-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-shows-nyc-covid-19-outbreak-had-european-and-u-s-origins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-next-step-on-coronavirus-inhaled-remdesivir-other-easier-to-use-versions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/exclusive-lonza-sets-new-goal-to-make-moderna-covid-19-vaccine-ingredients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/only-891-in-free-hiv-prevention-drug-program-meant-for-200000/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-set-to-resume-hydroxychloroquine-trial-in-battle-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-publishes-final-guidance-backing-tevas-ajovy-for-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pharma-sees-more-post-ma-rebrands-than-other-industries-and-it-does-them-better-too/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/abbvie-strikes-partnership-to-develop-covid-19-antibody-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/department-of-defense-awards-novavax-60-million-covid-19-vaccine-contract/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-forges-rna-modifying-protein-oncology-deal-with-accent-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lilly-bags-expanded-eu-approval-for-taltz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/imperial-college-london-forms-new-social-enterprise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-calquence-shows-promise-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/avigan-trial-to-stretch-beyond-june-as-japans-coronavirus-cases-plunge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-gilead-merger-doubted-by-wall-street-analysts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/daewoong-pharmaceutical-says-anti-parasitic-drug-effective-against-coronavirus-in-animal-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/the-university-of-tokyo-riken-nichi-iko-and-daiichi-sankyo-reach-basic-agreement-on-collaborative-rd-on-nafamostat-inhalation-formulation-for-treatment-of-novel-corona-virus-infection-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/high-blood-pressure-increases-risk-of-cognitive-impairment-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/solenos-drug-misses-key-goal-in-prader-willi-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-expands-reach-of-vertex-cf-drug-kalydeco/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/heads-up-biogen-after-digging-into-tecfidera-patent-arguments-analyst-predicts-a-loss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-confirms-july-start-for-key-study-of-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/japans-fujifilm-to-spend-928-million-to-double-capacity-of-danish-drug-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/abbvie-and-genmab-link-for-oncology-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/regeneron-sees-a-lot-of-reason-for-hope-as-human-testing-of-its-coronavirus-drug-begins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/register-for-the-fiercebiotech-virtual-series-technologys-role-in-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-bets-725m-on-heart-focused-corvidia-with-the-promise-of-1-4b-more/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/shiny-new-startup-egle-grabs-a-deal-with-takeda-for-cancer-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-rejects-sanofis-cablivi-in-draft-guidelines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-19-may-trigger-new-diabetes-experts-warn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-new-therapy-for-rare-disease-affecting-optic-nerve-spinal-cord/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-debt-in-mind-offloads-18-drugs-in-asia-pacific-to-celltrion-for-278m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-regulators-agree-to-review-leos-dermatitis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-approves-first-dispersible-tablet-formulation-of-tivicay/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dr-reddys-signs-licensing-agreement-with-gilead-sciences-for-remdesivir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/hong-kong-scientists-develop-probiotic-formula-to-help-combat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/steroid-drug-hailed-as-breakthrough-for-seriously-ill-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-shot-to-be-free-if-you-cant-afford-it-official-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novartis-ilaris-first-drug-approved-for-stills-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/a-new-hope-for-amarin-vascepa-generic-settlement-leaves-analysts-split-on-patent-appeal-success/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-for-chembio-antibody-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/adhesive-film-turns-smartwatch-into-biochemical-health-monitoring-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/msd-pfizers-diabetes-drug-steglatro-hits-goal-in-cv-outcomes-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-oks-epizymes-tazemetostat-for-treatment-resistant-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/antidepressant-fluoxetine-prozac-suppresses-replication-of-sars-cov-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/emergent-biosolutions-to-invest-75-million-in-canton-site-and-expand-viral-vector-and-gene-therapy-capability/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisks-am833-shows-early-success-in-obesity-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/beijing-coronavirus-cases-to-see-cliff-like-drop-this-week-expert/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-targets-two-million-remdesivir-courses-by-year-end/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novartis-pulls-plug-on-hydroxychloroquine-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-clinches-2-billion-vaccines-deal-with-translate-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mercks-next-gen-pneumococcal-vaccine-scores-in-phase-3-amid-race-with-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-to-start-testing-inhaled-remdesivir-eyeing-earlier-covid-19-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cyclica-banks-17m-to-decentralize-drug-discovery-speed-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/asymptomatic-covid-19-infections-show-weaker-immune-response-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-pens-500m-yumanity-pact-nabbing-2-neuro-hopefuls-in-the-process/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/one-and-done-gene-therapy-wipes-out-parkinsons-symptoms-in-mouse-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/second-largest-ebola-outbreak-in-history-is-finally-over/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sosei-abbvie-sign-drug-discovery-deal-worth-up-to-1-bln/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-inks-largest-settlement-in-pharma-history-with-10b-roundup-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-approach-drives-bacteria-to-produce-potential-antibiotic-antiparasitic-compounds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/international-study-discovers-three-potential-new-targets-for-treating-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/its-not-just-alzheimers-disease-research-highlights-form-of-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-receives-u-s-fda-approval-to-manufacture-entyvio-vedolizumab-drug-substance-at-manufacturing-facility-in-brooklyn-park-minnesota/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novartis-alcon-to-pay-combined-347-million-to-resolve-us-bribery-allegations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-new-therapy-for-dravet-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/expect-to-launch-25-products-in-us-this-fiscal-dr-reddys/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/french-drugmaker-sanofi-to-cut-up-to-1680-jobs-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cholesterol-lowering-drugs-help-reduce-covid-19-deaths-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/canada-federal-court-dismisses-drugmakers-plea-challenging-drug-price-rules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-study-warns-of-possible-new-pandemic-virus-from-pigs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-prices-covid-19-drug-candidate-remdesivir-at-390-vial-in-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/s-africa-in-talks-with-indias-macleods-to-set-up-hiv-drug-maker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-sinopharm-unit-completes-new-covid-19-vaccine-plant-doubles-capacity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fujifilm-pairs-with-dr-reddys-global-response-aid-to-make-covid-19-drug-avigan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-approves-bavencio-for-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-develop-a-new-ultrafast-insulin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-damages-the-endocrine-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-develops-novel-rabies-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/tesla-to-build-mobile-rna-microfactories-for-curevacs-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/granules-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-metformin-hydrochloride-extended-release-tablets-usp-750-mg-due-to-the-detection-of-n-nitrosodimethylamine-ndma-impurity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/a-common-asthma-drug-shows-promise-as-a-treatment-for-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-viivs-novel-hiv-treatment-rukobia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-regeneron-pull-plug-on-kevzara-covid-19-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/uk-study-to-research-long-term-health-impact-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mylan-prices-its-generic-remdesivir-in-india-at-64-per-100-mg-vial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-says-reviewing-nyt-article-on-concerns-over-airborne-spread-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cold-war-antiseptic-has-potential-in-fight-against-drug-resistant-germs-and-viruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-hypertension-medications-can-also-reduce-risk-of-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cr-uk-pairs-with-abcam/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-fda-approves-qwo-collagenase-clostridium-histolyticum-aaes-the-first-injectable-treatment-for-cellulite/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-trump-moves-to-pull-us-out-of-world-health-organization/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sandoz-collaborates-with-civica-rx-to-help-reduce-critical-generic-medicine-shortages-in-us-hospitals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mylan-recalls-lot-of-injectable-daptomycin-after-particulates-show-up-in-vial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-lilly-sanofi-and-others-raise-prices-to-start-july-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/israeli-researchers-discover-tiny-brain-region-controlling-sleep-depth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/concert-pharmaceuticals-receives-fda-breakthrough-therapy-designation-for-ctp-543-for-the-treatment-of-alopecia-areata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biogen-files-with-fda-for-approval-of-alzheimers-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-priority-review-for-az-brilinta-aspirin-combination/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-in-pact-wth-rovi-to-supply-virus-vaccine-outside-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-1-billion-fund-aims-to-steer-antibiotic-companies-in-tough-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/florida-sets-one-day-record-with-over-15000-new-covid-cases-more-than-most-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-finds-fatty-acid-that-kills-cancer-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scientists-may-have-found-one-path-to-a-longer-life-by-university-of-southern-california/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/plasma-coated-australian-bandages-to-revolutionize-treatment-of-wounds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roche-gene-testing-key-to-1-7-billion-deal-for-blueprint-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-expects-to-start-late-stage-covid-19-vaccine-trial-on-july-27/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scientists-discover-a-new-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-finds-fenofibrate-may-downgrade-covid-19-to-common-cold-level/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aspen-offers-to-cut-cancer-drug-prices-may-avoid-eu-antitrust-fine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/complete-dna-sequence-of-the-x-chromosome-revealed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/johnson-johnson-profit-dives-35-as-coronavirus-zaps-sales-of-beauty-products-medical-devices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/teva-to-serve-as-defendant-in-bellwether-trial-alleging-generic-drug-price-fixing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-committee-backs-terlipressin-approval-for-hrs-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-elanco-get-ftcs-final-antitrust-go-ahead-for-7-6b-animal-health-merger-after-divestitures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-sinopharm-begins-late-stage-trial-of-covid-19-vaccine-in-uae/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-preparing-full-mission-to-china-to-study-virus-origins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-farxiga-fast-tracked-for-heart-failure-following-mi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-backing-for-astellas-xospata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/indian-police-arrest-14-for-black-market-remdesivir-as-covid-19-cases-jump/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-vericiguat-is-primarily-tested-by-the-fda-in-the-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-eyes-acquisitions-in-us-including-principia-biopharma-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/grifols-to-acquire-green-cross-plasma-fractionation-facility-in-montreal-and-a-plasma-collection-organization-in-the-u-s-for-us460-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/avanti-polar-lipids-agrees-to-be-acquired-by-croda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oxytocin-the-love-hormone-could-be-used-to-treat-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/glenmark-announces-top-line-results-from-phase-3-clinical-trial-of-favipiravir-in-patients-with-mild-to-moderate-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sk-bioscience-to-contract-manufacture-astrazenecas-covid-19-vaccine-in-korea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-to-pay-pfizer-biontech-1-95-billion-for-100-million-covid-19-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jazzs-xywav-a-low-sodium-alternative-to-blockbuster-xyrem-snags-fda-nod-in-narcolepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/unichem-laboratories-gets-usfda-nod-for-drug-to-treat-irregular-heartbeat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-sciences-to-buy-49-9-stake-in-tizona-therapeutics-for-300m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/samsung-biologics-seeks-to-add-fourth-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-says-u-s-brazil-and-india-can-deal-with-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-copd-therapy-wins-us-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sixth-pharmaceutical-company-charged-in-ongoing-criminal-antitrust-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/indivior-to-resolve-u-s-opioid-treatment-marketing-claims-for-600-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-eyes-covid-19-vaccines-at-less-than-40-shuns-who-led-alliance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/panexcell-clinical-laboratories-suspension-of-medicines-over-flawed-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lonza-sees-no-delays-for-covid-19-vaccine-project-citing-trump-backing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-kite-bags-second-car-t-okay-with-tecartus-nod-in-mantle-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-stock-sinks-as-patent-case-spurs-concern-for-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/antiviral-method-against-herpes-paves-the-way-for-combatting-incurable-viral-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-says-covid-19-pandemic-is-one-big-wave-not-seasonal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-pharmaceutical-to-cut-sales-jobs-in-japan-sources-say/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dfc-to-sign-letter-of-interest-for-investment-in-kodaks-expansion-into-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-buys-remdesivir-to-treat-30000-covid-patients-seeks-more/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-says-covid-19-vaccine-pricing-to-ensure-broad-access/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-sends-warning-letters-to-seven-companies-illegally-selling-hangover-products/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dr-reddys-to-launch-covid-drugs-remdesivir-and-favipiravir-in-august/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/investment-health-policy-changes-are-key-for-new-alzheimers-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/medieval-medicine-remedy-could-provide-new-treatment-for-modern-day-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genentech-cuts-474-jobs-in-move-not-related-to-covid-19-programs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lgm-pharma-acquires-nexgen-pharmas-pharma-development-manufacturing-biz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gsk-and-sanofi-strike-2-1-billion-deal-with-u-s-government-for-100-million-doses-of-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/immunology-launches-buoy-abbvie-sales-as-covid-19-swamps-ex-allergan-aesthetics-biz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-banks-on-blockbuster-remdesivir-with-sunnier-2020-outlook/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-expands-scope-of-janssens-stelara/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mhra-oks-celltrions-phase-i-trial-of-covid-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-formally-investigated-over-epilepsy-drug-depakine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aussie-researchers-reverse-alzheimers-memory-loss-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/siemens-healthineers-expands-into-cancer-care-with-16-4-billion-deal-for-varian/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/janssens-depression-nasal-spray-spravato-bags-new-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/exposure-to-common-cold-coronaviruses-can-teach-the-immune-system-to-recognize-sars-cov-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pharmas-reputation-has-climbed-during-covid-19-pandemic-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scientists-discover-novel-drug-target-for-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-covid-med-remdesivir-is-scarce-and-costly-ags-say-urging-feds-to-sidestep-its-patents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-cuts-annual-guidance-as-q2-sales-hit-by-covid-19-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-gsks-blenrep-as-fourth-line-multiple-myeloma-monotherapy-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/drugmakers-slash-prices-to-win-chinas-bulk-buy-contracts-state-media/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-to-build-1b-london-rd-hub-for-its-first-ex-u-s-early-research-center/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biomarin-receives-complete-response-letter-crl-from-fda-for-valoctocogene-roxaparvovec-gene-therapy-for-severe-hemophilia-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jj-strikes-us6-5-billion-deal-for-autoimmune-disease-specialist-momenta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mexico-signs-up-to-italian-vaccine-trial-for-coronavirus-minister/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-starts-trial-of-covid-19-antibody-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/clinical-research-cut-87-at-peak-of-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/metformin-recalls-continue-as-bayshore-pulls-diabetes-drug-on-carcinogen-scare/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pandemic-pace-slows-worldwide-except-for-southeast-asia-eastern-mediterranean-who/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/translate-bio-sanofi-covid-19-vaccine-candidate-produces-immune-response-in-animal-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nih-to-conduct-studies-on-compound-similar-to-remdesivir-the-week/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-charges-teva-in-generic-drugs-price-fixing-probe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-sinovac-enters-supply-deal-with-indonesia-for-covid-19-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/contract-manufacturer-pci-sells-off-majority-stake-in-expansion-play-in-europe-asia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/abbott-to-ship-millions-of-5-card-sized-coronavirus-tests-offering-digital-health-passes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/are-antivitamins-the-new-antibiotics-research-team-from-university-of-gottingen-develops-drug-approach-against-bacterial-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gene-discovery-linked-to-alcohol-induced-liver-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/a-surprising-protein-player-in-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/phase-1-human-trials-suggest-uic-developed-breast-cancer-drug-is-safe-effective/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/trump-to-announce-deal-to-buy-150-mn-rapid-covid-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/preventing-infection-facilitating-healing-new-biomaterials-from-spider-silk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/elon-musk-to-show-off-working-brain-hacking-device/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-approves-roches-new-pan-tumour-liquid-biopsy-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/vir-biotechnology-and-gsk-start-phase-2-3-study-of-covid-19-antibody-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-provides-update-on-kevzara-sarilumab-phase-3-trial-in-severe-and-critically-ill-covid-19-patients-outside-the-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nestle-to-acquire-aimmune-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-willing-to-fast-track-coronavirus-vaccine-before-phase-three-trials-end/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-imfinzi-bags-new-approval-for-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-sciences-and-jounce-therapeutics-announce-exclusive-license-agreement-for-novel-immunotherapy-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/honeybee-venom-compound-shown-to-kill-aggressive-breast-cancer-cells-aussie-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jubilant-life-sciences-seeks-nod-to-roll-out-remdesivir-tablet/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oxford-biomedica-signs-supply-agreement-with-astrazeneca-to-expand-manufacturing-support-of-covid-19-vaccine-candidate-azd1222/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-updates-clinical-care-guidance-with-corticosteroid-recommendations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-gsk-to-start-potential-covid-19-vaccine-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/california-may-be-the-first-state-to-develop-its-own-generic-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-offers-coronavirus-vaccine-candidates-to-aviation-industry-workers-notice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/protein-discovery-could-improve-type-2-diabetes-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/does-the-covid-19-cytokine-storm-exist/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/leo-pharma-sells-portfolio-of-four-products-to-cheplapharm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/curevac-covid-19-vaccine-scale-production-seen-this-year-investor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-19-vaccine-developers-seek-to-reassure-public-over-safety/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/csl-to-produce-over-80-million-doses-of-covid-19-vaccines-for-australia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genentech-announces-fda-approval-of-gavreto-pralsetinib-for-the-treatment-of-adults-with-metastatic-ret-fusion-positive-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/exclusive-90-of-chinas-sinovac-employees-families-took-coronavirus-vaccine-says-ceo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-no-for-pierre-fabres-braftovi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oncology-biotech-prelude-guns-for-100m-ipo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-posts-mixed-phase-3-data-on-chronic-cough-drug-gefapixant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mylan-acquires-aspens-european-thrombosis-portfolio-for-757-3-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-covid-19-vaccine-study-put-on-hold-due-to-suspected-adverse-reaction-in-participant-in-the-u-k/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cansino-phase-3-covid-19-vaccine-trial-in-pakistan-expected-to-begin-this-month/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-divests-select-non-core-assets-in-europe-to-cheplapharm-for-approximately-562-million-usd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/france-fines-roche-novartis-444-million-euros-in-ongoing-eye-drug-clash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-developed-nasal-spray-vaccine-for-covid-19-approved-for-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/brazil-trials-of-sinovac-covid-19-vaccine-show-promising-results-governor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-trelegy-ellipta-as-the-first-once-daily-single-inhaler-triple-therapy-for-the-treatment-of-both-asthma-and-copd-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/hhs-authorizes-pharmacists-to-order-administer-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nih-activ-initiative-launches-adaptive-clinical-trials-of-blood-clotting-treatments-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-n-s-guterres-calls-for-35-billion-more-for-who-covid-19-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/britains-medical-regulator-says-urgently-reviewing-astrazeneca-covid-19-vaccine-trial-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/trump-signs-new-executive-order-on-prescription-drug-prices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/21-billion-gilead-sciences-to-acquire-immunomedics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/computer-scientists-from-royal-holloway-use-artificial-intelligence-to-predict-the-frequencies-of-drug-side-effects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-ceo-says-company-will-know-if-vaccine-works-by-end-of-october/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/the-uae-has-approved-a-chinese-made-coronavirus-vaccine-for-emergency-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/recovery-covid-19-phase-3-trial-to-evaluate-regenerons-regn-cov2-investigational-antibody-cocktail-in-the-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-coronavirus-vaccine-may-be-ready-for-public-in-november-official/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/baricitinib-in-combination-with-remdesivir-reduces-time-to-recovery-in-hospitalized-patients-with-covid-19-in-niaid-sponsored-actt-2-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-opens-new-rd-manufacturing-facility-for-cell-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-appeals-court-revives-new-york-tax-on-opioid-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/painless-paper-patch-test-for-glucose-levels-uses-microneedles/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-to-build-biomedical-agency-convene-health-summit-says-von-der-leyen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/some-volunteers-quit-jj-covid-19-trial-in-spain-after-astrazeneca-scare-investigator/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/germany-grants-biontech-curevac-745-million-to-speed-up-covid-19-vaccine-work/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/kodak-execs-didnt-illegally-trade-stock-while-touting-big-move-into-pharma-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-to-divest-tachosil-to-corza-health-for-e350-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/johnson-johnson-charged-by-new-york-with-civil-insurance-fraud-over-opioid-claims/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/another-rapid-covid-19-test-shows-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/imaging-probe-to-visualize-alzheimers-disease-related-gamma-secretase-in-the-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bms-opdivo-wins-new-nice-lung-cancer-backing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-acquires-dogmas-oral-pcsk9-inhibitor-programme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/keytruda-lenvima-combo-shows-promise-in-hard-to-treat-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lynparza-scores-long-term-benefit-data-in-brca-mutated-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ema-endorses-use-of-dexamethasone-in-covid-19-patients-on-oxygen-or-mechanical-ventilation-share/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/exclusive-eu-in-early-talks-with-italys-reithera-over-potential-vaccine-supply-deal-source/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-14-17-september-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-says-tagrisso-shown-to-slow-lung-cancer-spreading-to-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roche-acquires-irish-biotech-firm-inflazome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/another-one-down-ac-immune-and-genentechs-tau-drug-fails-alzheimers-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-plans-new-more-stringent-guidance-for-covid-19-vaccine-eua/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/genmab-and-janssen-head-to-arbitration-table-over-darzalex-royalties/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/evergreen-theragnostics-breaks-ground-on-radiopharmaceutical-factory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-drug-candidate-found-for-hand-foot-and-mouth-disease-targeting-rna-with-small-molecules-could-pave-the-way-for-new-antivirals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/once-a-week-insulin-for-type-2-diabetes-shows-promise-in-early-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/permira-buys-german-specialty-pharma-group-neuraxpharm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/relief-therapeutics-seeks-u-s-emergency-approval-for-drug-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/roche-alzheimers-drug-fails-joining-long-list-of-trial-flops/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aussie-research-links-diabetes-drug-usage-to-slower-cognitive-decline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/algenex-inaugurates-new-facility-with-capacity-to-produce-up-to-100-million-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/brazil-to-join-covax-vaccine-facility-as-chile-israel-uae-also-sign-up/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/australian-firm-says-its-nasal-spray-reduced-coronavirus-growth-in-animal-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/jjs-single-dose-covid-19-vaccine-generates-strong-immune-response-early-data-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-oral-jak-inhibitor-filgotinib-wins-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-places-partial-hold-on-inovios-planned-phase-ii-iii-covid-19-vaccine-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gsks-nucala-approved-in-the-us-for-hypereosinophilic-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-new-global-test-will-give-results-in-minutes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofis-dupixent-focus-will-pay-off-to-the-tune-of-12-5b-in-peak-sales-analysts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ai-drug-designer-xtalpi-raises-318m-from-softbank-tencent-others-for-digital-twin-simulation-efforts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/regeneron-says-its-covid-19-treatment-reduces-viral-levels-improves-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/more-than-60-million-indians-may-have-caught-coronavirus-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/discovery-enables-adult-skin-to-regenerate-like-a-newborns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/glaxosmithklines-nucala-targets-rival-astrazeneca-with-fda-nod-for-rare-white-blood-cell-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-infuses-200m-into-cstone-scoring-a-second-pd-l1-and-outlining-a-sprawling-china-pact/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/even-in-people-with-parkinsons-gene-coffee-may-be-protective/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/where-are-the-bugs-fda-knocks-indian-manufacturer-for-crude-microbe-testing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scientists-kill-cancer-cells-by-shutting-the-door-to-the-nucleus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/relief-therapeutics-announces-supply-deals-while-awaiting-covid-19-trial-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-widens-u-s-safety-inquiry-into-astrazeneca-coronavirus-vaccine-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/why-do-people-respond-differently-to-the-same-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-scores-a-speedy-review-in-the-us-for-duchenne-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nobel-prize-in-medicine-awarded-to-3-researchers-for-hepatitis-c-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/president-donald-trump-waved-to-supporters-outside-walter-reed-medical-center/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-truvada-faces-teva-generics-assault-amid-descovy-switching-campaign/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-10-of-worlds-people-may-have-been-infected-with-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-squibb-to-acquire-myokardia-for-13-1-billion-in-cash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/trump-back-at-white-house-after-being-discharged-from-walter-reed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-drug-shows-potential-for-treating-childhood-neuroblastoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/regeneron-pfizer-and-biontech-slapped-with-patent-lawsuits-for-covid-19-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/2-scientists-win-nobel-chemistry-prize-for-gene-editing-tool/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/stoke-therapeutics-announces-plans-to-move-forward-with-dosing-of-stk-001-in-children-and-adolescents-in-its-ongoing-phase-1-2a-monarch-study-for-dravet-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-opdivo-succeeds-in-late-stage-lung-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/abbott-says-id-now-covid-19-rapid-test-shows-high-sensitivity-in-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/remote-control-of-blood-sugar-electromagnetic-fields-treat-diabetes-in-animal-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/simple-sugar-possible-therapy-for-repairing-myelin-in-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-vaccine-document-shows-limit-of-no-profit-pledge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/neurocrine-biosciences-and-xenon-pharmaceuticals-provide-regulatory-update-on-ongoing-collaboration-to-develop-first-in-class-treatment-for-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-strikes-1b-biobucks-deal-with-arrowhead-for-genetic-liver-disease-asset/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/china-in-talks-with-who-over-assessing-its-covid-19-vaccines-for-global-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/80-year-old-antibiotic-redesigned-for-new-medical-uses-synthetic-strategy-to-enhance-natural-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/womens-expected-longevity-linked-to-age-at-birth-of-last-child/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizers-breast-cancer-drug-ibrance-fails-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eli-lilly-in-deal-to-supply-covid-19-drugs-to-low-income-countries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/amgens-big-cardiovascular-bet-with-cytokinetics-hits-phiii-primary-but-dramatically-disappoints-investors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/viiv-posts-positive-long-term-data-for-two-drug-hiv-regimen-dovato/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-zealand-signs-deal-with-pfizer-biontech-for-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gao-details-ongoing-problems-with-fdas-lab-safety-oversight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-group-begins-manufacturing-covid-19-plasma-treatment-ahead-of-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dutch-researchers-report-first-death-from-covid-19-reinfection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/six-indian-drug-companies-to-set-up-a-large-pharma-cluster-in-mexico/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dyno-therapeutics-strikes-aav-deal-with-roche-worth-up-to-1-8-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-gets-fda-ok-to-test-adolescents-in-covid-19-vaccine-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/edigene-gets-67-million-infusion-to-bring-gene-editing-to-the-clinic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-sinopharm-offers-experimental-covid-19-vaccines-to-students/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/prenatal-cannabis-exposure-linked-to-cognitive-deficits-altered-behavior/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/canaan-closes-800-million-vc-fund-for-life-sciences-and-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-makes-1-billion-euro-bet-on-gileads-covid-drug-before-trial-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/remdesivir-has-little-effect-on-covid-19-mortality-who-study-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aussie-smart-wound-dressing-prompts-faster-healing-less-pain-to-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/simple-treatment-that-could-free-diabetics-from-insulin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-threatens-to-reverse-progress-in-tb-fight-who/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/endo-pays-658m-in-a-further-bet-on-collagen-based-medicines-buying-out-longtime-biopharma-partner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/a-new-chapter-in-the-decentralized-clinical-trial-approach/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sinovac-coronavirus-vaccine-offered-by-chinese-city-for-emergency-use-costs-60/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-12-15-october-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-plans-to-ditch-perth-sterile-injectables-manufacturing-site-by-2024-endangering-470-positions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fierce-pharma-politics-pushback-escalates-after-drug-companies-restrict-340b-drug-discounts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/what-will-fdas-experts-review-at-their-first-covid-19-vaccine-hearing-agency-documents-set-the-tone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/virgin-coconut-oil-lowers-coronavirus-load-by-60-90-for-mild-cases-ph-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cvs-health-to-hire-15000-across-the-u-s-in-fourth-quarter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/first-long-acting-injectable-antiretroviral-therapy-for-hiv-recommended-for-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-accepts-review-for-angles-parsortix-system-for-metastatic-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pandemic-vaccine-programs-cannot-tell-us-whether-they-will-save-lives-doshi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/could-a-language-test-diagnose-alzheimers-ibm-is-laying-the-groundwork/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/storm-therapeutics-mettl3-inhibitor-moves-closer-to-the-clinic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pharmaceutical-giant-mallinckrodt-bankruptcy-threatens-lawsuit-filed-by-local-unions-and-delaware-valley-health-care-coalition-worth-hundreds-of-millions-of-dollars/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-treatment-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/afreximbank-ready-to-raise-up-to-5-billion-for-covid-19-vaccines-for-africa-cdc-head/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/two-dozen-deaths-after-vaccines-scare-people-away/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/danish-biotech-union-adds-program-to-prevent-covid-19-with-intranasal-delivery-of-niclosamide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/retrophin-buys-orphan-technologies-for-517-million-to-gain-enzyme-replacement-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/cancer-anti-sickness-drug-offers-hope-for-hallucinations-in-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/foghorn-therapeutics-announces-pricing-of-initial-public-offering/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/als-and-frontotemporal-dementia-early-diagnosis-thanks-to-an-experimental-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lilly-antibody-drug-fails-in-a-covid-19-study-others-go-on/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bayer-to-pay-up-to-4-billion-for-asklepios-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizers-much-anticipated-covid-19-vaccine-data-has-yet-to-materialize-can-it-still-roll-out-this-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/could-aspirin-be-the-first-over-the-counter-treatment-for-coronavirus-hospitalized-patients-already-taking-the-drug-daily-were-47-less-likely-to-die-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-says-early-data-from-covid-19-vaccines-expected-this-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/vaccine-hopes-rise-as-oxford-jab-prompts-immune-response-among-old-as-well-as-young-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-regeneron-chase-4th-dupixent-approval-with-rare-esophageal-disease-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/enhertu-bags-us-priority-review-for-her2-gastric-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-agrees-to-pay-eli-lilly-375-million-for-300000-doses-of-coronavirus-antibody-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-revenue-rises-17-driven-by-sales-of-coronavirus-treatment-remdesivir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-to-evaluate-thor-707-with-mercks-checkpoint-inhibitor-keytruda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bms-collaborates-with-insitro-to-develop-drugs-for-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-experts-talks-to-chinese-on-covid-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-divests-rights-to-two-cardiovascular-drugs-for-400-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fauci-predicts-first-covid-19-vaccine-by-late-december-for-high-risk-americans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/india-government-allows-exports-under-new-scheme-to-boost-api-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ibm-pfizer-develop-ai-to-predict-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-to-buy-kiadis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/imfinzi-maker-astrazenecas-notes-campaign-delivers-encouragement-to-lung-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/perkinelmer-snaps-up-crispr-provider-horizon-discovery-in-383m-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/drug-used-to-control-blood-pressure-may-improve-cancer-patients-response-to-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-approves-combination-of-pfizers-upjohn-and-mylan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/uk-to-pilot-new-covid-19-mass-testing-approach-in-liverpool/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/santhera-slashes-workforce-in-half-after-phase-iii-dmd-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-announces-e300-million-investment-in-irish-operations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/israel-begins-human-trials-on-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisks-saxenda-bags-nice-recommendation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/resonetics-acquires-medical-business-of-hutchinson-technology-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/ema-begins-evaluation-of-filgotinib-for-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-squibbs-psoriasis-med-hits-the-mark-in-phase-iii/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/royalty-pharma-tops-its-record-setting-3-3b-deal-with-cf-foundation-betting-575m-more-on-vertexs-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-fosun-to-seek-approval-for-biontechs-covid-19-second-vaccine-ends-trials-on-first/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biogen-alzheimers-drug-closer-to-approval-with-u-s-fda-staff-backing-shares-jump-40/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oregon-becomes-first-state-to-decriminalize-hard-drugs-like-heroin-and-cocaine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bristol-myers-squibb-execs-tout-progress-on-zeposia-reblozyl-and-onureg-launches/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-ceo-blames-trial-delays-not-manufacturing-for-covid-vaccine-delivery-shortfall/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-19-vaccine-from-pfizer-and-biontech-is-strongly-effective-early-data-from-large-trial-indicate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/japans-takeda-eyes-new-focus-on-vaccines-after-otc-asset-sales-ceo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/regeneron-predicts-300000-covid-19-cocktail-doses-ready-by-january-and-substantially-more-in-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-lays-out-1-8b-for-emisphere-and-its-oral-delivery-tech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-authorizes-monoclonal-antibody-for-treatment-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-soars-as-vaccine-prevents-90-of-covid-cases-in-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/bringing-drugs-to-the-brain-with-nanoparticles-to-treat-neurodegenerative-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/an-amazonian-tea-stimulates-the-formation-of-new-neurons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/byu-blood-test-can-detect-presence-of-deadly-superbugs-in-less-than-one-hour/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novartis-arthritis-drug-fails-to-help-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-on-track-to-report-covid-19-vaccine-data-later-this-month/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/robot-inoculators-accelerate-chinas-vaccine-rollout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-food-that-can-inhibit-covid-19-according-to-a-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chemicals-in-your-living-room-cause-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/taiho-and-lung-therapeutics-enter-into-an-exclusive-license-agreement-in-japan-for-lti-01-treatment-for-loculated-pleural/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-study-points-to-a-better-way-to-ward-off-asthma-triggers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/english-study-suggests-t-cells-could-be-sufficient-to-protect-from-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizers-abrocitinib-scores-another-phase-iii-win-in-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nice-green-light-for-cablivi-in-rare-blood-clotting-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazenecas-calquence-fails-covid-19-study-joining-the-list-of-repurposed-meds-that-have-fallen-short/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fears-for-covid-impact-on-measles-after-2019-spike/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/antidepressant-fluvoxamine-may-help-prevent-covid-19-severity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-says-its-coronavirus-vaccine-is-nearly-95-effective/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/diabetes-drug-can-treat-and-reverse-heart-failure-and-reduce-hospitalizations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-9-12-november-2020/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mouthwash-can-kill-coronavirus-within-30-seconds-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/samsung-biologics-says-mass-producing-eli-lillys-covid-19-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/hospitals-around-the-us-are-panic-buying-hyper-cold-freezers-in-anticipation-of-pfizers-coronavirus-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/viivs-cabotegravir-scores-breakthrough-designation-for-hiv-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/azs-brilinta-reduced-rate-of-stroke-and-death-in-high-risk-subgroup/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/arthritis-drug-may-improve-covid-19-survival-among-elderly-patients-says-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/buffetts-berkshire-bets-big-on-abbvie-bristol-myers-merck-pfizer-as-covid-19-drives-healthcare-investment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/experimental-drug-halves-cholesterol-levels-in-phase-2-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/amazon-jumps-into-the-pharmacy-business-with-online-prescription-fulfillment-free-delivery-for-prime-members/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/oxford-trial-chief-says-its-covid-vaccine-could-still-be-ready-at-a-similar-time-to-others/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/in-fight-against-blood-cancer-imago-doubles-down-with-80-million-series-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/alzheimers-disease-drug-may-help-fight-against-antibiotic-resistance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-advises-against-remdesivir-for-coronavirus-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/respiratory-failure-in-covid-19-usually-not-driven-by-cytokine-storm-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/viatris-inc-launches-as-a-new-kind-of-healthcare-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/mayo-clinic-905-staff-members-diagnosed-with-covid-19-in-past-2-weeks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/over-500-fishermen-hit-by-mysterious-skin-disease-in-senegal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-says-covid-19-vaccine-for-the-world-can-be-90-effective/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-prepares-for-first-covid-19-shots-as-another-vaccine-candidate-emerges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/experimental-drug-given-to-trump-to-treat-covid-19-wins-fda-clearance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/deep-frozen-arctic-microbes-are-waking-up/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-treatment-for-hutchinson-gilford-progeria-syndrome-and-some-progeroid-laminopathies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-first-drug-to-treat-rare-metabolic-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-plans-easier-access-to-generics-in-potential-blow-to-big-drugmakers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/therapeutic-pd-1-cancer-vaccine-shown-to-be-safe-and-effective-in-animal-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/compounds-in-traditional-chinese-medicine-herbs-may-inhibit-sars-cov-2-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/a-daily-glass-of-orange-juice-could-prevent-a-covid-infection-suggests-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-pharma-initiates-litigation-challenging-hhs-and-fda-action/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/who-proposes-update-of-gmps-for-investigational-products/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/scientists-say-enzyme-enriched-bread-as-good-as-blueberries-at-improving-blood-circulation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/janssens-tremfya-approved-for-active-psoriatic-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-mutations-do-not-appear-to-be-helping-it-spread-more-rapidly-study-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-to-review-mercks-targeted-lung-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nhs-to-trial-innovative-cancer-blood-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astellas-receives-approval-of-evrenzo-roxadustat-in-japan-for-the-treatment-of-anemia-of-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astellas-transfers-dificlir-in-europe-middle-east-africa-and-selected-cis-to-tillotts-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/dr-reddys-to-acquire-select-anti-allergy-brands-from-glenmark-in-russia-ukraine-kazakhstan-and-uzbekistan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/teladoc-eyes-several-new-phases-of-growth-for-telemedicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/moderna-to-file-for-fda-emergency-use-authorization-for-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-announces-advisory-committee-meeting-to-discuss-second-covid-19-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/worlds-leading-life-science-companies-now-enrolling-community-a-global-platform-trial-for-hospitalized-patients-with-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-and-biontech-submitted-application-for-conditional-marketing-authorization-for-covid-19-vaccine-to-the-ema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novavax-expects-delayed-u-s-covid-19-vaccine-trial-to-start-in-coming-weeks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sensor-can-detect-scarred-or-fatty-liver-tissue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/interpol-warns-of-organized-crime-threat-to-covid-19-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/in-world-first-uk-approves-pfizer-biontech-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-sells-rights-to-statin-med-crestor-to-grunenthal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-n-reclassifies-cannabis-as-a-less-dangerous-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lilly-announces-650000-additional-doses-of-neutralizing-antibody-bamlanivimab-ly-cov555-purchased-by-u-s-government-to-treat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/drug-reverses-age-related-cognitive-decline-within-days/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-scientists-developing-nasal-spray-to-prevent-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/brazil-gets-chinese-covid-19-vaccine-doses-senate-oks-british-vaccine-funding/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/glucosamine-may-reduce-overall-death-rates-as-effectively-as-regular-exercise-study-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-dna-modification-signature-discovered-in-zebrafish/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/anti-parasitic-drug-successfully-kills-covid-19-in-48-hours-reveals-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/research-team-develops-software-that-cuts-time-cost-from-gene-sequencing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/blackcurrants-are-favorable-for-glucose-metabolism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/antiviral-drug-molnupiravir-blocks-covid-19-virus-within-24-hours-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/new-wearable-sensor-can-track-healing-in-chronic-skin-wounds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-weight-management-drug-for-patients-aged-12-and-older/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/indonesias-bio-farma-says-not-yet-able-to-determine-sinovac-vaccine-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/study-finds-metformin-reduced-covid-19-death-risks-in-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/calquence-shows-long-term-efficacy-and-tolerability-in-mcl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/andhra-pradeshs-eluru-india-experts-investigate-mystery-illness/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/abbvies-hopes-of-replacing-humira-sales-with-rinvoq-gains-momentum-for-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/late-stage-trial-results-show-promise-for-eli-lillys-tirzepatide-as-treatment-for-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sinovac-announces-product-license-for-23-valent-pneumococcal-polysaccharide-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/us-house-approves-bill-to-widen-marijuana-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-authorizes-first-otc-covid-19-home-test-collection-kit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizers-pneumococcal-disease-vaccine-scores-fda-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gileads-car-t-therapy-yescarta-shows-potential-in-new-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/gilead-to-pay-1-4-billion-for-hepatitis-drug-maker-myr-gmbh-of-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/researchers-identify-the-physical-mechanism-that-can-kill-bacteria-with-gold-nanoparticles/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-canada-latest-country-to-approve-pfizer-biontech-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/boehringer-gets-into-guided-missile-drugs-with-1-5-billion-deal-for-nbe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-to-buy-alexion-pharmaceuticals-for-39bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/coronavirus-us-begins-vaccine-shipments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/trial-of-ruxolitinib-in-covid-19-complications-fails-novartis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/update-on-the-university-of-queensland-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/green-light-for-uk-trial-of-nasal-coronavirus-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/regenerons-blood-cancer-hopeful-odronextamab-hit-with-fda-partial-hold-across-several-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/harper-seidenbergs-westlake-village-biopartners-reels-in-500m-across-2-funds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/lilly-makes-another-gene-therapy-play-with-1b-deal-to-buy-prevail-tx/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/biontech-and-fosun-pharma-to-supply-china-with-mrna-based-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/no-more-pills-every-day-new-injection-for-hiv-acts-like-a-short-term-aids-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/israel-begins-second-phase-trial-of-potential-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-holdings-establishes-rare-bleeding-disorder-firm-hemab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-approves-margetuximab-plus-chemotherapy-in-her2-metastatic-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-states-to-start-covid-19-vaccinations-from-dec-27/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/elderly-woman-dies-after-taking-tablet-tainted-with-sleeping-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/sanofi-promised-pandemic-hazard-pay-to-vaccine-plant-workers-then-offered-3-days-off-instead-lawsuit-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/fda-plans-to-authorize-modernas-coronavirus-vaccine-quickly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/pfizer-files-request-for-japan-covid-19-vaccine-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/international-consortium-creates-open-platform-for-covid-19-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/novo-nordisk-eyes-eu-approval-for-once-weekly-semaglutide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/covid-us-approves-moderna-as-second-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/agios-offloads-oncology-unit-to-servier-in-1-8b-deal-zeroes-in-on-genetically-defined-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/neurogene-adds-another-115m-to-the-pot-for-trials-for-its-gene-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aimmunes-peanut-allergy-med-palforzia-wins-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinese-biotech-firm-beigenes-plans-move-into-high-gear/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eu-clears-pfizer-covid-19-vaccine-for-first-inoculations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/az-amgens-source-trial-misses-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/young-but-ambitious-taysha-lays-out-76m-for-commercial-gene-therapy-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/four-recent-fda-drug-approvals-myovant-integrum-astrazeneca-and-ridgeback/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/nephron-announces-fda-approval-of-ketorolac-signaling-new-phase-of-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/supernus-drug-meets-main-goal-of-study-in-adults-with-adhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/how-our-brains-help-us-find-misplaced-objects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-government-secures-100-million-more-pfizer-biontech-covid-19-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/arbor-biotechnologies-and-lonza-enter-into-gene-editing-technology-licensing-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/takeda-offloads-heart-and-metabolism-drugs-to-3-month-old-chinese-firm-for-322m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/brazil-institute-says-coronavac-efficacy-above-50-but-delays-full-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/research-team-reports-new-class-of-antibiotics-active-against-a-wide-range-of-bacteria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/chinas-covid-19-vaccine-over-50-effective-but-sinovac-withholds-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/merck-announces-supply-agreement-with-u-s-government-for-initial-doses-of-investigational-biological-therapy-for-the-treatment-of-patients-with-severe-and-critical-covid-19-save/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/u-s-fda-puts-early-stage-trial-of-altimmunes-covid-19-vaccine-on-hold/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/eavesdropping-on-the-ph-levels-inside-the-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/myovant-and-pfizer-ink-4-2-billion-deal-for-orgovyx-in-prostate-cancer-and-womens-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/iowa-state-university-approaches-covid-19-using-nanotechnology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/astrazeneca-could-get-green-light-in-uk-and-other-covid-19-vaccine-news/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/voyager-takes-a-hit-after-fda-places-hold-on-gene-therapy-for-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/drugmakers-agree-to-halve-prices-to-get-on-china-state-insurance-list/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/large-transporter-protein-linked-to-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/la-residents-can-use-their-phones-to-provide-covid-19-vaccination-proof/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/aprea-therapeutics-closes-out-2020-with-phase-iii-flop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/uk-government-authorizes-astrazenecas-covid-19-vaccine-for-emergency-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/protalixs-fabry-disease-treatment-hits-the-mark-in-phase-iii-switch-over-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/altimmune-begins-multinational-phase-2-clinical-trial-of-heptcelltm-a-novel-immunotherapeutic-for-the-treatment-of-chronic-hepatitis-b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2020/tracon-pharmaceuticals-announces-acceptance-of-the-envafolimab-kn035-nda-by-the-nmpa-in-china-that-was-submitted-by-its-corporate-partners-alphamab-oncology-and-3d-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/china-lab-leak-is-the-most-credible-source-of-the-coronavirus-outbreak-says-top-us-government-official-amid-bombshell-claims-wuhan-scientist-has-turned-whistleblower/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fauci-vaccinations-are-increasing-in-a-glimmer-of-hope/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nanoparticle-drug-delivery-system-developed-to-treat-brain-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-grants-emergency-validation-to-pfizer-biontech-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-dont-mess-with-the-covid-19-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/chemo-drug-potentially-more-potent-than-remdesivir-against-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/two-companies-ring-in-2021-with-cash-for-cancer-and-rare-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fujifilm-diosynth-opening-viral-vector-manufacturing-plant-near-boston/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biopharma-money-on-the-move-december-30-january-5/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/farxiga-granted-priority-review-in-the-us-for-the-treatment-of-patients-with-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-accepts-for-priority-review-the-new-drug-application-for-mirabegron-for-oral-suspension-and-supplemental-new-drug-application-for-myrbetriq-mirabegron-tablets-in-pediatric-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/feds-tell-pharma-companies-to-pony-up-340b-discounts-but-its-unclear-whether-they-will/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/oncorus-to-build-viral-immunotherapy-production-facility-in-mass/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/artificial-enzyme-may-be-first-step-toward-treatment-for-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayer-curevac-form-alliance-on-covid-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-paves-way-for-more-pfizer-vaccine-shots-after-extra-dose-allowed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/china-says-who-experts-to-arrive-thursday-for-virus-origins-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cancer-cells-hibernate-like-bears-to-evade-harsh-chemotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-issues-alert-regarding-sars-cov-2-viral-mutation-to-health-care-providers-and-clinical-laboratory-staff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-benches-immune-boosting-cancer-therapy-with-clinical-hold/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-priority-review-to-dapagliflozin-for-ckd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-avapritinib-for-gastrointestinal-stromal-tumor-with-a-rare-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/several-gorillas-test-positive-for-covid-19-at-california-zoo-first-in-the-world/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gilead-updates-2020-guidance-with-post-holiday-covid-19-spike/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-hails-alzheimers-win-with-donanemab-boasting-significant-slowing-of-decline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/chinese-researchers-develop-new-enzyme-to-treat-neuroinflammation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-to-buy-antibody-maker-kymab-in-1-45-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/johnson-johnsons-covid-19-vaccine-production-lags-goals-as-data-readout-nears-nyt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gilead-and-vir-unite-to-find-a-functional-cure-for-hepatitis-b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-approval-for-viivs-tivicay-for-children-living-with-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/monash-university-leads-breakthrough-against-antibiotic-resistance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/clinical-trial-finds-vitamin-d-does-not-ward-off-colds-and-flu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/trade-secrets-theft-allegations-levied-against-merck-employee/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/patent-expiries-loom-as-bayer-looks-to-mid-2020s-for-return-on-cell-gene-therapy-bets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/rotten-egg-gas-may-help-protect-aging-brain-cells-from-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/global-stockpile-of-ebola-vaccine-created-to-tackle-future-outbreaks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sinovac-says-its-covid-19-vaccine-more-effective-with-longer-dosing-interval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-action-alert-merck-aurinia-and-amgen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-jjs-darzalex-faspro-for-rare-light-chain-amyloidosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biohaven-provides-update-on-phase-2-3-trial-and-alzheimers-disease-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/could-nrf2-be-your-magic-molecule-for-eternal-youth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/thermo-fisher-scientific-acquires-viral-vector-manufacturing-business-from-novasep/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/xalkori-bags-fda-green-light-for-rare-paediatric-non-hodgkin-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/smc-kicks-of-the-new-year-by-accepting-five-new-medicines-for-nhs-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/research-establishes-antibiotic-potential-for-cannabis-molecule/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/japan-to-use-data-from-outside-clinical-trials-in-drug-approvals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/yesse-technologies-secures-another-grant-from-the-michael-j-fox-foundation-to-sniff-out-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/doptelet-avatrombopag-approved-in-the-eu-for-treatment-of-itp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mark-cuban-launches-low-cost-generic-drug-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/monoclonal-antibody-treatment-by-eli-lilly-found-to-cut-risk-of-serious-covid-19-drugmaker-reports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-priority-review-to-genentechs-esbriet-pirfenidone-for-unclassifiable-interstitial-lung-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-announces-u-s-fda-approval-of-verquvo-vericiguat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/boston-scientific-announces-agreement-to-acquire-preventice-solutions-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/servier-and-mina-partner-to-create-entirely-new-class-of-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/janssen-announces-u-s-fda-approval-of-cabenuva-rilpivirine-and-cabotegravir-the-first-long-acting-regimen-for-the-treatment-of-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eli-lillys-loxo-oncology-enters-into-1-6-billion-research-and-collaboration-agreement-with-merus-n-v/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cdc-study-says-abbotts-rapid-covid-19-antigen-test-may-miss-two-thirds-of-asymptomatic-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-aurinia-pharmaceuticals-lupkynis-voclosporin-for-adult-patients-with-active-lupus-nephritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-toripalimab-fast-track-designation-for-mucosal-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tscan-adds-another-100m-to-the-pot-to-as-it-plots-new-tcr-cancer-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-test-drug-that-reduces-growth-of-oncogenes-by-90-in-breakthrough-for-cancer-care/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ten-leading-biopharma-companies-announce-formation-of-accumulus-synergy-to-develop-global-data-sharing-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/exelixis-announces-u-s-fda-approval-of-cabometyx-cabozantinib-in-combination-with-opdivo-nivolumab-as-a-first-line-treatment-for-patients-with-advanced-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-discontinues-development-of-sars-cov-2-covid-19-vaccine-candidates-continues-development-of-two-investigational-therapeutic-candidates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/low-carb-diet-for-12-weeks-put-type-2-diabetes-into-remission/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-accidental-discovery-giving-hope-to-asthma-sufferers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/second-generation-double-antibody-protects-from-sars-cov-2-and-its-tested-variants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pharmamar-says-paper-in-journal-science-confirms-drugs-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/regen-cov-antibody-cocktail-is-active-against-sars-cov-2-variants-first-identified-in-the-uk-and-south-africa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/prilenia-enrolls-first-subject-in-europe-in-its-proof-hd-phase-3-clinical-trial-for-huntingtons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nasal-spray-developed-in-turkey-kills-coronavirus-in-1-minute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-and-asahi-kasei-pharma-announce-license-agreement-for-chronic-pain-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/exclusive-sinopharm-led-consortium-plans-3-3-billion-take-private-of-hk-listed-china-tcm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jj-vaccine-adds-to-covid-19-armoury-with-66-global-trial-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/az-daiichi-sankyos-antibody-drug-conjugates-prove-promising-in-early-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/anticoagulant-drug-heparin-targets-coronavirus-spike-protein-and-could-be-repurposed-to-treat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/colchicine-may-have-therapeutic-potential-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ema-recommends-covid-19-vaccine-astrazeneca-for-authorisation-in-the-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/invasive-candidiasis-treatment-rezafungin-wins-orphan-drug-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eli-lillys-covid-19-antibody-picks-up-871m-in-q4-and-carries-blockbuster-hopes-for-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/matinas-biopharma-announces-topline-results-from-enhance-it-study-of-lypdiso-against-vascepa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-squibb-application-for-zeposia-ozanimod-for-the-treatment-of-ulcerative-colitis-accepted-for-filing-with-priority-review-by-u-s-food-and-drug-administration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vaccine-manufacturing-greenhorn-bayer-to-make-160m-doses-of-curevacs-covid-19-shot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-psoriasis-drug-succeeds-in-late-stage-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/study-supports-delay-of-second-dose-of-astrazenecas-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/horizon-therapeutics-to-purchase-viela-bio-for-3-1-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/drug-metformin-can-affect-breast-cancer-risk-in-women-with-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amgen-cuts-500-u-s-jobs-primarily-sales-reps-as-covid-19-speeds-a-shift-to-digital/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jazz-pharmaceuticals-to-acquire-gw-pharmaceuticals-plc-creating-an-innovative-high-growth-global-biopharma-leader/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-find-promising-avenue-to-restore-cognitive-function-impaired-by-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayer-reaches-2-billion-deal-over-future-roundup-cancer-claims/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-squibb-and-the-rockefeller-university-announce-license-agreement-for-sars-cov-2-neutralizing-monoclonal-antibody-combination-for-the-treatment-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/china-approves-astrazenecas-forxiga-for-heart-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/crinetics-pharmaceuticals-lead-acth-antagonist-for-congenital-adrenal-hyperplasia-and-cushings-disease-crn04894-advances-into-phase-1-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-tepmetko-as-the-first-and-only-once-daily-oral-met-inhibitor-for-patients-with-metastatic-nsclc-with-metex14-skipping-alterations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/south-africa-halts-astrazeneca-vaccine-after-shots-fail-against-new-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tg-therapeutics-announces-fda-accelerated-approval-of-ukoniq-umbralisib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moleculin-announces-grant-awarded-to-polish-research-institute-for-independent-clinical-trial-of-annamycin-in-sarcoma-lung-metastases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/azs-imfinzi-fails-to-improve-overall-survival-in-head-and-neck-cancer-again/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mosaic-gene-mutations-could-explain-some-cases-of-autism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cannabis-reduces-blood-pressure-in-older-adults-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/first-in-class-gpr119-agonist-of-dong-a-st-da-1241-improved-glucose-control-in-patients-with-type-2-diabetes-in-us-phase-1b-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/china-grants-approval-to-sinovacs-vaccine-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/climate-change-may-have-created-an-ideal-environment-for-emergence-of-covid-19-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/hiv-an-innovative-therapeutic-breakthrough-to-optimize-the-immune-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/function-identified-of-mystery-protein-that-kills-brain-cells-of-people-with-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/climate-change-may-have-created-an-ideal-environment-for-emergence-of-covid-19-study-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lonza-agrees-to-divest-specialty-ingredients-business-for-4-7-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-hope-for-b-cell-lymphoma-patients-as-fda-approves-bms-car-t-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/refile-french-pharma-ingredients-maker-seqens-prepped-for-sale-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abbvie-and-caribou-enter-340m-deal-to-develop-car-t-cell-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/artios-pharma-announces-the-start-of-first-clinical-study-with-the-dosing-of-its-atr-inhibitor-art0380-to-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-eua-to-eli-lillys-antibody-therapies-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tocilizumab-reduces-deaths-in-patients-hospitalised-with-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novo-nordisks-semaglutide-injection-effective-in-weight-loss-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/galapagos-and-gilead-sciences-to-halt-phase-iii-ipf-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fresenius-kabi-hid-dirty-laundry-from-fda-pleads-guilty-to-criminal-charges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/university-of-oxford-to-begin-testing-astrazeneca-vaccine-on-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/japan-approves-use-of-pfizers-covid-19-vaccine-ahead-of-olympics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ebola-vaccination-campaign-begins-in-democratic-republic-of-congo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-g1-therapeutics-cosela-to-prevent-chemo-damage-in-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-lists-two-additional-covid-19-vaccines-for-emergency-use-and-covax-roll-out/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofis-mrna-covid-19-vaccine-candidate-not-ready-this-year-ceo-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-sanofi-ordered-to-pay-hawaii-834-million-over-plavix-warning-label/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-and-vir-expand-antiviral-pact-in-645-million-plus-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-books-150-million-extra-moderna-covid-19-vaccines-for-2021-option-for-more-in-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/68286-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bluebird-bio-hits-pause-on-rollout-for-ill-fated-gene-therapy-zynteglo-as-trial-flags-2-cancer-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-and-rigel-enter-strategic-collaboration-to-develop-ripk1-inhibitors-for-the-potential-treatment-of-immunological-and-neurodegenerative-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/centrient-pharmaceuticals-to-acquire-astral-steritech-expanding-its-product-portfolio-with-sterile-injectable-antibiotic-finished-dosage-forms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/un-chief-urges-global-vaccination-plan-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/immunic-inc-announces-positive-top-line-data-from-investigator-sponsored-phase-2-proof-of-concept-clinical-trial-of-imu-838-in-primary-sclerosing-cholangitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/entire-brazilian-city-will-be-vaccinated-against-covid-19-in-giant-experiment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-identify-over-140000-virus-species-in-the-human-gut/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/charles-river-laboratories-to-acquire-cognate-bioservices-to-create-a-premier-scientific-partner-for-cell-and-gene-therapy-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/an-anti-aging-medicine-that-removes-senescent-cells-has-been-discovered/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/az-withdraws-imfinzi-indication-in-the-us-for-advanced-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/brainstorm-receives-feedback-on-potential-bla-submission-for-als-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/doctors-highly-positive-on-abbvies-rinvoq-in-ibd-but-not-so-much-on-bristol-myers-zeposia-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/after-pfizer-deal-sanofi-offers-a-hand-to-johnson-johnson-for-covid-19-vaccine-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/clover-biopharmaceuticals-raises-230-million-in-oversubscribed-series-c-financing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-to-provide-manufacturing-support-to-johnson-johnson-for-their-covid-19-vaccine-to-help-address-global-supply-demands/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/exclusive-astrazeneca-to-miss-second-quarter-eu-vaccine-supply-target-by-half-eu-official/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/wavelength-pharmaceuticals-further-strengthens-its-global-supply-chain-with-acquisition-of-vanamali-organics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-to-acquire-pandion-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/night-owls-may-be-twice-as-likely-as-morning-larks-to-underperform-at-work/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-announces-additional-capital-investments-to-increase-global-manufacturing-capacity-for-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/catalent-to-acquire-delphi-genetics-and-launch-us-plasmid-manufacturing-site-to-establish-global-pdna-development-and-manufacturing-capabilities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-amgen-drug-could-widen-treatment-options-for-severe-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/alzheimers-may-strike-women-and-men-in-different-ways/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-to-test-third-dose-tweaked-vaccine-to-target-s-african-strain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/japans-takeda-sells-four-diabetes-products-to-teijin-pharma-for-1-25-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-issues-emergency-use-authorization-for-third-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/congo-confirms-three-new-ebola-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/coronavirus-covid-19-update-fda-allows-more-flexible-storage-transportation-conditions-for-pfizer-biontech-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/santhera-announces-positive-results-with-lonodelestat-in-early-phase-cystic-fibrosis-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-treatment-for-molybdenum-cofactor-deficiency-type-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-at-home-covid-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-device-designed-to-protect-athletes-from-traumatic-brain-injuries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-liquid-filled-aspirin-capsule/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-agrees-1-billion-deal-with-debiopharm-for-head-and-neck-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-develop-vaccine-strategy-for-urinary-tract-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/kempharm-announces-fda-approval-of-azstarys-serdexmethylphenidate-and-dexmethylphenidate-capsules-for-oral-use-cii-a-new-once-daily-treatment-for-adhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tired-of-reading-glasses-eye-drop-submitted-for-fda-approval-may-help-you-read-without-them/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/takeda-secures-global-rights-from-ovid-therapeutics-to-develop-and-commercialize-soticlestat-for-the-treatment-of-children-and-adults-with-dravet-syndrome-and-lennox-gastaut-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-court-rules-in-favour-of-astrazeneca-in-symbicort-patent-litigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-targets-vaccine-production-capacity-of-2-3-billion-doses-year-by-end-2021-paper/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-expands-approval-of-pfizers-lorbrena-as-first-line-treatment-for-alk-positive-metastatic-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cells-have-memories-why-men-get-certain-ailments-more-than-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/smoking-cessation-drug-may-treat-parkinsons-in-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/prime-time-for-five-prime-as-amgen-snaps-up-this-once-moribund-biotech-for-1-9b-and-its-phoenix-from-the-flames-cancer-asset/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/despite-strong-data-from-a-would-be-rival-sanofi-and-regenerons-dupixent-can-grow-in-asthma-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/rapid-3d-printing-method-moves-toward-3d-printed-organs-%d1%82echnique-speeds-up-conventional-3d-printing-by-10-50-times/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-inc-announced-its-plans-to-build-a-new-gene-therapy-manufacturing-facility-at-its-research-triangle-park/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-vir-hit-as-covid-19-drug-hopeful-halted-on-possible-weak-efficacy-in-key-nih-phase-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/effect-of-ivermectin-on-time-to-resolution-of-symptoms-among-adults-with-mild-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-gilead-kites-yescarta-as-first-car-t-for-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/potential-blockbuster-drugs-for-2021-alzheimers-prostate-cancer-and-more/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-drug-approval-could-be-on-horizon-for-alzheimers-after-17-year-drought/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/teva-announces-launch-of-first-generic-version-of-azopt-brinzolamide-ophthalmic-suspension-1-used-to-treat-high-pressure-inside-the-eye-in-the-united-states/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/indian-drugmaker-to-pay-50mn-in-fine-for-destroying-records-before-fda-inspection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lupin-launches-generic-diarrhea-drug-in-us-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-biontech-covid-19-vaccine-neutralizes-brazil-variant-in-lab-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/roche-withdraws-us-indication-for-tecentriq-in-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-announces-first-participants-dosed-in-study-evaluating-covid-19-booster-vaccine-candidates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novartis-canakinumab-fails-to-improve-overall-survival-in-lung-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vertex-announces-fda-fast-track-designation-and-initiation-of-a-phase-1-2-clinical-trial-for-vx-880-a-novel-investigational-cell-therapy-for-the-treatment-of-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/second-shot-of-covid-19-vaccine-may-not-be-necessary-in-previously-infected-individuals-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/viiv-healthcare-presents-positive-proof-of-concept-findings-for-gsk3640254-a-novel-investigational-maturation-inhibitor-for-the-treatment-of-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ai-helps-identify-possible-alzheimers-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-boost-potency-of-an-hiv-1-antibody-tracing-new-pathways-for-vaccine-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/youtube-removed-30000-videos-with-vaccine-misinformation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novavaxs-covid-19-vaccine-highly-effective-against-uk-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-presents-trial-data-on-alzheimers-drug-showing-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/roche-to-buy-covid-test-maker-genmark-diagnostics-for-1-8-bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/spain-germany-france-and-italy-pause-astrazeneca-vaccine-rollout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bat-virus-94-5-similar-to-covid-19-found-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-begins-testing-next-generation-coronavirus-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-melinta-antibiotic-for-serious-skin-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/janssens-psoriatic-arthritis-drug-proves-long-term-efficacy-in-two-year-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/drug-delivery-system-injections-or-light-irradiation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/94-of-older-adults-prescribed-drugs-that-raise-risk-of-falling/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-german-mercks-4-2b-bintrafusp-alfa-drug-flops-again-but-companies-squint-to-see-glimmers-of-hope/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-halts-biosimilar-programs-in-crowded-china-market-sells-plant-to-wuxi-biologics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/coronaviruses-may-be-vulnerable-to-ultrasound-vibrations-study-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/leprosy-drug-holds-promise-as-at-home-treatment-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abbvie-in-talks-to-sell-5-billion-womens-drugs-portfolio-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/anima-biotech-announces-strategic-collaboration-with-takeda-to-discover-and-develop-mrna-translation-modulators-for-neurological-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-ever-treatment-for-recurrent-pericarditis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-approves-lynparza-plus-avastin-via-cancer-drugs-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/uk-approval-for-daiichi-sankyos-cholesterol-lowering-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-us-data-shows-vaccine-effective-for-all-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/detonating-fuse-for-breast-cancer-discovered/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/anti-tuberculosis-drug-can-be-safely-dosed-even-higher/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-identify-two-drugs-that-delay-bone-marrow-cancer-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/could-viagra-help-men-with-heart-disease-live-longer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-to-go-solo-on-new-vaccines-using-mrna-technology-wsj/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/roche-said-its-anti-covid-cocktail-significantly-shortens-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/three-common-antiviral-drugs-potentially-effective-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/first-ever-vaccine-for-malignant-brain-tumors-reported-safe-effective-in-early-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bmi1-a-promising-gene-to-protect-against-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cure-pharmaceutical-augments-its-existing-u-s-dea-license-in-order-to-initiate-development-of-its-psychedelics-based-pharmaceutical-clinical-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-continues-streamlining-of-established-products-with-sale-of-anti-inflammatory-drugs-to-fidia-farmaceutici/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/india-delays-big-exports-of-astrazeneca-shot-including-to-covax-as-infections-surge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abbvie-legal-complaint-alleges-alvotech-misappropriated-humira-trade-secrets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-new-indication-for-drug-to-treat-neurogenic-detrusor-overactivity-in-pediatric-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gyroscope-eyes-clinical-success-against-amd-with-148-million-in-series-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazenecas-updated-covid-19-vaccine-trial-results-show-76-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizers-ibrance-under-threat-from-novartis-and-lilly-leans-on-real-world-data-in-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-slaps-guillain-barre-warning-on-glaxosmithklines-star-vaccine-shingrix/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-ide-cel-for-relapsed-refractory-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-and-vir-biotechnology-seek-eua-for-covid-19-monoclonal-antibody/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-gets-late-stage-win-in-test-of-new-type-of-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astellas-receives-positive-chmp-opinion-for-xtandi-enzalutamide-for-patients-with-metastatic-hormone-sensitive-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novartis-closes-u-s-gene-therapy-site-as-zolgensma-sales-fell-from-q3-to-q4/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-covid-strain-detected-in-israel-pfizer-vaccine-appears-effective-against-it/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mercks-busy-day-fda-rejection-eu-recommendation-and-a-spinoff-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/wave-culls-leading-huntingtons-meds-as-shares-go-under-after-rival-roche-hit-by-similar-fate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/roche-scores-eu-approval-for-at-home-sma-treatment-evrysdi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-recommends-sobis-kineret-for-first-line-use-in-stills-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/in-second-acquisition-this-month-amgen-buys-rodeo-for-721-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/anavex-life-sciences-reports-data-review-by-the-independent-data-safety-monitoring-board-for-its-phase-2b-3-clinical-trial-of-anavex2-73-in-patients-with-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/synthetic-mucus-can-mimic-the-real-thing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biontech-stock-pops-as-company-projects-11-5-billion-in-covid-vaccine-sales/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ftc-challenges-illuminas-proposed-acquisition-of-cancer-detection-test-maker-grail/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/takeda-completes-sale-of-its-japan-consumer-health-care-business-unit-to-blackstone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/why-johnson-johnson-throwing-out-15-million-covid-19-vaccine-doses-shouldnt-scare-you/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novel-pharmacological-strategies-to-treat-alcoholism-focus-on-epigenetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-find-genetic-link-to-clogged-arteries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/exclusive-fauci-says-u-s-may-not-need-astrazeneca-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-sarclisa-isatuximab-in-combination-with-carfilzomib-and-dexamethasone-for-patients-with-relapsed-or-refractory-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-alirocumab-for-treating-homozygous-familial-hypercholesterolemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-2-rapid-coronavirus-tests-to-be-sold-over-the-counter-for-at-home-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/servier-completes-acquisition-of-agios-pharmaceuticals-oncology-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-show-you-can-collect-dna-from-the-air/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/phase-1-clinical-trial-of-unique-covid-19-vaccine-begins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lab-grown-meat-uses-spinach-skeletons-for-greener-process/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ec-approval-for-ontozry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/supernus-announces-fda-approval-of-qelbree-spn-812-for-the-treatment-of-adhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/phase-1-clinical-trial-of-wrair-developed-covid-19-vaccine-begins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jj-bets-up-to-780-million-on-cidaras-universal-influenza-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-issues-guidance-on-generic-development-and-submissions-during-pandemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/artificial-intelligence-to-explore-the-biomolecular-world/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/paleopharmaceuticals-from-baltic-amber-might-fight-drug-resistant-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-develop-materials-for-oral-delivery-of-insulin-medication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gene-discovery-suggests-new-treatment-approach-for-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/more-vaccine-sites-halt-johnson-johnson-shots-after-adverse-reactions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-trodelvy-the-first-treatment-for-metastatic-triple-negative-breast-cancer-shown-to-improve-progression-free-survival-and-overall-survival/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-co-says-adjuvant-keytruda-hits-main-goal-of-late-stage-rcc-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-begins-study-on-allergic-reaction-risk-in-moderna-pfizer-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-pfizer-biontech-covid-19-vaccine-is-less-effective-against-the-south-african-and-uk-variants-than-against-the-original-virus-according-to-a-new-real-world-study-from-israel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-acquires-biotech-company-tidal-therapeutics-for-470m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-to-invest-in-a-leading-edge-production-site-in-singapore-continues-to-strengthen-its-vaccines-manufacturing-capacities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazenecas-diabetes-drug-farxiga-falls-short-in-covid-19-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/joint-cdc-and-fda-statement-on-johnson-johnson-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/inhaled-asthma-drug-accelerates-recovery-from-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-approval-for-first-ai-device-to-help-detect-colon-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/19-drug-makers-fined-for-inflating-prices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/resilience-continues-expansion-with-acquisition-of-biologics-manufacturing-company-ology-bioservices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amylyx-pharmaceuticals-provides-global-regulatory-update-on-amx0035-for-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scaled-up-remdesivir-production-two-fold-cipla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-myovant-begin-dosing-in-relugolix-contraceptive-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/protein-found-to-control-drivers-of-normal-growth-and-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eli-lilly-axes-163-dermira-staffers-shutters-menlo-park-site-as-it-closes-in-around-dupixent-rival-lebrikizumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/alnylam-faces-doj-probe-over-onpattro-marketing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-discovery-could-lead-to-therapies-for-patients-with-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novel-antibiotic-deceives-bacteria-through-mimicry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abzena-to-create-325-jobs-in-north-carolina/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-immunotherapy-for-initial-treatment-of-gastric-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-drug-for-group-3-ph/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/thermo-fisher-expands-pharma-service-business-with-17-4-bln-ppd-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sinopharm-to-inject-4-6-bln-vaccine-assets-into-unit-tiantan-biological/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-setting-up-its-1st-research-institute-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-drops-425-million-covid-19-drug-refocusing-on-another-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/indian-pharma-exports-grow-at-18-to-24-44-billion-in-fy-21-from-20-58-bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/china-is-starting-clinical-trials-of-a-covid-vaccine-that-can-be-inhaled/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofis-sarclisa-earns-second-ec-clearance-for-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/curevac-initiates-rolling-submission-for-covid-19-vaccine-with-swissmedic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nyu-abu-dhabi-researchers-develop-micro-fluidic-probe-to-isolate-cancer-spreading-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/kalvista-pharmaceuticals-provides-regulatory-update-for-phase-2-clinical-trial-of-kvd824/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-report-finds-significant-problems-at-baltimore-plant-that-contaminated-johnson-johnson-covid-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/revolution-medicines-announces-dosing-of-first-patient-in-phase-1-1b-clinical-study-of-rmc-5552-in-patients-with-advanced-solid-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sleep-duration-associated-with-dementia-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-flush-with-pair-of-car-t-approvals-blueprints-first-cell-therapy-factory-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novo-nordisk-plans-study-of-oral-semaglutide-in-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-incyte-report-positive-results-for-baricitinib-in-alopecia-areata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-sars%e2%80%90unique-domain-sud-of-sars%e2%80%90cov-and-sars%e2%80%90cov%e2%80%902-interacts-with-human-paip1-to-enhance-viral-rna-translation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-immunotherapy-for-endometrial-cancer-with-specific-biomarker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-continues-important-steps-to-ensure-quality-safety-and-effectiveness-of-authorized-covid-19-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/evotec-accelerates-access-to-biologic-therapeutics-with-initiation-of-manufacturing-facility-in-toulouse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eight-new-medicines-recommended-for-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-concluding-deal-for-1-8-billion-more-biontech-pfizer-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/experimental-drug-shows-potential-against-alzheimers-disease-by-albert-einstein-college-of-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/coloured-compounds-may-help-coronavirus-evade-antibodies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tagrisso-recommended-for-approval-in-the-eu-by-chmp-for-the-adjuvant-treatment-of-patients-with-early-stage-egfr-mutated-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jj-covid-19-vaccine-hold-lifted-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-to-scrutinize-unproven-cancer-drugs-after-10-year-gap/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/israel-examines-heart-inflammation-cases-after-pfizer-shot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-drugmakers-step-up-supplies-as-india-battles-covid-19-surge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-buys-amplyx-to-expand-drug-resistant-treatment-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayer-confirms-200m-berkeley-cell-therapy-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amid-humanitarian-crisis-in-india-merck-announces-voluntary-licensing-agreements-with-five-indian-generics-manufacturers-to-accelerate-and-expand-global-access-to-molnupiravir-an-investigational-ora/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lantern-pharmas-proprietary-a-i-platform-for-precision-oncology-drug-development-radr-surpasses-4-6-billion-datapoints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ema-starts-evaluating-use-of-olumiant-in-hospitalised-covid-19-patients-requiring-supplemental-oxygen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tris-pharma-announces-acquisition-of-park-therapeutics-pain-company-with-first-in-class-phase-iii-ready-new-chemical-entity-nce/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/world-to-spend-157-billion-on-covid-19-vaccines-through-2025-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/treadwell-announces-initiation-of-patient-dosing-in-twt-202-a-phase-1b-2-study-of-plk4-inhibitor-cfi-400945-in-patients-with-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biocryst-receives-european-commission-approval-of-orladeyo-berotralstat-first-oral-once-daily-therapy-to-prevent-attacks-in-hereditary-angioedema-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/phathom-pharmaceuticals-announces-positive-topline-results-from-pivotal-phase-3-trial-of-vonoprazan-in-helicobacter-pylori-h-pylori-infection-study-met-all-primary-and-secondary-endpoints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-invests-to-make-up-to-3-billion-more-covid-vaccines-in-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-discovery-of-blood-clotting-mechanism-could-lead-to-new-antithrombotic-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jacobio-announces-fda-approves-ind-application-to-develop-kras-g12c-inhibitor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/iqvia-report-forecasts-global-medicine-spending-to-hit-1-6-trillion-in-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-administers-243-5-mln-doses-of-covid-19-vaccines-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/harvard-scientists-create-gene-editing-tool-that-could-rival-crispr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biovaxys-bioelpida-collaborate-to-produce-ovarian-cancer-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/esteve-and-kowa-pharmaceuticals-america-enter-into-an-exclusive-license-and-commercialization-agreement-for-rights-to-e-58425-for-the-potential-management-of-acute-pain-in-the-united-states/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/teva-announces-the-launch-of-the-first-generic-version-of-absorica-isotretinoin-capsules-for-the-treatment-of-severe-recalcitrant-nodular-acne-in-patients-12-years-of-age-and-older-in-the-un/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/big-three-drug-distributors-blame-doctors-regulators-in-trial-over-opioid-epidemic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/last-resort-antibiotic-pops-bacteria-like-balloons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/janssen-seeks-eu-approval-for-first-car-t-therapy-cilta-cel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/azs-farxiga-scores-us-approval-in-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-hit-by-staff-accusations-fda-scrutiny-at-covid-drug-factories/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-lifts-covid-19-vaccine-sales-forecast-to-19-2-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tecentriq-approved-for-first-line-metastatic-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-supports-waiving-ip-for-covid-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-extends-tie-up-with-cn-bio-to-test-lung-on-a-chip-tech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-accelerated-approval-to-pembrolizumab-for-her2-positive-gastric-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-biontech-seek-full-fda-approval-for-their-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/first-genetically-modified-mosquitoes-released-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/orphazyme-announces-topline-data-from-pivotal-trial-of-arimoclomol-in-amyotrophic-lateral-sclerosis-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-grants-sinopharms-covid-19-vaccine-emergency-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vectura-inspira-team-up-to-develop-inhaled-covid-19-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lonza-announces-expansion-plans-for-next-generation-mammalian-manufacturing-facilities-in-visp-ch-and-portsmouth-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-theory-may-revolutionize-treatment-of-endometriosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-children-ages-12-to-15-could-begin-covid-19-vaccinations-thursday/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pharma-industrys-reputation-hits-plateau-amid-spike-in-vaccine-hesitancy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-classifies-triple-mutant-covid-variant-from-india-as-global-health-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-produce-a-universal-flu-vaccine-using-nanoparticles-to-induce-long-lasting-immunity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-investigate-antibodies-that-best-neutralize-sars-cov-2-in-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/move-over-sniffer-dogs-bees-could-be-trained-to-smell-the-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/boosting-body-heat-production-a-new-approach-for-treating/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ginkgo-bioworks-to-go-public-raise-2-5-billion-via-spac-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amgen-astrazeneca-strengthen-case-for-approval-of-tezepelumab-in-severe-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/heron-therapeutics-announces-u-s-fda-approval-of-zynrelef-htx-011-for-the-management-of-postoperative-pain-for-up-to-72-hours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/women-who-drink-2-sodas-a-day-have-a-higher-risk-of-developing-colorectal-cancer-before-they-reach-50-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-hit-with-charges-of-widespread-email-deletion-in-legal-saga-stemming-from-zantac-recalls/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-design-new-drug-compound-to-stop-malaria-in-its-tracks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/drug-rd-innovation-reshaping-manufacturing-and-the-cdmo-sector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-says-good-reason-to-believe-in-success-of-anti-viral-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-buys-into-minas-protein-boosting-rna-tech-in-1-25bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-gsks-covid-19-vaccine-achieves-positive-phase-ii-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogens-inherited-eye-disease-gene-therapy-misses-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-administers-273-5-mln-doses-of-covid-19-vaccines-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vitamin-b3-as-a-possible-treatment-for-glaucoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-technology-makes-tumor-eliminate-itself/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/neurodon-announces-initiation-of-investigational-new-drug-ind-enabling-studies-for-ndc-0009-a-novel-small-molecule-for-the-treatment-of-type-1-diabetes-t1d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/innocare-announces-approval-of-clinical-trial-of-tyk2-inhibitor-icp-332-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/incytes-ruxolitinib-cream-hits-goal-in-vitiligo-phase-3-trials-teeing-up-regulatory-submissions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/wuxi-bio-answers-the-growing-demand-for-adc-manufacturing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/exclusive-g20-snubs-covid-patent-waiver-waters-down-pledge-on-whos-funding-draft/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/google-announces-health-tool-to-identify-skin-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/stanford-study-reveals-new-biomolecule/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-hands-over-200m-upfront-1-36b-in-biobucks-for-agenus-preclinical-tigit-asset/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-to-make-covid-19-vaccine-component-at-dublin-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/charles-river-laboratories-to-acquire-vigene-biosciences-to-enhance-gene-therapy-capabilities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-announces-sale-of-stake-in-innoviva-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-waves-through-jjs-targeted-drug-rybrevant-for-subset-of-nsclc-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/generos-biopharmas-clinflamozyde-approved-for-clinical-trials-for-covid-19-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/five-pharmaceutical-companies-get-approval-to-make-black-fungus-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/chmp-puts-eight-new-medicines-forward-for-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-partners-with-ginkgo-bioworks-on-gene-therapy-manufacturing-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/general-atlantic-backed-centessa-targets-1-7-bln-valuation-in-u-s-ipo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/qelbree-viloxazine-extended-release-capsules-a-new-non-controlled-substance-now-available-for-the-treatment-of-adhd-in-pediatric-patients-6-17-years-of-age/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gene-signature-discovered-for-plaque-eating-microglia-in-alzheimers-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-have-found-a-way-to-break-the-limit-of-human-longevity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/takedas-dengue-shot-keeps-84-of-kids-out-of-hospital-regardless-of-prior-infection-giving-it-a-leg-up-over-sanofis-dengvaxia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-hits-u-k-antitrust-roadblock-with-39b-alexion-buy-despite-u-s-ftc-clearance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-and-samsung-biologics-announce-agreement-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/one-step-closer-to-nasal-spray-drug-delivery-for-parkinsons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/one-of-two-americans-have-received-at-least-one-dose-of-covid-19-vaccine-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/uk-pharma-group-vectura-agrees-1-4-billion-takeover-by-carlyle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-e-u-may-seek-billions-in-penalties-if-astrazenecas-vaccine-deliveries-fall-short/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/janssens-erleada-maintains-quality-of-life-for-prostate-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ec-approves-ponvory-for-relapsing-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/coronavirus-covid-19-update-fda-authorizes-additional-monoclonal-antibody-for-treatment-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/teva-launches-first-dtc-for-austedo-into-competitive-tardive-dyskinesia-2-drug-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/with-latest-fda-nod-biohavens-nurtec-becomes-first-migraine-med-to-prevent-and-treat-attacks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/inflammatory-drug-could-prevent-severe-complications-from-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/expert-reaction-to-one-dose-janssen-covid-19-vaccine-being-approved-by-the-mhra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-bristol-myers-zeposia-for-uc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vaccine-protects-against-more-hpv-variants-than-previously-known/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/experimental-treatment-offers-new-hope-against-lupus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/successful-test-of-cancer-killing-trojan-horse-drug-marks-important-advance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amgen-and-kyowa-kirin-agree-to-jointly-develop-eczema-med/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-halts-venglustat-clinical-programme-in-adpkd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/alkermes-lybalvi-gains-fda-approval-for-schizophrenia-bipolar-i-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novartis-deal-may-lead-to-cellerys-sale/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/covid-chinas-sinovac-vaccine-gets-who-emergency-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vietnam-detects-a-suspected-new-coronavirus-variant-thats-a-hybrid-of-the-uk-and-india-strains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/janssens-myeloma-car-t-therapy-cilta-cel-demonstrates-sustained-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/morphosys-to-buy-constellation-pharmaceuticals-for-1-7-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-and-sanofis-first-and-only-six-in-one-pediatric-combination-vaccine-now-available-in-the-united-states/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/aptamer-group-and-pinotbio-collaborate-to-develop-new-therapeutic-drug-conjugates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-partners-with-thermo-fisher-to-scale-up-covid-19-vaccine-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazenecas-lynparza-reduces-relapse-death-in-breast-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nih-launches-clinical-trial-of-universal-influenza-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nih-researchers-identify-potential-new-antiviral-drug-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/luring-bacteria-into-a-trap/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/blackstone-carlyle-and-hellman-friedman-to-invest-in-medline-partnership-to-accelerate-medlines-growth-and-international-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-approves-biogen-alzheimers-drug-hailed-as-a-big-day/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-administers-300-3-million-doses-of-covid-19-vaccines-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/many-existing-drugs-could-be-potent-covid-fighters-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-report-found-it-plausible-covid-19-leaked-from-wuhan-lab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-research-identifies-single-biomarker-that-can-indicate-underlying-neurodegeneration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/smc-backs-five-new-medicines-for-nhs-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/69353-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-takes-parp-battle-to-court-seeking-a-larger-claim-to-gsks-key-cancer-med-zejula-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/on-a-vaccine-roll-pfizer-scores-fda-nod-for-prevnar-13-follow-up-ahead-of-rival-merck/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/empowerpharm-becomes-the-first-canadian-pharmaceutical-company-with-a-certified-gmp-facility-fully-dedicated-to-manufacture-cbd-tablets-and-capsules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/with-1-2b-deal-for-molnupiravir-u-s-bets-on-mercks-oral-covid-19-antiviral/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-grilled-on-hefty-alzheimers-drug-price/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pandemic-inevitably-slows-pharma-ma-activity-but-appetite-for-deals-remains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayer-subsidiary-doses-first-patient-with-parkinsons-disease-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astellas-xtandi-bags-nice-approval-in-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/research-identifies-potential-antiviral-compound-for-covid-19-flu-different-viral-an-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-adds-another-rare-blood-condition-as-side-effect-of-astrazeneca-shot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/third-member-of-fda-expert-panel-exits-amid-alzheimers-drug-flap/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mhra-approves-venclyxto-for-newly-diagnosed-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/glenmark-pharma-releases-interim-data-from-pms-study-on-favipiravir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-create-ceiling-mounted-covid-sensor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/iteos-therapeutics-and-gsk-announce-development-and-commercialisation-collaboration-for-eos-448-an-anti-tigit-monoclonal-antibody-enabling-novel-next-generation-immuno-oncology-combinations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-super-resolution-technique-allows-for-more-detailed-brain-imaging/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogens-56k-price-on-aduhelm-simply-unacceptable-alzheimers-association-says-after-vouching-for-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-daiichi-sankyo-launch-enhertu-head-to-head-trial-with-eyes-on-a-new-breast-cancer-standard/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-launches-global-generic-drug-cluster/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novavax-covid-vaccine-90-effective-in-phase-3-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nih-study-offers-new-evidence-of-early-sars-cov-2-infections-in-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/monoclonal-antibodies-cut-risk-of-dying-from-covid-19-but-only-in-some-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazenecas-antibody-cocktail-fails-to-prevent-covid-19-in-latest-trial-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-in-ireland-identify-the-reason-covid-19-patients-develop-blood-clots/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-avapritinib-for-advanced-systemic-mastocytosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogens-ambitions-in-gene-therapy-hit-by-another-failed-pivotal-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/yposkesi-set-to-double-capacity-and-become-a-viral-vector-force/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/boehringer-lilly-and-takeda-join-matchmaker-pharmstars-digital-health-accelerator/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/horizon-therapeutics-plc-announces-purchase-of-manufacturing-facility-to-support-growth-of-on-market-rare-disease-and-pipeline-biologics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/health-chiefs-recall-dozens-of-batches-of-common-blood-pressure-pills-because-they-contain-worlds-most-explosive-chemical-which-also-causes-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eqt-private-equity-to-sell-aldevron-to-danaher-corporation-for-enterprise-value-of-usd-9-6-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-shelves-gosuranemab-after-no-benefit-seen-in-phase-ii-alzheimers-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-eisai-in-up-to-3-1-billion-deal-to-develop-cancer-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/chinese-patent-reforms-to-bolster-pharma-innovation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-astepro-allergy-nasal-spray-for-over-the-counter-use-in-the-united-states/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizers-jak-inhibitor-xeljanz-shows-benefit-in-covid-19-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/after-fda-rejection-eu-says-yes-to-sanofis-aubagio-in-kids-with-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-supreme-court-rebuffs-abbvie-appeal-in-patent-fight-involving-androgel-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-oral-blood-thinning-medication-for-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-green-lights-az-msds-rare-disease-therapy-koselugo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jj-cell-therapy-partner-legend-carves-out-production-foothold-in-belgium-as-myeloma-drug-nears-finish-line/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-inks-another-revlimid-patent-settlement-this-time-with-sun-pharma-as-copycats-near/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novavaxs-covid-19-shot-wont-see-much-u-s-use-but-a-big-global-market-awaits-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/strand-snags-52m-to-develop-next-gen-mrna-meds-for-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-has-renamed-its-coronavirus-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/deepmind-uses-ai-to-tackle-neglected-deadly-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsks-drugs-arm-to-get-11-bln-windfall-from-consumer-spin-off/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-to-file-for-accelerated-fda-approval-of-alzheimers-drug-after-aduhelm-ok-opens-the-floodgates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amid-outcry-over-aduhelm-price-biogen-says-it-may-consider-adjustment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nearly-17-million-people-had-undiagnosed-covid-19-infections-during-early-months-of-pandemic-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-halts-global-chantix-distribution-after-testing-flags-impurities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-approves-roche-drug-for-emergency-use-against-severe-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/arkansas-governor-says-final-fda-approval-of-covid-19-vaccine-would-help-fight-hesitancy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lillys-tirzepatide-beats-ozempic-in-head-to-head-type-2-diabetes-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-actemra-for-emergency-use-in-hospitalised-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-breakthrough-device-designation-for-deep-brain-stimulation-in-alzheimer-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-lambda-variant-was-originally-discovered-in-peru-and-81-percent-of-the-coronavirus-cases-in-the-country-since-april-are-related-to-the-strain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/69541-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/teva-and-bioeq-announce-commercial-partnership-for-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-offloads-16-consumer-health-brands-to-stada-amid-ceo-hudsons-refocusing-effort/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-clues-point-to-the-liver-playing-a-causal-role-in-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gilead-seeks-us-approval-for-long-acting-hiv-drug-lenacapavir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mhra-approves-paions-ultra-short-acting-anaesthetic-byfavo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/walmart-revolutionizes-insulin-access-affordability-for-patients-with-diabetes-with-the-launch-of-the-first-and-only-private-brand-analog-insulin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/heart-failure-is-associated-with-an-increased-risk-of-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/from-30-million-cases-to-zero-china-is-certified-malaria-free-by-who/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/curevac-final-data-from-phase-2b-3-trial-of-first-generation-covid-19-vaccine-candidate-cvncov-demonstrates-protection-in-age-group-of-18-to-60/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-rylaze-for-subsets-of-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/philip-morris-international-announces-agreement-to-acquire-fertin-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-alector-to-develop-parkinsons-alzheimers-drugs-in-2-2-bln-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jjs-covid-19-vaccine-shows-promise-against-delta-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mylan-sues-generic-rival-teva-over-sophisticated-scheme-to-block-copaxone-copycats/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fujifilms-multibillion-dollar-expansion-spree-rolls-on-with-850m-capacity-boost-in-u-s-u-k/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lupins-novel-laboratories-knocked-by-fda-for-cleanliness-quality-issues-at-new-jersey-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-jazz-pharmas-rylaze-for-treating-common-leukemia-in-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/s-korea-in-talks-with-mrna-vaccine-makers-to-make-up-to-1-bln-doses-govt-official/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/parexel-snapped-up-again-as-goldman-sachs-eqt-spend-8-5b-on-the-cro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazenecas-39b-alexion-buyout-scores-eu-blessing-but-still-awaits-key-nod-from-the-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/innovation-on-hold-during-the-pandemic-fda-says-no-with-29-approvals-in-first-half-of-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-recommends-life-saving-interleukin-6-receptor-blockers-for-covid-19-and-urges-producers-to-join-efforts-to-rapidly-increase-access/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/provention-bio-receives-complete-response-letter-crl-to-biologics-license-application-bla-for-teplizumab-for-the-delay-of-clinical-type-1-diabetes-t1d-in-at-risk-individuals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/unraveling-the-mechanisms-that-create-the-individualized-metabolism-in-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mrna-vaccines-slash-risk-of-covid-19-infection-by-91-percent-in-fully-vaccinated-people-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/az-amgen-get-speedy-fda-review-for-asthma-drug-tezepelumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-plans-triple-vaccine-targeting-flu-covid-and-rsvphil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-narrows-patient-group-for-biogens-alzheimers-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/study-finds-lower-covid-19-infection-prevalence-in-fully-vaccinated-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/parliament-votes-to-expand-remit-of-european-medicines-agency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/with-500m-in-local-pledges-recipharm-plans-moroccan-factory-to-help-africa-secure-vaccine-sovereignty/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/philip-morris-strikes-1-45b-deal-for-vectura-sending-another-would-be-buyer-back-to-the-drawing-board/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/morphic-therapeutic-reports-new-data-from-positive-phase-1-study-of-morf-057-oral-integrin-inhibitor-candidate-for-ibd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayers-kerendia-finerenone-receives-u-s-fda-approval-for-treatment-of-patients-with-chronic-kidney-disease-associated-with-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/f-star-therapeutics-enters-into-exclusive-licensing-agreement-with-astrazeneca-for-novel-sting-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/stem-cell-therapy-company-amniotics-raises-sek-60-million-in-first-north-ipo-to-advance-lead-candidate-pulmostem-into-clinic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-no-for-orchard-therapeutics-gene-therapy-libmeldy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gene-therapy-success-offers-hope-for-reversing-rare-genetic-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mechanical-stimuli-significantly-influence-organ-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogens-aduhelm-probe-in-congress-escalates-as-lawmakers-ask-for-info-on-fda-meetings-pricing-tactics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/florida-judge-rules-for-generic-over-the-counter-manufacturers-of-zantac-knockoffs-backing-preemption-claim/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-publishes-guidelines-for-human-genome-editing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/metal-based-molecules-show-promise-against-the-build-up-of-alzheimers-peptides/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/drug-combination-shows-meaningful-responses-for-malignant-peritoneal-mesothelioma-patient/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/methamphetamine-use-drove-surge-in-heart-failure-hospitalizations-costs-in-california/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-and-innocare-announce-license-and-collaboration-agreement-for-orelabrutinib-an-innovative-cns-penetrant-btk-inhibitor-for-the-potential-treatment-of-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/robots-are-joining-the-fight-against-coronavirus-in-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eli-lilly-gets-glucose-sensing-smart-insulin-via-buyout-of-preclinical-protomer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/uk-fines-pharma-companies-360-million-for-overcharging-nhs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pharmacies-pull-jj-sunscreens-off-shelves-after-carcinogen-found-in-some-sprays/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/remdesivir-hydroxychloroquine-fail-to-show-antiviral-effects-in-patients-with-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-priority-review-for-pfizer-biontech-covid-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-antes-up-345m-to-settle-long-running-epipen-antitrust-claims-as-viatris-case-moves-ahead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-advisory-committee-votes-against-approval-of-az-fibrogens-roxadustat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vaxneuvance-pneumococcal-15-valent-conjugate-vaccine-for-the-prevention-of-invasive-pneumococcal-disease-in-adults-18-years-and-older-caused-by-15-serotypes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/kadmon-shares-jump-on-fda-approval-of-rezurock-for-chronic-gvhd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biontech-produces-10-times-more-antibodies-than-chinas-sinovac-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biontech-to-acquire-kites-neoantigen-tcr-cell-therapy-rd-platform-and-manufacturing-facility-in-gaithersburg-md/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-states-to-unveil-26-billion-opioid-settlement-with-drug-distributors-jj-sources/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-sleeping-sickness-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-tacrolimus-for-lung-transplants-in-adults-kids-the-first-immunosuppressant-approved-for-this-population/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/first-total-artificial-heart-successfully-transplanted-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/catalent-plans-multi-phase-100-million-expansion-of-italian-facility-to-increase-biologics-manufacturing-capabilities-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/az-licenses-pneumonia-mab-to-aridis-pharmaceuticals-for-11m-upfront/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-closes-mega-39b-alexion-buyout-despite-antitrust-fears-making-a-splash-in-rare-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/two-doses-of-pfizer-astrazeneca-shots-effective-against-delta-variant-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/johnson-johnson-eyes-2-5b-in-covid-vaccine-sales-as-key-immunology-oncology-meds-trounce-expectations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/albireos-bylvay-approved-in-eu-and-us-for-rare-paediatric-liver-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/done-deal-johnson-johnson-and-3-distributors-agree-to-historic-26-billion-opioid-settlement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/excess-coffee-use-shown-to-decrease-brain-volume-increase-dementia-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/evidence-of-sustained-benefits-of-pimavanserin-for-dementia-related-psychosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-orders-200-mn-more-pfizer-biontech-vaccine-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/dalvance-dalbavancin-receives-fda-approval-to-treat-acute-bacterial-skin-and-skin-structure-infections-in-pediatric-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/iterum-therapeutics-fda-recommends-more-data-on-oral-sulopenem/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/perkinelmer-continues-rapid-life-science-growth-with-massive-5-25b-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/a-rationally-designed-therapeutic-vaccine-for-herpes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/inmune-bio-inc-announces-design-of-upcoming-phase-2-alzheimers-disease-clinical-trial-and-new-phase-1b-ad-biomarker-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-19-22-july-2021-share/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/regeneron-and-astrazeneca-to-research-develop-and-commercialize-new-small-molecule-medicines-for-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biontech-to-develop-a-mrna-based-malaria-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mercks-keytruda-scores-first-in-class-nod-in-early-triple-negative-breast-cancer-despite-fdas-prior-reluctance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ac-immune-acquires-parkinsons-disease-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lawmakers-press-fda-for-answers-about-its-plans-to-restart-foreign-inspections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/study-could-lead-to-blood-based-diagnostic-test-for-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/2-5b-teneobio-deal-complements-amgens-core-and-capabilities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-allows-lillys-covid-19-drug-to-be-taken-without-remdesivir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-alerts-patients-and-health-care-professionals-about-clinical-trial-results-showing-an-increased-risk-of-death-associated-with-pepaxto-melphalan-flufenamide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/self-destructing-malaria-spreading-mosquitos-how-genetic-engineering-could-make-it-so/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/viatris-inc-and-biocon-biologics-receive-historic-approval-for-first-interchangeable-biosimilar-semglee-insulin-glargine-yfgn-injection-for-the-treatment-of-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/proof-covid-is-turning-into-a-mild-illness-survivors-who-get-reinfected-have-lower-viral-loads-which-make-them-less-likely-to-become-unwell-or-spread-the-virus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eli-lilly-and-kumquat-seek-enhanced-tumor-specific-immune-response-in-2b-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ckd-drug-hit-phase-iii-endpoints-yet-rejected-by-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-curious-case-of-eohilia-takeda-drug-hit-with-mysterious-fda-delay-as-company-leans-on-launches-for-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gop-report-on-covid-19-origins-homes-in-on-lab-leak-theory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/full-fda-approval-for-covid-19-vaccine-may-come-in-couple-of-months-report-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ipsen-goes-all-in-on-neuro-with-1-billion-deal-for-exicures-oligonucleotides/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazenecas-fda-approval-brings-new-hope-to-the-lupus-community/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/as-veklurys-sales-slide-gilead-hopes-for-a-quicker-rebound-from-biktarvy-other-hiv-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-pulls-an-istodax-lymphoma-use-10-years-after-fda-accelerated-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-and-moderna-raised-their-vaccine-prices-in-their-latest-e-u-contracts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tecentriq-wins-fda-priority-review-for-certain-early-nsclc-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/chilean-study-shows-variations-in-success-of-covid-19-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-bets-on-mrna-vaccines-beyond-covid-in-3-2-bln-translate-bio-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/masitinib-inhibits-the-replication-of-sars-cov-2-in-preclinical-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/aldeyra-therapeutics-receives-orphan-drug-designation-from-the-u-s-food-and-drug-administration-for-adx-2191-to-treat-retinitis-pigmentosa-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-announces-positive-top-line-results-from-phase-2b-3-trial-of-ritlecitinib-in-alopecia-areata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jj-notches-a-win-in-50m-talc-lawsuit-but-tens-of-thousands-still-pending/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/softbank-acquires-5-billion-stake-in-roche/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayer-drops-2-billion-to-drug-the-undruggable/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bayer-strengthens-drug-discovery-platform-through-acquisition-of-vividion-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/spectrum-pharmaceuticals-receives-complete-response-letter-from-fda-for-rolontis-eflapegrastim/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/first-ever-single-dose-chikungunya-vaccine-touts-positive-phase-iii-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eisai-and-biogen-gun-for-speedy-approval-for-another-alzheimers-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-approves-another-sanofi-drug-for-rare-muscle-disorder-pompe-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gilead-to-require-u-s-workers-receive-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/azs-forxiga-gains-ec-mhra-approvals-for-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-covid-19-vaccine-approval-live-updates-on-pfizer-moderna-and-jj-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/university-of-glasgow-researchers-propose-a-smartphone-based-dna-diagnostics-for-malaria-detection-using-deep-learning/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bavarian-nordic-reports-initial-results-from-first-in-human-trial-of-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/australian-researchers-develop-hydrogel-to-combat-parkinsons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nearly-60-of-americans-at-least-partially-vaccinated-against-covid-19-cdc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/seagen-and-remegen-announce-exclusive-worldwide-license-and-co-development-agreement-for-disitamab-vedotin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biontech-soars-as-it-says-its-developing-updated-covid-shot-for-delta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abbvie-ditches-late-stage-eye-drug-license-collab-with-molecular-partners/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/terumo-blood-and-cell-technologies-and-photonpharma-inc-announce-collaboration-to-develop-a-novel-cancer-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mhra-approves-for-epidyolex-cannabidiol-for-tsc-seizure-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-to-bring-mrna-vaccine-manufacturing-facility-to-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fibrogen-receives-complete-response-letter-from-the-fda-for-roxadustat-for-anemia-of-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sars-cov-2-iota-variant-increases-mortality-risk-among-older-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approval-of-jazzs-xywav-will-leave-more-people-sleeping-less/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-moving-mrna-vaccine-candidates-for-hiv-into-the-clinic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/whos-solidarity-clinical-trial-enters-a-new-phase-with-three-new-candidate-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mhra-nod-for-janssens-relapsing-multiple-sclerosis-drug-ponvory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ema-starts-evaluating-use-of-roactemra-in-hospitalised-adults-with-severe-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lillys-lebrikizumab-significantly-improved-skin-clearance-and-itch-in-people-with-moderate-to-severe-atopic-dermatitis-in-two-phase-3-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-ticovac-tick-borne-encephalitis-tbe-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-approval-for-lillys-verzenios-is-fantastic-news-for-thousands-of-women/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bimekizumab-new-results-in-psoriasis-pave-way-for-potential-best-in-class-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mercks-vhl-drug-becomes-first-ever-hif-2%ce%b1-inhibitor-approved-in-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/serum-institute-of-india-acquires-50-stake-of-schott-kaisha/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/teva-wins-three-loses-six-in-patent-battle-over-migraine-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-receives-fda-accelerated-approval-for-jemperli-dostarlimab-gxly-for-adult-patients-with-mismatch-repair-deficient-dmmr-recurrent-or-advanced-solid-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/benefits-of-covid-19-vaccines-far-outweigh-very-rare-risk-of-bells-palsy-lancet-study-confirms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/potential-new-drug-targets-may-enhance-the-treatment-of-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-fast-tracks-breast-cancer-candidate-samuraciclib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/south-korea-aims-to-make-vaccine-industry-more-competitive-with-emphasis-on-covid-19-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/otsuka-reports-topline-outcomes-on-a-phase-ii-trial-that-evaluated-brexpiprazole-for-the-treatment-of-borderline-personality-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-bio-medicines-splits-into-neuroscience-immunology-units/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-approval-for-boehringer-ingelheim-lillys-heart-failure-drug-jardiance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pimavanserin-use-linked-with-greater-risk-of-hospitalization-mortality-in-patients-with-parkinson-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sutro-stro-ovarian-cancer-drug-gets-fdas-fast-track-tag/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/zealand-pharma-announces-first-patient-dosed-in-ease-sbs-4-phase-3b-trial-assessing-glepaglutide-in-patients-with-short-bowel-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bms-obtains-fda-approval-for-opdivo-as-bladder-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/evrenzo-approved-for-ckd-related-anaemia-treatment-in-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-to-acquire-trillium-therapeutics-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/right-wing-media-pushed-a-deworming-drug-to-treat-covid-19-that-the-fda-says-is-unsafe-for-humans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/virginia-tech-scientists-distill-cows-milk-into-nano-capsules-for-drug-delivery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abecma-is-the-first-treatment-approved-by-ec-for-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/study-confirms-viraleze-antiviral-nasal-spray-provides-protection-against-sars-cov-2-in-challenge-model/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-kgaa-gsks-bintrafusp-alfa-chalks-up-another-loss-in-biliary-tract-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-could-control-covid-by-spring-2022-if-more-people-get-shots-fauci/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/theravances-izencitinib-fails-in-phase-iib-ulcerative-colitis-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novartis-kymriah-fails-to-meet-primary-goal-in-non-hodgkin-lymphoma-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lilly-and-lycia-therapeutics-enter-into-strategic-collaboration-to-discover-and-develop-novel-lysosomal-targeting-chimera-lytac-degraders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/european-commission-approves-abbvies-rinvoq-for-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cara-vifor-receive-fda-nod-for-pruritus-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/msds-pneumococcal-vaccine-hits-key-endpoints-in-phase-iii/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-no-for-janssens-darzalex-combo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biomarin-climbs-as-dwarfism-drug-improves-growth-in-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-machine-learning-method-enhances-computational-prediction-of-rna-structures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ema-fast-tracks-marinus-pharmas-rare-epilepsy-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sonys-head-of-ai-research-wants-to-build-robots-that-can-win-a-nobel-prize/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-microtransponder-vivistim-paired-vns-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cellmax-lifes-cancer-blood-test-designated-fda-breakthrough-device/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sesen-bio-pulls-eu-application-for-cancer-drug-fda-rejected/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/redhill-biopharmas-opaganib-demonstrates-strong-inhibition-of-covid-19-delta-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/catalent-to-extend-leadership-in-rapidly-growing-nutraceuticals-market-with-proposed-1-billion-acquisition-of-bettera-a-leading-gummies-manufacturer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/roche-withdraws-us-approval-for-tecentriq-in-mtnbc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/china-cdc-experts-suggest-survey-on-cold-chain-suppliers-to-wuhan-in-whos-2nd-phase-probe-on-virus-origins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/a-drug-costing-less-than-e2-a-day-helps-in-the-treatment-of-severely-ill-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ucb-announces-briviact-brivaracetam-now-fda-approved-to-treat-partial-onset-seizures-in-pediatric-patients-one-month-of-age-and-older/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-tibsovo-for-adjuvant-treatment-of-idh1-mutated-uc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-pembrolizumab-for-first-line-treatment-of-advanced-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/in-a-major-blow-to-vaccine-efforts-senior-fda-leaders-stepping-down/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/xywav-set-to-become-jazzs-next-blockbuster-in-the-narcolepsy-market-says-globaldata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/early-use-of-uptravi-reduces-risk-of-disease-progression-in-pah-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sk-bioscience-gsk-launch-phase-3-trial-for-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/takedas-pevonedistat-fails-to-meet-primary-goal-in-phase-iii-leukaemia-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-in-brief-fda-reaches-milestone-in-competitive-generic-therapy-drug-approvals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amazon-pushes-deworming-drug-falsely-touted-as-covid-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/statement-by-the-board-of-directors-of-swedish-orphan-biovitrum-ab-in-relation-to-the-public-cash-offer-by-advent-and-gic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/congress-concerned-by-apparent-anomalies-around-fdas-approval-of-aduhelm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-zanubrutinib-in-adults-with-waldenstrom-macroglobulinemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/oxycontin-maker-purdue-dissolved-family-to-pay-4-5-billion-in-bankruptcy-settlement-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-invega-hafyera/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/toripalimab-fda-approval-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/dr-reddys-lab-gains-on-deal-with-citius-pharma-for-anti-cancer-agent-e7777/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biden-administration-unveils-65-billion-plan-to-combat-next-pandemics-after-covid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/covid-19-immunosuppressant-drug-remdesivir-mix-shows-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/roches-polivy-to-hit-2-4b-as-doctors-expect-significant-switching-in-newly-diagnosed-lymphoma-analyst/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bristol-myers-pfizer-score-another-win-in-their-eliquis-patent-defense-protecting-the-blockbuster-until-2028/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/after-moderna-contamination-mess-takeda-strikes-deal-with-japan-to-supply-novavax-covid-19-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/hibercell-receives-fast-track-designation-from-fda-for-first-in-human-studies-of-perk-inhibitor-perki-hc-5404-fu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-declines-emergency-use-approval-for-humanigens-covid-19-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vor33-granted-u-s-fda-fast-track-designation-for-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eloxx-pharmaceuticals-gets-fda-fast-track-designation-for-elx-02-in-cystic-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-empagliflozin-breakthrough-therapy-designation-in-hfpef/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sandoz-strengthens-pipeline-by-entering-into-agreement-for-biosimilar-bevacizumab-a-key-oncology-medicine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/engeneic-initiates-phase-i-trial-of-nanocellular-anti-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/a-new-collaboration-deal-with-eli-lilly-could-be-worth-up-to-1-3-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-reports-positive-data-from-pt027-fixed-dose-combination-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approved-gout-medicine-could-also-battle-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/frances-sanofi-to-buy-u-s-biopharma-firm-kadmon-in-1-9-bln-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/from-pfizer-to-argenx-a-look-at-potential-blockbusters-awaiting-fda-decisions-this-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bausch-pays-whopping-300m-to-settle-diabetes-antitrust-dispute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-fda-has-only-fully-approved-one-drug-for-treating-covid-19-and-its-not-ivermectin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/isa-pharmaceuticals-receives-fast-track-designation-for-lead-product/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nhs-england-launches-large-scale-trial-of-revolutionary-cancer-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/senhwa-doses-first-subject-in-trial-of-pidnarulex-for-solid-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abbvie-and-regenxbio-announce-eye-care-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pancreatic-cancer-research-ramps-up-as-roche-and-novocure-announce-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jj-on-pace-for-another-vaccine-success-this-time-for-ebola/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/research-identifies-possible-link-between-antibiotic-use-and-breast-cancer-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pulmocides-lead-drug-candidate-opelconazole-pc945-granted-orphan-drug-fast-track-and-qualified-infectious-disease-product-designations-by-us-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sage-therapeutics-receives-fast-track-designation-for-sage-718-for-the-treatment-of-huntingtons-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bridgebio-gets-fda-fast-track-designation-for-limb-girdle-muscular-dystrophy-type-2i-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-exkivity-as-first-oral-therapy-for-lung-cancer-subset/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/obseva-announces-submission-of-new-drug-application-to-u-s-fda-for-linzagolix-for-the-treatment-of-uterine-fibroids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-accepts-investigational-new-drug-application-for-peanut-allergy-candidate-developed-by-cour-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-announces-positive-topline-results-from-phase-2-convey-study-for-vixotrigine-in-small-fiber-neuropathy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/hospitalizing-the-unvaccinated-has-cost-u-s-nearly-6-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/world-alzheimers-day-2021-september-21/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/aveo-oncology-announces-ficlatuzumab-granted-fast-track-designation-by-the-u-s-fda-for-the-treatment-of-relapsed-or-recurrent-head-and-neck-squamous-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/combinations-as-another-her2-targeted-breast-cancer-drug-emerges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vumerity-recommended-for-eu-approval-as-rrms-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/samsung-bioepis-biogens-biosimilar-for-lucentis-obtains-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/oral-molnupiravir-has-at-least-350-patients-left-to-recruit-in-phase-iii-covid-19-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/amgen-wins-lawsuit-against-sandoz-and-zydus-for-otezla-patent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/grifols-agrees-to-acquire-tiancheng-pharmaceutical-for-1-3bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-and-biontech-report-positive-covid-19-vaccine-trial-data-in-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/zenith-epigenetics-and-newsoara-announce-initiation-of-a-randomized-phase-2b-metastatic-castration-resistant-prostate-cancer-mcrpc-study-evaluating-the-combination-of-zen-3694-and-enzalutamide-in-mc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/inventiva-announces-fda-decision-that-fast-track-designation-granted-to-lanifibranor-in-nash-encompasses-the-treatment-of-nash-with-compensated-cirrhosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/micro-robots-propelled-by-air-bubbles-and-ultrasound/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-opzelura-as-treatment-for-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sage-718-on-fda-fast-track-as-potential-huntingtons-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/carisma-therapeutics-announces-u-s-food-and-drug-administration-grants-fast-track-designation-to-ct-0508-for-the-treatment-of-patients-with-solid-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-to-discover-and-develop-self-amplifying-rna-therapeutics-in-new-collaboration-with-vaxequity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/alrizomadlin-lands-fda-fast-track-designation-for-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-ready-to-use-norepinephrine-injections-for-severe-hypertension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-fda-accelerated-drug-approval-program-benefits-and-limitations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-begins-study-of-oral-drug-for-prevention-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/japan-panel-approves-second-drug-for-mildly-ill-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/reveragen-and-santhera-announce-fda-orphan-grant-funding-for-clinical-trial-with-vamorolone-in-becker-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/genetx-and-ultragenyx-announce-fda-has-removed-clinical-hold-on-phase-1-2-clinical-study-of-gtx-102-for-the-treatment-of-angelman-syndrome-in-the-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/a-new-oral-antiviral-drug-for-covid-is-being-tested-in-humans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/more-effective-treatment-of-alzheimers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/kids-too-young-for-a-covid-19-vaccine-how-to-keep-them-safe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approved-alzheimers-drug-will-help-spur-innovation-toward-personalized-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/frances-sanofi-halts-work-on-anti-covid-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eisai-initiates-rolling-submission-to-the-u-s-fda-for-biologics-license-application-of-lecanemab-ban2401-for-early-alzheimers-disease-under-the-accelerated-approval-pathway/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nucana-receives-fast-track-designation-from-the-u-s-food-and-drug-administration-for-acelarin-nuc-1031-for-the-treatment-of-biliary-tract-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/astrazeneca-to-buy-rare-disease-drugmaker-caelum-in-small-dealer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/top-fda-official-takes-over-vaccine-office-as-agency-weighs-covid-19-shots-for-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/catalyst-wins-favorable-court-ruling-on-orphan-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jaguar-healths-founder-and-ceo-lisa-conte-to-be-honored-with-pure-earth-impact-award/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pacira-biosciences-begins-commercial-production-of-exparel-at-swindon-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-abbvies-migraine-prevention-drug-qulipta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-covid-19-vaccine-might-not-be-authorized-for-young-children-until-november/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mirums-oral-drug-becomes-first-u-s-approved-alagille-syndrome-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/reata-pharmaceuticals-plans-nda-submission-for-omaveloxolone-in-first-quarter-of-2022-following-completion-of-pre-nda-meeting-with-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/narsoplimab-fda-approval-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/diamedica-therapeutics-announces-fast-track-designation-granted-to-dm199-for-the-treatment-of-acute-ischemic-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/latest-fda-approved-preventive-treatment-for-migraine-qulipta-enters-a-highly-competitive-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/two-americans-win-medicine-nobel-for-work-on-heat-and-touch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/jcr-pharmaceuticals-us-fda-grants-fast-track-designation-for-jr-171-for-the-treatment-of-mucopolysaccaridosis-type-i-mpsi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/teva-halts-output-at-u-s-drug-plant-after-fda-flags-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-nobel-prize-in-physics-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/coronavirus-covid-19-update-fda-authorizes-additional-otc-home-test-to-increase-access-to-rapid-testing-for-consumers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-nobel-prize-in-chemistry-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/statin-initiation-linked-to-greater-progression-of-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/natural-compound-in-basil-may-protect-against-alzheimers-disease-pathology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-discover-three-rare-cannabinoids-reduce-seizures-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gilead-nabs-second-approval-for-car-t-lymphoma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/70698-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/recursions-rec-2282-granted-fda-fast-track-designation-for-nf2-mutated-meningiomas-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/denali-therapeutics-announces-positive-clinical-results-and-regulatory-progress-for-development-programs-in-amyotrophic-lateral-sclerosis-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/in-major-decision-who-recommends-broad-rollout-of-worlds-first-malaria-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/covid-variant-mu-made-a-splash-disappeared-without-a-peep/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/chemocentryx-announces-fda-approval-of-tavneos-avacopan-in-anca-associated-vasculitis-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/will-covid-19-antiviral-pill-become-key-to-treat-mild-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-and-ridgeback-announce-submission-of-emergency-use-authorization-application-to-the-u-s-fda-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-innovative-treatment-for-pediatric-patients-with-congenital-athymia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/melanoma-alrizomadlin-fast-track-designation-for-advanced-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cancer-treatment-from-himalayan-fungus-shows-promising-results-in-phase-1-trials-but-could-it-be-the-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/immunotherapy-combination-could-be-alternative-to-extreme-chemotherapy-in-some-head-and-neck-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-dextenza-for-ocular-itching-from-allergic-conjunctivitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gensight-biologics-announces-fda-grant-of-fast-track-designation-for-optogenetic-therapy-gs030-as-treatment-for-retinitis-pigmentosa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/antiviral-compound-blocks-sars-cov-2-from-entering-cells-new-compound-also-could-be-effective-against-other-coronaviruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-adjuvant-abemaciclib-plus-endocrine-therapy-for-select-hr-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/revance-continues-to-anticipate-fda-approval-of-daxibotulinumtoxina-for-injection-for-the-treatment-of-glabellar-lines-in-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approved-drugs-promises/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nrx-pharmaceuticals-announces-progress-on-worldwide-commercial-scale-development-of-zyesami-aviptadil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-pembrolizumab-combination-for-the-first-line-treatment-of-cervical-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ohio-law-that-bans-non-fda-approved-vaccines-now-in-effect/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-fda-approves-agilents-ki-67-ihc-mib-1-pharmdx-for-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/regeneron-pushes-its-versatile-antibody-cocktail-closer-to-finish-line-as-a-multiuse-covid-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/indias-everest-organics-starts-making-ingredient-for-mercks-covid-19-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-clears-opdivo-for-resected-oesophageal-or-gastro-oesophageal-junction-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/one-coronavirus-vaccine-may-protect-against-other-coronaviruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-fast-track-designation-to-aoc-1001-for-the-treatment-of-myotonic-dystrophy-type-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/experts-warn-that-expensive-covid-19-pill-and-stockpiling-could-cause-treatment-inequality/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-oyster-points-nasal-spray-for-dry-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/new-asthma-drug-approved-on-nhs-branded-a-wonder-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-cyltezo-the-first-interchangeable-biosimilar-to-humira/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vertexs-type-1-diabetes-therapy-hits-the-mark-in-phase-i-ii-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-delays-decision-on-modernas-covid-19-vaccine-in-12-17-age-group-because-of-myocarditis-concerns-wsj/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/despite-legal-troubles-johnson-johnson-is-in-the-financial-drivers-seat-for-2022-and-beyond-cfo-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/akero-therapeutics-receives-fda-fast-track-designation-for-efruxifermin-efx-for-the-treatment-of-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nih-reports-interferon-is-ineffective-in-hospitalised-covid-19-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-expected-to-approve-jj-moderna-covid-booster-shots-mix-and-match-doses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approved-drug-encourages-sensory-neurons-to-regrow-after-injury/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-oks-roche-s-tecentriq-for-some-nsclc-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sio-gene-therapies-announces-granting-of-fda-fast-track-designation-for-investigational-axo-aav-gm1-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-fda-authorizes-moderna-and-j-j-covid-vaccine-boosters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/omeros-gets-fda-complete-response-letter-over-narsoplimab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-pfizer-vaccine-for-emergency-use-in-children-aged-5-to-11/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/takeda-to-acquire-gammadelta-therapeutics-to-accelerate-development-of-allogeneic-t-cell-therapies-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-nih-and-15-private-organizations-join-forces-to-increase-effective-gene-therapies-for-rare-disea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/az-to-transfer-certain-drug-rights-to-covis-pharma-for-270m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-genentech-s-susvimo-for-wet-amd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-search-for-people-who-never-get-covid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/deepmind-s-protein-folding-ai-has-solved-a-50-year-old-grand-challenge-of-biology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-sees-up-to-7-billion-in-sales-of-covid-19-drug-through-end-of-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-s-covid-19-pill-treatment-reduces-risk-of-being-hospitalized-or-dying-by-89-company-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/opiant-receives-fda-fast-track-designation-for-opnt003-nasal-nalmefene-for-treatment-of-opioid-overd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/who-authorisation-for-covaxin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/paxlovid-fda-approval-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-eprontia-topiramate-oral-solution-for-epilepsy-and-preventive-treatment-of-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ec-approves-valneva-covid-19-vaccine-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/organon-to-acquire-forendo-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ema-flags-johnson-johnson-covid-vaccine-for-rare-disorder-passes-mrna-shots-for-one-side-effect-but-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/acrivon-therapeutics-secures-100m-to-give-eli-lilly-cancer-drug-another-try/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/world-diabetes-day-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eu-regulator-backs-covid-19-drugs-from-regeneron-roche-celltrion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-ceo-calls-those-spreading-vaccine-misinformation-criminals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-treatment-for-rare-blood-disease-treatment-is-first-fda-approved-option-patients-can-ta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-accepts-investigational-new-drug-application-and-grants-fast-track-designation-of-trehalose-for-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-recommends-cenobamate-for-treatment-of-adult-epilepsy-patients-in-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/rice-lab-first-to-mimic-molecule-found-in-poppies-undergraduate-leads-synthesis-of-scarce-extract-po/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-asks-fda-to-clear-covid-pill-for-high-risk-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cellectar-s-iopofosine-i-131-exhibits-signals-of-efficacy-in-phase-i-study-for-pediatric-brain-and-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/blood-biomarker-identified-that-predicts-type-2-diabetes-many-years-before-diagnosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/lokelma-granted-fast-track-designation-in-the-us-to-reduce-cardiovascular-outcomes-in-patients-on-ch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/moderna-seeks-fda-approval-to-authorize-booster-shots-for-all-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-us-ink-5-29b-deal-for-possible-covid-19-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/bridgebio-pharma-nabs-750m-in-non-dilutive-debt-financing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novo-nordisk-to-buy-rnai-therapy-developer-dicerna-for-3-3-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-pembrolizumab-for-adjuvant-treatment-of-renal-cell-carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/reata-pharmaceuticals-receives-fast-track-designation-from-the-fda-for-omaveloxolone-for-the-treatme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mhra-authorises-vumerity-for-multiple-sclerosis-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/scientists-say-plant-derived-drug-is-effective-in-blocking-sars-cov-2-delta-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/the-data-point-america-s-covid-19-immunity-is-waning/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-recommends-inrebic-for-rare-blood-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gilead-exercises-option-for-three-programmes-of-arcus-biosciences/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/neurocrine-pens-2-6b-biobucks-pact-with-sosei-heptares-for-next-gen-neuro-targets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/it-s-a-wrap-merck-collects-enough-acceleron-shares-for-11-5b-buyout-despite-activist-investor-defian/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/isofol-medical-ab-publ-receives-fda-fast-track-designation-for-arfolitixorin-in-advanced-colorectal-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-treatment-for-common-type-of-post-transplant-infection-that-is-resistant-to-other/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/seqirus-announces-u-s-fda-approval-for-multi-dose-vial-presentation-of-first-ever-adjuvanted-cell-ba/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/johnson-johnson-covid-19-vaccine-fully-approved-by-health-canada-to-prevent-covid-19-in-individuals-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/aadi-clinches-first-fda-nod-for-ultrarare-sarcoma-drug-fyarro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/takeda-s-post-transplant-cmv-drug-livtencity-shouldering-800m-in-sales-expectations-scores-fda-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-fast-track-status-to-arfolitixorin-for-metastatic-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-sues-departing-employee-it-says-stole-covid-19-vaccine-secrets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-fast-track-designation-to-novel-i-o-agent-for-advanced-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/covid-omicron-no-need-to-panic-south-africa-minister-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-stock-jumps-on-plan-to-boost-covid-pill-production-in-fight-against-omicron-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/tracon-pharmaceuticals-notes-partners-receipt-of-approval-of-envafolimab-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/alembic-pharmaceuticals-generic-formoterol-fumarate-inhalation-solution-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/krystal-biotech-touts-positive-results-for-gene-therapy-treating-tissue-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/hepion-pharmaceuticals-receives-fda-fast-track-designation-for-crv431-for-the-treatment-of-nash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-grants-bionomics-fast-track-designation-to-bnc210-for-the-acute-treatment-of-social-anxiety-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/first-trial-of-a-vaccine-against-alzheimer-s-launches/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/us-regulators-set-to-approve-oral-antiviral-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-to-acquire-origimm-biotechnology-in-first-move-to-treat-acne-with-vaccine-based-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-approves-cytalux-injection-for-identifying-ovarian-cancer-during-surgery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/premas-biotech-and-oravax-to-test-their-vaccine-candidate-against-omicron/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gsk-says-antibody-drug-sotrovimab-works-against-omicron-mutations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/phase-iii-trial-with-nubeqa-darolutamide-in-combination-with-docetaxel-and-androgen-deprivation-ther/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/court-rejects-moderna-s-challenge-to-arbutus-biopharma-patents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/nice-endorses-astrazeneca-s-tagrisso-for-nsclc-patients-with-specific-mutation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/abbvie-s-rinvoq-pfizer-s-xeljanz-and-lilly-s-olumiant-slapped-with-new-fda-warnings-amid-jak-safety-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-under-renewed-fire-over-dubious-approval-of-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/keytruda-gains-eighth-fda-approval-this-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biohaven-to-seek-fda-approval-for-second-migraine-drug-after-study-success/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approval-sought-for-poziotinib-in-her2-exon-20-mutated-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/uk-study-shows-mixing-pfizer-and-astrazeneca-covid-19-vaccines-with-moderna-elicits-better-immune-re/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/dendreon-ups-its-provenge-marketing-game-with-help-from-nba-all-star-grant-hill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-authorizes-new-long-acting-monoclonal-antibodies-for-pre-exposure-prevention-of-covid-19-in-cert/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-s-hilleman-laboratories-tees-up-58m-investment-at-new-singapore-vaccine-hub/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/transthyretin-amyloidosis-ionis-and-astrazeneca-team-up-on-antisense-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/heron-therapeutics-announces-fda-approval-of-a-significant-indication-expansion-for-zynrelef/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/crispr-cas9-gene-editing-boosts-effectiveness-of-ultrasound-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-advisers-unanimously-agree-reata-s-kidney-drug-is-not-effective-at-slowing-disease-progression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-augments-inflammation-and-immunology-business-with-6-7-billion-buy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-lifts-trial-hold-on-aprea-s-nonhodgkin-s-lymphoma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eli-lilly-focuses-on-obesity-and-diabetes-with-1-5-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/gbs-inc-announces-application-for-fda-breakthrough-device-designation-to-fast-track-rapid-saliva-glu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pfizer-says-its-covid-pill-near-90-effective-in-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/denovo-biopharma-llc-announces-partner-aytu-biopharma-receives-fda-clearance-and-orphan-drug-designa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sapience-therapeutics-receives-fda-fast-track-designation-for-st101-for-advanced-cutaneous-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/mount-sinai-researchers-present-encouraging-clinical-trial-results-on-novel-therapy-for-bone-marrow-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/needle-free-covid-19-vaccine-trialled-in-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-fda-approves-pfizer-s-xeljanz-tofacitinib-for-the-treatment-of-active-ankylosing-spondylitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novartis-receives-fda-fast-track-designation-for-branaplam-lmi070-for-the-treatment-of-huntington-s-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/rinvoq-upadacitinib-receives-u-s-fda-approval-for-active-psoriatic-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-tarpeyo-budesonide-to-reduce-proteinuria-in-iga-nephropathy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/veru-announces-fda-approval-of-entadfi-a-new-treatment-for-benign-prostatic-hyperplasia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/xalud-therapeutics-receives-fda-fast-track-designation-for-xt-150-for-the-treatment-of-pain-associat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novavax-s-covid-vaccine-becomes-the-fifth-jab-to-be-approved-for-use-in-the-eu-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-s-alzheimer-s-drug-aduhelm-is-rejected-by-eu-advisors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/relief-for-az-amgen-as-fda-okays-severe-asthma-hope-tezepelumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/biogen-cuts-the-price-tag-on-its-alzheimer-s-drug-in-half/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/omicron-sweeps-across-nation-now-73-of-new-us-covid-cases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approves-first-injectable-treatment-for-hiv-pre-exposure-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/vivoryon-therapeutics-receives-fda-fast-track-designation-for-varoglutamstat-in-early-alzheimer-s-di/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/sanofi-to-buy-cancer-immunotherapy-biotech-for-1b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cytodyn-receives-positive-response-from-fda-in-regard-to-its-phase-3-registrational-trial-in-covid-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/ketamine-therapy-swiftly-reduces-depression-and-suicidal-thoughts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/eight-substances-added-to-15th-report-on-carcinogens/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-authorizes-first-oral-antiviral-for-treatment-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-authorizes-additional-oral-antiviral-for-treatment-of-covid-19-in-certain-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/u-s-army-reports-progress-on-covid-vaccine-that-fights-all-variants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/2022-forecast-biopharma-s-covid-response-next-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-fast-track-designation-to-eisai-biogen-s-alzheimer-s-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/novavax-say-their-vaccines-are-effective-against-omicron/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/faraday-pharmaceuticals-announces-publication-of-results-from-its-phase-2-study-of-fdy-5301-for-the-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/researchers-discover-antibodies-that-neutralize-omicron-and-other-sars-cov-2-variants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/merck-ridgeback-s-molnupiravir-receives-special-emergency-approval-in-japan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/doesn-t-an-excessive-intake-of-simple-sugar-affect-higher-brain-function/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-grants-fast-track-designation-to-cynk-001-for-aml-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/phase-2-study-of-selinexor-for-myelofibrosis-progresses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/fda-approved-vuity-eyedrops-could-replace-your-reading-glasses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/do-not-resuscitate-scientists-detect-brain-tsunamis-in-human-beings/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/pennsylvania-generics-facility-receives-483-for-quality-failures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2021/cell-and-gene-therapies-saw-banner-year-with-new-indications-on-the-horizon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/samsung-in-talks-to-buy-biogen-for-42bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/omicron-hospitalization-risk-lower-than-delta-vaccines-provide-good-protection-u-k-study-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/is-energy-the-key-to-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bridgebio-s-cardiomyopathy-drug-candidate-falters-in-phase-3-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/viona-recalls-33-lots-of-diabetes-drug-due-to-possible-nmda-contamination/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/leo-pharma-s-eczema-drug-wins-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-reports-record-1-million-coronavirus-cases-in-a-single-day/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-status-to-genprex-s-drug-for-nsclc-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-eua-of-pfizer-biontech-s-covid-19-booster-shot-to-adolescents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-blood-test-can-identify-presence-of-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-two-pediatric-indications-for-j-j-s-xarelto/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-iliad-biotechnologies-fast-track-designation-for-next-generation-pertussis-vaccine-bpze1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mystery-brain-illness-baffles-canadian-doctors-as-cases-continue-to-spread-among-young-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/idorsia-s-insomnia-drug-gets-u-s-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cour-pharmaceuticals-receives-fda-fast-track-designation-for-cnp-104-for-the-treatment-of-primary-bi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/france-to-see-record-of-more-than-350-000-new-covid-infections-tuesday-minister/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/amgen-nabs-eu-approval-for-lumykras-for-treating-kras-mutated-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/future-of-biogen-s-aduhelm-hinges-on-u-s-medicare-alzheimer-s-coverage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/free-ai-protein-software-packages-nearly-predicted-structure-of-the-omicron-coronavirus-variant-corr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/in-1st-us-surgeons-transplant-pig-heart-into-human-patient/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/generic-version-of-sanofi-aventis-multaq-gets-tentative-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/top-five-fda-dermatology-approval-stories-of-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/adamis-seeks-fda-fast-track-designation-for-tempol-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cannabinoids-may-prevent-infection-with-sars-cov-2-including-variants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/herpes-virus-likely-main-cause-of-multiple-sclerosis-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fastest-dna-sequencing-technique-helps-undiagnosed-patients-find-answers-in-mere-hours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/marksans-pharma-wins-fda-approval-for-zyrtec-copycat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/india-s-gennova-working-on-omicron-specific-covid-19-vaccine-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/dementia-popular-sandwich-could-increase-the-risk-of-brain-disease-by-44-percent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/green-valley-obtains-ind-approval-from-u-s-fda-for-sodium-oligomannate-s-global-phase-ii-clinical-tr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/takeda-s-and-denali-s-alzheimer-s-drug-hit-with-clinical-hold/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ema-launches-review-of-liver-disease-drugs-containing-terlipressin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sarepta-lysogene-end-gene-therapy-pact-for-rare-inherited-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/celcuity-shares-rise-6-after-fast-track-designation-for-gedatolisib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/antares-pharma-receives-fda-fast-track-designation-for-atrs-1902-for-adrenal-crisis-rescue/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-cynk-101-for-her2-gastric-gej-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/evotec-and-lilly-enter-into-drug-discovery-collaboration-in-metabolic-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biotech-billionaire-launches-large-vaccine-manufacturing-plant-in-south-africa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/prospective-of-graphene-and-graphene-based-derivatives-to-combat-sars-cov-2-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mpp-inks-deals-with-27-generics-makers-to-produce-merck-s-covid-19-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/santa-cruz-company-gets-on-fda-fast-track-for-pathogen-sequencing-method-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/elon-musk-s-neuralink-is-hiring-a-clinical-trial-director/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-status-for-new-alzheimer-s-drug-lecanemab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ucb-wins-permit-to-market-psoriasis-drug-in-japan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-fda-expands-its-approval-of-remdesivir-to-patients-who-are-not-hospitalized/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-s-skyrizi-wins-fda-approval-for-psoriatic-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/innovative-phase-2-trial-targets-advanced-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/seagen-canada-announces-availability-of-padcev-to-treat-advanced-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/j-j-forecasts-sales-of-3-5-billion-for-its-covid-19-jab-in-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-revokes-euas-for-two-monoclonal-antibodies-shown-to-be-ineffective-against-omicron/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/big-insulin-makers-spent-big-money-on-lobbying-in-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/moderna-starts-clinical-trial-of-booster-shot-targeting-omicron-covid-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/omicron-relief-pfizer-and-biontech-initiate-study-into-targeted-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-fda-declines-to-approve-merck-s-cough-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/iavi-and-moderna-launch-trial-of-hiv-vaccine-antigens-delivered-through-mrna-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/samsung-shells-out-2-3-billion-for-biogen-stake-in-biosimilar-joint-venture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/senhwa-s-pidnarulex-receives-us-fda-fast-track-designation-for-the-treatment-of-solid-tumors-with-br/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/glenmark-pharma-arm-gets-final-usfda-approval-for-blood-pressure-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-pfizer-s-lorviqua-for-treating-alk-positive-advanced-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/china-nmpa-accepts-beigene-s-snda-for-brukinsa-to-treat-cll-and-grants-breakthrough-therapy-designat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-and-ionis-end-vupanorsen-program-for-heart-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lilly-to-build-1bn-manufacturing-plant-in-concord-north-carolina/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/oxford-biomedica-homology-medicines-to-create-aav-manufacturing-jv-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/immunitybio-announces-positive-study-results-for-kick-and-kill-hiv-cure-strategy-to-reduce-hiv-viral/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-glenmark-pharmaceuticals-generic-metronidazole-gel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-pill-that-releases-rna-in-the-stomach-could-offer-a-new-way-to-administer-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-generic-of-restasis-for-dry-eye-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-develop-new-approach-to-discover-pervasive-forever-chemicals-known-as-pfas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/timber-pharmaceuticals-announces-successful-end-of-phase-2-meeting-with-fda-for-tmb-001-in-moderate-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-places-partial-clinical-hold-on-umbralisib-and-ublituximab-trials-in-cll-and-nhl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-to-get-1-25-bln-to-settle-hiv-drug-patent-row-with-gilead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/navitor-pharmaceuticals-announces-janssen-has-acquired-anakuria-therapeutics-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-delays-application-for-experimental-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bayer-will-discontinue-phase-ii-development-candidate-eliapixant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/covid-medications-help-big-pharma-groups-beat-expectations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/wistar-scientists-move-hiv-vaccine-research-forward-by-developing-an-immunogen-that-produces-tier-2-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/valneva-pfizer-lyme-disease-vaccine-candidate-to-enter-phase-3-testing-following-positive-immune-sho/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/drug-halts-immune-reactions-to-save-damaged-lungs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/texas-225-million-opioid-settlement-is-biggest-to-date-for-generic-drugmaker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/receives-orphan-drug-designation-for-retinoblastoma-from-the-u-s-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-may-halt-approval-on-cancer-drugs-developed-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lupin-s-generic-bronchoconstriction-medicine-gains-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/anti-microbial-nasal-spray-effective-against-covid-19-in-nonhospitalized-patients-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/qurient-announces-u-s-fda-clearance-of-ind-application-for-q901-a-novel-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-antiviral-drug-combination-is-highly-effective-against-sars-cov-2-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bayer-receives-u-s-fda-fast-track-designation-for-asundexian-stroke-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novo-nordisk-gets-nice-okay-for-obesity-drug-wegovy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rsv-vaccine-candidate-granted-fast-track-status-for-seniors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-azurity-pharmaceuticals-fleqsuvy-for-treating-spasticity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-authorizes-new-monoclonal-antibody-for-treatment-of-covid-19-that-retains-activity-against-omicr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-find-trove-of-proteins-that-may-influence-cystic-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/drugs-have-dangerously-polluted-the-world-s-rivers-scientists-warn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/roche-lilly-push-back-against-cms-painting-their-alzheimer-s-meds-with-the-same-brush-as-biogen-s-ad/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-biohaven-tout-positive-phase-3-results-for-migraine-drug-study-in-asia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sensonics-wins-fda-approval-for-eversense-e3-cgm-with-implantable-sensor-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/us-fda-grants-fast-track-status-to-axcella-s-axa1125-for-nash-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-limits-its-340b-drug-discount-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ema-follows-fda-in-reviewing-safety-of-jak-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/califf-wins-narrow-senate-vote-for-second-turn-as-fda-commissioner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-astrazeneca-s-lupus-drug-saphnelo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-halts-legend-biotech-s-car-t-cell-therapy-trial-after-just-one-patient-is-dosed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/moderna-s-commercial-network-grows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/inside-the-tactical-tug-of-war-over-the-controversial-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-priority-review-to-bms-supplemental-bla-for-breyanzi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/teva-suffers-another-blow-in-skinny-labeling-case-against-gsk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/covid-19-pandemic-six-african-countries-to-receive-mrna-vaccine-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-global-view-on-fatty-liver-and-diabetes-helps-to-fight-other-non-communicable-diseases-and-covid-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/-chemdiv-s-triazoles-library-contains-4000-compounds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-treatment-for-anemia-in-adults-with-rare-inherited-disorderves-treatment-for-anemia-in-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/how-an-otc-cough-med-could-serve-as-a-steppingstone-for-creating-heart-rhythm-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-and-ridgeback-statement-on-clinical-trial-of-hetero-s-generic-molnupiravir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biomarin-says-gene-therapy-hold-will-endure-as-fda-questions-cancer-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sackler-family-owners-of-purdue-pharma-propose-up-to-6-billion-opioid-settlement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-immune-onc-s-io-202-fast-track-status-for-treating-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-in-close-race-with-pfizer-slams-brakes-on-phase-3-maternal-rsv-vaccine-program-over-safety-signa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/minimally-invasive-epilepsy-treatment-easee-receives-fda-breakthrough-device-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-bayer-s-kerendia-for-chronic-kidney-disease-associated-with-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/clinical-research-forum-names-top-10-research-efforts-of-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-launches-genetic-medicine-and-rna-focused-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/discovery-of-als-and-dementia-mechanism-points-to-new-treatment-strategy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/orpha-labs-ag-announces-the-initiation-of-a-phase-iii-trial-evaluating-orl-101-for-treatment-of-leuk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sanofi-gsk-post-58-efficacy-in-omicron-affected-covid-19-vaccine-trial-teeing-up-race-to-regulators/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-names-consumer-health-venture-haleon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-breakthrough-therapy-designation-for-ipf-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/repurposing-fda-approved-drugs-may-help-combat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/scientists-discover-new-approach-to-fighting-antibiotic-resistance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/contract-research-organization-draws-fda-warning-letter-for-glp-violations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/health-canada-approves-plant-based-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-boehringer-ingelheim-s-jardiance-clinches-heart-failure-edge-with-fda-nod-for-wider-label/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/viatris-unloads-biosimilar-business-to-partner-biocon-for-3-3b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-orphan-drug-designation-to-ct103a-for-relapsed-refractory-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/melbourne-scientists-snare-killer-molecule/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-seeks-new-indication-for-imbruvica-in-pediatric-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/deep-learning-technique-predicts-clinical-treatment-outcomes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biohaven-gains-experimental-drugs-from-two-new-pacts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-vaccine-much-less-potent-in-kids-aged-5-11/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-tells-karyopharm-to-conduct-another-trial-on-endometrial-cancer-drug-xpovio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-gets-fda-breakthrough-therapy-designation-for-maternal-rsv-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sanofi-picks-a-safe-bet-for-adagene-s-antibody-tech-in-2-5b-biobucks-tie-up/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-role-of-lipids-in-the-development-of-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cti-biopharma-granted-fda-accelerated-approval-of-vonjo-pacritinib-for-the-treatment-of-myelofibrosi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/johnson-johnson-vision-care-receives-fda-approval-for-acuvue-theravision-with-ketotifen-world-s-firs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-amgen-s-sotorasib-for-nonsmall-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-orphan-drug-designation-to-mocravimod-for-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ocugen-fails-to-get-eua-for-covid-19-vaccine-in-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/dna-test-revolutionises-disease-diagnosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gilead-draws-harsh-reviews-as-phiii-for-21b-immunomedics-drug-underwhelms-wall-street/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-oks-molnupiravir-as-treatment-for-covid-19-after-new-data-from-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/this-app-can-diagnose-rare-diseases-from-a-child-s-face/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-resolves-humira-adalimumab-u-s-litigation-with-alvotech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/covid-19-can-cause-brain-shrinkage-memory-loss-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-into-prophylaxis-treatment-meets-key-endpoints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-u-s-is-about-to-approve-a-fourth-covid-vaccine-that-could-be-a-silver-bullet-solution-to-the-ant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lonza-completes-lab-expansion-at-chinese-api-production-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bms-obtains-fda-approval-for-opdivo-combo-for-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ec-approves-boehringer-lilly-s-jardiance-for-chronic-heart-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/deltacron-with-genes-of-delta-and-omicron-found/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-begins-phase-2-3-pediatric-paxlovid-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-and-richter-partner-to-develop-neuropsychiatric-diseases-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abivax-reports-promising-rheumatoid-arthritis-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-re-engineer-red-blood-cells-to-trigger-immune-system-against-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/oral-paratyphoid-vaccine-to-begin-human-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/scientists-identify-possible-new-treatment-for-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-olaparib-for-adjuvant-treatment-of-high-risk-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-concludes-arena-pharmaceuticals-acquisition-for-6-7bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-donor-derived-car-t-for-advanced-kidney-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-declines-approval-for-astrazeneca-s-chronic-rhinosinusitis-antibody/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/is-it-pre-alzheimer-s-or-normal-aging-poll-finds-many-americans-unclear/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ready-set-go-scientists-discover-a-brain-circuit-that-triggers-the-execution-of-planned-movement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/are-statin-side-effects-all-in-the-mind-international-experts-recommend-ways-to-improve-adherence-to/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nektar-shares-halve-on-cancer-trial-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-generic-of-symbicort-to-treat-asthma-and-copd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/exelixis-shuts-down-snda-plans-for-cabometyx-following-negative-phase-3-study-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/allarity-therapeutics-requests-type-c-meeting-with-fda-to-discuss-dovitinib-in-third-line-rcc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/roche-posts-positive-results-for-evrysdi-in-type-2-and-3-spinal-muscular-atrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rinvoq-upadacitinib-receives-fda-approval-for-the-treatment-of-adults-with-moderately-to-severely-ac/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/medicines-patent-pool-inks-deal-with-35-companies-for-generic-paxlovid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-kgaa-to-pay-over-3-million-to-patients-after-thyroid-drug-formulation-change/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/brazil-study-finds-ivermectin-did-not-reduce-hospital-admissions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nhs-fast-tracks-new-targeted-drug-for-rare-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/marinus-pharmaceuticals-announces-fda-approval-of-ztalmy-for-cdkl5-deficiency-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-opdualag-for-unresectable-or-metastatic-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-elosulfase-alfa-for-morquio-a-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/covid-19-vaccine-manufacturers-submit-appeals-to-fda-for-fourth-dose/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nature-paper-bioage-s-oral-drug-targeting-the-aging-immune-system-prevents-death-from-covid-19-in-ag/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-eisai-unveil-new-data-on-lecanemab-but-questions-linger-on-aria-e/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fujifilm-expands-c-g-therapy-options-with-acquisition-of-recombinant-protein-maker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-recalls-blood-pressure-drug-lots-and-affiliated-generics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/roquette-invests-25-million-for-polyols-at-its-site-in-lestrem-france/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/huma-and-astrazeneca-collaborate-to-advance-digital-innovation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novartis-radiotherapy-pluvicto-nabs-fda-approval-for-prostate-cancer-with-2b-plus-peak-sales-expecta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/an-aurobindo-plant-that-received-a-scathing-fda-rebuke-several-years-back-is-shutting-its-doors-for-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/teva-pharmaceuticals-axes-phase-2-asthma-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/widely-used-nausea-drugs-linked-to-heightened-risk-of-stroke/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/artificial-intelligence-and-robotics-uncover-hidden-signatures-of-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/jazz-pharmaceuticals-reveals-new-manufacturing-facility-for-cannabis-based-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/octopus-like-tentacles-help-cancer-cells-invade-the-body-new-knowledge-about-a-fundamental-mechanism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/male-contraceptive-pill-found-99-effective-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/moderna-projects-21-billion-annual-revenue-for-its-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-delays-sbla-decision-date-on-bristol-myers-squibb-anemia-drug-reblozyl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-approval-for-ucb-s-fintepla-in-lennox-gastaut-syndrome-associated-seizures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/stealth-omicron-ba-2-is-now-globally-dominant-covid-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/alzheimer-s-leads-to-changes-in-the-small-blood-vessels-in-the-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/axsome-therapeutics-to-acquire-jazz-pharmaceuticals-sleep-combating-drug-sunosi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-higher-dose-of-novo-nordisk-s-type-2-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/telix-s-tlx66-gets-orphan-drug-designation-for-hsct-patientstelix-s-tlx66-gets-orphan-drug-designati/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-requests-nearly-34-increase-in-funding-as-part-of-the-president-s-fiscal-year-2023-budget/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-redefine-the-mechanisms-of-dravet-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-priority-review-to-futibatinib-for-metastatic-cholangiocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/baricitinib-produces-significant-hair-regrowth-in-adults-with-severe-alopecia-areata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/genentech-phase-3-study-of-immunotherapy-in-es-sclc-fails-to-meet-co-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vuity-from-allergan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-asc-therapeutics-gene-therapy-for-hemophilia-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-triumeq-pd-for-children-with-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/reversing-hearing-loss-with-regenerative-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-oral-testosterone-replacement-therapy-for-hypogonadism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-s-covid-19-drug-lagevrio-shows-promise-in-phase-3-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-evenity-for-patients-with-severe-osteoporosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-delays-decision-on-merck-s-pediatric-pneumococcal-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-recalls-blood-pressure-drug-accuretic-in-uk-due-to-nitrosamine-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-million-times-faster-dna-nanotechnology-could-speed-up-pharmaceutical-development-while-minimizing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-harness-probiotics-to-deliver-parkinson-s-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-puts-emavusertib-clinical-trial-for-r-r-aml-and-mds-on-partial-hold/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-immunocore-s-kimmtrak-for-patients-with-unresectable-metastatic-uveal-melanoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/how-did-merck-record-an-11-tax-rate-last-year-the-senate-finance-chairman-would-like-to-know/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/alnylam-s-onpattro-follow-on-delayed-thanks-to-manufacturing-holdup-at-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/african-clinical-trial-denied-access-to-key-covid-drug-paxlovid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/theravance-s-investigational-drug-ampreloxetine-fails-second-phase-3-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/china-kintor-s-covid-drug-candidate-cuts-hospital-death-risk-in-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-s-azd8233-shows-positive-results-for-hypercholesterolemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bioxcel-s-schizophrenia-and-bipolar-associated-agitation-drug-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-hyftor-sirolimus-topical-gel-for-facial-angiofibroma-associated-with-tuberous-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novartis-manufacturing-facility-approved-for-zolgensma-production/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/medicare-will-only-cover-aduhelm-for-alzheimer-s-patients-in-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bayer-to-inject-more-than-2-billion-into-upgrading-manufacturing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/treating-diabetes-without-drugs-novel-non-pharmacologic-treatments-on-the-horizon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novel-drug-from-neuro-bio-effective-in-a-mouse-model-of-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-asc618-for-hemophilia-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-updates-eua-for-j-j-covid-19-vaccine-to-extend-shelf-life/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-s-pfizer-s-covid-pill-paxlovid-gets-boost-in-britain-thanks-to-spot-in-national-trialcovid-pi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novartis-global-revamp-to-cost-thousands-of-jobs-for-simpler-structures-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/redhill-touts-potential-of-its-investigational-cancer-drug-against-omicron-subvariants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/research-reveals-a-protein-that-regulates-body-weight/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-new-experimental-tool-reveals-how-immune-cells-find-their-targets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bristol-myers-squibb-publishes-promising-phase-3-data-on-new-opdivo-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/halozyme-therapeutics-to-acquire-antares-pharma-for-nearly-1-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/shionogi-s-investigational-covid-19-drug-linked-to-fetal-abnormalities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-biogen-s-multiple-sclerosis-drug-vumerity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-fda-delays-decision-on-regeneron-roche-covid-antibody-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vitamin-e-can-boost-immunotherapy-responses-by-reinvigorating-dendritic-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/briacell-receives-fda-fast-track-approval-for-targeted-breast-cancer-immunotherapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-announces-u-s-fda-has-granted-breakthrough-therapy-designation-for-v116-the-company-s-investig/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-alymsys-bevacizumab-maly-a-biosimilar-to-avastin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/house-committee-targets-mckinsey-for-dealings-with-drugmakers-and-the-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-merck-serono-s-nsclc-drug-tepmetko/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cassava-faces-renewed-speculation-over-experimental-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/two-strains-of-tb-bacterium-attack-the-lungs-in-completely-different-fashion-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/tg-therapeutics-pulls-bla-snda-for-u2-in-cll-and-sll-and-sale-of-ukoniq/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bioxcel-ascends-on-260-mln-strategic-funding-pact-creation-of-onkosxcel-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-amneal-s-avastin-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/european-commission-gives-nod-to-astellas-and-seagen-s-padcev-for-urothelial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/investigators-release-results-of-4-trials-of-immunotherapy-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-pulls-plug-on-parkinson-s-partnership-with-bioarctic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-adi-001-in-relapsed-refractory-non-hodgkin-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/enzyvant-to-build-regenerative-medicine-manufacturing-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/axsome-agrees-to-post-marketing-commitments-with-fda-signaling-potential-ok-for-long-delayed-depress/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/zambon-receives-u-s-fda-breakthrough-therapy-designation-for-cms-i-neb-in-patients-with-non-cystic-f/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/arcturus-covid-19-vaccine-phase-3-study-shows-promising-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-reveals-inappropriate-antibiotic-prescription-practices/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/landmark-dna-study-finds-58-new-mutations-that-cause-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-cmg901-for-gastrointestinal-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/catalent-snaps-up-nj-cell-therapy-plant-for-44-5m-days-after-revealing-big-biologics-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vitamin-d-omega-3-exercise-can-reduce-cancer-risk-by-61-studyvitamin-d-omega-3-exercise-can-reduce-c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astellas-drops-duchenne-muscular-dystrophy-gene-therapies-and-other-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/leo-janssen-teva-lundbeck-otsuka-europe-daiichi-sankyo-and-roche-named-in-advertisements-for-breache/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-priority-review-to-astrazeneca-s-adjunct-hcc-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ema-has-more-questions-about-valneva-s-inactive-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-recalls-blood-pressure-and-heart-failure-drug-accupril-due-to-nitrosamine-content/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-reveals-pharmaceutical-companies-reputations-improved-due-to-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nektar-cuts-70-of-workforce-on-heels-of-bms-partnered-collapse/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-suggests-late-stage-asset-could-delay-progression-of-alzheimer-s-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vigeneron-and-daiichi-sankyo-to-develop-therapy-for-eye-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-and-biohaven-get-eu-nod-for-vydura-migraine-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-s-and-daiichi-sankyo-s-enhertu-gains-another-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/many-dietary-supplements-are-tainted-with-hidden-pharmaceuticals-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-for-sqz-s-solid-tumour-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lianbio-licensed-camzyos-gets-fda-approval-for-treatment-of-hypertrophic-cardiomyopathy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-kapruvia-for-ckd-associated-pruritus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-mycovia-pharmaceuticals-vivjoa-oteseconazole-the-first-and-only-fda-approved-medication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-epsolay-cream-for-rosacea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/aviadobio-gene-therapy-drug-avb-101-gets-orphan-drug-tags-in-u-s-and-eu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-closes-busy-week-with-11b-in-revenue-new-r-d-site/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lilly-s-tirzepatide-delivered-up-to-22-5-weight-loss-in-adults-with-obesity-or-overweight-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/supernus-announces-fda-approval-of-qelbree-for-the-treatment-of-adhd-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/orphalan-pushes-first-drug-for-wilson-s-disease-in-5-decades-over-fda-finish-line/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-s-covid-19-drug-paxlovid-fails-in-postexposure-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/it-s-crl-day-at-the-fda-as-axsome-junshi-and-coherus-get-bad-news/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-touts-another-fda-approval-for-rinvoq-posts-strong-first-quarter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/teva-settles-with-lupin-over-austedo-patent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/european-commission-greenlights-idorsia-s-insomnia-drug-quviviq/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/phathom-wins-approvals-against-antibiotic-resistance-in-h-pylori/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-accepts-bayer-s-application-to-expand-nubeqa-into-new-prostate-cancer-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/washington-state-settles-with-three-drug-distributors-for-518-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/anticipating-fda-rejection-spero-cuts-75-of-workforce/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-sends-ceo-to-the-exit-abandons-aduhelm-sales-team-in-1b-overhaul/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cordenpharma-part-of-germany-s-mrna-contingency-plan-sold-to-private-equity-outfit-astorg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/virus-found-in-pig-heart-used-in-human-transplant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/quantum-mechanics-could-explain-why-dna-can-spontaneously-mutate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-recommends-veklury-for-high-risk-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-discovery-to-improve-malaria-elimination-strategies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-delays-snda-decision-for-pfizer-myovant-endometriosis-pain-drug-myfembree/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-lifts-clinical-hold-on-logicbio-s-pediatric-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/french-regulatory-agency-to-file-criminal-charges-against-didier-raoult-led-institute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-drops-a-cool-11-6-billion-on-migraine-leader-biohaven/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-requests-more-data-on-clovis-oncology-s-rubraca-for-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/experimental-drug-shows-early-potential-to-treat-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/uk-study-shows-promising-data-for-fourth-covid-19-vaccine-shot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/university-of-aberdeen-study-finds-diabetes-almost-doubles-risk-of-covid-19-death/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/common-steroids-after-long-covid-recovery-may-cut-risk-of-death-by-up-to-51/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/stealth-biotherapeutics-receives-orphan-drug-designation-from-fda-for-elamipretide-for-treatment-of-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-delays-pdufa-date-for-amicus-at-gaa-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-data-reinforces-astrazeneca-and-sanofi-s-nirsevimab-as-effective-rsv-immunisation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-oral-form-for-the-treatment-of-adults-with-amyotrophic-lateral-sclerosis-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/polarityte-announces-fda-regenerative-medicine-advanced-therapy-designation-granted-to-skinte/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ucb-psoriasis-drug-will-need-to-wait-for-us-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/aurobindo-gets-hit-with-another-form-483/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lilly-s-new-drug-mounjaro-tirzepatide-wins-us-fda-approval-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-gedeon-richter-s-ryeqo-for-uterine-fibroids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/flu-causes-cardiac-complications-by-directly-infecting-the-heart/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fujirebio-s-diagnostic-test-for-beta-amyloid-plaques-given-fda-ok/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-authorizes-first-covid-19-test-available-without-a-prescription-that-also-detects-flu-and-rsv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-astrazeneca-s-imfinzi-for-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/otsuka-ends-partnership-with-akebia-over-crl-related-ckd-anemia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/evotec-sernova-striving-for-functional-diabetes-cure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mhra-approves-verzenios-for-certain-types-of-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-says-use-of-pfizer-s-covid-19-antiviral-up-315/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/drug-treatment-for-cataracts-moves-a-step-closer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-declines-to-grant-eua-for-antidepressant-to-treat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ultragenyx-gains-rights-to-abeona-therapeutics-gene-therapy-for-rare-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/zealand-pharma-announces-positive-results-from-phase-3-trial-of-dasiglucagon-in-pediatric-patients-w/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fighting-neurodegeneration-by-targeting-fossil-viruses-in-dna-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ascentage-s-drug-shows-potential-to-treat-covid-19-in-preclinical-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/uk-mhra-approves-roche-s-faricimab-for-wet-amd-and-dmo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-grants-eul-to-cansinobio-s-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-gains-license-option-to-cugene-s-autoimmune-and-inflammatory-disease-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-snaps-up-cancer-drug-from-china-s-kelun-in-1-4bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-files-continuous-parkinson-s-therapy-abbv-951-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/chmp-backs-sanofi-s-xenpozyme-as-first-drug-for-asmdphil-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bayer-bails-on-670m-car-t-partnership-with-atara/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/medicinal-cannabis-may-compensate-cancer-related-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/trial-on-vaccine-for-pancreatic-cancer-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/siga-receives-approval-from-the-fda-for-intravenous-iv-formulation-of-tpoxx-tecovirimat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-expected-to-pay-290-000-to-patients-in-four-states-in-settlement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/europe-pause-recommended-for-100-generics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/junshi-biosciences-oral-covid-drug-wraps-up-trials-to-seek-sales-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-and-lilly-zero-in-on-success-in-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bavarian-nordic-enters-first-larger-vaccine-contract-with-government-in-response-to-monkeypox-outbre/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-adds-to-vraylar-data-as-fda-considers-depression-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lilly-sets-aside-2-1bn-for-domestic-investments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-to-expand-its-largest-manufacturing-site-to-increase-paxlovid-supply/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/senate-passes-legislation-to-address-medication-accessibility-affordability/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ucla-researchers-identify-hiv-drug-that-could-combat-memory-loss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/united-therapeutics-tyvaso-dpi-approved-for-rare-high-blood-pressure-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-sanofi-and-regeneron-s-libtayo-for-cscc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-granted-fda-fast-track-designation-for-ervogastat-clesacostat-combination-for-the-treatment-o/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/servier-gets-expanded-fda-approval-of-tibsovo-for-idh1-mutated-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/hyundai-bioscience-to-seek-fast-track-processing-from-us-fda-for-oral-antiviral-medicine-cp-cov03-to/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nirogacestat-improves-progression-free-survival-in-adults-with-progressing-desmoid-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-mrna-covid-19-vaccines-perform-better-than-viral-vector-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/european-commission-conditionally-approves-janssen-and-legend-biotech-s-carvykti-for-multiple-myelom/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fdi-inflow-into-pharma-sector-declines-5-in-2021-22/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/us-fda-declines-to-approve-eton-pharma-s-anti-seizure-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/britain-s-gsk-to-buy-affinivax-for-up-to-3-3-billion-in-vaccines-push/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bms-preps-lupus-treatment-to-become-third-new-launch-of-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/with-600m-in-funding-ultima-is-removing-cost-barriers-to-genomic-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-to-sell-stake-in-haleon-following-gsk-de-merger/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-pulls-approval-for-tg-therapeutics-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-says-monkeypox-has-been-spreading-undetected-as-global-cases-rise-to-more-than-550/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astellas-subsidiary-xyphos-go-therapeutics-ink-research-and-license-agreement-to-develop-novel-antib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/chemical-inhibitor-blocks-final-path-to-cell-death-in-mice-with-parkinson-s-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-ucb-s-fintepla-for-dravet-syndrome-related-seizures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/us-fda-grants-fast-track-designation-to-midatech-pharma-s-mtx110-to-treat-recurrent-glioblastoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-mocravimod-with-hsct-for-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/roche-repare-ink-1-2b-deal-for-development-of-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bms-picks-up-high-potential-nsclc-drug-in-4-1b-turning-point-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-measles-vaccine-in-half-a-century/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-supports-paxlovid-s-efficacy-against-covid-19-and-omicron-variant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-withdraws-umbralisib-due-to-elevated-mortality-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/tau-targeting-treatment-slows-cognitive-functional-declines-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gut-bacterial-metabolite-promotes-neural-cell-death-leading-to-cognitive-decline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vbi-vaccines-gets-uk-mhra-approval-for-its-prehevbri-adult-hepatitis-b-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bluebird-bio-blazes-trail-for-lentiviral-vectors-at-upcoming-fda-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rapamycin-increases-alzheimer-s-associated-plaques-in-mice-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/common-drug-resistant-superbug-develops-fast-resistance-to-last-resort-antibiotic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/praxis-investigational-depression-drug-prax-114-fails-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nyc-cancer-trial-delivers-unheard-of-result-complete-remission-for-everyone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-bets-more-than-700m-on-alectos-preclinical-oral-parkinson-s-drug-to-shore-up-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/veru-submits-eua-for-treatment-of-covid-19-hospitalized-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mhra-gives-alnylam-innovation-passport-for-hypertension-drug-zilebesiran/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbott-makes-progress-with-wearable-for-diabetic-ketoacidosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/investigators-discover-a-double-life-for-a-key-parkinson-s-disease-protein/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-for-biocryst-s-alk-2-inhibitor-bcx9250/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-covid-cases-and-deaths-falling-nearly-everywhere/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ai-identifies-cancer-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-age-of-outbreaks-experts-warn-of-more-animal-disease-threats/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/barda-orders-500-000-more-smallpox-vaccine-doses-from-bavarian-nordic-against-monkeypox/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-vazkepa-and-evrenzo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/alembic-pharmaceuticals-receives-usfda-tentative-approval-for-dasatinib-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/plastic-pollution-in-ocean-may-harbor-novel-antibiotics-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/canada-approves-amylyx-s-als-drug-albrioza/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/dr-reddy-s-launch-generic-version-of-nexavar-sorafenib-tablets-200-mg-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lilly-s-olumiant-okayed-in-alopecia-with-pfizer-concert-in-hot-pursuit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nrx-pharma-fda-denies-breakthrough-therapy-designation-request-for-zyesami/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-alnylam-s-amvuttra-for-hattr-amyloidosis-polyneuropathy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/oxford-university-researchers-identify-gene-linked-to-chronic-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/in-tough-biotech-market-third-rock-raises-new-1-1b-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-new-oncology-therapies-faster-than-ema-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/kintara-therapeutics-gains-after-fda-fast-track-nod-for-brain-cancer-treatment-val-083/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-halts-als-asset-agreement-with-karyopharm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/another-amyloid-miss-in-alzheimer-s-as-roche-s-crenezumab-fails-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/j-j-seals-2-1bn-deal-on-sale-of-major-diabetes-devices-firm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/decentralised-trials-gaining-ground-in-oncology-says-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bavarian-nordic-takes-on-pfizer-biontech-with-covid-19-booster-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/addex-terminates-dipraglurant-phase-2b-3-study-in-patients-with-dyskinesia-associated-with-parkinson/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/acadia-s-alzheimer-s-drug-voted-down-by-fda-advisory-committee/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-s-skyrizi-becomes-first-fda-approved-il-23-inhibitor-for-crohn-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/hepion-pharmaceuticals-receives-fda-orphan-drug-status-designation-for-rencofilstat-for-the-treatmen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pharmacy-chain-walgreens-plans-to-disrupt-clinical-trial-sector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/anti-hunger-molecule-forms-after-exercise-scientists-discover/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/similarities-between-alzheimer-s-and-long-covid-found-in-new-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-eli-lilly-s-verzenios-for-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nuvectis-pharma-announces-fda-clearance-of-ind-for-nxp800/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/experimental-drug-developed-in-sweden-could-revolutionize-diabetes-treatment-for-four-million-briton/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/clovis-abandons-previous-fda-approval-of-rubraca-following-study-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/az-preps-fda-filing-for-3-6bn-amyloidosis-drug-eplontersen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/is-merck-planning-a-30bn-plus-move-for-seagen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/paratek-pharma-shares-rise-after-nuzyra-gets-fda-fast-track/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-fda-approves-merck-s-vaxneuvance-pneumococcal-15-valent-conjugate-vaccine-for-the-prevention-of-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-files-qulipta-for-chronic-migraine-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/enanta-lawsuit-claims-pfizer-s-paxlovid-infringes-its-patent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novartis-faces-threat-of-early-generic-of-ms-drug-gilenya-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/erectile-dysfunction-drugs-could-help-treat-oesophageal-cancer-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-rejects-fampyra-for-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/galapagos-acquires-cellpoint-and-aboundbio-for-over-250-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/world-health-organization-says-monkeypox-is-not-a-global-health-emergency-right-now/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/otsuka-lundbeck-tout-positive-phase-iii-results-for-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-find-oral-antiviral-drug-that-could-provide-an-effective-treatment-against-respiratory-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/us-fda-accepts-emergent-biosolutions-bla-for-av7909-anthrax-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/federal-judge-lets-stand-6-4-billion-suit-claiming-bms-stalled-new-car-t-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/most-women-unaware-of-alzheimer-s-risk-survey-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biomarin-gene-therapy-for-haemophilia-on-course-for-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-s-hepatitis-drug-candidate-shows-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ipsen-acquires-epizyme-in-initial-deal-worth-247-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gilead-tries-again-with-twice-yearly-hiv-drug-lenacapavir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cannabis-derived-ms-treatment-disappoints-in-phase-iii-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ocuphire-granted-new-u-s-patent-for-late-stage-oral-drug-candidate-apx3330-for-use-in-diabetics-and-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pollution-linked-to-10-of-cancers-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-asks-for-formal-u-s-approval-of-oral-covid-treatment-paxlovid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-sanofi-s-xenpozyme-and-nexviadyme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-rejection-of-spero-s-tebipenem-raises-resistance-threat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-pushes-back-review-period-for-provention-bio-s-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-government-inks-3-2-billion-contract-with-pfizer-biontech-for-vaccine-booster-campaign/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-declines-emergency-use-authorization-for-zyesami-aviptadil-for-subgroup-of-patients-with-critica/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/protecting-the-brain-from-dementia-inducing-abnormal-protein-aggregates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fast-and-facile-synthesis-of-antibacterial-amino-acid-schiff-base-copper-complexes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/dramatic-surprise-discovery-finds-cancer-drug-delays-muscular-dystrophy-progression-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/after-coeliac-fail-9-meters-plots-phase-3-in-short-bowel-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sirana-pharma-and-pfizer-to-work-on-treatment-for-brittle-bone-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-recommends-modified-covid-19-vaccine-boosters-adapted-to-omicron-ba-4-and-ba-5-subvariants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-bolsters-blood-cancer-pipeline-with-1-27b-teneotwo-takeover/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-accepts-aflibercept-sbla-for-treatment-of-diabetic-retinopathy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-halts-tests-of-sanofi-drug-acquired-in-3-7b-buyout-due-to-side-effects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-us-approved-the-ecstasy-test-for-ptsd-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eisai-biogen-could-get-fda-verdict-on-new-alzheimer-s-drug-by-6-jan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-priority-review-to-roche-s-lunsumio-for-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/analyst-value-of-accelerated-approvals-exceeds-minimal-medicaid-costs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-in-advanced-talks-for-40bn-seagen-bid-report/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-backs-pharmacist-prescribing-of-paxlovid-for-covid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/supergene-wreaks-havoc-in-a-genome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/adhd-drugs-could-help-treat-symptoms-of-alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/synthetic-peptide-acts-on-endocannabinoid-system-to-combat-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-lifts-clinical-hold-of-vertex-s-type-1-diabetes-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/2-common-psychiatric-drugs-may-slow-progression-of-alzheimer-s-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-belzupacap-sarotalocan-for-non-muscle-invasive-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-sbla-for-krystexxa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/doctors-using-ai-catch-breast-cancer-more-often-than-either-does-alone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-declines-nrx-s-eua-for-zyesami-a-second-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sobi-and-adc-therapeutics-ink-licensing-deal-worth-up-to-435-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-approval-to-pfizer-biontech-covid-19-vaccine-for-children-12-to-15-years-old/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/world-health-organization-warns-covid-19-is-running-freely-and-global-deaths-are-unacceptably-high/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/chemical-heals-wounds-twice-as-fast-could-be-antibiotic-alternative/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vertex-to-acquire-viacyte-for-320-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-cuts-alzheimer-s-alliance-with-alector-in-half/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/genetically-engineered-pig-hearts-transplanted-into-dead-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/horizon-s-krystexxa-approved-for-treating-uncontrolled-gout/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-designation-to-abelacimab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/twist-bioscience-launches-monkeypox-virus-synthetic-dna-controls/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bavarian-nordic-s-danish-manufacturing-plant-fda-inspected-for-jynneos-monkeypox-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/real-world-data-support-the-use-of-sobi-and-sanofi-s-elocta-for-hemophilia-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/alzheimer-s-research-moves-ahead-with-whole-blood-exchange-tau-revelations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-fast-tracks-investigational-drug-for-the-treatment-of-recurrent-brain-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-breakthrough-status-for-accucinch-ventricular-restoration-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/microparticles-could-be-used-to-deliver-self-boosting-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gr-nenthal-acquires-rights-to-nebido-from-bayer-for-up-to-503-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ema-accepts-byondis-application-of-trastuzumab-duocarmazine-for-her2-positive-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/high-flying-experiment-do-stem-cells-grow-better-in-space/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/polpharma-in-pole-position-for-biosimilar-tysabri-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/als-early-disease-mechanisms-discovered/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/azurity-gets-fda-nod-for-zonisade-in-patients-with-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-approval-of-incyte-s-opzelura-topical-drug-for-vitiligo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-qsymia-for-the-treatment-of-obesity-in-adolescents-ages-12-17/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/daewoong-pharmaceutical-gets-first-korean-us-fda-fast-track-for-new-idiopathic-pulmonary-fibrosis-dr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/japan-s-health-ministry-delays-emergency-approval-of-shionogi-s-covid-19-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vbl-therapeutics-investigational-drug-ofra-vec-fails-phase-3-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/freeline-s-one-dose-gene-therapy-could-transform-hemophilia-b-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/severe-acute-hepatitis-of-unknown-causes-in-children-is-on-the-rise-why/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-drug-regulator-recommends-clearing-vaccine-for-monkeypox/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-agrees-to-pay-900-million-in-settlement-over-multiple-sclerosis-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-more-concise-way-to-synthesize-tetrodotoxin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-rhythm-s-imcivree-for-obesity-and-hunger/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/takeda-s-hyqvia-shows-promise-for-cidp-in-phase-3-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-to-spend-470-million-in-expansion-of-vaccine-research-facilities/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/years-of-alzheimer-s-research-were-based-on-a-key-finding-now-an-investigation-alleges-it-was-faked-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-discover-gene-that-promotes-muscle-strength-during-exercise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-s-oncologic-drugs-advisory-committee-to-discuss-three-nda-cancer-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/as-omicron-mutates-researchers-compare-efficacy-of-therapeutic-antibodies-and-antivirals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/teva-proposes-5b-settlement-for-thousands-of-opioid-lawsuits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-and-biontech-push-hard-on-omicron-specific-vaccine-while-fending-off-lawsuits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gingko-bioworks-to-acquire-zymergen-in-deal-worth-300-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-gets-much-needed-pipeline-lift-with-speedy-als-drug-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/dupixent-drives-sanofi-to-hike-its-full-year-profit-forecasts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/opdualag-off-to-a-flying-start-says-bms-ceo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-s-benlysta-becomes-first-biologic-approved-for-lupus-nephritis-in-kids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/stem-cell-transplant-cures-oldest-hiv-patient/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/deepmind-s-alphafold-tool-has-determined-the-structures-of-around-200-million-proteins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-greenlights-jynneos-monkeypox-vaccine-for-additional-manufacturing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/growing-evidence-supports-the-link-between-air-pollution-and-dementia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-orphan-drug-designation-to-omeros-masp-3-inhibitor-oms906-for-treatment-of-paroxysmal-noc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sarepta-plans-on-submitting-bla-for-duchenne-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ipsen-invests-potential-1-6b-to-turbo-charge-marengo-s-path-to-the-clinic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/us-government-buys-66m-doses-of-moderna-s-omicron-booster/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-approval-of-janssen-s-stelara-for-pediatric-psoriatic-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vertex-s-vx-548-gets-breakthrough-therapy-designation-for-acute-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mbx-biosciences-hypoparathyroidism-drug-candidate-gains-orphan-drug-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-arcutis-zoryve-for-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/axcella-s-investigational-drug-shows-promise-in-long-covid-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/european-commission-orders-hipra-s-covid-19-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ipsen-s-onivyde-failed-to-meet-primary-endpoint-in-sclc-phase-3-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vivjoa-oteseconazole-to-treat-recurrent-vulvovaginal-candidiasis-usa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-issues-48-product-specific-guidances-for-generic-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vax-24-pneumococcal-vaccine-receives-fda-fast-track-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/anheart-therapeutics-receives-fda-breakthrough-therapy-designation-for-taletrectinib-in-ros1-positiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/civica-launches-its-first-lower-cost-generic-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-to-make-bebtelovimab-commercially-available/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-declines-travere-s-second-attempt-at-accelerated-approval-for-sparsentan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-considers-splitting-jynneos-vaccine-into-fifths-for-monkeypox/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/genentech-inks-licensing-deal-with-kiniksa-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/newly-discovered-chemical-reactions-may-explain-the-origin-of-life/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-approval-of-bayer-s-nubeqa-for-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/marius-receives-fda-approval-of-kyzatrex-for-hypogonadism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-lifts-clinical-hold-on-celyad-oncology-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-to-acquire-global-blood-therapeutics-for-5-4-billion-to-enhance-presence-in-rare-hematology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/karuna-shares-soar-on-schizophrenia-drug-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fresh-off-enhertu-success-astrazeneca-and-daiichi-claim-progress-for-next-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-pushed-back-pdufa-date-on-omaveloxolone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-status-for-relmada-s-major-depressive-disorder-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-returns-to-alzheimer-s-disease-with-1-1b-cerevance-pact/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bms-bets-up-to-1-9-billion-on-gentibio-s-treg-platform-for-inflammatory-bowel-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-s-type-2-diabetes-drugs-potentially-contaminated-with-nitrosamines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/aura-biosciences-receives-fast-track-designation-for-bladder-cancer-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-sanofi-and-haleon-facing-billions-of-dollars-in-zantac-liability/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biogen-expected-to-cut-costs-by-1b-as-industry-braves-economic-instability/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sanofi-s-tolebrutinib-phase-3-clinical-trial-paused-globally-after-fda-clinical-hold/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-treatment-for-acid-sphingomyelinase-deficiency-a-rare-genetic-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ec-authorizes-ranivisio-a-lucentis-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-opioid-review-slow-to-produce-actionable-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-gains-fast-track-designation-for-its-investigational-anticoagulant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/hepatitis-of-unknown-origin-affecting-hundreds-of-young-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/targeting-500m-opportunity-amneal-files-for-fda-approval-of-extended-release-parkinson-s-prospect/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/boehringer-ingelheim-s-spevigo-bags-first-fda-approval-for-rare-skin-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-orphan-drug-status-to-maze-s-pompe-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/amneal-submits-nda-for-ipx203-for-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/experimental-drug-combo-inhibits-growth-of-lethal-lung-cancer-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022// monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-approval-of-vertex-s-orkambi-to-include-younger-age-group/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/8-billions-cvs-to-buy-signify-health-in-deal-pushing-beyond-retail/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ammax-bio-announces-amb-05x-granted-fda-fast-track-designation-for-the-treatment-of-tenosynovial-gia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ec-approves-kite-s-tecartus-for-relapsed-refractory-acute-lymphoblastic-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/revance-announces-fda-approval-of-daxxify-daxibotulinumtoxina-lanm-for-injection-the-first-and-only-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/valneva-and-vbi-vaccines-ink-partnership-deal-over-hepatitis-b-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/dr-reddy-s-laboratories-announces-the-launch-of-lenalidomide-capsules-in-the-u-s-with-two-of-six-str/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/scilex-receives-fast-track-designation-for-back-pain-combo-product/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/intellia-s-ntla-2002-receives-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-nod-for-sotyktu-in-moderate-to-severe-plaque-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/patients-with-refractory-metastatic-colorectal-cancer-experience-survival-benefits-with-fruquintinib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-and-ema-accept-pfizer-submissions-for-ritlecitinib-for-alopecia-areata/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-s-omicron-ba-4-ba-5-vaccine-recommended-by-chmp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/two-fda-committees-to-discuss-perrigo-s-opill-drug-for-otc-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-accepts-new-drug-application-for-aripiprazole-long-acting-injectable-for-schizophrenia-bipolar-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/atyr-pharma-receives-fast-track-designation-for-efzofitimod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/imhe-modeling-shows-307-percent-increase-in-long-covid-cases-from-2020-to-2021/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/malaria-vaccine-candidate-safe-and-immunogenic-following-first-in-human-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-new-covid-variant-is-now-spreading-omicron-ba-4-6/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-mallinckrodt-s-terlivaz-for-injection-for-treatment-of-hepatorenal-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-spevigo-for-treatment-of-generalized-pustular-psoriasis-flares-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-begins-phase-3-clinical-trial-to-evaluate-mrna-based-influenza-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mirati-releases-promising-adagrasib-results-for-advanced-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-denounces-gsk-vir-regeneron-covid-drugs-following-lancet-criticism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/jasper-therapeutics-jsp191-gains-fast-track-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-scores-phase-3-win-with-novel-complement-drug-danicopan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/phase-3-readout-sets-up-filings-for-pfizer-s-meningitis-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cdc-guidance-considers-tecovirimat-in-monkeypox/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nearly-one-in-10-in-the-us-reports-having-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rheumatoid-arthritis-drug-effective-against-myasthenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-identify-molecular-mechanisms-leading-to-zika-associated-microcephaly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/roche-s-vabysmo-receives-eu-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/amerisourcebergen-acquires-pharmalex-for-1-28-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/otsuka-aurinia-claim-eu-okay-for-oral-lupus-nephritis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-fast-tracks-approval-of-novel-therapy-for-rare-neurologic-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-heron-s-aponvie-for-postoperative-nausea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-orphan-drug-designation-to-atg-101-for-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/seagen-s-sgen-tukysa-gets-fda-priority-review-for-new-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-slams-spectrum-and-oncopeptides-cancer-drugs-over-efficacy-concerns-ahead-of-odac-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fennec-pharma-receives-fda-approval-of-pedmark/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rocket-pharmaceuticals-to-acquire-renovacor-extending-leadership-in-aav-based-cardiac-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ec-approves-astrazeneca-s-tezspire-for-severe-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/kinnate-biopharma-inc-receives-fast-track-designation-from-the-u-s-fda-for-kin-2787-an-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ultomiris-approved-in-europe-for-the-treatment-of-adults-with-generalised-myasthenia-gravis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-to-supply-up-to-six-million-paxlovid-treatment-courses-to-global-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-s-retevmo-wins-fda-nod-to-treat-all-cancer-types-with-rare-ret-biomarker/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/despite-being-approved-in-europe-oncopeptides-pepaxto-will-remain-sidelined-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-infant-bacterial-therapeutics-orphan-drug-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/liver-focused-startup-nabs-115m-in-exchange-for-rare-disease-drug-royalties/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/atea-pharma-s-investigational-dengue-treatment-fast-tracked-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-recommends-ibrance-and-keytruda-for-nhs-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-and-merck-s-lynparza-withdrawn-for-specific-ovarian-cancer-population/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-biontech-and-moderna-seek-euas-for-pediatric-omicron-adapted-covid-19-shots/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ema-warns-about-drug-shortages/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/game-changing-new-theory-upends-what-we-know-about-how-charged-macromolecules-self-assemble/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nmd-pharma-s-nmd670-gets-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ayala-pharmaceuticals-received-fast-track-status-for-al102/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/santen-scores-another-fda-eye-drop-nod-this-time-in-glaucoma-and-ocular-hypertension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pharming-gets-priority-review-for-leniolisib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/enalare-therapeutics-snags-barda-contract-for-intramuscular-ena-001/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/crispr-therapeutics-receives-regenerative-medicine-advanced-therapy-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/shionogi-reports-promising-results-on-its-covid-19-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/avastin-biosimilar-gets-fda-approval-for-six-types-of-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-third-ever-drug-for-als-amylyx-s-amx0035/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fore-biotherapeutics-announces-fast-track-designation-granted-by-fda-to-fore8394-for-the-treatment-o/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-identify-key-player-in-cellular-response-to-stress/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-turns-down-translarna-for-nonsense-mutation-dmd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/positive-phase-3-results-for-zealand-pharma-s-glepaglutide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/otsuka-gains-accelerated-approval-for-bile-duct-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/santhera-seeks-eu-authorization-for-dmd-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/myovant-sciences-rejects-2-5-billion-takeover-offer-from-sumitovant-sumitomo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-nobel-prize-in-chemistry-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vir-biotechnology-snags-barda-contract-potentially-worth-up-to-1-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sanofi-wagers-400m-on-mirecule-muscular-dystrophy-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cue-biopharma-granted-fast-track-status-for-cue-101/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bill-aims-to-limit-cms-overreach-on-alzheimer-s-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-to-immutep-s-eftilagimod-alpha-combo-for-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-gets-fast-track-status-for-tirzepatide-in-obese-and-overweight-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/takeda-s-takhzyro-sbla-gains-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biotech-investors-and-ceos-see-two-paths-to-growth-but-are-they-equally-viable/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-boostrix-for-whooping-cough-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/kite-pharma-gets-fda-ok-for-retroviral-vector-manufacturing-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-alnylam-s-snda-for-oxlumo-in-advanced-primary-hyperoxaluria-type-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/theratechnologies-trogarzo-receives-fda-approval-for-30-second-iv-push/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-and-c-path-team-up-over-rare-genetic-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-s-intranasal-covid-vaccine-fails-first-clinical-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-scpharmaceuticals-furoscix-for-chronic-heart-failure-congestion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nanoscope-therapeutics-gets-fast-track-designation-for-mco-010/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gilead-sciences-gets-priority-review-for-new-trodelvy-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-new-compound-that-destroys-the-mrsa-superbug-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eligo-bioscience-s-eb300-gains-orphan-drug-and-rare-pediatric-disease-designations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/aptar-launches-digital-disease-management-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-priority-review-to-regeneron-s-eylea-sbla-in-retinopathy-of-prematurity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rigel-pharmaceuticals-plans-not-to-file-fostamatinib-snda-following-fda-feedback/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-decides-to-exercise-option-regarding-pcv-with-moderna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/bayer-s-vividion-unit-forges-930m-cancer-alliance-with-tavros/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/remegen-gains-orphan-drug-designation-for-telitacicept-in-myasthenia-gravis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-accepts-biomarin-s-bla-resubmission-of-aav-gene-therapy-for-severe-hemophilia-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/helsinn-to-withdraw-nda-for-cholangiocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/takeda-s-qdenga-nears-approval-in-eu-and-beyond-thanks-to-special-regulatory-pathway/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gilead-macrogenics-unite-against-hematologic-cancers-in-1-7b-biobuck-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/korea-s-antitrust-regulator-fines-astrazeneca-and-alvogen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/reata-pharmaceuticals-announces-that-the-fda-does-not-plan-to-hold-an-advisory-committee-meeting-to-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/milestone-pharmaceuticals-announces-positive-results-from-phase-3-rapid-clinical-trial-of-etripamil-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-pushes-back-action-date-for-biogen-s-tofersen-nda-for-als/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/unblinded-analysis-shows-positive-findings-for-fosgonimeton-warranting-further-development-in-alzhei/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-announces-19-grants-in-rare-disease-research-during-nord-annual-summit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ec-approves-kite-s-yescarta-for-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/jazz-drops-50m-for-exclusive-rights-to-zymeworks-bispecific-her2-hopeful/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/noema-pharma-gets-fast-track-for-neuralgia-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-merck-and-j-j-back-uk-startup-mining-the-dark-genome-for-autoimmune-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ptc-therapeutics-pauses-phase-2-study-of-pct518-in-huntington-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/salarius-pauses-enrollment-in-seclidemstat-phase-1-2-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/avrobio-receives-innovation-passport-from-mhra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/tvardi-therapeutics-tti-101-gets-fast-track-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novavax-gains-eua-for-adjuvanted-covid-19-booster-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/venatorx-s-cefepime-taniborbactam-shows-positive-results-in-phase-3-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eureka-therapeutics-receives-orphan-drug-designation-for-et140203/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-gsk-s-single-vial-meningitis-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cancer-patients-want-pharma-s-support-but-many-aren-t-getting-it-survey/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-s-imjudo-finally-snags-first-approval-only-in-an-ever-crowded-liver-cancer-field/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sumitomo-to-purchase-myovant-for-2-9-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/daiichi-sankyo-s-quizartinib-gets-priority-review-for-newly-diagnosed-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/tiziana-life-sciences-plans-ind-for-phase-1-study-of-intranasal-foralumab-in-alzheimer-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-agents-clinical-research-promise-more-personalized-treatment-for-patients-with-diabetic-kidney-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/acumen-antibody-granted-fast-track-designation-for-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vanda-pharmaceuticals-gains-orphan-drug-status-for-investigational-cholera-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/j-j-nabs-fda-okay-for-bcma-bispecific-tecvayli/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novaccess-global-gains-orphan-drug-status-for-brain-cancer-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-shelves-arthritis-blockbuster-hope-otilimab-after-lacklustre-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/stevanato-and-dwk-life-sciences-enter-non-exclusive-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cladribine-shows-efficacy-tolerability-among-patients-with-ms-switching-from-infusion-dmts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/diet-drug-jab-could-help-patients-lose-10-of-their-weight-in-months-by-taking-over-body-s-appetite-r/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/exploring-novel-mechanisms-and-therapeutic-targets-for-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/itm-gets-fast-track-for-radiopharmaceutical-treatment-for-neuroendocrine-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mt-101-granted-fast-track-designation-by-fda-for-cd5-relapsed-refractory-peripheral-t-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researcher-combines-ai-and-microelectronics-to-create-neural-implants-that-fight-brain-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/c-reactive-protein-score-may-predict-pd-1-inhibitor-treatment-efficacy-in-intrahepatic-cholangiocarc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ancient-viral-dna-in-human-genome-guards-against-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/cellular-biomedicine-lung-cancer-ind-application-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/researchers-unravel-how-the-brain-chemical-dopamine-relates-to-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-approach-increases-the-likelihood-of-detecting-antiphospholipid-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-new-control-system-for-synthetic-genes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/invasive-malaria-mosquito-spreading-in-africa-researchers-warn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-turns-down-withdrawal-petition-for-lung-cancer-drug-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/norstella-citeline-merge-to-create-5bn-pharma-tech-firm/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-suggests-oral-cephalosporins-as-safe-effective-alternative-for-treating-acute-kidney-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/amneal-receives-approval-for-leuprolide-acetate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/unique-genetic-signature-found-by-research-in-different-types-of-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-defers-action-on-pompe-disease-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/hlb-s-u-s-subsidiary-scores-fda-fast-track-designation-for-merkel-cell-cancer-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/arcturus-teams-with-csl-to-develop-mrna-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/emalex-raises-250m-for-tourette-syndrome-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/h-pylori-eradication-protects-against-aspirin-associated-peptic-ulcer-bleeding/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/lupin-plant-draws-fda-warning-letter-for-cleaning-and-contamination-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/az-sanofi-get-first-green-light-for-rsv-prophylactic-antibody/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-s-car-t-rival-blenrep-fails-multiple-myeloma-trial-endangering-its-accelerated-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/brentuximab-vedotin-found-to-lower-relapse-rate-in-pediatric-patients-with-high-risk-hodgkin-lymphom/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-places-hold-on-verve-s-ind-for-gene-editing-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/viatris-to-buy-two-eye-drug-developers-in-deals-worth-up-to-750m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/adc-s-accelerated-review-troubles-signal-fda-s-tough-new-stance-on-confirmatory-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/clinical-overview-auvelity-dextromethorphan-and-bupropion-for-major-depressive-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/teva-resubmits-nda-for-long-acting-schizophrenia-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-plans-phase-3-for-hepatitis-b-drug-bepirovirsen-despite-efficacy-drop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-libtayo-chemotherapy-as-first-line-treatment-for-advanced-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/can-gene-therapies-for-haemophilia-defend-their-high-price-tags/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mhra-authorizes-cosentyx-for-two-forms-of-juvenile-arthritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/neurotech-s-treatment-for-macular-telangiectasia-shows-promise-in-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-panel-backs-az-s-pt027-asthma-rescue-drug-but-in-adults-only/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pharmacogenomics-offers-a-glimpse-into-the-future-of-pharmacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/uk-allows-interchangeability-of-biosimilars/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-sobi-emergency-authorization-for-kineret-to-treat-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eli-lilly-ordered-to-pay-teva-approximately-176-5-million-in-damages/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/royalty-pharma-acquires-royalty-interest-in-olpasiran-for-250m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/stada-and-xbrane-get-eu-approval-for-lucentis-biosimilar-for-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-astrazeneca-s-imfinzi-and-imjudo-for-stage-4-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eqrx-drops-u-s-plans-for-nsclc-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-accepts-new-drug-application-for-zilucoplan-for-generalized-myasthenia-gravis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/satsuma-sts101-migraine-candidate-fails-late-stage-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gsk-limits-ovarian-cancer-drug-s-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/seagen-s-adcetris-gains-expanded-label-for-pediatric-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/how-high-blood-sugar-really-causes-type-2-diabetes-chemicals-produced-when-glucose-is-broken-down-ar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-reaches-54-4-million-settlement-over-its-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/walmart-enters-settlement-agreement-over-opioid-lawsuits-joining-cvs-and-walgreens/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/indivior-agrees-to-acquire-opiant-pharmaceuticals-for-145m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/jnana-partners-with-roche-to-discover-drugs-for-multiple-targets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/canbridge-pharmaceuticals-granted-orphan-drug-designation-for-can-106-for-the-treatment-of-myastheni/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vistagen-announces-publication-in-cells-demonstrating-av-101-s-potential-for-treating-levodopa-induc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-may-approve-naloxone-for-nonprescription-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-panel-backs-ardelyx-ckd-drug-despite-agency-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-adds-revises-product-specific-guidances/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nice-rejects-five-covid-drugs-and-backs-three-on-price-efficacy-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/novel-ai-blood-test-detects-liver-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/camber-pharmaceuticals-launches-generic-lamictal-xr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/tzield-drug-that-can-delay-onset-of-type-1-diabetes-has-a-pricetag-close-to-200-000/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-second-interchangeable-insulin-product-rezvoglar-insulin-glargine-aglr-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/regeneron-cytomx-announce-bispecific-therapeutics-for-cancer-collab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/anti-amyloid-oligomer-antibody-acu193-gains-fda-fast-track-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-bulks-up-in-haematology-buying-imago-for-1-35bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-breakthrough-therapy-status-to-iveric-bio-s-zimura-for-amd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/nona-and-dragonfly-enter-hcab-based-drug-discovery-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-accepts-new-data-on-apellis-new-drug-application/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-new-dosing-schedule-for-jazz-pharmaceuticals-rylaze/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/j-j-builds-case-for-antidepressant-spravato-with-head-to-head-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/diagnostic-marker-found-for-deadly-brain-disease-marked-by-dementia-movement-problems-discovery-coul/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/biovac-and-ivi-enter-deal-to-develop-oral-cholera-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-crispr-based-tool-inserts-large-dna-sequences-at-desired-sites-in-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-gene-therapy-to-treat-adults-with-hemophilia-b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ec-grants-approval-for-abbvie-s-skyrizi-to-treat-crohn-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/senators-introduce-new-bill-to-promote-research-and-access-to-mdma-psilocybin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-fast-track-to-palisade-bio-s-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-launches-ai-powered-real-world-data-project-for-cancer-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/chemotherapy-could-increase-disease-susceptibility-in-future-generations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/neurology-news-network-for-the-week-ending-november-26-2022/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-delays-decision-date-on-gamida-cell-bla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/c4x-discovery-shares-jump-after-it-signs-astrazeneca-deal-worth-up-to-us-402mln/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/axs-05-meets-primary-end-point-in-phase-3-trial-of-alzheimer-agitation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/full-life-technologies-acquires-focus-x-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mhra-approves-nubeqa-treatment-combination-for-advanced-form-of-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/invitrx-draws-warning-letter-for-unapproved-products/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ananda-scientific-announces-fda-approval-of-the-ind-for-a-clinical-trial-exploring-treatment-of-soci/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/x4-pharmaceuticals-announces-positive-top-line-results-for-whim-syndrome-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/donanemab-shows-greater-ability-to-clear-amyloid-plaque-than-aducanumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-fecal-transplant-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/addressing-unmet-needs-of-dementia-with-lewy-bodies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/olutasidenib-gains-fda-approval-for-idh1-mutated-relapsed-refractory-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ifenprodil-for-ipf-earns-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-s-bla-for-its-rsv-vaccine-gets-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/who-covid-disruption-resulted-in-63-000-more-malaria-deaths/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/colorado-submits-drug-importation-plan-to-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-takeda-s-dengue-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/court-ruling-may-allow-pharma-giants-to-escape-multiple-zantac-lawsuits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/istesso-s-idiopathic-pulmonary-fibrosis-candidate-gains-fast-track/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/sabcs-pharmas-show-their-working-in-hr-her2-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/ash-cd20-bispecific-antibodies-take-centre-stage-in-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/moleculin-biotech-s-wp1122-receives-fast-track-status-for-glioblastoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/the-effect-of-aging-in-multiple-sclerosis-and-the-model-of-care-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/rare-disease-moonshot-launched-at-european-health-summit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/mirati-s-krazati-gets-accelerated-approval-for-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/british-pharma-industry-cites-six-companies-for-code-violations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/merck-and-moderna-s-mrna-cancer-vaccine-aces-its-first-efficacy-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/u-s-government-orders-3-7-million-more-paxlovid-courses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-advisors-reject-cytokinetics-heart-failure-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/usp-and-phlow-partner-to-validate-continuous-manufacturing-processes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/intranasal-therapy-for-major-depressive-disorder-gets-fast-track-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/astrazeneca-s-alexion-hopes-to-extend-dominance-in-pnh-as-big-pharma-competitors-close-in/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/prime-to-cover-biosimilars-alongside-humira/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/centrient-api-plant-receives-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/kintara-s-val-083-gets-orphan-drug-status-for-rare-childhood-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/neurophth-receives-ind-clearance-from-fda-for-aav-nd1-gene-therapy-of-lhon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/vanda-loses-hetlioz-patent-case/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-first-gene-therapy-for-specific-form-of-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-expands-approval-for-cytalux-imaging-for-lung-cancer-detection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-regulators-issue-guidance-on-decentralised-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/abbvie-s-vraylar-gets-expanded-approval-for-major-depressive-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-pauses-ind-submission-for-duchenne-therapy-entr-601-44/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/a-way-to-make-asthma-drugs-last-longer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-preservative-free-latanoprost-drug-for-elevated-intraocular-pressure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/pfizer-files-blockbuster-hope-etrasimod-for-ulcerative-colitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-grants-priority-review-for-enfortumab-vedotin-ejfv-pembrolizumab-for-treatment-of-urothelial-can/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/eu-approves-atara-s-ebvallo-for-posttransplant-lymphoproliferative-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-bispecific-antibody-mosunetuzumab-axgb-to-treat-relapsed-refractory-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-tocilizumab-as-first-monoclonal-antibody-treatment-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/china-to-stop-publishing-daily-covid-count-as-leaked-document-suggests-250-million-fresh-cases-in-ju/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-survivors-of-hodgkin-lymphoma-show-signs-of-dementia-in-early-adulthood/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/legochem-amgen-partner-to-develop-antibody-drug-conjugates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/gilead-sciences-sunlenca-gains-fda-approval-for-hiv-type-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/new-method-predicts-the-right-treatment-for-breast-cancer-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/study-results-show-direct-evidence-of-serotonin-disruption-linked-with-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/roche-s-lunsumio-gets-accelerated-approval-for-later-line-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-approves-actemra-for-hospitalized-adults-with-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2022/fda-slaps-partial-hold-on-biogen-innocare-ms-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/az-announces-us-fast-track-designation-for-il-5-inhibitor-fasenra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/acelyrin-acquires-valenzabio-strengthens-immunology-position/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-briumvi-for-relapsing-multiple-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/chiesi-farmaceutici-to-acquire-amryt-pharma-for-1-48bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/astrazeneca-buys-cincor-in-a-deal-worth-up-to-1-8b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/france-based-ipsen-acquires-albireo-pharma-enriching-its-rare-disease-portfolio-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/amgen-licenses-synaffix-adc-platform-in-2-billion-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-grants-priority-review-to-roche-s-glofitamab-bla-in-large-b-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/abbvie-and-anima-biotech-have-announced-that-they-are-collaborating-in-a-deal-worth-up-to-over-580-m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/biomarin-gets-first-access-deal-in-eu-for-gene-therapy-roctavian/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-foundationone-liquid-cdx-to-identify-genomic-profile-in-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/bayer-taps-google-s-quantum-power-for-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-rejects-biocon-insulin-biosimilar-over-data-manufacturing-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-approves-astrazeneca-avillion-s-asthma-treatment-airsupra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/phase-3-clinical-trial-of-ambroxol-for-parkinson-s-confirmed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/evergreen-sanofi-ventures-increases-to-750m-with-further-sanofi-commitment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/australian-scientists-closer-to-finding-new-lung-cancer-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/luye-claims-its-first-fda-approval-for-bi-weekly-schizophrenia-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/abbvie-lilly-pull-out-of-uk-voluntary-drug-pricing-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/hallucination-drug-could-help-treat-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-novo-nordisk-s-rybelsus-as-first-line-treatment-for-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/oramed-s-oral-insulin-flunks-phase-3-diabetes-test-sending-stock-down-70/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/boehringer-takeda-make-it-into-global-top-15-employer-list/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-adacel-vaccine-during-pregnancy-to-protect-infants-against-pertussis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/amylyx-and-neopharm-sign-licence-agreement-for-als-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/angion-stock-falls-after-agreeing-elicio-therapeutics-merger/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/avidity-biosciences-gets-fast-track-for-facioscapulohumeral-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/coherus-acquires-rights-from-klinge-biopharma-for-eylea-biosimilar-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/national-institutes-of-health-grant-to-fund-alzheimer-s-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sun-pharma-to-buy-concert-pharma-gaining-potential-alopecia-areata-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/nice-recommends-vutrisiran-for-transthyretin-related-amyloidosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/merck-finds-causes-of-nitrosamine-in-diabetes-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/adam-s-secret-draws-warning-letter-for-misbranded-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/FDA Grants Rare Pediatric Disease Designation to OR-449 for Treatment of Adrenocortical Carcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/cadrenal-therapeutics-nasdaq-cvkd-granted-fda-fast-track-designation-for-tecarfarin-for-prevention-o/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-denies-accelerated-approval-for-donanemab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/takeda-pays-400m-to-buy-into-hutchmed-s-colorectal-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/theracosbio-today-announced-that-the-u-s-food-and-drug-administration-fda-has-approved-brenzavvy-bex/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-expands-sources-for-cannabis-clinical-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/lilly-injects-450m-into-plant-making-mounjaro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-clears-transcenta-s-ind-for-rett-syndrome-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/syros-gets-fast-track-status-for-higher-risk-myelodysplastic-syndrome-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eloxx-pharmaceuticals-announces-first-patients-enrolled-in-phase-2-clinical-study-evaluating-elx-02-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-pulls-az-s-evusheld-for-covid-citing-lack-of-efficacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-expands-approval-for-merck-s-keytruda-in-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-lifts-clinical-hold-on-inhibikase-candidate-for-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/cassava-claims-phase-2-win-for-its-alzheimer-s-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-stemline-s-orserdu-for-several-forms-of-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-grants-accelerated-approval-to-eli-lilly-s-jaypirca-in-mantle-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/roche-boehringer-tap-biosensor-firms-for-patient-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eu-expands-dupixent-s-authorization-for-eosinophilic-esophagitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-sutimlimab-jome-with-long-term-safety-efficacy-data-for-cold-agglutinin-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/nice-recommends-epidyolex-for-tuberous-sclerosis-complex-seizures/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/api-distributor-lgm-pharma-enters-consent-decree/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-pushes-back-decision-date-on-argenx-bla-to-june/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/jesduvroq-daprodustat-approved-by-us-fda-for-anaemia-of-chronic-kidney-disease-in-adults-on-dialysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-updates-letters-of-authorization-for-covid-drugs-paxlovid-and-lagevrio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/icer-questions-benefit-of-fezolinetant-for-hot-flashes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-approves-ellipses-pharma-s-ind-for-aml-therapy-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/medicago-to-shut-down-despite-covid-19-vaccine-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gilead-buoyed-by-trodelvy-ok-in-new-breast-cancer-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ground-breaking-results-in-phase-2-scleroderma-study-by-certa-therapeutics-demonstrates-improvement-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eisai-s-new-alzheimer-s-drug-leqembi-hits-the-u-s-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/mesoblast-resubmits-bla-for-remestemcel-l/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/daewoong-pharmaceutical-begins-the-first-administration-of-the-bersiporocin-new-treatment-for-idiopa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/aldeyra-s-reproxalap-for-dry-eye-disease-accepted-by-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/roche-s-crovalimab-trial-reaches-endpoints-in-patients-with-pnh/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sage-and-biogen-s-depression-drug-candidate-gets-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/rocket-pharmaceuticals-gets-rmat-designation-for-danon-disease-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/janssen-s-nipocalimab-shines-in-hdfn-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/court-rejects-phrma-lawsuit-over-canadian-drug-importation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ema-clarifies-its-policy-on-biosimilar-interchangeability/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/mesoblast-cell-therapy-gets-rmat-designation-for-chronic-low-back-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-expands-approval-for-takeda-s-takhzyro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-regeneron-s-eylea-for-infants-with-rop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-extends-ibuprofen-suspension-guidance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-accepts-biologics-license-application-for-proposed-biosimilar-denosumab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gsk-s-jemperli-gets-regular-approval-for-endometrial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/cms-will-require-drugmakers-to-pay-if-price-hikes-exceed-inflation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/frequency-therapeutics-announces-topline-results-for-its-phase-2b-study-of-fx-322-for-the-treatment-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ema-to-review-pseudoephedrine-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-places-partial-clinical-hold-on-blueprint-medicines-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/soligenix-gets-refusal-to-file-letter-for-hybryte-in-cutaneous-t-cell-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/labeling-changes-for-aduhelm-detail-risks-of-aria-brain-bleeds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/kinnate-biopharma-gets-fast-track-status-for-bile-duct-cancer-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/biocon-and-viatris-draw-complete-response-letter-for-bevacizumab-bla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/hhs-pilots-seek-to-complement-ira-in-lowering-drug-costs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/aqilion-inks-research-collaboration-with-merck-to-discover-develop-and-commercialize-small-molecule-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/maze-therapeutics-to-present-phase-1-results-from-first-in-human-trial-evaluating-mze001-as-a-potent/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/travere-therapeutics-announces-fda-accelerated-approval-of-filspari-sparsentan-the-first-and-only-no/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/daiichi-sankyo-wins-round-in-enhertu-patent-dispute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/covid-19-infection-can-increase-a-patient-s-risk-of-new-onset-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/chiesi-group-s-lamzede-gets-fda-approval-for-rare-genetic-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/moderna-announces-interim-results-from-phase-3-safety-and-immunogenicity-trial-of-mrna-1010-vaccine-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/drugmakers-support-sanofi-and-regeneron-in-supreme-court-case/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-accepts-two-sndas-for-merck-s-prevymis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/regeneron-is-off-to-chaple-as-fda-starts-pozelimab-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/modus-therapeutics-announces-positive-topline-data-from-its-phase-1b-lps-provocation-study-evaluatin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/lagevrio-disappoints-in-phase-3-study-for-post-exposure-prevention-of-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-first-treatment-for-geographic-atrophy-accepts-nda-for-same-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/cognition-therapeutics-and-actc-receive-fda-clearance-for-phase-2-start-study-of-oral-ct1812-in-earl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-austedo-xr-extended-release-tablets-for-huntington-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/theravance-viatris-seek-to-block-copies-of-copd-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eu-authorizes-csl-s-gene-therapy-for-hemophilia-b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/alzheimer-s-antibody-therapy-from-eli-lilly-granted-us-fda-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-creates-task-force-to-fast-track-covid-19-drugs-registration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/first-of-its-kind-study-examines-the-impact-of-cannabis-use-on-surgical-patients-post-procedure-heal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-sanofi-and-sobi-s-altuviiio-for-hemophilia-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/dr-reddy-s-bolsters-us-generics-business-with-105m-deal-to-buy-mayne-pharma-assets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-accepts-ind-and-grants-priority-review-for-springworks-desmoid-tumors-therapeutic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-offers-advice-on-macular-degeneration-drug-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-s-approval-of-friedreich-s-ataxia-drug-is-a-game-changer-for-treatment-of-rare-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gene-therapy-consortium-to-launch-rare-diseases-pilot/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/forcast-orthopedics-gets-qidp-nod-for-investigational-antibiotic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/confo-hands-baton-to-lilly-for-non-opioid-pain-med-development-in-40m-upfront-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/jazz-pharmaceuticals-loses-rems-patent-appeal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-spent-nearly-32b-in-public-funds-on-mrna-vaccine-development-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/lilly-slashes-insulin-price-70-patient-cost-cap-now-35/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/exelixis-provides-update-on-phase-3-contact-03-trial-evaluating-cabozantinib-in-combination-with-ate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/future-of-generative-ai-in-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-will-review-eisai-and-biogen-s-alzheimer-s-treatment-leqembi-with-decision-on-full-approval-expe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/astrazeneca-says-cancer-drug-enhertu-showed-positive-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ractigen-s-als-drug-candidate-gains-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-denies-petition-to-grant-simufilam-breakthrough-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/merck-s-mk-0616-an-investigational-oral-pcsk9-inhibitor-significantly-reduced-ldl-c-in-patients-with/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-im-administration-of-merck-s-mmrv-family-of-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-expands-approval-of-eli-lilly-s-verzenio-for-high-risk-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/j-j-backed-rapport-therapeutics-snags-100m-for-precision-approach-to-neurological-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-accepts-ionis-nda-for-eplontersen-in-rare-hereditary-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/many-accelerated-approval-drug-labels-lack-required-marketing-information/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/tagrisso-demonstrated-strong-overall-survival-benefit-in-the-adaura-phase-iii-trial-for-adjuvant-tre/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gilead-prevails-in-antiviral-patent-challenge/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/innocare-announces-first-subject-dosed-in-clinical-trial-of-bcl2-inhibitor-icp-248-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/despite-fda-doubts-advisors-back-first-line-polivy-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-pfizer-s-drug-zavzpret-in-acute-treatment-of-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/solanezumab-fails-to-halt-amyloid-and-cognitive-decline-in-preclinical-alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-approves-acadia-pharmaceuticals-rett-syndrome-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gilead-awarded-175-2-million-over-hiv-drug-fraud-scheme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-will-retain-some-guidances-after-end-to-covid-emergency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/satellos-bioscience-announces-further-preclinical-progress-with-sat-3153-as-a-potential-treatment-fo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ellipses-pharma-s-acute-myeloid-leukemia-candidate-gets-orphan-drug-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sanofi-to-acquire-provention-bio-for-2-9b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/after-3-4b-deal-and-eu-withdrawal-novartis-looks-to-sell-xiidra-bloomberg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/formology-lab-gets-warning-letter-for-lax-identity-testing-other-lapses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/positive-phase-2-data-from-atrial-fibrillation-clinical-trial-primary-endpoint-met/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/amgen-to-cut-450-jobs-in-second-round-of-layoffs-this-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sarepta-slides-as-fda-about-turn-on-panel-clouds-gene-therapy-approval-path/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-offers-advice-on-ndas-for-postoperative-local-anesthetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-novartis-treatment-combination-for-pediatric-glioma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/paxlovid-gets-advisory-panel-support-for-full-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/mayo-clinic-cancer-expert-highlights-advancements-in-treating-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/xtandi-shows-promise-in-prostate-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/j-j-settles-remicade-antitrust-suit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/six-month-ozempic-shortage-mostly-over-after-weight-loss-craze-drained-supply/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-green-lights-clinical-trial-of-low-dose-psilocybin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fusion-pharmaceuticals-announces-first-patient-dosed-in-phase-1-study-of-fpi-2059-a-targeted-alpha-t/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-declines-to-approve-abbvie-s-parkinson-s-disease-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-evkeeza-for-kids-with-ultra-rare-cholesterol-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eu-authorizes-dupixent-for-young-kids-with-severe-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-issues-warning-letter-on-nyquil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-rezzayo-a-novel-echinocandin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/arkansas-drug-manufacturer-draws-fda-warning-letter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-sandoz-high-concentration-version-of-adalimumab-biosimilar-hyrimoz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-sandoz-s-citrate-free-adalimubab-formulation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/abbvie-hits-snag-for-parkinson-s-disease-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/astrazeneca-and-ionis-build-case-for-amyloidosis-drug-eplontersen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-first-ever-treatment-for-activated-phosphoinositide-3-kinase-delta-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/nice-recommends-upstaza-for-rare-genetic-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/incyte-gets-crl-for-jakafi-extended-release-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/glenmark-pharmaceuticals-generic-of-leo-pharma-s-enstilar-approved/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/cyclerion-s-mitochondrial-diseases-candidate-gets-orphan-drug-nod/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/astrazeneca-amgen-s-asthma-launch-tezspire-picks-up-backing-from-england-s-nice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eu-approves-amicus-therapeutics-pombiliti-for-late-onset-pompe-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/viatris-cipla-and-aurobindo-sign-up-to-make-generics-of-gsk-s-long-acting-hiv-prep-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ema-highlights-trial-innovation-real-world-data-advances/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/esperion-sues-daiichi-sankyo-over-300m-milestone-payment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-and-lupus-research-alliance-form-drug-development-consortium/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/anticancer-drugs-with-fewer-side-effects-scientists-decode-the-crystal-structure-of-a-key-cell-cycle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/camber-pharmaceuticals-recalls-antifungal-drug-due-to-contamination-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eisai-presents-new-phase-3-analyses-of-aria-and-quality-of-life-of-lecanemab-treated-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/enrollment-and-topline-data-expected-sooner-for-phase-3-trial-of-pitolisant-in-idiopathic-hypersomni/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/shionogi-secures-fast-track-designation-for-investigational-covid-19-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-grants-eua-to-inflarx-s-covid-19-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/caribou-s-car-t-cell-therapy-receives-fast-track-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/merck-and-proxygen-partner-in-deal-worth-up-to-2-5bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sartorius-signs-agreement-to-acquire-polyplus-for-2-4bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/johnson-johnson-offers-8-9bn-to-resolve-all-talcum-powder-lawsuits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/signs-of-change-in-korean-diabetes-treatment-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-classifies-abbott-s-freestyle-libre-readers-recall-as-the-most-serious-type/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/india-emerging-as-world-s-leading-pharmacy-hub/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/biontech-and-duality-biologics-team-up-to-develop-adc-drug-candidates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/merck-eisai-decide-to-discontinue-advanced-melanoma-therapy-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/us-fda-advisers-to-weigh-full-approval-for-eisai-biogen-s-alzheimer-s-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/idorsia-urges-dea-to-deschedule-chronic-insomnia-drug-class/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/drugmakers-sign-letter-supporting-fda-and-calling-for-reversal-of-texas-judge-s-mifepristone-drug-ru/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/potential-nitrosamine-contamination-results-in-another-voluntary-pharmaceutical-recall/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/novo-nordisk-and-aspect-biosystems-partner-in-billion-dollar-deal-for-diabetes-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sumitomo-pharma-s-ewing-sarcoma-candidate-gains-orphan-drug-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/biogen-to-develop-amyloid-beta-targeting-antibody-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/the-fda-commissioner-who-approved-the-abortion-pill-is-still-fighting-for-it/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-accepts-sbla-for-pembrolizumab-plus-chemotherapy-in-advanced-gastric-gej-adenocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/regenxbio-gene-therapy-candidate-gets-fast-track-status-for-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-rejects-eli-lilly-s-mirikizumab-for-ulcerative-colitis-citing-manufacturing-concerns/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-grants-breakthrough-device-status-for-genetesis-cardioflux-mcg/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-updates-safety-labeling-and-prescribing-information-for-opioid-pain-meds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/pipeline-therapeutics-announces-global-license-and-development-agreement-for-investigational-neurosc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/omega-3-fatty-acids-might-reduce-cognitive-decline-risk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gsk-to-acquire-bellus-for-1-6-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/big-pharmas-finally-strike-with-acquisitions-signaling-accelerating-pace-of-m-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/agenus-rises-on-fast-track-tag-for-cancer-combo-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/gamida-cell-receives-fda-approval-for-blood-cancer-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/acadia-commercialises-first-us-rett-syndrome-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-expands-abbvie-s-abbv-qulipta-label-in-chronic-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/university-of-rochester-researchers-discover-how-to-steer-army-of-immune-cells-toward-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sleeping-pill-reduces-levels-of-alzheimer-s-proteins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/a-gene-involved-in-down-syndrome-puts-the-brakes-on-neurons-activity-in-mice-new-study-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/dr-reddy-s-laboratories-announces-the-launch-of-treprostinil-injection-in-the-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/big-pharma-s-patent-cliff-is-fast-approaching/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/trinity-team-develops-promising-gene-therapy-for-glaucoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/xortx-gets-orphan-drug-nod-for-polycystic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eli-lilly-to-sell-low-blood-sugar-drug-to-amphastar-for-around-1-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/avidity-biosciences-inc-granted-fda-fast-track-designation-for-antibody-aoc-1044/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/astrazeneca-and-ionis-attrv-pn-therapy-meets-trial-endpoints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/trefoil-therapeutics-reports-new-findings-from-fecd-therapy-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/in8bio-s-inb-400-inb-410-gmb-treatments-designated-orphan-drug-by-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/janssen-gets-eu-approval-for-prostate-cancer-drug-akeega/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/the-eu-outlined-its-plan-to-equalize-drug-access-and-lower-prices-pharma-firms-are-not-happy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sun-pharma-pauses-us-drug-exports-from-india-plant-after-fda-scolding/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/eli-lilly-raises-annual-profit-forecast-on-strength-of-diabetes-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/chmp-recommends-approval-for-gsk-s-rsv-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/national-institute-for-health-and-care-excellence-approves-expanded-use-of-yescarta-and-tecartus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-drug-which-helps-to-slow-progression-of-rare-form-of-mnd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/labeling-error-forces-teva-to-recall-13-lots-of-fentanyl-buccal-tablets/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/danaher-s-aldevron-unit-plots-mrna-manufacturing-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-turns-back-ascendis-hormone-drug-over-manufacturing-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/teva-medincell-win-fda-approval-for-slow-release-schizophrenia-drug-uzedy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/astrazeneca-fda-vote-worth-potentially-us-500mln-annual-peak-sales/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/with-fda-nod-for-lumryz-avadel-is-set-to-jazz-up-the-narcolepsy-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sanofi-signs-agreement-worth-up-to-750m-for-maze-s-pompe-disease-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/alzheimer-s-drug-developed-by-lilly-slows-cognitive-decline-by-35-pct/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/merck-agrees-to-build-bioprocessing-production-plant-in-south-korea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/sun-pharma-s-deuruxolitinib-ind-placed-on-partial-clinical-hold/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-approves-first-ever-rsv-vaccine-after-brutal-2022-season/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/vertex-secures-fda-clearance-for-infants-cystic-fibrosis-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/boehringer-ingelheim-earns-breakthrough-therapy-designation-for-pustular-psoriasis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/lupin-to-acquire-french-firm-medisol-for-around-rs-160-crore/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/ema-to-review-ctis-transparency-rules/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/cognixion-receives-fda-breakthrough-device-designation-for-assisted-communication-device/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/japan-s-eisai-inks-2-b-oncology-deal-with-china-based-startup-bliss-biopharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2023/fda-warns-vs-fake-versions-of-popular-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/thermo-fisher-scientific-announces-latest-round-of-oncomine-clinical-research-grant-awardees/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/wuxi-advanced-therapies-receives-fda-approval-to-manufacture-iovance-s-amtagvi-lifileucel-for-advanc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/study-reveals-t-cells-could-provide-more-protection-against-omicron-in-future-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-model-identifies-drugs-that-shouldn-t-be-taken-together/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-says-hiv-shot-is-better-than-daily-pills-for-some-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-s-velsipity-granted-ec-approval-for-ulcerative-colitis-in-patients-aged-from-16-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pepgen-earns-fda-fast-track-designation-for-myotonic-dystrophy-type-1-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-study-identifies-over-275-million-new-genetic-variants-from-nih-research-programme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cyberattack-at-unitedhealth-s-change-healthcare-hits-us-pharmacies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-generic-drug-approvals-rose-in-2023-in-bid-for-improved-access/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abbvie-and-tentarix-partner-to-develop-oncology-and-immunology-biologics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ocugen-completes-dosing-of-first-cohort-in-trial-of-gene-therapy-for-stargardt-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-issues-full-response-letter-to-cefepime-taniborbactam-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-rybrevant-chemo-combination-for-egfr-positive-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/does-yogurt-reduce-risk-of-diabetes-the-fda-says-it-might/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/blossomhill-secures-100m-for-cancer-discovery-programmes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cleveland-clinic-researchers-uncover-how-virus-causes-cancer-point-to-potential-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/jacobio-pharma-receives-ind-approval-for-p53-y220c-activator-jab-30300-in-the-u-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-pushing-back-uti-filing-by-a-year-shows-antibiotic-s-gonorrhea-potential-in-phase-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-alvotech-and-teva-s-simlandi-as-interchangeable-humira-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/neomorph-links-together-with-novo-nordisk-in-a-1-46-billion-molecular-glue-partnership-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/survodutide-improves-liver-disease-progression-in-more-than-80-of-patients-with-mash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-s-rsv-vaccine-abrysvo-shown-to-maintain-strong-efficacy-in-older-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-doubles-down-on-patient-engagement-to-support-rare-disease-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/zinpentraxin-alfa-comparable-to-placebo-in-idiopathic-pulmonary-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/first-uk-cancer-patients-receive-moderna-s-experimental-mrna-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-kgaa-is-now-the-fourth-big-pharma-to-sign-on-to-a-collaboration-with-c4-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nodthera-s-nlrp3-inhibitor-nt-0796-reverses-neuroinflammation-in-parkinson-s-disease-phase-ib-iia-tr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-announces-plans-to-invest-650m-in-uk-to-boost-life-sciences-sector/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amylyx-als-drug-fails-crucial-study-putting-company-s-future-in-doubt/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/johnson-johnson-acquires-ambrx-biopharma-for-2bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-says-fda-delays-approval-of-alzheimer-s-drug-in-surprise-move/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/obesity-drug-wegovy-semaglutide-is-approved-to-cut-heart-attack-and-stroke-risk-in-overweight-patien/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/valneva-s-chikungunya-virus-vaccine-recommended-by-us-cdc-advisory-committee/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-fda-declines-to-approve-viatris-s-injection-for-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-seeks-7-2-billion-to-enhance-food-safety-and-nutrition-advance-medical-product-safety-and-streng/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novo-nordisk-owner-to-expand-in-india-this-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/skincare-products-maker-galderma-gears-up-for-long-awaited-2-6b-ipo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-takes-keytruda-patent-dispute-with-johns-hopkins-university-from-the-court-to-the-patent-offic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/team-performs-the-first-gene-therapy-tests-in-a-whole-human-liver/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/regeneron-s-praluent-receives-fda-approval-for-paediatric-patients-with-genetic-high-cholesterol/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/protein-discovery-sparks-treatment-hope-for-aggressive-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mmvira-s-oncolytic-product-mvr-t3011-it-intratumoral-injection-receives-fda-fast-track-designation-f/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/researchers-identify-mutation-that-alters-alzheimer-s-disease-progression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-snaps-up-amolyt-for-1-05bn-to-boost-rare-disease-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/advances-in-multiple-myeloma-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-beigene-s-tevimbra-for-oesophageal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-to-acquire-radioconjugate-biotech-fusion-in-2-4bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/orchard-follows-buyout-with-fda-approval-of-rare-disease-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novartis-begins-expansion-of-singapore-biopharmaceutical-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bristol-myers-squibb-acquires-karuna-therapeutics-for-14bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/despite-inquiry-fda-adcom-backs-bms-abecma-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/world-s-most-expensive-drug-is-now-4-25-million-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bristol-myers-squibb-announces-ec-approval-for-multiple-myeloma-therapy-abecma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/keytruda-combination-treatment-for-nsclc-falls-short-in-phase-iii/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/researchers-reveal-imaging-technology-could-help-diagnose-and-treat-bowel-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nurix-presents-the-discovery-and-chemical-structure-of-first-in-class-cbl-b-inhibitor-nx-1607-at-the/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-orphan-drug-status-to-hi-bio-s-felzartamab-for-amr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/breakthrough-therapy-obliterates-deadly-brain-tumor-in-days/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-italfarmaco-s-duvyzat-as-first-nonsteroidal-duchenne-muscular-dystrophy-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mission-therapeutics-commences-landmark-trial-of-mtx325-a-potential-disease-modifying-treatment-for-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lisata-therapeutics-clinches-rare-disease-status-for-osteosarcoma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sanofi-and-owkin-expand-ai-collaboration-to-include-drug-positioning-in-immunology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gilead-acquires-cymabay-therapeutics-for-4-3bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-ultomiris-for-neuromyelitis-optica-spectrum-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/irlab-moving-on-phase-3-trial-of-mesdopetam-to-treat-dyskinesia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designation-to-nipocalimab-for-fetal-neonatal-alloimmune-thrombocytopenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-reportedly-eyeing-shockwave-medical-for-takeover/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/researchers-reveal-structural-interface-in-lung-cancer-protein-as-potential-treatment-target/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/teva-uk-and-closed-loop-medicine-partner-to-advance-development-of-personalised-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/akebia-receives-fda-approval-of-vafseo-vadadustat-tablets-for-the-treatment-of-anemia-due-to-chronic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/japan-approves-astrazeneca-s-truqap-with-faslodex-for-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/utidelone-injectable-granted-fda-orphan-drug-designation-for-breast-cancer-brain-metastasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-cobas-malaria-the-first-molecular-test-to-help-reduce-risks-infections-from-transfused-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bristol-myers-squibb-provides-update-on-the-first-phase-3-yellowstone-trial-evaluating-oral-zeposia-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/otsuka-and-lundbeck-s-schizophrenia-treatment-gains-ec-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/krazati-slows-disease-progression-in-certain-patients-with-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/partnership-to-advance-digital-biomarker-platform-for-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/xilio-fires-21-of-its-workforce-and-reprioritises-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ipsen-joins-the-adc-club-with-deal-worth-up-to-900m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-s-voydeya-granted-fda-approval-for-rare-blood-disease-pnh/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/beckley-psytech-reports-positive-results-in-trial-of-treatment-resistant-depression-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-abecma-as-earlier-line-of-therapy-for-triple-class-exposed-multiple-myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/effector-therapeutics-announces-topline-results-of-phase-2-kickstart-trial-of-tomivosertib-combined-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/as-humira-biosim-sales-languish-boehringer-ingelheim-plots-layoffs-in-pivot-to-hybrid-marketing-mode/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-expands-asia-pacific-reach-for-trelegy-ellipta-with-singapore-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amylyx-axes-als-drug-from-market-after-phase-iii-failure-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/acumen-and-lonza-to-produce-alzheimer-s-drug-sabirnetug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-accepts-shorla-s-oral-liquid-leukaemia-drug-nda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-and-legend-s-carvykti-scores-early-line-approval-for-mm-by-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/targeting-ras-proteins-may-prevent-relapse-in-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/acorda-inks-185m-asset-sale-to-merz-files-for-bankruptcy-after-years-of-disappointing-sales/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/european-lab-services-company-buys-ascend-clinical-llc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-meets-phase-iii-primary-endpoints-for-rsv-vaccine-abrysvo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/adrenomed-receives-fda-fast-track-designation-for-enibarcimab-for-treatment-of-septic-shock/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novartis-shares-positive-real-world-data-for-leqvio-in-atherosclerotic-cvd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mhra-approves-tmc-pharma-s-nulibry-to-treat-rare-genetic-disease-mocd-type-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/most-cancer-drugs-granted-accelerated-fda-approval-may-not-work/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/patient-dosing-continues-in-clinical-trial-of-novel-gene-therapy-for-wilson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/vertex-to-expand-autoimmune-and-inflammatory-disease-pipeline-with-4-9bn-alpine-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-gives-fast-track-designation-to-lyt-200-in-advanced-head-and-neck-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-astrazeneca-s-fasenra-for-asthma-in-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure-prophylaxis-agains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-halts-neumora-s-schizophrenia-drug-trial-over-convulsions-in-rabbits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/qureight-secures-series-a-funding-to-accelerate-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/icr-scientists-reveal-new-ways-to-convert-inhibitor-style-targeted-cancer-drugs-into-degraders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/glenmark-announces-recall-of-high-blood-pressure-medication-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/alvotech-and-teva-gain-fda-approval-of-selarsdi-for-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/american-brain-foundation-funds-research-in-lewy-body-dementia-neuroinflammation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-announces-fda-acceptance-of-new-meningococcal-jab-bla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/essential-pharma-acquires-reminyl-from-janssen-pharmaceutica/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-s-weight-loss-drug-could-help-sleep-apnea-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-genentech-s-alecensa-as-first-adjuvant-treatment-for-people-with-alk-positive-early-sta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/alvotech-moves-to-bring-its-humira-biosimilar-to-us-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/moderna-stock-on-track-for-the-eighth-consecutive-day-of-losses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lack-of-harmonisation-in-europe-hindering-gene-therapy-growth/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/askbio-s-ab-1002-gene-therapy-receives-fda-fast-track-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/aspirin-may-have-direct-role-in-augmenting-the-immune-system-to-fight-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ipsen-and-skyhawk-announce-1-8bn-partnership-to-advance-rare-neurological-disease-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/investigational-cushing-s-syndrome-medication-reduces-bp-glucose-in-open-label-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-nogapendekin-alfa-inbakicept-plus-bcg-for-bcg-unresponsive-nmibc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-s-antibiotic-combination-receives-ec-approval-to-treat-multidrug-resistant-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/colombia-issues-compulsory-license-to-enable-it-to-access-generic-hiv-drug-dolutegravir-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/long-flu-season-winds-down-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-scores-fda-nod-for-hemophilia-b-gene-therapy-will-charge-3-5m-per-dose/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designation-to-ctx-009-plus-paclitaxel-for-pretreated-biliary-tract-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/scientists-reveal-new-method-that-could-reduce-waste-from-drug-manufacturing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/x4-enters-commercial-fold-with-fda-approval-of-rare-disease-drug-xolremdi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-preservative-free-version-of-lumify-redness-reliever-eye-drops/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/enhertu-delays-disease-progression-in-certain-patients-with-metastatic-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-genmab-s-tivdak-granted-full-fda-approval-for-recurrent-or-metastatic-cervical-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-libervant-film-for-epilepsy-in-young-children/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/vertex-reports-net-profits-of-2-69bn-in-q1-2024/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bioversys-and-gsk-expand-their-partnership-for-tb-treatment-alpibectir/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/study-reveals-two-copies-of-apoe4-gene-could-increase-risk-of-developing-alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dana-farber-researchers-discover-new-target-for-potential-leukemia-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gerry-rubin-receives-the-2024-gruber-neuroscience-prize/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-announces-global-withdrawal-of-covid-19-vaccine-cites-commercial-reasons/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/first-fda-approval-for-accord-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/formosa-and-tabuk-sign-deal-for-fda-approved-ophthalmic-suspension/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/snb-101-receives-fda-fast-track-designation-for-sclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-clears-qiagen-s-respiratory-syndromic-testing-panel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ac-immune-and-takeda-sign-exclusive-option-and-license-agreement-for-active-immunotherapy-targeting-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/neosphere-biotechnologies-partners-with-kymera-therapeutics-for-novel-molecular-glue-target-discover/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-updated-label-for-altuviiio-to-include-full-data-on-pediatric-patients-with-hemophilia-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abbvie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-option-to-license-agreement-to-devel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-fda-approves-drug-for-treating-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ionis-and-biogen-discontinue-experimental-als-drug-after-phase-i-ii-flop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/regeneron-wins-temporary-restraining-order-preventing-eylea-generic-launch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/adhd-drug-shortage-shows-signs-of-letting-up-but-some-patients-still-struggle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/newly-identified-biomarkers-may-warn-of-cancer-7-years-before-symptoms-set-in/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/china-s-nmpa-approves-zai-lab-s-xacduro-nda-for-pneumonia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/glenmark-to-market-beigene-s-oncology-medicines-in-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-withdraws-infigratinib-approval-for-cholangiocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-targets-80-billion-in-total-revenue-by-2030-in-post-covid-era/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/durect-corporation-receives-fda-breakthrough-therapy-designation-for-larsucosterol-in-alcohol-associ/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/phase-2-study-demonstrates-oral-rilzabrutinib-reduces-loss-of-control-events-in-patients-with-asthma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designation-to-rag-01-in-nmibc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/genmab-acquires-biotechnology-company-profoundbio-in-1-8bn-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/johnson-johnson-shares-positive-phase-3-results-for-tremfya-versus-stelara-in-crohn-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/otsuka-cuts-development-for-avp-786-following-phase-iii-flop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/the-south-korean-ministry-of-food-and-drug-safety-mfds-has-granted-approval-for-eisai-and-biogen-s-l/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/study-finds-guidance-is-needed-for-health-technology-assessments-of-biosimilars/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lilly-doubles-investment-in-indiana-site-to-enhance-api-manufacturing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sarclisa-accepted-for-fda-priority-review-for-the-treatment-of-transplant-ineligible-newly-diagnosed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/asahi-kasei-offers-to-buy-sweden-s-calliditas-for-1-04bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/asco-2024-msd-s-adc-shows-efficacy-in-lung-and-breast-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merus-touts-positive-phase-ii-data-for-head-and-neck-cancer-antibody/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ec-approves-celltrion-s-omlyclo-for-allergic-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abdera-therapeutics-announces-fda-clearance-of-ind-application-for-abd-147/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novartis-atrasentan-phase-iii-data-show-clinically-meaningful-proteinuria-reduction-further-advancin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-clonidine-hydrochloride-for-treatment-of-adhd-in-pediatric-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novel-antibiotic-kills-pathogenic-bacteria-but-spares-healthy-gut-microbes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-interchangeable-biosimilar-to-soliris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-breakthrough-therapy-designation-for-atacicept-in-immunoglobulin-a-nephropathy-igan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-to-acquire-numab-s-yellow-jersey-therapeutics-in-deal-worth-1-25bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cell-therapy-bemdaneprocel-gets-fda-rmat-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/chmp-approves-backing-for-first-acanthamoeba-keratitis-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-fast-tracks-quince-therapeutics-rare-ataxia-drug-erydex/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/aurigene-pharmaceutical-opens-biologics-facility-in-hyderabad-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-hit-with-high-stakes-setback-in-zantac-saga-as-judge-allows-tens-of-thousands-of-lawsuits-to-pro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bluejay-touts-positive-data-for-chronic-hepatitis-d-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-advisors-reject-mdma-therapy-for-ptsd-amid-concerns-over-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/innovating-small-molecule-injectables-market-forecast-to-2033/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/be-bio-s-haemophilia-b-treatment-gains-fda-orphan-drug-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/repare-rptx-up-14-as-ovarian-cancer-combo-gets-fast-track-tag/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/agomab-wins-fda-orphan-drug-status-for-idiopathic-pulmonary-fibrosis-asset/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cycle-pharmaceuticals-offers-to-acquire-vanda-pharma-for-466m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/india-s-dcgi-approves-orchid-pharma-s-api-enmetazobactam/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/huntington-s-disease-clinical-trials-enrolling-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-ai-algorithm-detects-rare-epileptic-seizures-from-eeg-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/third-person-in-us-tests-positive-for-h5n1-bird-flu-cdc-emphasizes-risk-remains-low/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-status-to-gc-biopharma-s-sanfilippo-syndrome-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/elafibranor-now-iqirvo-wins-fda-accelerated-approval-for-pbc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/researchers-identify-new-major-cause-of-inflammatory-bowel-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-kgaa-invests-in-life-science-business-facility-in-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/santa-ana-bio-secures-168m-for-inflammatory-disease-treatments/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-astrazeneca-s-farxiga-for-paediatric-t2d-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abbvie-gains-rights-to-futuregen-s-inflammatory-bowel-disease-candidate-in-deal-worth-1-7bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bristol-myers-squibb-s-augtyro-granted-expanded-fda-approval-for-solid-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/apple-watch-can-detect-symptoms-of-parkinson-s-disease-study-reveals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/berberine-could-treat-eczema-exacerbated-staphylococcus-aureus-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astrazeneca-imfinzi-regimen-for-endometrial-cancer-gains-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/smartphone-stroke-detection-breakthrough-announced-by-australian-team/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pyros-wins-fda-approval-for-ready-to-use-infantile-spasm-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/biotest-wins-fda-approval-for-plasma-protein-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/china-nmpa-approves-dizal-s-golidocitinib-for-ptcl-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/day-one-targets-the-growing-adc-market-with-mabcare-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/liraglutide-better-at-preventing-heart-outcomes-vs-three-other-glucose-lowering-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/phase-2-trial-of-risvodetinib-for-parkinson-s-now-fully-enrolled/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/johnson-johnson-blueprints-125m-plant-upgrade-as-part-of-5-year-italy-investment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/tern-501-significantly-improved-the-efficacy-of-a-glp-1-receptor-agonist/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sarepta-s-elevidys-secures-us-label-expansion-for-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sanofi-and-biovac-partner-to-produce-polio-vaccines-in-africa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/tufts-new-ingestible-microbiome-sampling-pill-completes-preclinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/argenx-s-vyvgart-hytrulo-snares-2nd-us-nod-as-fda-gives-green-light-in-autoimmune-disease-cidp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/alzheimer-s-vaccine-beginning-human-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/alnylam-reveals-positive-phase-iii-results-for-rare-heart-disease-drug-vutrisiran/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fractyl-health-presents-new-preclinical-data-on-sustained-weight-maintenance-and-improved-body-compo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/iregene-receives-ind-approval-from-u-s-fda-to-start-clinical-trial-for-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/oncoinvent-s-radspherin-has-fda-fast-track-status-for-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sona-s-cancer-therapy-triggers-abscopal-effect-eliminating-distant-tumors-in-preclinical-melanoma-st/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/carisma-therapeutics-solid-tumour-therapy-obtains-fda-fast-track-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mira-pharmaceuticals-announces-ketamir-2-shows-promising-safety-profile-in-comparison-to-traditional/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abbvie-gains-fda-approval-for-epkinly-in-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cannabis-terpenes-exhibit-anti-cancer-effects-in-preclinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/daewoong-pharmaceutical-collaborate-with-ipb-to-enhance-preclinical-drug-research-in-indonesia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cytodyn-announces-start-of-preclinical-mash-study-results-expected-in-fall-2024/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-justice-dept-cracks-down-on-healthcare-fraud-schemes-linked-to-2-75bn-loss/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sh-105-gains-fda-approval-for-breast-ovarian-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abbvie-completes-acquisition-of-celsius-therapeutics-for-250m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designation-to-tub-040-for-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/study-suggests-connection-between-anxiety-and-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dianthus-reveals-preclinical-data-for-its-phase-ii-neuromuscular-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/chain-sees-its-owners-charged-with-wire-fraud-conspiracy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ustekinumab-ttwe-receives-fda-approval-as-new-stelara-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-priority-review-for-neurocrine-s-crinecerfont-ndas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gri-bio-announces-publication-of-positive-preclinical-data-from-lead-program-gri-0621-in-the-america/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-eylea-biosimilar-fyb203-ahzantive/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/almirall-s-ilumetri-shown-to-improve-and-maintain-well-being-in-plaque-psoriasis-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-s-donanemab-wins-fda-approval-for-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/longboard-pharmaceuticals-receives-breakthrough-therapy-designation-for-bexicaserin-lp352/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/navidea-drops-rheumatoid-arthritis-programme-after-failed-phase-iii-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/hyderabad-three-day-73rd-indian-pharmaceutical-congress-from-july-5/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/shilpa-medicare-sizzles-after-unicycive-gets-positive-results-in-clinical-trials-of-olc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-fast-tracks-personalized-therapy-for-hard-to-treat-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/viatris-closes-3-37bn-divestitures-with-otc-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-labour-government-backs-pharma-reform-in-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/preclinical-cro-services-market-research-report-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ascentage-pharma-s-olverembatinib-approved-in-macau-for-leukaemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nj-congressman-pushes-for-fda-to-fast-track-approval-process-for-new-sunscreen-products/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-and-mvv-launch-malaria-medicine-in-brazil-and-thailand/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lilly-bolsters-ibd-portfolio-with-3-2bn-morphic-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/biotech-company-eradivir-is-developing-lead-drug-ev25-to-treat-influenza/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cresilon-completes-first-phase-preclinical-study-of-hemostatic-gel-technology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/preclinical-analyses-of-tgr-63-demonstrate-blood-brain-barrier-permeability-and-safety-profile/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/preclinical-studies-cannot-provide-sufficient-evidence-that-ivermectin-helps-treat-cancer-in-people/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/recce-pharmaceuticals-announces-positive-preclinical-efficacy-data-against-who-priority-pathogen-aci/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ausperbio-ahb-137-gains-breakthrough-status-in-china-for-chronic-hepatitis-b-chb/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/revolution-medicines-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/hong-kong-approves-leqembi-for-alzheimer-s-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merz-therapeutics-wins-185m-bid-for-bankrupt-acorda-assets-and-increases-us-workforce-by-50/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designation-to-askbio-s-ab-1005-for-pd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/askbio-secures-fda-fast-track-designation-for-ab-1005-to-treat-pd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-advances-development-of-once-daily-formulation-of-oral-glp-1-receptor-agonist-danuglipron/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nhs-rolls-out-more-convenient-ocrevus-injection-for-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/some-diabetes-drugs-like-ozempic-may-lower-risks-of-10-cancers-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/msd-closes-1-3bn-eyebio-acquisition-plans-pivotal-trial-for-lead-asset/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/roche-touts-early-trial-success-of-second-obesity-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/egle-therapeutics-to-share-preclinical-data-for-its-first-autoimmune-disease-program-egl-003-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novo-nordisk-and-eli-lilly-shares-slide-on-new-obesity-drug-trial-from-roche/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/repurposing-fda-approved-drugs-may-decrease-fibrosis-in-butterfly-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mira-pharmaceuticals-announces-promising-results-for-mira-55-in-multiple-preclinical-tests-compared-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-fda-grants-priority-review-for-pierre-fabre-s-ebv-ptld/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-establishes-rare-disease-innovation-hub-to-accelerate-treatment-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/boehringer-ingelheim-offers-humira-biosimilar-at-92-discount/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/seventh-patient-cured-of-hiv-among-highlights-at-aids-2024/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/preclinical-study-shows-promise-of-systemic-targeted-therapy-in-a-rare-form-of-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/zuranolone-offers-a-much-needed-option-for-postpartum-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/israeli-heart-failure-treatment-secures-fda-breakthrough-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mira-pharmaceuticals-reveals-preclinical-success-ketamir-2-optimized-for-brain-delivery-avoiding-ket/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/samsung-bioepis-epyscyi-gets-fda-approval-as-biosimilar-to-soliris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dsp-5336-receives-fast-track-designation-from-the-fda-for-acute-myeloid-leukemia-subtype/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/preclinical-model-offers-new-insights-into-parkinson-s-disease-process/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/beigene-opens-biologics-facility-in-new-jersey-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/the-crowd-and-panel-gave-gilead-a-standing-ovation-after-the-full-data-from-the-phase-iii-purpose-tr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-blasts-indian-cdmo-brassica-for-routine-data-falsification-poor-hygiene-and-more/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sage-therapeutics-collapses-21-after-biogen-tied-essential-tremor-drug-fails/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pembrolizumab-keytruda-biosimilar-antibody-pipeline-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cue-biopharma-lays-off-25-prioritizing-preclinical-autoimmune-assets-over-clinical-stage-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-luye-pharma-s-erzofri-for-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/boehringer-inks-1-3b-acquisition-of-nerio-and-its-preclinical-checkpoint-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/aaic-2024-the-evolution-of-alzheimer-s-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/tau-blood-test-flags-preclinical-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/biogen-eisai-s-alzheimer-s-drug-shows-continued-cognitive-improvement-in-long-term-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-expands-gsk-s-jemperli-approval-for-endometrial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sanofi-invests-1-4bn-in-insulin-production-in-germany/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-vs-novo-nordisk-a-recent-study-suggests-this-company-has-the-best-weight-loss-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-signs-off-on-adaptimmune-s-tecelra-as-the-first-engineered-cell-therapy-for-a-solid-tumor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-buys-mirus-bio-to-boost-viral-vector-bioprocessing-capacity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bridgene-biosciences-expands-strategic-collaboration-with-galapagos-to-develop-selective-oral-smarca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-s-obesity-drug-shows-a-heart-benefit-is-it-time-to-buy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/promising-glioblastoma-therapy-targets-newly-discovered-pathway-in-preclinical-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eximia-research-network-acquires-tidewater-clinical-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/biomarin-continues-pipeline-clearout-by-halting-preclinical-gene-therapy-for-heart-condition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/servier-snags-fda-approval-for-voranigo-the-first-targeted-therapy-for-a-common-type-of-brain-tumor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pharmacosmos-picks-up-g1-therapeutics-fda-approved-drug-cosela-in-merger-worth-405m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lantern-pharma-highlights-promising-preclinical-results-of-lp-184-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/a4-study-data-now-available-to-aid-preclinical-alzheimer-s-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-nalmefene-injection-approval-for-emergency-treatment-of-opioid-overdose/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/accelerate-diagnostics-completes-preclinical-trial-for-antimicrobial-test-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-judge-denies-initial-attempt-by-novartis-to-block-generic-entresto-launch/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-ascendis-pharma-s-yorvipath-for-hypoparathyroidism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ovid-halts-preclinical-work-iv-seizure-program-in-wake-of-soticlestat-s-phase-3-stumble/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-priority-review-for-bavarian-nordic-s-chikungunya-vaccine-bla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/acelyrin-deprioritises-lead-therapy-despite-phase-iii-win-fires-33-of-staff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/world-health-organization-declares-new-mpox-outbreak-a-global-public-health-emergency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-expands-astrazeneca-s-azn-imfinzi-label-in-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-accepts-deciphera-s-vimseltinib-nda-for-priority-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/researchers-develop-new-chemical-method-to-enhance-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/covid-19-is-on-the-upswing-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/xf-platform-to-be-tested-against-cf-related-mrsa-lung-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/forget-mounjaro-eli-lilly-s-next-big-blockbuster-has-arrived/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-york-biotech-firm-s-anti-bleed-gel-for-soldiers-receives-fda-clearance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/type-2-diabetes-increased-by-almost-20-over-a-decade/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amneal-receives-u-s-fda-approval-for-propofol-injectable-emulsion-single-dose-vials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dr-reddy-s-aurigene-and-kainomyx-to-co-develop-anti-malarials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-compound-shows-promise-in-alzheimer-s-preclinical-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/in-drug-development-diversity-must-be-extended-to-preclinical-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cti-announces-partnership-for-oncology-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-s-milliporesigma-agrees-to-acquire-mirus-bio-for-600m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eisai-s-leqembi-deemed-too-costly-for-nhs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/innovent-s-dupert-approved-in-china-to-treat-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designation-to-arthrosi-therapeutics-s-ar882-for-gout-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lexicon-to-face-fda-adcomm-for-zynquista-approval-in-diabetes-and-ckd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/multiple-sclerosis-appears-to-protect-against-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/vaxart-announces-publication-in-vaccines-of-preclinical-data-supporting-the-potential-of-its-mucosal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/flagship-pioneering-and-quotient-therapeutics-announce-agreement-under-strategic-partnership-with-pf/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ec-approves-astellas-padcev-for-urothelial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/soleno-wins-fda-priority-review-for-prader-willi-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/psilera-receives-positive-preclinical-in-vivo-data-for-frontotemporal-dementia-ftd-candidate-psil-00/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-targets-generalised-myasthenia-gravis-landscape-with-nipocalimab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/emergent-gains-fda-approval-for-acam2000-vaccine-for-mpox/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/thinkcyte-secures-32-million-in-series-c-funding-to-drive-global-expansion-of-visionsort/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-weight-loss-medication-could-be-a-medical-marvel-or-the-next-health-crisis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/medicines-posts-positive-results-for-triple-combo-blood-pressure-drug-on-heels-of-fda-submission/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/breast-cancer-drug-found-to-help-slow-growth-of-rare-childhood-brain-tumour/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bayer-bets-big-on-kerendia-s-potential-to-treat-heart-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-priority-review-to-new-drug-application-of-neurofibromatosis-agent-mirdametinib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/aurobindo-pharma-to-focus-on-growth-trajectory-r-d-investment-and-capacity-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/inflarx-presents-new-preclinical-findings-for-inf904/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dr-reddy-s-banned-from-china-s-drug-procurement-program-after-inspectors-turn-up-manufacturing-probl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer-on-opposite-sides-of-two-promising-vaccine-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-azurity-s-nymalize-oral-solution-in-prefilled-syringe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/actimed-s-als-candidate-wins-fda-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-prostate-cancer-treatment-shows-promise-in-preclinical-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sensei-biotherapeutics-to-present-preclinical-data-on-sns-103-at-the-cri-enci-eighth-international-i/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-orphan-drug-designation-to-certepetide-in-cholangiocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lilly-partners-with-haya-for-lncrna-obesity-target-deal-worth-1bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-amneal-and-shilpa-s-oncology-product-boruzu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-hails-positive-results-of-nucala-clinical-trials-in-lung-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gene-therapy-restores-vision/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amplia-therapeutics-narmafotinib-gets-fast-track-designation-from-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/neuroactive-drugs-show-promising-anti-glioblastoma-effects-in-preclinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/preclinical-studies-suggest-a-drug-free-nasal-spray-could-ward-off-respiratory-infections/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-osimertinib-for-advanced-egfr-mutated-nsclc-after-chemoradiation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/boehringer-ingelheim-opens-66-8m-new-cancer-research-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-hits-ozempic-and-mounjaro-counterfeit-compounders-with-warning-letters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bms-wins-approval-for-schizophrenia-drug-acquired-from-karuna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/biomea-s-stock-bounces-back-as-fda-lifts-clinical-hold-on-diabetes-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-second-niemann-pick-disease-type-c-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/simufilam-found-safe-in-review-of-ongoing-alzheimer-s-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/valerio-therapeutics-announces-acquisition-of-emglev-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/orx142-promotes-wakefulness-at-very-low-doses-preclinical-data-shows/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bms-skates-again-on-6-4b-celgene-shareholder-lawsuit-but-is-still-not-free-from-another-filing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approved-antidepressant-treats-incurable-brain-cancer-in-preclinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/alzecure-pharma-ab-announces-an-abstract-with-preclinical-data-on-neurorestore-acd856-demonstrating-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/who-raises-alarm-over-marburg-virus-outbreak-in-rwanda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/otulfi-is-the-fourth-stelara-biosimilar-approved-in-the-us-but-will-not-launch-until-early-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/making-preclinical-sepsis-research-stronger-faster-and-more-responsive-to-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bms-and-prime-ink-potential-3-5bn-deal-to-develop-t-cell-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/experts-release-the-latest-guide-for-systematic-reviews-of-preclinical-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/recordati-to-acquire-worldwide-rights-to-sanofi-s-antibody-enjaymo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/teva-and-mabxience-partner-to-develop-biosimilar-candidate-for-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/chiesi-group-invests-400m-to-establish-biotech-centre-of-excellence-in-italy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/researchers-develop-new-approach-to-target-cells-affected-by-motor-neurone-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-top-iv-fluid-maker-baxter-voices-uncertainty-about-recovery-timeline-at-north-carolina-facility-h/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/2024-nobel-prize-in-chemistry-three-scientists-win-for-groundbreaking-work-in-proteins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bayer-and-moma-therapeutics-partner-for-oncology-programme/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/biogen-receives-u-s-fda-breakthrough-therapy-designation-for-felzartamab-for-the-treatment-of-antibo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-has-unveiled-positive-data-from-its-phase-iii-aresvi-006-clinical-trial-of-arexvy-its-rsv-vaccin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/johnson-johnson-discontinues-phase-iii-study-of-treatment-for-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/activist-investor-starboard-cries-foul-play-in-exec-u-turn-at-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-adcom-votes-in-favour-of-stealth-s-barth-syndrome-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gilead-gives-up-on-15m-mash-bet-with-yuhan-after-mulling-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-marstacimab-hncq-for-adults-adolescents-with-hemophilia-a-or-b-without-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sunvozertinib-granted-breakthrough-therapy-designation-by-china-cde-for-the-first-line-treatment-of-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sanofi-in-talks-to-sell-stake-in-consumer-healthcare-unit-to-cd-r/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/catalent-ctlt-to-sell-somerset-nj-oral-solids-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cepi-backed-trial-of-rift-valley-fever-jab-starts-in-kenya/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/enhertu-by-astrazeneca-daiichi-wins-new-approval-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/prime-medicine-to-highlight-new-preclinical-data-including-in-vivo-data-in-wilson-s-disease-at-upcom/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bright-minds-reports-positive-preclinical-data-for-bmb-201/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-will-build-new-way-of-doing-science-in-uk-amid-297m-pledge-to-government/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gri/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gepotidacin-nda-under-priority-review-by-fda-for-uncomplicated-uti/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amgen-shares-positive-late-stage-results-for-uplizna-in-generalised-myasthenia-gravis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/rectify-pharmaceuticals-to-present-new-preclinical-data-at-the-american-association-for-the-study-of/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sagimet-soars-fda-breakthrough-therapy-designation-and-lancet-review-validate-denifanstat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/rani-therapeutics-shares-hold-buy-rating-on-positive-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/intercept-s-liver-disease-drug-ocaliva-faces-fda-approval-delay/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/chengdu-baiyu-enters-into-a-license-agreement-for-the-development-and-commercialization-of-its-anti-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/zolbetuximab-clzb-receives-fda-approval-for-treatment-of-advanced-gastric-and-gej-adenocarcinoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/europe-drug-regulator-s-advising-panel-recommends-approval-of-novo-nordisk-s-australia-approved-hemo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/indian-pharma-firms-trail-global-peers-in-r-d-innovation-and-talent-metrics-fast-india-iifl-securiti/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/paris-backs-15b-sale-of-paracetamol-maker-to-us-fund-after-winning-guarantees/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fibrobiologics-and-charles-river-link-for-chronic-disease-therapies-manufacture/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/first-patient-to-receive-breakthrough-sickle-cell-gene-therapy-leaves-hospital/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/oric-114-shows-promise-in-preclinical-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-pfizer-s-respiratory-syncytial-virus-vaccine-abrysvo-for-adults-below-60-years/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mira-pharmaceuticals-reports-promising-preclinical-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/study-shows-diabetes-drug-ozempic-also-has-positive-effect-in-chronic-kidney-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/after-prior-rejection-iterum-nabs-long-sought-fda-nod-for-oral-uti-drug-orlynvah/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/taurine-reduces-atherosclerotic-plaque-area-and-stability-in-mice/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-eli-lilly-pad-immunology-profiles-with-trial-readouts-in-new-patient-groups/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/this-is-huge-news-for-novo-nordisk-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pharma-companies-must-adapt-to-keep-pace-with-ai-developments-say-experts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/social-media-engagement-boosts-rare-disease-outreach/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-report-demands-greater-understanding-of-the-impact-of-change-on-academia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astellas-withdraws-europe-acp-application-for-amd-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/genprex-reports-positive-preclinical-gene-therapy-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ec-approves-astrazeneca-s-fasenra-for-egpa-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/skyrizi-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nhs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lexicon-loses-fda-adcomm-vote-on-insulin-adjunct-for-patients-with-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/oki-219/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-mcguff-pharmaceuticals-facility-in-santa-ana-ca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approved-drug-for-ulcerative-colitis-also-effective-for-crohn-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-court-upholds-avadel-s-narcolepsy-drug-approval-amid-exclusivity-battle/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cullinan-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/scholar-rock/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nektar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/vertex/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bio-agelabs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/teva-s-generics-and-biosimilars-fuel-another-booming-quarter/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/intra-cellular-bolsters-caplyta-data-with-another-phase-iii-win/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lisata-therapeutics-and-valo-therapeutics-announce-preclinical-research-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-amplifies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sitc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lupin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/vitalityxtra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mustang-bio-s-mb-108/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eisai/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-takes-step-toward-removal-of-ineffective-decongestants-from-the-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/international-congress-for-ataxia-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-breakthrough-status-to-j-j-s-nipocalimab-for-sjd-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/drug-r-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/evaxion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-novel-gene-therapy-for-rare-neurometabolic-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novo-nordisk-insulin-plans-spark-angst-among-diabetes-patients/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-reviews-sanofi-and-regeneron-s-dupixent-label-expansion-for-urticaria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abelzeta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dr-reddy-s-laboratories-fdc-recall-products-in-us-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/silo-pharma-discloses-promising-results-from-preclinical-study-on-spc-15/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ideaya-hires-gilead-leader-to-head-up-commercialization-push/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/rectify-pharma-presents-preclinical-data-supporting-development-of-lead-candidate-rty-694-at-the-liv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-gains-rights-to-lanova-s-pd-1-vegf-bispecific-antibody-in-deal-worth-over-3-2bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ucb-s-bimzelx-granted-fda-approval-to-treat-hidradenitis-suppurativa-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/remix/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/veeva-commercial-summit-increased-investment-in-medical-affairs-by-pharma-companies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/breakthrough-therapy-designation-market-is-booming-worldwide-2024-2032-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/phase-3-trials-of-treatment-combo-for-hepatitis-d-expected-in-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/exclusive-us-fda-finds-widely-used-asthma-drug-impacts-the-brain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-eyes-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/rome-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/us-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/amneal-files-again-for-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/the-little-known-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/enveric/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-gains-approval-in-japan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novartis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/medicenna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nhs-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/roche-to-acquire-poseida-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-delays-decision-of-soleno-s-prader-willi-syndrome-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/arrowhead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/dev4all-and-pharmaseed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/uk-government-to-launch-first-ever-men-s-health-strategy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/applied-therapeutics-stock-plummets-after-fda-rejects-metabolic-disease-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/beigene-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-probes-potential/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-therapy-from-ui-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/quabodepistat/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/evaxion-to-present-preclinical-proof-of-concept/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/cbc-acquires-ucb-s-neurology-and-allergy-business-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sana/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/j-j-s-sblas-seek-fda-approval-of-tremfya-for-paediatric-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gsk-goes-east-again-snagging-option-on-preclinical-dualitybio-adc-for-30m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/lundbeck-acquires-all-outstanding-shares-of-longboard-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nls-pharmaceutics-reveals-promising-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ipsen-enters-610m-licensing-deal-with-biomunex-to-advance-mait-cell-engager/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/eli-lilly-invests-3b-to-expand-wisconsin-factory-to-help-meet-demand-for-mounjaro-zepbound/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/teva-takeda-sell-generics-joint-venture-in-japan-to-focus-on-innovative-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ashp-identify-and-counsel-patients-at-high-risk-for-severe-covid-19/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/chinese-biotech-gets-relief-as-us-softens-view-on-biosecure-act/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nurexone-announces-promising-preclinical-results-in-restoring-vision-after-optic-nerve-damage/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/new-study-finds-obesity-costs-us-industry-347bn-a-year/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/serina-raises-10m-to-develop-ser-252-for-advanced-parkinson-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/daiichi-sankyo-secures-breakthrough-therapy-designation-for-nsclc-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/citryll-gains-series-b-funds-to-develop-net-targeting-antibody/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/ensem-therapeutics-to-present-preclinical-data-for-potential-best-in-class-oral-cdk2-inhibitor-at-sa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/imetelstat-shows-promise-for-lr-mds-patients-post-other-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/c4-therapeutics-presents-cemsidomide-phase-1-data-at-ash/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-fast-track-designations-to-2-combination-influenza-and-covid-19-vaccine-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/vifor-pharma-offers-23m-to-nhs-to-resolve-cma-investigation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/china-nmpa-approves-santhera-s-dmd-treatment-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/evaxion-achieves-preclinical-success-with-ai-cancer-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-grants-plt012-orphan-drug-designation-for-liver-intrahepatic-bile-duct-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/nemolizumab-granted-fda-approval-for-moderate-to-severe-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/4dmt-announces-landmark-publication-of-4d-150-preclinical-data-for-the-treatment-of-neovascular-reti/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/abbvie-to-acquire-nimble-therapeutics-for-200m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sun-pharma-inks-pact-with-ucsf-and-tiller-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/sk-biopharmaceuticals-partners-with-proen-therapeutics-for-radiopharmaceutical-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/gilead-and-terray-link-to-develop-small-molecule-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/merck-co-boosts-glp-1-portfolio-by-paying-112m-upfront-for-hansoh-s-preclinical-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/trio-of-indian-drugmakers-issue-recalls-tied-to-impurity-labeling-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novo-holdings-completes-catalent-acquisition-for-16-5bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/bioage-labs-announces-collaboration-with-novartis-to-target-age-related-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/astellas-and-sangamo-sign-capsid-deal-for-neurological-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novo-commits-1-2b-for-new-danish-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/aadi-pulls-commercial-to-preclinical-pivot-buying-adcs-and-selling-approved-drug-to-reboot-business/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/mirroring-merck-s-problem-gsk-s-jemperli-zejula-study-in-ovarian-cancer-misses-survival-goal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-awards-fast-track-designation-to-staphylococcus-aureus-vaccine-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/endo-recalls-adrenalin-chloride-solution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/tirzepatide-gets-fda-approval-for-sleep-apnea-in-adults-with-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/novo-gets-the-green-light-for-once-daily-haemophilia-drug-following-setbacks-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/xbiotech-halts-all-rheumatology-research-after-missing-phase-ii-endpoints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2024/fda-approves-first-generic-daily-glp-1-injection-for-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/iit-guwahati-and-bose-institute-develop-injectable-hydrogel-for-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/testing-services-market-outlook-2025-2035-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-s-nmpa-prioritises-hutchmed-s-lung-cancer-therapy-review/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/researchers-expect-fda-to-approve-a-twice-yearly-shot-that-reduces-risk-of-hiv-infection-by-96/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-has-increased-prices-on-over-60-drugs-in-the-u-s-as-of-jan-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/quris-ai-s-bio-ai-platform-integrated-by-merck-kgaa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/maia-biotechnology-announces-clinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-designation-to-posdinemab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/resolute-s-rz358/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-releases-draft-guidance-on-confirmatory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/menarini-group/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/climb-bio-ascends-from-eliem-legacy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-cder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lilly-doubles-down-on-its-presence-in-india/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/jp-morgan-healthcare-conference/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/india-genome-project/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/2025-r-d-layoffs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eterna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/bbo-8520/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lilly-gains-us-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/jp-morgan-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/immune-complex-removes-receptors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-clears-axcynsis-at03-65-ind/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/antibiotic-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amgen-s-lumakras-vectibix/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-beats-ema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/impact/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cde-grants-breakthrough/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-issues-warning/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/moderna-from-hhs-for-mrna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/arrowhead-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/withdraws-u-s-from-world-health-organization/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/dyne/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/bluejay-therapeutics-receives/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ziapin2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biogen-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/india-eyes-asean-to-boost-pharma-exports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/emcure-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ascentage-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/takeda-bids-adieu-to-uloric/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/merck-eisai-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fitusiran/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/new-research-unlocks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-vertex-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nih-supported-clinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/rentschler-closes-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pvri-congress/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/j-j-for-cancer-treatment-costs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-third-biosimilar-of-actemra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/io-biotech-announces-publication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/thermo-fisher/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astellas-seeks-conditional-approval-for-ga-treatment-in-japan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mozart-therapeutics-presents-compelling/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/rani-therapeutics-announces-preclinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lipella-pharmaceuticals-granted-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/x4-lays/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/bain-capital-buys-mitsubishi-tanabe-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/genentech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/international-alzheimer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/us-fda-approves-abbvie-pfizer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/palisade-bio-presents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lilly-sells-6-5-billion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/arrowhead-pharmaceuticals-announces-closing-of-global-license/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-priority/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novartis-bolsters/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aardvark-prices-94-2m-ipo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/conduit-taps-charles-river/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/infectopharm-invests-in-audiocure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/us-government/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/robert-f-kennedy-jr-confirmed-as-hhs-secretary/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-merilog/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cell-therapy-weekly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/galderma-enters-fierce-european/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/bahrain-makes-history/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/diabetes-heart-failure-and-kidney-disease-medication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gsk-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/drug-discovery-preclinical-cro/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-status-to-rznomics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/innate-s-lacutamab-gains-fda-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/telomir-pharmaceuticals-announces-results-from-preclinical-studies-of-telomir-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/japanese-researchers-enhance-mrna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/thetis-pharmaceuticals-presents-new-preclinical-and-clinical-data-for-tp-317-at-ecco-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-status-to-sigx1094/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/japan-s-mhlw-approves-csl-behring-s-andembry-to-stop-hae-attacks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-moves-closer-to-selling-controlling-stake-in-17bn-valued-opella/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/io-biotech-announces/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-first-treatment-for-cerebrotendinous-xanthomatosis-a-rare-lipid-storage-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/boston-scientific-announces-pricing-of-1-5-billion-of-senior-notes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/zealand-pharma-steadfastly-upholds-amylin-based-obesity-drug-strategy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-focus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ec-authorises-celltrion-s-avtozma-for-multiple-indications/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/the-second-pharma-west-africa-conference/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/diabetes-reversed-in-islet-transplantation-preclinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/adtalem-global-education-to-participate-in-barclays-27th-annual-global-healthcare-conference/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/indian-drugmakers-likely-to-stay-competitive-as-us-tariffs-loom-dr-reddy-s-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/chmp-recommends-abbvie-s-rinvoq-be-approved-for-adult-gca/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mission-nixes-preclinical-studies-falls-back-on-clinical-candidates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-gives-sanofi-aventis-green-light-for-novolog-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-accepts-alvotech-teva-s-bla-for-proposed-eylea-biosimilar/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/jasper-therapeutics-presents-clinical-and-preclinical-briquilimab-data-at-the-american-academy-of-al/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/avenacy-intros-generic-zometa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novartis-hands-over-55m-upfront-to-license-preclinical-hives-prospect-from-japan-s-kyorin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/magnet-biomedicine-and-lilly-link-for-molecular-glue-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/abbvie-enters-obesity-space-with-2-3bn-gubra-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/allegro-reports-positive-safety-data-for-its-injectable-osteoarthritis-treatment-in-three-preclinica/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/combination-of-approved-drugs-offers-new-strategies-for-acute-myeloid-leukemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-fast-tracks-investigational-nonopioid-treatment-for-acute-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/the-acquisition-will-give-jazz-access-to-chimerix-s-lead-investigational-candidate-dordaviprone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/indonesia-approves-antengene-s-xpovio-nda-for-multiple-indications/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cero-therapeutics-to-present-preclinical-data-on-cer-1236-for-ovarian-cancer-at-sitc-conference/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ascentage-secures-third-breakthrough-therapy-for-ph-all-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/oruka-therapeutics-announces-preclinical-data-for-orka-002-at-the-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tris-pharma-eyes-approval-after-pain-drug-triumphs-in-second-phase-iii-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-expansion-for-furosemide-injection-to-treat-edema-in-patients-with-ckd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uk-s-pricing-watchdog-rejects-alzheimer-treatments-for-the-second-time/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/us-tariffs-on-pharma-imports-can-severely-hit-indian-firms-experts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/roche-genentech-innovation-center-boston-launched-at-harvard-s-enterprise-research-campus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/polyrizon-initiates-preclinical-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sun-pharma-agrees-to-acquire-checkpoint-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lundbeck-s-amlenetug-gains-orphan-drug-status-in-japan-for-msa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ec-approves-otsuka-and-lundbeck-s-rxulti-for-schizophrenia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/epirium-bio-to-present-mf-300-preclinical-data-at-the-international-conference-on-frailty-and-sarcop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mallinckrodt-and-endo-sign-6-7bn-merger-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cannabis-terpenes-relieve-fibromyalgia-pain-in-preclinical-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/unsafe-and-unregulated-cell-therapies-being-sold-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cidara-therapeutics-announces-publication-of-cd388-preclinical-data-in-nature-microbiology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/taiho-outlays-1-14bn-to-acquire-adc-specialist-araris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/incyte-stock-hit-11-despite-paediatric-dermatology-trials-hitting-target/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-study-of-kio-104-in-a-proliferative-vitreoretinopathy-model-accepted-for-poster-presenta/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/j-j-receives-fda-fast-track-designation-for-nipocalimab-for-moderate-to-severe-sj-gren-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/atea-pharmaceuticals-announces-presentation-of-bemnifosbuvir-preclinical-data-at-the-38th-internatio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-arvinas-vepdegestrant-shows-promise-in-phase-3-breast-cancer-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approved-alzheimer-s-drug-found-to-be-less-effective-in-females/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sona-nanotech-s-cancer-therapy-shows-promising-preclinical-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/newly-fda-approved-painkiller-hopes-to-lower-addiction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/poxel-announces-positive-results-from-a-preclinical-study-for-pxl065/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-johnson-johnson-s-tremfya-to-treat-crohn-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-outlays-1-9bn-to-purchase-dren-bio-s-bispecific-antibody/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-conditionally-approves-hutchmed-s-tazverik-for-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/j-j-boosts-us-operations-with-55bn-investment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/promis-neurosciences-showcases-preclinical-data-on-platform-derived-antibody-and-vaccines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-to-invest-2-5bn-in-r-d-centre-in-china/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alnylam-s-amvuttra-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alumis-and-kaken-sign-agreement-in-japan-to-develop-esk-001/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/apitegromab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/allegro-shares-promising-preclinical-results-for-osteoarthritis-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pharming-group-doses-first-patient-in-phase-2-trial-of-leniolisib-in-cvid/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/how-india-can-better-its-clinical-trials-for-cell-and-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/briacell-to-present-clinical-and-preclinical-data-at-the-2025-aacr-conference/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gr-nenthal-receives-fda-breakthrough-therapy-designation-for-knee-osteoarthritis-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novo-inks-1b-biobucks-lexicon-obesity-deal-after-seeing-preclinical-prospect-shine-with-semaglutide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-fitusiran-for-reducing-bleeds-in-patients-with-hemophilia-a-b/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/adc-emi-le-fast-tracked-for-her2-low-negative-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/genmab-s-tivdak-approved-in-japan-for-advanced-cervical-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-expands-pluvicto-indication-for-earlier-use-in-patients-with-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/vertex-halts-development-of-diabetes-cell-therapy-after-trial-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tharimmune-announces-positive-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/voyager-presents-robust-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/blockbuster-potential-drugs-ruled-the-2024-pipeline-with-53-rise-over-2023/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/subtle-cognitive-deficits-identified-in-preclinical-stages-of-alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/keeping-your-bad-cholesterol-in-check-protects-you-from-dementia-new-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-orphan-drug-designation-for-mds-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/accord-healthcare-receives-positive-chmp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/neoadjuvant-darovasertib-receives-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-success-for-gene-control-system-for-rett-syndrome-rett-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-designation-to-investigational-tau-targeting-therapy-for-alzheimer-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/new-melanoma-therapy-prevents-brain-metastasis-in-preclinical-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/daiichi-and-astrazeneca-s-enhertu-gains-ec-approval-for-breast-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/us-fda-declines-to-approve-aldeyra-s-eye-disease-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-awards-orphan-drug-designation-status-to-sanofi-s-rilzabrutinib-for-two-rare-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/abl-bio-and-gsk-link-on-neurodegenerative-conditions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novo-nordisk-commits-1-12-billion-to-expand-ozempic-production-in-brazil/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-s-nmpa-authorises-santen-s-glaucoma-treatment-application/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/new-target-for-lyme-disease-vaccine-shows-promise-in-preclinical-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/is-the-fda-about-to-break/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tonix-and-makana-partner-on-xenotransplantation-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/us-fda-approves-an-updated-label-for-tryvio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/trump-says-major-tariffs-coming-on-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ruvidar-tld-1433-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-injectable-antibiotics-for-b-braun-drug-delivery-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/stealthy-cholesterol-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/glycomine-raises-115m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/neurelis-nasal-spray/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/experimental-bird-flu-vaccine-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uniqure-announces-fda-breakthrough-therapy-designation-granted-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/american-startup-receives-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/trump-administration-plans-deep-cuts-to-federal-health-budget/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/spinal-cord-stimulation-promising-for-diabetic-neuropathy-pain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/leo-pharma-and-the-parker-institute-join-forces-to-advance-dermatology-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-digital-therapeutic-for-migraine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/debiopharm-and-oncodesign-services/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/veraxa-to-go-public-in-1-6bn-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/equillium-announces-feedback-from-the-u-s-food-and-drug-administration/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/scribe-therapeutics-to-unveil-latest-preclinical-data-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/thermo-fisher-scientific-to-invest-2bn-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/earlier-ocrevus-treatment-may-reduce-cerebellar-shrinkage-in-ms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-s-new-weight-loss-drug-may-have-the-worst-name-in-pharmaceutical-histrory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ipsen-s-elafibranor-shows-promise-in-rare-liver-disease-primary-sclerosing-cholangitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/wall-street-s-new-tariff-safe-haven-high-tax-biotech-stocks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ec-grants-orphan-drug-designation-to-dyne-therapeutics-duchenne-muscular-dystrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-s-sasanlimab-improves-event-free-survival-in-phase-3-bladder-cancer-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/portage-biotech-reports-confirmatory-preclinical-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/abbvie-receives-fda-approval-for-rinvoq-in-treating-giant-cell-arteritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amgen-to-invest-900m-in-ohio-manufacturing-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nuvalent-reveals-preclinical-data-on-cancer-drug-zidesamtinib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/abeona-cell-therapy-approved-by-fda-for-rare-skin-condition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/boehringer-oxford-university-and-cumulus-to-explore-brain-activity-in-bpd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/newamsterdam-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/silo-pharma-s-sp-26/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/dimerix-and-amicus-to-commercialise-dmx-200-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/scientists-at-the-university-of-east-anglia-uea-have-developed-a-revolutionary-new-way/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-clears-ind-application-for-trop-2-targeting-adc-in-solid-tumors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/avutometinib-combo-shows-activity-safety-for-hr-her2-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-awards-rmat-status-to-4dmt-diabetic-macular-oedema-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hhs-launches-500m-universal-vaccines-initiative/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/chinese-regulator-grants-priority-review-for-innocare-s-solid-tumour-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-study-reveals-how-alcohol-promotes-fat-buildup-in-liver/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/q1-earnings-pulse-check-companies-tentative-on-pharma-specific-tariffs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/palatin-presents-promising-preclinical-data-for-melanocortin-agonist-pl9588/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-s-calquence-approved-by-ec-for-first-line-mantle-cell-lymphoma-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-exec-tells-biotechs-not-to-scrimp-on-clinical-trial-design/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aptevo-therapeutics-provides-program-update-for-bispecific-apvo711-pd-l1-kh-cd40/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/takeda-pledges-30b-in-u-s-argues-against-trump-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-data-on-first-in-class-btk-sh2-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-plans-to-expand-unannounced-inspections-of-foreign-drug-plants/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/viridian-therapeutics-receives-fda-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hls-therapeutics-and-esperion-partner/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/windtree-therapeutics-announces-presentation-of-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/roche-plans-700m-manufacturing-plant-in-the-us-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/he001-receives-orphan-drug-designation-for-soft-tissue-sarcoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novo-nordisk-taps-septerna-in-2-2bn-deal-for-oral-obesity-therapies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-european-hematology-association-2025-congress/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amneal-receives-u-s-fda-approval-for-brekiya/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gsk-to-spend-2bn-on-phase-iii-liver-disease-drug-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/roger-hajjar-md-on-helping-to-bring-preclinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/merck-rolls-to-third-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-strikes-1-3bn-gene-therapy-deal-with-rznomics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/incyte-gets-fda-approval-for-zynyz-in-new-cancer-indication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-biosimilar-approvals-set-for-record-breaking-year-amid-us-pricing-reforms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hhs-sets-most-favoured-nation-pricing-targets-for-drug-makers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/regeneron-buys-bankrupt-23andme-for-256m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/filipino-pharma-medethix-bags-two-asia-health-awards/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mineralys-to-present-lorundrostat-trial-data-at-esh-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/new-kras-g12c-inhibitor-shows-breakthrough-potential-in-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/silexion-therapeutics-completes-key-preclinical-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biontech-to-invest-up-to-1-34bn-in-uk-r-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/polyrizon-emerges-with-positive-preclinical-data-on-nasal-protection-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/orionis-and-genentech-link-on-oncology-small-molecule-glue-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-gains-rights-to-3sbio-s-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/asco25-roche-s-itovebi-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fujitsu-thers-utilise-ai-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/medicus-gains-uae-doh-approval-for-basal-cell-carcinoma-treatment-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/dr-reddy-s-gets-2-observations-from-usfda-for-telangana-api-plant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/navigating-the-fda-s-accelerated-approval-pathways-for-oncology-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/poxel-announces-positive-preclinical-data-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/chmp-recommends-gsk-s-blenrep-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-s-cde-grants-breakthrough/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/quadria-s-third-fund/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ema-validates-soleno-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-designation-to-drug-candidate-for-celiac-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sevabertinib-given-fda-priority-review-for-her2-nsclc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/silexion-therapeutics-announces-preclinical-results-on-sil204/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ucla-study-finds-ssris-enhance-t-cell-activity-and-reduce-tumor-growth-in-preclinical-cancer-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alvotech-and-advanz-to-commercialise-biosimilars-in-europe/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-phasing-out-animal-testing-in-preclinical-safety-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/four-states-ask-f-d-a-to-lift-special-restrictions-on-abortion-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/darolutamide-receives-fda-approval-for-mcspc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/radiopharm-theranostics-reports-preclinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/dyne-therapeutics-to-present-new-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-s-calquence-approved-by-ec-for-first-line-chronic-lymphocytic-leukaemia-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ozempic-linked-to-rare-cases-of-serious-eye-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/rfk-jr-looks-to-alter-rare-disease-regulation-by-fast-tracking-drug-approvals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/finerenone-plus-sglt2-inhibitor-reduces-albuminuria-more-than-either-drug-alone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-and-camurus-enter-cardiometabolic-health-partnership-worth-up-to-870m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/jade-biosciences-presents-jade101/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-yoltech-s-yolt-101-for-familial-hypercholesterolemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/psilera-collaborates-with-drug-development-leader-hesperos/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aytu-biopharma-to-commercialise-exxua-for-major-depressive-disorder-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/msd-receives-fda-approval-for-enflonsia-to-prevent-respiratory-syncytial-virus-rsv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pancreatic-cancer-vaccines-eliminate-disease-in-preclinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nhs-to-receive-29bn-funding-boost/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gilead-hit-with-fda-clinical-hold-for-batch-of-hiv-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/trump-s-push-to-onshore-pharma-manufacturing-clouded-by-lack-of-clarity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/windtree-receives-offer-for-its-preclinical-oncology-drug-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fractyl-health-to-present-new-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/texas-governor-signs-bill-allocating-up-to-100-million-in-funding-for-psychedelics-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sun-pharma-s-halol-plant-gets-8-usfda-observations-post-inspection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-taps-chinese-biotech-in-5-2bn-chronic-disease-research-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/adc-therapeutics-shutters-uk-r-d-site/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/positive-preclinical-data-supports-potential-of-neurizon-s-nuz-001-in-huntington-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-designation-to-nuvisertib-in-myelofibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/european-pharma-needs-scalable-models-to-succeed-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/skye-bioscience-to-present-expanded-preclinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-to-miss-approval-deadline-for-kalvista-drug-due-to-resource-constraints/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hoth-therapeutics-reports-positive-preclinical-safety-data-for-ht-kit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-commissioner-s-national-priority-vouchers-will-endanger-americans/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tisento-s-melas-treatment-receives-fast-track-status-from-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/telomir-pharmaceuticals-reports-positive-results-for-progeria-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/us-fda-approves-gilead-s-twice-yearly-injection-for-hiv-prevention/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/bioage-labs-inc-reports-promising-preclinical-results-for-apj/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novartis-ribociclib-approved-in-canada-for-early-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/boehringer-s-spevigo-recommended-by-nice-for-generalised-pustular-psoriasis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aptevo-announces-addition-of-preclinical-candidate-apvo455-to-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/this-drug-may-lower-stroke-risk-in-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/translating-promising-drug-candidates-from-preclinical-screening-to-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/olive-oil-may-help-prevent-cancer-alzheimer-s-heart-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biotechnologists-learned-to-turn-toxic-tomb-fungus-into-anti-tumor-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/inmed-stock-soars-after-promising-alzheimer-s-drug-preclinical-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/deucravacitinib-shows-efficacy-in-psoriatic-arthritis-could-be-used-in-the-future/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aprea-reports-anti-proliferative-results-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-gets-usfda-nod-for-new-constipation-drug-stock-gains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-receives-fda-approval-for-amyvid-label-update/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cellectar-biosciences-provides-update-on-clinical-programs-and-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gilead-eyes-kymera-s-adhesive-cancer-drug-in-750m-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/7-7-million-doses-of-illegal-medicines-seized-in-uk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/who-scientific-advisory-group-for-the-origins-of-novel-pathogens-reports-on-sars-cov-2-origins/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hotspot-therapeutics-to-present-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hcw-biologics-to-showcase-important-updates/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-breakthrough-therapy-designation-to-daraxonrasib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cassava-presents-promising-preclinical-simufilam-data-at-tsc-alliance-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/siemens-finalizes-5-1b-dotmatics-acquisition/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/torrent-pharmaceuticals-to-acquire-stake-in-jb-pharma-for-3bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-s-riliprubart-riliprubart-gains-orphan-drug-designation-status-from-japan-s-mhlw-for-cidp/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-gamifant-for-macrophage-activation-syndrome-in-still-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/car-t-cells-engineered-to-attack-two-leukemia-proteins-show-promise-in-preclinical-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alembic-pharmaceuticals-acquires-utility-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mustang-bio-granted/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cyclacel-announces-publication-of-preclinical-data-on-plogosertib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/silo-pharma-advances-ptsd-drug-spc-15/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/artelo-biosciences-art12-11/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/merck-spends-10-billion-for-verona-gaining-access-to-its-copd-medication/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/trump-s-200-tariff/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/klotho-neurosciences-als-therapy-awarded-fda-orphan-drug-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/harmony-biosciences-preclinical-data-for-narcolepsy-drug-bp1-15205-shows-promise/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-s-everest-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-accepts-new-supplemental-biologics-license-application-for-review-for-winrevair/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cto-east-coast-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approved-drug-can-reduce-post-surgery-pain-without-heavy-opioid-use/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-orphan-drug-designation-to-quemliclustat-in-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aviva-biopharm-inc-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-receives-resubmitted-bla/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-to-review-msd-s-doravirine-islatravir-nda-for-hiv-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sino-biopharma-spends-951m-to-acquire-china-based-lanova-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-announces-plan-to-phase-out-animal-testing-will-that-work/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/zanubrutinib-outperforms-acalabrutinib-in-adjusted-head-to-head-analysis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/maia-biotechnology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/simvastatin-does-not-enhance-escitalopram/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uc-san-diego-expands-its-capacity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-votes-against-proposed/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-fast-tracks-one-time-intravitreal-gene-therapy-for-geographic-atrophy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-announces-major-recall-of-popular-deodorant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/imcheck-s-ict01-earns-fda-orphan-drug-designation-for-aml/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gene-therapy-maker-sarepta-tells-fda-it-won-t-halt-shipments-despite-patient-deaths/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/easi-scores-fall-71-with-apg777-for-patients-with-atopic-dermatitis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/j-j-seeks-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/life-sciences-vc-omega-funds-closes-647m-funding-round/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-moving-to-nonanimal-testing-methodologies-in-preclinical-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/trump-threatens-200-drug-tariff-as-astrazeneca-leads-50-billion-us-investment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/new-class-of-chiral-molecules-offers-strong-stability-for-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/breaking-news-fda-approves-the-first-treatment-for-moderate-to-severe-chronic-hand-eczema/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novavax-s-h5n1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lantheus-holdings-expands-alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sun-pharma-lupin-dr-reddy-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uk-india-4-8bn-fta-poised-to-benefit-medtech-and-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ai-at-the-fda-help-or-hindrance/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/maia-biotechnology-reports-fda-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gsk-s-12-billion-hengrui-pharma-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-knew-drugmaker-had-poor-record-it-waited-four-years-to-inspect-one-factory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/roche-s-alzheimer-s-therapy-shows-continued-benefit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/metriopharm-gains-orphan-drug-status-from-ema-for-mp1032/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ivonescimab-displays-preclinical-feasibility-in-frontline-ccrcc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mira-pharmaceuticals-reports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/scotiabank-raises-apellis-pharmaceuticals-stock-price-target-on-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/african-countries-plan-shift-to-healthcare-funding-autonomy-amid-aid-cuts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/moderna-sharpens-focus-on-1-5bn-cost-cutting-plan-after-41-revenue-slump/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/supernus-strengthens-neuropsychiatric-portfolio-with-sage-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/high-blood-pressure-alone-can-damage-kidneys-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/how-inflammation-affects-depression-treatment-in-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/two-cancer-drugs-may-reverse-alzheimer-s-symptoms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/How the FDA Response on UX111/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/trump-says-he-will-get-drug-prices-down-by-500-to-1500/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cassava-sciences-reports-positive-preclinical-study-evaluating-simufilam-for-tsc-related-epilepsy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-data-shows-potential-for-bird-flu-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lilly-confirms-plan-to-sell-nj-plant-amid-larger-us-production-ramp-up/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/vertex-pharmaceutical-stock-dives-as-firm-to-stop-developing-acute-pain-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/boosting-enzyme-in-brain-immune-cells-could-help-treat-alzheimer-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/what-to-know-about-legionnaires-disease-which-has-sickened-dozens-in-new-york-city/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-expanded-indication-to-tocilizumab-anoh-iv-for-crs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-accelerated-approval-to-dordaviprone-for-diffuse-midline-glioma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/epkinly-breaks-ground-in-phase-iii-fl-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/boehringer-ingelheim/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/epipen-patent-expiry-opens-new-era-for-innovation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sar446523/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/dyne-therapeutics-dyn-is-up-17-0/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/swiss-leaders-seek-roche-novartis-talks-amid-us-tariffs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-unveils-precheck-programme-to-enhance-us-domestic-pharma-supply-chain/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/newron-notes-the-publication-of-new-preclinical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-links-popular-diabetes-drugs-to-rare-but-serious-infection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fosun-and-expedition-make-645m-licensing-deal-for-respiratory-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/csl-s-venofer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-and-gsk/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sana-biotechnology-drops-washington-plant-build-out-pivots-to-cdmos-instead/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-seeks-more-gpcr-weight-loss-drugs-in-1-3bn-research-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/abbvie-expands-north-chicago-api-production-with-195m-investment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-designation-to-hld-0915-in-prostate-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-vietnam-named-among-asia-s-best-workplaces/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novo-nordisk-s-wegovy-semaglutide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-breakthrough-therapy-to-daraxonrasib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-s-tzield-type-1-diabetes-immunotherapy-wins-uk-first/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/merck-announces-ec-approval-of-ogsiveo-for-desmoid-tumours/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aaic-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-launches-bosentan/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/santen-and-remegen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pharmaceuticals-modeyso/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/back-in-the-u-s-a/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/johnson-johnson/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uk-pharma-drug-price/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/merck-valuation-in-focus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/swedish-startup/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/daiichi-sankyo-and-astrazeneca-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/rusfertide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-483/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/rumour/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lilly-links-up-with-jd-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-mrna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/d3s-001-receives/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/although-saxenda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-s-wayrilz-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/santhera-and-ikris/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/young-immune-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sfda-approves-rapid-biotech-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/clopidogrel/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/capvest/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-subcutaneous-leqembi-for-alzheimer-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/recall-alert/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amgen/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/8th-avg-and-3rd-imrp-2025-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aligos-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gelteq/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/clene-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-breakthrough-therapy-designation-to-olomorasib/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/senhwa-biosciences-cx-5461/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/epigenic/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ionis-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novartis-snaps/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tolerance-bio-and-zipcode-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-continues-focus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/art12-11/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/medison-and-ipsen-s-bylvay/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/capricor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-s-tzield/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/adjunctive-use-approved-cbd/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gtcr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/apple-watch-series-11-receives-fda-approval-for-hypertension-alerts/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/polyrizon/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/artificial-intelligence/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lb-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amneal-secures-fda-approval-for-sodium-oxybate-solution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novartis-returns-to-monte-rosa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biomea-fusion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/corstasis-therapeutics-announces-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gyala-therapeutics-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gsk-plans-30bn-investment-for-r-d-in-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nurix-reports/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biocon-biologics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/modus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/moderna/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/antengene/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/zurzuvae/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-s-pune/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/barth-syndrome/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sanofi-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-buys-monthly-glp-1ra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astellas-izervay/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/hanmi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/autism-symptoms-in-kids/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/igc-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/breakthrough-therapy-designation-to-povetacicept/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/akari-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nrx-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nightmare-bacteria/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/wsu-study-first/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biotech-stocks-facing/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/synaffix-and-qurient/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-lilly-s-inluriyo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pharma-tariffs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pila-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mytesi-seeks-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/climb-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/genmab/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/from-patent-to-patient/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mammoth-biosciences-to-present-preclinical-data-on-mb-111/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mercury-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/intravitreal-injection-of-retinal-progenitor/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/taysha-says/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/takeda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/usfda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/briacell-to-present-bria-ots-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aavantgarde-announces-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/rocket-company/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-announces-new-domestic-generic-drug-fast-track-review-program/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/engineered-il-21-cytokine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/igc-pharma-s-preclinical-data-for-igc-1c/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/spruce-biosciences-receives-u-s-fda-breakthrough-therapy-designation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mcmaster-university-and-mit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-and-daiichi-s-datroway/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fractyl-health/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/china-accounts-for-one-fifth-of-global-drugs-in-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/editas-medicine-reports-90-ldl-c-reduction-in-preclinical-studies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/boehringer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/three-scientists-win-nobel-prize/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/os-therapies-eyes-global-osteosarcoma-vaccine-approvals-after-phase-iib-win/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ireland-s-largest-cancer-research-initiative-launches-second-phase/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/adults-65-years-and-older-not-immune-to-the-opioid-epidemic-new-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-s-new-jersey-facility-passes-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-at-home-lasix-for-heart-failure/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-study-finds-antidepressant-may-boost-smn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tvardi-therapeutics-stock-crashes-on-phase-ii-ipf-flop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-study-identifies-genetic-misfire-in-lupus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-breakthrough-designation-signals-new-therapeutic-avenue-in-r-r-mcl/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/teva-gets-fda-nod-for-uzedy-label-expansion-in-bipolar-i-disorder/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-status-to-enterome-s-eo2463-for-follicular-lymphoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/gene-therapy-protects-kidneys-in-preclinical-model-of-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/kompaniya-60-degrees-pharmaceuticals/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/telomir-pharmaceuticals-reports-new-preclinical-data-on-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-touts-tukysa-in-front-line-breast-cancer-after-phase-iii-victory/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/j-j-s-tecvayli-darzalex/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pelage-pharmaceuticals-alopecia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/clarametyx/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/esmo-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/car-m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/liberate-bio-s-car-m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-glaukos-epioxa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ibio-to-present-new-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/acquisition-strengthens-aspire-pharma-s-strategic-portfolio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-roche-s-gazyva-for-lupus-nephritis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/health-canada/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/nanoviricides/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alkermes-to-acquire-avadel-for-2-1bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/aspire-pharma-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ventus-and-genentech/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cullinan-therapeutics-showcases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tylenol-paracetamol/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/evotec-announces-progress-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/myeloma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/orum-therapeutics-announces-presentation-of-preclinical-data-for-orm-1153/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/praxis-announces/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/femasys-gets-fda-ok-for-final-fembloc-trial-secures-12m-financing-stock-surges/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/kimberly-clark-buys-troubled-tylenol-maker-kenvue-for-48-7bn/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uniqure-staggers-as-fda-questions-data-for-huntington-s-gene-therapy-candidate/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lunai-bioworks/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/celltrion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cencora/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-first-treatment-for-rare-thymidine-kinase-2-deficiency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/spinogenix-s-als-hopeful-to-advance-to-registrational-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/the-world-s-healthiest-countries-aren-t-the-richest-study-finds/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sana-camp4/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-warns-18-websites-for-selling-fake-botox-linked-to-injuries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-s-bioresearch-center-aces-u-s-fda-inspection-with-zero-observations/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-fast-tracks-6-more-drugs-obesity-and-cancer-drugs-included/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/preclinical-study-supports-use-of-psychedelics-for-treating-alcohol-use-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-fast-track-designation-to-drug-combo-for-colorectal-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-commissioner-on-lifting-warnings-on-hormone-therapy-for-menopause/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/verismo-therapeutics-presents/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/granules-india-s-hyderabad-based-facility-gets-first-u-s-fda-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/metagenomi-sheds-25-of-workforce/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-caplyta-for-major-depressive-disorder-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/optimizing-preclinical-data-for-seamless-translation-in-clinical-scenarios/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/astrazeneca-reports-positive-results-from-phase-3-blood-pressure-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/richard-pazdur/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amneal-secures-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/general-proximity-and-daiichi-sankyo-link-on-oncology/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/scientists-uncover-new-drug-target/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alembic-pharma-gets-us-fda/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/msd-bets-big-on-flu-antivirals-with-9-2bn-buyout-of-cidara/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/health-check-genetic-signatures-holds-course/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ai-driven-method/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-confirms-animal-rule/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/medicxi-unveils-500m-fund-for-asset-centric-biotechs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/corrixr-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/blood-based-screening-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alvotech-and-advanz/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/als-oral-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-perioperative-enfortumab-vedotin-plus-pembrolizumab-for-cisplatin-ineligible-mibc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/merck-kgaa/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/navigating-the-fda-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/actio-biosciences-to-present-new-preclinical-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/angelini-rapped-for-criticism-of-ema-approval/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/eli-lilly-flies-the-pharma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/glp-1ra/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-treatment-for-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/where-tomorrow-s-medicines-begin-and-africa-s-health-future-is-forged/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/glenmark-pharmaceuticals-receives-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/valneva-trims-r-d-footprint-by-shutting-french-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-grants-priority-review-to-sonrotoclax/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/bayer-takes-alport-syndrome-drug-into-phase-2/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/curi-bio-10-million-series-b-closed-to-scale-human-relevant-preclinical-platforms/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/modified-herpes-virus-helps-destroy-glioblastoma-in-preclinical-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/parkinson-s-drug-as-basis-for-new-anti-infectives/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uk-and-us-agree-on-landmark-pharma-pricing-tariff-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/akari-therapeutics-highlights/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lunai-bioworks-advances/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biosecure-act/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/amneal-stock-rises/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/pfizer-gains/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/plasma-p-tau217/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/io-therapeutics-inc/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/novartis-and-uk-based-relation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/kymera-therapeutics-announces-u-s-/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/beijing-institute/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/first-gonorrhoea-antibiotics-in-decades-herald-new-era-of-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/lupin-gets-eir-from-us-fda-for-nagpur-based-injectable-facility/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/sumitomo-pharma-presents-encouraging-new-data-on-dsp-5336/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/zelluna-publishes-compelling-preclinical-data-for-zi-ma4-1/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/uk-approves-gsk-s-twice-yearly-asthma-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/promising-target-improves-antitumor-response/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/tsc-alliance-endowment-fund-invests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/how-ai-may-revolutionize-the-pharmaceutical-industry/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ec-approves-incyte-s-minjuvi/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/alnylam-plans-250m/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/als-in-small-group/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/cytokinetics/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/biomarin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/mondego-bio/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/enhertu/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/health-canada-approves-zurzuvae/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/ipsen-simcere-deal-sim0613-adc-oncolog/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/radiopharmaceuticals-preclinical-models-innovation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/fda-approves-mitapivat-for-alpha-and-beta-thalassemia-anemia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2025/phase-ii-success-for-parkinson-s-stem-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/diabetes-drug-prevent-dementia-glp1-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/bioatla-gatc-health-phase-iii-trial-oz-v/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/valneva-ixchiq-chikungunya-vaccine-supply-asia/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approval-mitapivat-thalassemia-pill/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-reforms-pdcd-dca-deregulation-test/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/accelerating-clinical-trials-indonesia-strategic-partnership-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/glioblastoma-breakthrough-tmz-edu-combination-therapy-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/merck-negotiations-acquire-revolution-medicines-oncology-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/procalcitonin-blood-test-sepsis-antibiotic-stewardship-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/vectory-therapeutics-vtx-002-fda-fast-track-als-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/novel-small-molecule-inhibitors-prexasertib-acr2316-endometrial-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/iza-bren-egfr-her3-adc-advanced-cancer-therapy-guide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/octapharma-fibryga-2g-fda-approval-acquired-fibrinogen-deficiency/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/clinical-trials-cornerstone-medical-progress-innovation-guide/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/eli-lilly-acquires-ventyx-biosciences-nlrp3-inflammation-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/nvidia-eli-lilly-1-billion-ai-medical-research-lab-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-urgent-recall-modern-warrior-ready-supplements-illegal-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/synebio-project-syntopia-microfluidic-platform-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-draft-guidance-bayesian-methodology-clinical-trials-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/gene-therapy-for-chronic-pain-targeted-cns-circuits-without-addiction/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-breakthrough-designation-etx101-dravet-syndrome-gene-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/mane-acquires-chemosensoryx-biosciences-flavor-fragrance-innovation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/phase3-clinical-trials-2026-fda-approvals-lyme-hcv-crab-hiv/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/blue-pharmaceuticals-marine-drug-discovery-eribulin-biorefineries/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/gelteq-preclinical-cannabinoid-absorption-oral-gel-platform/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/autobahn-therapeutics-elunetirom-preclinical-data-acnp-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/jj-caplyta-mdd-remission-data-acnp-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/stdp-improves-coronary-blood-flow-in-angina-patients-phase-iv-trial-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/axsome-begins-phase-iii-axs-14-forward-trial-for-fibromyalgia-management/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/vibrant-therapeutics-raises-61m-to-advance-vib305-and-intelligent-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/china-medicine-exports-hit-100b-licensing-deals-soar-to-135b-in-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/nxera-reports-positive-phase-iii-results-for-daridorexant-in-south-korea/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/nucleome-nominates-ntp464-first-antibody-agonist-for-inflammation-resolution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/indian-pharma-exports-surge-brazil-nigeria-emerge-as-key-markets-in-fy26/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-grants-breakthrough-therapy-to-novartis-ianalumab-for-sj-gren-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/bionxt-odf-cladribine-shows-40-higher-delivery-for-multiple-sclerosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/worldwide-clinical-trials-to-acquire-oncology-cro-catalyst-clinical-research/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/sandoz-optimistic-on-golden-decade-for-us-biosimilars-and-affordable-medicines/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/shionogi-expands-viiv-healthcare-stake-to-21-7-as-pfizer-exits/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/olatec-presents-preclinical-evidence-of-dapansutrile-activity-in-parkinson-s/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/corcept-stock-rises-as-relacorilant-meets-os-goal-in-phase-iii-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/bms-signs-850m-deal-with-janux-for-novel-solid-tumour-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/igc-pharma-adds-new-york-site-for-calma-phase-ii-alzheimer-s-disease-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/enzyme-blocking-treatment-reverses-chronic-pain-in-preclinical-study/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/cancer-tumors-may-protect-against-alzheimer-s-by-cleaning-protein-clumps/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/msd-ends-takeover-talks-with-revolution-medicines-over-price/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/aclaris-ati-2138-shows-rapid-hair-regrowth-in-alopecia-areata-model/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/trial-of-myeloma-therapy-kln-1010-gets-fda-green-light-to-expand-to-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/china-clears-huahui-health-s-libevitug-as-first-drug-for-chronic-hepatitis-d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/boehringer-pens-1-05b-deal-for-simcere-s-preclinical-ibd-bispecific-sim0709/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/solvonis-expands-svn-015-into-depression-following-positive-preclinical-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/eli-lilly-outlays-1-12bn-for-hearing-loss-gene-therapy-partnership/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/astrazeneca-pledges-15bn-for-china-r-d-and-manufacturing-expansion/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/biogen-s-autoimmune-candidate-litifilimab-gets-fda-breakthrough-status/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-accepts-otsuka-s-centanafadine-application-for-adhd-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/pharma-m-a-set-to-boom-in-2026-240-billion-deal-value-in-2025/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/corcept-shares-tumble-after-fda-letter-reveals-warnings-before-drug-rejection/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/thousands-of-cholesterol-drug-bottles-recalled-nationwide-over-defects/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/gsk5764227-hs-20093-new-her2-targeted-adc-treatment-for-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-s-new-precheck-scheme-to-boost-us-manufacturing-commences-applications/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/limitations-of-mash-preclinical-studies-challenge-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/relay-thera-s-zovegalisib-wins-fda-breakthrough-status-for-breast-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/umsom-launches-trial-for-inna-051-intranasal-spray-against-respiratory-viruses/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/seqster-expands-partnership-with-praxis-to-accelerate-cns-clinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/triple-kras-inhibition-in-pancreatic-cancer-preclinical-success-vs-clinical-reality/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/international-collaboration-spurs-ai-powered-drug-discovery-tool/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/apotex-and-gr-nenthal-sign-deal-for-nebido-canadian-distribution/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/alteogen-touts-monthly-obesity-drug-matching-retatrutide-in-preclinical-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/neomorph-s-molecular-glue-neo-811-begins-kidney-cancer-clinical-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/u-s-fda-grants-mexiletine-orphan-drug-designation-for-myotonic-disorders/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/senolytics-clear-70-of-zombie-cells-breakthrough-preclinical-study-results/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/nanoviricides-seeks-fda-orphan-drug-status-for-nv-387-measles-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/enanta-to-present-edp-978-preclinical-data-at-2026-aaaai-annual-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/novartis-begins-construction-on-new-global-research-facility-in-san-diego/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/eli-lilly-buys-orna-therapeutics-for-2-4bn-a-bet-on-in-vivo-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-issues-refusal-to-file-letter-for-moderna-s-seasonal-flu-mrna-vaccine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/preclinical-study-car-t-cell-therapy-clears-alzheimer-s-amyloid-plaques/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/devonian-reports-positive-preclinical-data-for-thykamine-in-lung-fibrosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approved-seizure-drug-levetiracetam-may-prevent-alzheimer-s-plaques/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/madrigal-expands-mash-pipeline-with-4-4bn-sirna-deal-with-suzhou-ribo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approves-msd-s-keytruda-combo-for-platinum-resistant-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-grants-orphan-drug-designation-to-hcb101-for-gastric-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ec-approves-amgen-s-uplizna-for-generalized-myasthenia-gravis-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ampersand-capital-acquires-purna-pharmaceuticals-trans-atlantic-cdmo-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/clinical-trials-nitrous-oxide-offers-hope-for-treatment-resistant-depression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/alkem-s-enzene-unit-gets-usfda-form-483-6-observations-no-data-issues/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/cue-biopharma-reports-positive-safety-data-for-autoimmune-drug-cue-401/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ptc-withdraws-translarna-nda-for-duchenne-muscular-dystrophy-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/excellthera-s-zemcelpro-grants-german-nub-status-1-for-stem-cell-transplant/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/clinical-trial-dexamethasone-safe-in-encephalitis-early-use-may-help/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/who-urges-development-of-universal-influenza-vaccines-to-save-millions/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/preclinical-drug-rytvela-blocks-preterm-birth-outperforming-nifedipine/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approves-astrazeneca-s-calquence-plus-venetoclax-for-cll-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/preclinical-vs-clinical-obesity-new-definitions-to-reshape-diagnosis/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/gilead-acquires-car-t-specialist-arcellx-for-7-8b-to-boost-cell-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/start-appoints-dr-frank-smith-as-president-of-xenostart-preclinical-unit/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/preclinical-study-hypoxia-therapy-controls-diabetes-via-red-blood-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/alembic-pharma-secures-us-fda-approval-for-generic-antifungal-topical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/gibson-oncology-starts-phase-2-trial-of-lmp744-for-recurrent-glioblastoma/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-accepts-beren-therapeutics-nda-for-niemann-pick-disease-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/hotspot-therapeutics-to-present-irf5-data-at-15th-european-lupus-meeting/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/agentic-ai-the-human-element-building-trustworthy-clinical-trial-automation/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ema-backs-orphan-drug-status-for-soligenix-s-sgx945-in-beh-et-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/new-promising-drug-pxs-5505-for-invasive-lobular-breast-cancer-tested/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/iqvia-to-acquire-charles-river-drug-discovery-assets-to-expand-r-d-pipeline/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/india-s-single-dose-dengue-vaccine-candidate-advancing-to-phase-3-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/quotient-ipsen-extend-partnership-for-ultra-rare-fop-disease-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-unveils-ultra-rare-therapy-pathway-fast-tracks-new-lung-cancer-drug/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/asahi-kasei-acquires-aicuris-anti-infective-cures-for-920-7-million/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approves-eton-s-desmoda-oral-solution-for-central-diabetes-insipidus/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/engineered-immune-cells-carma-show-promise-against-brain-metastases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/roche-s-phase-iii-trial-of-fenebrutinib-in-rms-meets-primary-endpoint/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/natco-pharma-launches-generic-blood-cancer-drug-pomalidomide-in-the-us/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/novo-nordisk-starts-432m-ireland-facility-upgrade-for-oral-wegovy-pills/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/propanc-s-prp-shows-85-tumor-growth-inhibition-in-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/hotspot-therapeutics-presents-preclinical-data-on-irf5-lupus-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/vericel-wins-fda-approval-for-new-maci-cell-therapy-manufacturing-site/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/phase-2a-trial-data-shows-alnodesertib-slows-ovarian-cancer-progression/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/j-j-secures-fda-approval-for-tecvayli-darzalex-multiple-myeloma-combo/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/affinia-s-aftx-201-gene-therapy-earns-fda-fast-track-for-bag3-heart-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/study-links-gestational-diabetes-prenatal-depression-to-child-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ai-tool-streamlines-drug-synthesis-cutting-lab-work-from-months-to-days/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/vinay-prasad-leaves-fda-again-amidst-leadership-shake-ups-controversies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/amplia-data-narmafotinib-enhances-kras-inhibitors-in-mutated-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/servier-buys-day-one-biopharmaceuticals-for-2-5bn-in-rare-cancer-deal/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ema-proposes-faster-clinical-trial-approvals-during-health-emergencies/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-widens-approval-of-leucovorin-a-drug-previously-hyped-for-autism/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/hoth-therapeutics-data-ht-va-restores-cholesterol-in-female-masld-model/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/iu-researchers-identify-clotting-protein-as-target-in-pancreatic-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/redx-achieves-fda-fast-track-designation-for-crohn-s-disease-drug-rxc008/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/heartworks-advances-new-model-for-preclinical-biomedical-innovation-in-wisconsin/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/iovance-announces-positive-data-for-lifileucel-til-therapy-in-sarcomas/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/mhra-approves-sun-pharma-s-leqselvi-for-severe-alopecia-areata-in-adults/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/ucb-s-bimzelx-bests-skyrizi-in-phase-iii-psa-study-analysts-skeptical/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/parkinson-s-research-reaches-pivotal-stage-new-models-funding-barriers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/new-nanomedicine-gel-by-bits-pilani-for-rheumatoid-arthritis-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/new-liquid-biopsy-tech-cf-epitracing-detects-disease-from-a-blood-drop/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/new-car-nkt-immunotherapy-destroys-endometrial-cancer-in-preclinical-tests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-grants-fast-track-to-argo-biopharma-s-bw-20805-sirna-therapy-for-hae/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/astrazeneca-s-imfinzi-gets-eu-approval-for-early-gastric-gej-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/engineered-probiotic-bacteria-successfully-attack-tumors-in-mouse-models/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/hoth-therapeutics-applies-ai-in-development-of-ht-kit-for-rare-cancers/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/nia-therapeutics-wins-fda-breakthrough-nod-for-memory-loss-neuromod-system/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-issues-crl-to-aldeyra-s-reproxalap-application-for-dry-eye-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/arvinas-reports-strong-phase-1-results-for-arv-102-in-parkinson-s-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/roche-halts-phase-iii-plans-for-emugrobart-in-muscle-wasting-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/shionogi-enrols-first-patients-in-esprit-trial-for-pompe-disease-therapy/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/caliway-to-present-preclinical-data-on-cbl-514-with-glp-1r-at-eco-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/omega-therapeutics-stock-jumps-on-positive-op-101-preclinical-cancer-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/j-j-wins-fda-approval-for-icotyde-to-enter-plaque-psoriasis-pill-market/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/mira-s-mira-55-shows-no-thc-like-cns-side-effects-in-preclinical-trials/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/immunitybio-wins-macau-approval-for-anktiva-combo-therapy-in-bladder-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/maia-biotech-advances-ateganosine-with-fast-track-and-phase-3-nsclc-trial/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/earendil-labs-lands-787m-to-accelerate-ai-biologics-development-push/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-grants-sanofi-s-venglustat-breakthrough-therapy-for-gaucher-type-3/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/biolojic-design-reaches-teva-milestone-for-ai-designed-multibody-tev-325/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approves-denali-s-avlayah-drug-for-hunter-syndrome-rare-disease-win/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/forx-therapeutics-unveils-forx-428-preclinical-data-at-acs-spring-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/alzheimer-s-disease-may-be-an-autoimmune-condition-new-theory-suggests/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/cdr-life-s-experimental-ms-therapy-cdr111-meets-preclinical-milestone/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/assessing-ipsen-valuation-after-new-preclinical-oncology-data-at-aacr/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/fda-approves-novo-nordisk-s-awiqli-first-once-weekly-insulin-for-t2d/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/wave-life-sciences-stock-plummets-50-on-weak-phase-i-obesity-trial-data/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/simulations-plus-and-pharma-partners-advance-ai-driven-drug-development/ monthly 0.5 https://www.chemdiv.com/company/media/pharma-news/2026/recordati-considers-10-9b-cvc-capital-acquisition-offer-before-q1-close/ monthly 0.5 https://www.chemdiv.com/company/media/news/2013/09-30-2013-chemdiv-launches-macrolead-tm-platform/ monthly 0.5 https://www.chemdiv.com/company/media/news/2013/10-08-2013-viriom-reports-clinical-efficacy-data-for-vm1500-a-new-hiv-nnrti/ monthly 0.5 https://www.chemdiv.com/company/media/news/2014/read-chemistry-cures-newsletter-14-2-june-2014/ monthly 0.5 https://www.chemdiv.com/company/media/news/2015/iressa-gefitinib-approved-u-s-food-drug-administration-first-line-treatment-advanced-egfr-mutation-positive-non-small-cell-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/news/2015/2015-chinese-medicinal-chemistry-symposiumcmcs2015-5th-cpa-rsc-symposium-medicinal-chemistry-august/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/chemdiv-announces-achievement-development-milestone-drug-discovery-collaboration-janssen/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/chemdiv-abbott-expand-collaboration-develop-branded-generic-pharmaceuticals-high-growth-emerging-markets/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/viriom-announces-receipt-funding-skolkovo-foundation-chemrar-torrey-pines-investment-develop-elpida-novel-preventive-long-acting-treatment-hivaids-3/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/satrx-llc-announces-first-registration-russia-satrx-gosogliptin-innovative-drug-treatment-type-2-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/subsidiary-rostec-corporation-htc-chemrar-launch-joint-venture-development-manufacturing-next-generation-antivirals-russia-eurasian-economic-union/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/chemdiv-insilico-medicine-form-strategic-alliance-develop-oncology-focused-libraries-using-artificial-intelligence/ monthly 0.5 https://www.chemdiv.com/company/media/news/2016/chemdiv-torrey-pines-investment-dzne-announce-research-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/viriom-announces-collaboration-nih-zika-major-viral-diseases/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/newvac-reports-primary-endpoint-met-phase-ii-clinical-trial-quisinostat-combination-paclitaxel-carboplatin-platinum-resistant-ovarian-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-announces-key-milestones-abbott-pharma-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-reaches-milestone-viriom-collaboration/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/regen-biopharma-begins-optimization-nr2f6-small-molecule-modulators/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-selected-arcus-biosciences-sole-chemistry-provider-discovery-screening-collection/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-announces-multi-year-hit-identification-collaboration-janssen-2/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-successfully-achieves-milestone-discovery-chemistry-collaboration-uc-davis-professor-gino-cortopassi/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdivs-executive-director-delivers-two-lectures-drug-discovery-china-2/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-help-afraxis-advance-synaptic-profiling-platform-cns-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/nature-communications-publishes-study-identified-small-molecule-imposes-metabolic-stress-cellular-death-malignant-cells/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdivs-discovery-chemistry-platform-help-advance-tri-institutional-therapeutics-discovery-institute-programs/ monthly 0.5 https://www.chemdiv.com/company/media/news/2017/chemdiv-context-therapeutics-torrey-pines-investment-announce-cns-co-development-agreement/ monthly 0.5 https://www.chemdiv.com/company/media/news/2018/chemdiv-dzne-torrey-pines-investment-launch-inflammasome-discovery-program-translational-collaboration-neurodegeneration-2/ monthly 0.5 https://www.chemdiv.com/company/media/news/2018/chemdiv-announces-expansion-multi-year-hit-identification-collaboration-janssen/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/snap-bio-i2020-accelerator-torrey-pines-investment-reach-lead-compounds-milestone-pediatric-oncology-advanced-liver-cancer-programs/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/macrocyclic-peptidomimetics-library-design-synthesis-2/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/chemdiv-posters-efmc-asmc19-macrocyclic-peptidomimetics-library-covalent-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/first-principle-concept-designing-small-molecules-targeting-rna-expansion-repeats/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/ai-gets-access-to-big-novel-chemistry-space-for-quick-and-effective-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/insilico-medicine-and-chemdiv-form-a-strategic-drug-discovery-service-alliance/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/i2020-accelerator-invests-in-developing-novel-highly-specific-approaches-to-treatment-of-neurodegenerative-diseases-based-on-previously-unrecognized-protein-protein-interactions/ monthly 0.5 https://www.chemdiv.com/company/media/news/2019/new-article-a-selective-ligand-for-estrogen-receptor-proteins-discriminates-rapid-and-genomic-signaling/ monthly 0.5 https://www.chemdiv.com/company/media/news/2020/viriom-inc-announced-the-initiation-of-a-phase-2-clinical-study-to-evaluate-the-efficacy-of-elsulfavirine-in-adults-with-moderate-manifestations-of-covid-19-novel-coronavirus/ monthly 0.5 https://www.chemdiv.com/company/media/news/2020/store-chemdiv-com/ monthly 0.5 https://www.chemdiv.com/company/media/news/2020/chemdiv-created-unique-kato-tm-platform-for-development-of-innovative-drugs-against-coronavirus-infection/ monthly 0.5 https://www.chemdiv.com/company/media/news/2021/chemdiv-is-now-a-discovery-partner-with-gwynant-therapeutics-and-celyn-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/news/2021/visit-our-virtual-booth-at-the-european-chemical-biology-symposium/ monthly 0.5 https://www.chemdiv.com/company/media/news/2021/chemdiv-at-the-international-symposium-on-medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media/news/2021/we-made-a-chemistry-game-for-you-have-fun-and-enjoy-it/ monthly 0.5 https://www.chemdiv.com/company/media/news/2022/chemdiv-inc-statement-on-impact-of-russia-military-actions-in-ukraine/ monthly 0.5 https://www.chemdiv.com/company/media/news/2022/chemdiv-and-jacobs-university-announce-strategic-partnership-in-drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/news/2022/happy-holidays-2023/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/join-chemdiv-inc-at-chi-drug-discovery-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/join-chemdiv-inc-at-the-international-helmholtz-drug-discovery-conference-hddc/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/chemdiv-shares-an-update-on-its-cutting-edge-biology-facility-in-portugal/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/meet-chemdiv-inc-at-the-discovery-on-target-2023/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/novel-compounds-with-antiviral-activity-from-chemdiv-collection/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/chemdiv-presented-non-clinical-summary-data/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/presented-non-clinical-summary-data-for-the-best-in-class-selective-bcl2-/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/happy-holidays-from-chemdiv-inc/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/bill-farley-named-new-ceo-of-chemdiv-/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/chemdiv-helps-advance-viriom-s-influenza-treatment-to-successful-phase/ monthly 0.5 https://www.chemdiv.com/company/media/news/2023/chemdiv-forges-strategic-partnership-with-the-university-of-texas-medical-branch-utmb/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/chemdiv-marks-a-milestone/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/meet-chemdiv-at-the-42nd-annual-jpm-healthcare-conference-in-san-francisco/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/meet-chemdiv-at-drug-discovery-chemistry-in-san-diego-april-1-4/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/the-drug-discovery-chemistry-conference-in-san-diego/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/aacr-2024/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/team-chemdiv-inc-at-aacr-2024-san-diego/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/chemdiv-to-participate-in-the-ef-hutton-annual-global-conference/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/chemdiv-inc-is-coming-to-bio2024-/ monthly 0.5 https://www.chemdiv.com/company/media/news/2024/bio2024/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/slas-2025/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/msd-wins-fda/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/bia-report/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/amgen-opens-new-drug-substance/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/gossamer-bio/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/chemdiv-partnership-with-mondego-bio/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/chemdiv-continues-r-d-services-support-for-clywedog-therapeutics/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/egfr-kinase-inhibitors-for-gfr-mutant-lung-cancer/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/chemdiv-extends-cmc-services/ monthly 0.5 https://www.chemdiv.com/company/media/news/2025/happy-holidays-from-chemdiv-inc-2026/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/from-treating-diabetes-to-preventing-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/innovative-treatments-for-sickle-cell-disease/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/gaba-antagonists-convulsants-and-antidotes/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/molecule-that-is-capable-to-cure-obesity/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/protein-kinases/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/a-molecule-that-can-cure-type-1-diabetes/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/scientists-launched-regeneration-after-a-heart-attack-and-healed-the-heart/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/epigenetics/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/scientists-have-created-bacteria-that-feed-cancer-fighting-immune-cells/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/central-nervous-system-drugs/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/how-to-stop-cancer-attack-on-the-microtubules/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/microneedle-patches-new-drug-carriers-improve-cancer-treatment/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/the-human-brain-has-learned-to-save-energy-on-signal-transmission/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/how-to-save-the-lives-of-people-with-cancer-who-are-not-cured/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/targeted-libraries/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/gpcr-libraries/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/compounds-DMSO/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/focused-library/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2022/risk-benefit-profiles-of-currently-approved-oral-antivirals-for-treatment-of-covid-19-similarities-a/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/combinatorial-libraries/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/Allosteric-inhibitors/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/adme/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/drug-discovery/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/opportunistic-pathogens/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/aurora-kinases/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/gpcr/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/dmso/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/annotated-libraries/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/medicinal-chemistry/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/screening-compounds/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/chemical-compounds/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/chemical-database/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2021/for-supplier-chemical-vendors/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2023/novel-inhibitors-of-ovarian-cancer-from-chemdiv-collection/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2023/novel-potent-tim-3-inhibitors-were-discovered-in-chemdiv-s-collection-/ monthly 0.5 https://www.chemdiv.com/company/media/pop-science/2026/rna-inhibitors-small-molecules-targeting-rna-chemdiv-libraries/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-june-2021-part-i/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-june-2021-part-ii/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-july-2021-part-i/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-july-2021-part-ii/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-august-2021-part-i/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-august-2021-part-ii/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-october-2021-part-i/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-october-2021-part-ii/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2021/science-nature-reviews-december-2021/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2022/science-nature-reviews-january-2021-part-i/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2022/science-nature-reviews-january-2021-part-ii/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2022/science-nature-reviews-february-2022-part-i/ monthly 0.5 https://www.chemdiv.com/company/media/science-nature-digest/2022/science-nature-reviews-february-2022-part-ii/ monthly 0.5 https://www.chemdiv.com/company/media/chemdiv-in-publications/2021/chemdiv-company-in-publications-and-patents/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/a-helix-3-d-mimetics-library/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/macrocyclic-peptidomestics-library-design-and-synthesis/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/cusersbelianina-tndocudesign-of-three-dimensional-core-building-blocks-adapted-for-decl-synthesis/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/first-principle-concept-in-designing-small-molecules-for-targeting-rna-expansion-repeats/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/unexplored-chemical-space-medium-and-large-sized-alanine-based-lactams/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/synthesis-and-cytotoxic-properties-of-novel-derivatives-of-noscapine/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/design-of-sp-enriched-helix-mimetics-library/ monthly 0.5 https://www.chemdiv.com/company/media/posters/2021/beyond-binary-scaled-molecular-fingerprints-for-maximum-diversity-picking/ monthly 0.5